0001174947-23-000239.txt : 20230222 0001174947-23-000239.hdr.sgml : 20230222 20230222170623 ACCESSION NUMBER: 0001174947-23-000239 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 102 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230222 DATE AS OF CHANGE: 20230222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: STURM RUGER & CO INC CENTRAL INDEX KEY: 0000095029 STANDARD INDUSTRIAL CLASSIFICATION: ORDNANCE & ACCESSORIES, (NO VEHICLES/GUIDED MISSILES) [3480] IRS NUMBER: 060633559 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-10435 FILM NUMBER: 23654438 BUSINESS ADDRESS: STREET 1: 1 LACEY PLACE CITY: SOUTHPORT STATE: CT ZIP: 06490 BUSINESS PHONE: 2032597843 MAIL ADDRESS: STREET 2: 1 LACEY PLACE CITY: SOUTHPORT STATE: CT ZIP: 06490 10-K 1 rgr-20221231.htm 10-K

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-K

 

FOR ANNUAL AND TRANSITION REPORTS

PURSUANT TO SECTION 13 OR 15(d) THE SECURITIES EXCHANGE ACT OF 1934

(Mark One)

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2022

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________ to ___________

 

Commission File Number 0-4776

 

STURM, RUGER & COMPANY, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware 06-0633559

(State or Other Jurisdiction of

Incorporation or Organization)

(I.R.S. Employer

Identification No.)

 

1 Lacey Place, Southport, Connecticut 06890
(Address of Principal Executive Offices) (Zip Code)

 

(203) 259-7843

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered
Common Stock, $1 par value RGR New York Stock Exchange

 

Securities registered pursuant to Section 12(g) of the Act:

None

(Title of Class)

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. YES ☒ NO ☐

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. YES ☐ NO

Indicate by check mark whether registrant (1) has filed all reports required to be filed by Section 13 or Section 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or shorter such period of time that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES ☒ NO ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). YES ☒ NO ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of “accelerated filer,” “large accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES ☐ NO

The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of June 30, 2022:

Common Stock, $1 par value - $1,112,555,000

The number of shares outstanding of the registrant's common stock as of February 15, 2023: Common Stock, $1 par value –17,596,600 shares

DOCUMENTS INCORPORATED BY REFERENCE.

Portions of the registrant’s Proxy Statement relating to the 2023 Annual Meeting of Stockholders to be held June 1, 2023 are incorporated by reference into Part III (Items 10 through 14) of this Report.

1 

 

TABLE OF CONTENTS

 

PART I
     
Item 1. Business  4
     
Item 1A. Risk Factors 11
     
Item 1B. Unresolved Staff Comments 15
     
Item 2. Properties 16
     
Item 3. Legal Proceedings 17
     
Item 4. Mine Safety Disclosures 17
     
PART II
     
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 18
     
Item 6. [Reserved] 20
     
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations 21
     
Item 7A. Quantitative and Qualitative Disclosures About Market Risk 43
     
Item 8. Financial Statements and Supplementary Data 44
     
Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure 77
     
Item 9A. Controls and Procedures 77
     
Item 9B. Other Information 78
     
Item 9C. Disclosure Regarding Foreign Jurisdictions That Prevent Inspections 78
     
PART III
     
Item 10. Directors, Executive Officers and Corporate Governance 78
     
Item 11. Executive Compensation 78
     
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 79
     
Item 13. Certain Relationships and Related Transactions and Director Independence 79
     
Item 14. Principal Accountant Fees and Services 80
     

2 

 

 

PART IV
     
Item 15. Exhibits and Financial Statement Schedules 81
     
Signatures   84
Exhibit Index   85
Financial Statement Schedule   87
Exhibits   89
       

 

 

 

 

EXPLANATORY NOTE:

 

 

 

In this Annual Report on Form 10-K, Sturm, Ruger & Company, Inc. and Subsidiary (the “Company”) makes forward-looking statements and projections concerning future expectations. Such statements are based on current expectations and are subject to certain qualifying risks and uncertainties, such as market demand, sales levels of firearms, anticipated castings sales and earnings, the need for external financing for operations or capital expenditures, the results of pending litigation against the Company, the impact of future firearms control and environmental legislation, and accounting estimates, any one or more of which could cause actual results to differ materially from those projected. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “will,” “should,” “could” and other words and terms of similar meaning, typically identify such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company undertakes no obligation to publish revised forward-looking statements to reflect events or circumstances after the date such forward-looking statements are made or to reflect the occurrence of subsequent unanticipated events.

3 

 

PART I

 

ITEM 1—BUSINESS

 

Company Overview

Sturm, Ruger & Company, Inc. and Subsidiary (the “Company”) is principally engaged in the design, manufacture, and sale of firearms to domestic customers. Virtually all of the Company’s sales for the year ended December 31, 2022 were from the firearms segment, with less than 1% from the castings segment. Export sales represent approximately 6% of firearms sales. The Company’s design and manufacturing operations are located in the United States and almost all product content is domestic.

 

The Company has been in business since 1949 and was incorporated in its present form under the laws of Delaware in 1969. The Company primarily offers products in three industry product categories – rifles, pistols, and revolvers. The Company’s firearms are sold through independent wholesale distributors, principally to the commercial sporting market.

 

The Company manufactures and sells investment castings made from steel alloys and metal injection molding (“MIM”) parts for internal use in the firearms segment and has minimal sales to outside customers. The castings and MIM parts are sold to outside customers, either directly or through manufacturers’ representatives.

 

On November 23, 2020, the Company acquired substantially all of the Marlin Firearms assets. The agreement to purchase these assets emanated from the Remington Outdoor Company, Inc. bankruptcy and was approved by the United States Bankruptcy Court for the Northern District of Alabama on September 30, 2020. The purchase price of approximately $28.3 million was paid with available cash on hand. Shipments of Ruger-made, Marlin lever action rifles commenced late in the fourth quarter of 2021.

 

For the years ended December 31, 2022, 2021, and 2020, net sales attributable to the Company's firearms operations were $593.3 million, $728.1 million and $565.9 million. The balance of the Company's net sales for the aforementioned periods was attributable to its castings operations.

 

Firearms Products

The Company presently manufactures firearm products, under the “Ruger” name and trademark, in the following industry categories:

 

Rifles   Revolvers
Single-shot   Single-action
Autoloading   Double-action
Bolt-action      
Modern sporting      
         
Pistols      
Rimfire autoloading      
Centerfire autoloading      

4 

In addition, the Company manufactures lever-action rifles under the “Marlin” name and trademark.

 

Most firearms are available in several models based upon caliber, finish, barrel length, and other features.

 

Rifles

A rifle is a long gun with spiral grooves cut into the interior of the barrel to give the bullet a stabilizing spin after it leaves the barrel. Net sales of rifles by the Company accounted for $305.4 million, $317.5 million, and $234.3 million of total net sales for the years 2022, 2021, and 2020, respectively.

 

Pistols

A pistol is a handgun in which the ammunition chamber is an integral part of the barrel and which typically is fed ammunition from a magazine contained in the grip. Net sales of pistols by the Company accounted for $184.7 million, $278.4 million, and $198.1 million of revenues for the years 2022, 2021, and 2020, respectively.

 

Revolvers

A revolver is a handgun that has a cylinder that holds the ammunition in a series of chambers which are successively aligned with the barrel of the gun during each firing cycle. There are two general types of revolvers, single-action and double-action. To fire a single-action revolver, the hammer is pulled back to cock the gun and align the cylinder before the trigger is pulled. To fire a double-action revolver, a single trigger pull advances the cylinder and cocks and releases the hammer. Net sales of revolvers by the Company accounted for $70.0 million, $84.4 million, and $79.1 million of revenues for the years 2022, 2021, and 2020, respectively.

 

Accessories

The Company also manufactures and sells accessories and replacement parts for its firearms. These sales accounted for $33.2 million, $47.8 million, and $54.1 million of total net sales for the years 2022, 2021, and 2020, respectively.

 

Castings Products

 

Net sales attributable to the Company’s casting operations (excluding intercompany transactions) accounted for $2.6 million, $2.6 million, and $3.0 million, for 2022, 2021, and 2020, respectively. These sales represented less than 1% of total net sales in each of 2022, 2021, and 2020.

 

Manufacturing

 

Firearms

The Company produces produces one model of pistol, all of its revolvers and some of its rifles at the Newport, New Hampshire facility. One model of revolver and most of the Company’s pistols are produced at the Prescott, Arizona facility. Some rifle models and pistol models are produced at the Mayodan, North Carolina facility.

 

Many of the basic metal component parts of the firearms manufactured by the Company are produced by the Company's castings segment through processes known as precision investment

5 

casting. The Company also uses many MIM parts in its firearms. See "Manufacturing- Investment Castings and Metal Injected Moldings" below for a description of these processes. The Company believes that investment castings and MIM parts provide greater design flexibility and result in component parts which are generally close to their ultimate shape and, therefore, require less machining than processes requiring machining a solid billet of metal to obtain a part. Through the use of investment castings and MIM parts, the Company endeavors to produce durable and less costly component parts for its firearms.

 

All assembly, inspection, and testing of firearms manufactured by the Company are performed at the Company's manufacturing facilities. Every firearm, including every chamber of every revolver manufactured by the Company, is test-fired prior to shipment.

 

Investment Castings and Metal Injection Moldings

To produce a product by the investment casting method, a wax model of the part is created and coated (“invested”) with several layers of ceramic material. The shell is then heated to melt the interior wax, which is poured off, leaving a hollow mold. To cast the desired part, molten metal is poured into the mold and allowed to cool and solidify. The mold is then broken off to reveal a near net shape cast metal part.

 

Metal injection molding is a three part powder metallurgy process by which a feedstock consisting of finely powdered metal and binders is processed through injection molding, debinding, and sintering equipment to produce steel, stainless steel, and alloy parts of complex shape and geometry.  This process allows for high volume production while eliminating many of the wastes of traditional metal working methods, yielding net shape and near net shape parts.

 

Marketing and Distribution

 

Firearms

The Company's firearms are primarily marketed through a network of federally licensed, independent wholesale distributors who purchase the products directly from the Company. They resell to federally licensed, independent retail firearms dealers who in turn resell to legally authorized end users. All retail purchasers are subject to a point-of-sale background check by law enforcement. These end users include sportsmen, hunters, people interested in self-defense, law enforcement and other governmental organizations, and gun collectors. Each domestic distributor carries the entire line of firearms manufactured by the Company for the commercial market. Currently, 15 distributors service the domestic commercial market, with an additional 25 distributors servicing the domestic law enforcement market and 45 distributors servicing the export market.

 

In 2022, the Company’s largest customers and the percent of firearms sales they represented were as follows: Lipsey’s - 23%; Davidson’s - 23%; and Sports South - 21%.

 

In 2021, the Company’s largest customers and the percent of firearms sales they represented were as follows: Lipsey’s - 21%; Sports South - 19%; and Davidson’s - 19%.

6 

In 2020, the Company’s largest customers and the percent of firearms sales they represented were as follows: Sports South - 22%; Lipsey’s - 22%; and Davidson’s - 18%.

 

The Company employs 15 employees who service these distributors and call on retailers and law enforcement agencies. Because the ultimate demand for the Company's firearms comes from end users rather than from the independent wholesale distributors, the Company believes that the loss of any distributor would not have a material, long-term adverse effect on the Company, but may have a material adverse effect on the Company’s financial results for a particular period. The Company considers its relationships with its distributors to be satisfactory.

 

The Company also exports its firearms through a network of selected commercial distributors and directly to certain foreign customers, consisting primarily of law enforcement agencies and foreign governments. Foreign sales were 6% of the Company’s consolidated net sales for the year ended December 31, 2022, and no more than 5% of the Company's consolidated net sales for each of the years ended December 31, 2021 and 2020.

 

The Company does not consider its overall firearms business to be predictably seasonal; however, orders of many models of firearms from the distributors tend to be stronger in the first quarter of the year and weaker in the third quarter of the year.

 

Investment Castings and Metal Injection Moldings

The castings segment provides castings and MIM parts for the Company’s firearms segment. In addition, the castings segment produces some products for a number of customers in a variety of industries.

 

Competition

 

Firearms

Competition in the firearms industry is intense and comes from both foreign and domestic manufacturers. While some of these competitors concentrate on a single industry product category such as rifles or pistols, several competitors manufacture products in all four industry categories (rifles, shotguns, pistols, and revolvers). The principal methods of competition in the industry are product innovation, quality, availability, brand, and price. The Company believes that it can compete effectively with all of its present competitors.

 

Investment Castings and Metal Injection Moldings

There are a large number of investment castings and MIM manufacturers, both domestic and foreign, with which the Company competes. Competition varies based on the type of investment castings products and the end use of the product. Companies offering alternative methods of manufacturing such as wire electric discharge machining (EDM) and advancements in computer numeric controlled (CNC) machining also compete with the Company’s castings segment. Many of these competitors are larger corporations than the Company with substantially greater financial resources than the Company, which could affect the Company’s ability to compete with these competitors. The principal methods of competition in the industry are quality, price, and production lead time.

7 

Human Capital

 

The Company is an equal opportunity employer dedicated to the attraction, development, and retention of our employees by providing a preferred work environment that promotes and celebrates our core values of Integrity, Respect, Innovation and Teamwork. Our goal is to develop, motivate, retain and reward passionate and dedicated employees.

 

As of February 1, 2023, the Company employed approximately 1,880 full-time employees, approximately 28% of whom had at least ten years of service with the Company.

 

The Company attracts candidates and retains employees by offering competitive compensation packages, which include:

 

Base wages,
Profit sharing,
Medical and welfare benefits,
Holidays and other “paid time off” (PTO), and
401(k) plan participation and matching program.

 

The Company believes its compensation packages:

 

Provide a base level of compensation to reflect an individual’s role and responsibilities,
Recognize and reward employees for the Company’s success, and
Provide for the safety, security and well-being of employees.

 

Our primary vehicle for human capital development is Ruger University, which has a mission to:

 

Enhance the understanding of our industry, Company and culture,
Strengthen the technical, interpersonal and leadership skills of each employee, and
Allow employees to positively change their own lives while creating value for all Ruger stakeholders.

 

In addition to providing a competitive compensation package and emphasizing the development of employees, the Company retains its employees by maintaining a safe, responsible, and preferred workplace. The Company is committed to conducting business in conformance with the highest ethical standards and in compliance with all applicable legal and regulatory requirements. The “Code of Business Conduct and Ethics” and the “Corporate Compliance Program” are two active programs that guide the Company’s practices to achieve these goals.

 

In addition, since the beginning of the global outbreak of the Coronavirus disease 2019 (“COVID-19”) in March 2020, the Company continues to take multiple proactive steps to promote the health and safety of its employees and maintain a clean, safe, and preferred workplace.

 

To assess and improve employee retention and engagement, the Company surveys employees on an annual basis with the assistance of a third-party consultant, and takes actions to address areas of employee concern and build on the competencies that are important for our future success.

8 

Research and Development

 

In 2022, 2021, and 2020, the Company spent approximately $9.6 million, $11.7 million, and $8.0 million, respectively, on research and development activities relating to new products and the improvement of existing products. Research and development expenses are included in costs of products sold. As of February 1, 2023, the Company had approximately 57 employees whose primary responsibilities were research and development activities.

 

Patents and Trademarks

 

The Company owns various United States and foreign patents and trademarks which have been secured over a period of years and which expire at various times. It is the policy of the Company to apply for patents and trademarks whenever new products or processes deemed commercially valuable are developed or marketed by the Company. The Company deems its patents and trademarks to be valuable and therefore works to police and protect them.

 

Environmental Matters

 

The Company is committed to achieving high standards of environmental quality and product safety, and strives to provide a safe and healthy workplace for its employees and others in the communities in which it operates. The Company has programs in place that monitor compliance with various environmental regulations. However, in the normal course of its manufacturing operations the Company is subject to governmental proceedings and orders pertaining to waste disposal, air emissions, and water discharges into the environment. These regulations are integrated into the Company’s manufacturing, assembly, and testing processes. The Company believes that it is generally in compliance with applicable environmental regulations and that the outcome of any environmental proceedings and orders will not have a material adverse effect on the financial position of the Company, but could have a material adverse effect on the financial results for a particular period.

 

9 

Information about our Executive Officers

 

Set forth below are the names, ages, and positions of the executive officers of the Company. Officers serve at the discretion of the Board of Directors of the Company.

 

Name Age Position With Company
     
Christopher J. Killoy 64 President and Chief Executive Officer
     
Thomas A. Dineen 54 Senior Vice President, Treasurer, and Chief Financial Officer
     
Thomas P. Sullivan 62 Senior Vice President of Operations
     
Kevin B. Reid, Sr. 62 Vice President, General Counsel, and Corporate Secretary
     
Shawn C. Leska 51 Vice President, Sales

 

Christopher J. Killoy became President & Chief Executive Officer on May 9, 2017. Previously he served as President and Chief Operating Officer since January 1, 2014. Prior to that he served as Vice President of Sales and Marketing since November 27, 2006. Mr. Killoy originally joined the Company in 2003 as Executive Director of Sales and Marketing, and subsequently served as Vice President of Sales and Marketing from November 1, 2004 to January 25, 2005.

 

Thomas A. Dineen became Senior Vice President on July 10, 2017. Previously he served as Vice President since May 24, 2006. Prior to that he served as Treasurer and Chief Financial Officer since May 6, 2003 and had been Assistant Controller since 2001. Mr. Dineen joined the Company as Manager, Corporate Accounting in 1997.

 

Thomas P. Sullivan became Senior Vice President of Operations on July 1, 2017. Mr. Sullivan joined the Company as Vice President of Newport Operations for the Newport, New Hampshire Firearms and Pine Tree Castings divisions on August 14, 2006.

 

Kevin B. Reid, Sr. became Vice President and General Counsel on April 23, 2008. Previously he served as the Company’s Director of Marketing from June 4, 2007. Mr. Reid joined the Company in July 2001 as an Assistant General Counsel.

 

Shawn C. Leska became Vice President, Sales on November 6, 2015. Mr. Leska joined the Company in 1989 and has served in a variety of positions in the sales department. Most recently, Mr. Leska served as Director of Sales since 2011.

 

Where You Can Find More Information

 

The Company is subject to the informational requirements of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and accordingly, files its Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Definitive Proxy Statements, Current Reports on Form 8-K, and other information with the Securities and Exchange Commission (the “SEC”). As an electronic filer, the Company's public filings are maintained on the SEC's Internet site that contains reports,

10 

proxy and information statements, and other information regarding issuers that file electronically with the SEC. The address of that website is http://www.sec.gov.

 

The Company makes its Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Definitive Proxy Statements, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act accessible free of charge through the Company's Internet site after the Company has electronically filed such material with, or furnished it to, the SEC. The address of that website is http://www.ruger.com. However, such reports may not be accessible through the Company's website as promptly as they are accessible on the SEC’s website.

 

Additionally, the Company’s corporate governance materials, including its Corporate Governance Guidelines, the charters of the Audit, Compensation, Nominating and Corporate Governance, Risk Oversight and Capital Policy committees, and the Code of Business Conduct and Ethics may also be found under the “Investor Relations” subsection of the “Corporate” section of the Company’s Internet site at http://www.ruger.com/corporate. A copy of the foregoing corporate governance materials is available upon written request to the Corporate Secretary at Sturm, Ruger & Company, Inc., 1 Lacey Place, Southport, Connecticut 06890.

 

ITEM 1A—RISK FACTORS

 

The Company’s operations could be affected by various risks, many of which are beyond its control. Based on current information, the Company believes that the following identifies the most significant risk factors that could adversely affect its business. Past financial performance may not be a reliable indicator of future performance and historical trends should not be used to anticipate results or trends in future periods.

 

In evaluating the Company’s business, the following risk factors, as well as other information in this report, should be carefully considered.

 

Changes in government policies and firearms legislation could adversely affect the Company’s financial results.

The sale, purchase, ownership, and use of firearms are subject to thousands of federal, state and local governmental regulations. The basic federal laws are the National Firearms Act, the Federal Firearms Act, and the Gun Control Act of 1968. Federal law generally prohibits the private ownership of fully automatic weapons manufactured after 1986 and places certain restrictions on the interstate sale of firearms unless certain licenses are obtained. The Company does not manufacture fully automatic weapons and holds all necessary licenses under these federal laws. If the scope of the National Firearms Act is expanded to regulate firearms currently regulated by the Gun Control Act, it could make acquisition of commonly owned and used firearms more expensive and complicated for consumers, which could have a material adverse impact on demand for Company products. Several states currently have laws in effect similar to the aforementioned legislation.

 

In 2005, Congress enacted the Protection of Lawful Commerce in Arms Act (“PLCAA”). The PLCAA was enacted to address abuses by cities and agenda-driven individuals who wrongly

11 

sought to make firearms manufacturers liable for legally manufactured and lawfully sold products if those products were later used in criminal acts. The Company believes the PLCAA merely codifies common sense and long standing tort principles. If the PLCAA is repealed or efforts to circumvent it are successful and lawsuits similar to those filed by cities and agenda-driven individuals in the late 1990s and early 2000s are allowed to proceed, it could have a material adverse impact on the Company.

 

Currently, federal and several states’ legislatures are considering additional legislation relating to the regulation of firearms. These proposed bills are numerous and extremely varied, but many seek either to restrict or ban the sale and, in some cases, the ownership of various types of firearms. Other legislation seeks to require new technologies, such as microstamping and so-called “smart gun” technology, which are not proven, reliable or feasible. Such legislation became effective in California in 2013, which has limited our ability to sell certain products in California. If similar legislation is enacted in other states, or at the Federal level, it could effectively ban or severely limit the sale of affected firearms. There also are legislative proposals to limit magazine capacity.

 

The Company believes that the lawful private ownership of firearms is guaranteed by the Second Amendment to the United States Constitution and that the widespread private ownership of firearms in the United States will continue. However, there can be no assurance that the regulation of firearms will not become more restrictive in the future and that any such restriction would not have a material adverse effect on the business of the Company. Numerous bills regulating the ownership of firearms have been proposed at the state and federal levels, and these bills propose a wide variety of restrictions including, for example, limiting the number of firearms that may be purchased in a specified time, increasing the age for ownership, imposing additional licensing or registration requirements, creating additional restrictions on certain, common firearm features, and levying new taxes on firearms and/or ammunition.

 

The Company’s results of operations could be further adversely affected if legislation with diverse requirements is enacted.

With literally thousands of laws being proposed at the federal, state and local levels, if even a small percentage of these laws are enacted and they are incongruent, the Company could find it difficult, expensive or even practically impossible to comply with them, impeding new product development and distribution of existing products.

 

The COVID-19 pandemic could have a significant adverse impact on the Company’s operations, financial results, cash flow, and financial condition.

The COVID-19 pandemic created significant uncertainty and adversely impacted many industries throughout the global economy. Thus far, the Company has been able to mitigate the impact of COVID-19 through its proactive measures. The extent to which it impacts the Company’s operations, financial results, cash flow, and financial condition is difficult to predict and dependent upon many factors over which the Company has no control. These factors include, but are not limited to, the duration and severity of the pandemic; government restrictions on businesses and individuals; potential significant adverse impacts on the Company’s employees, customers, suppliers, or service providers; the impact on U.S. and global economies and the timing and rate of economic recovery; and potential adverse effects on the financial markets, any of which could negatively impact the Company.

 

12 

The Company’s results of operations could be adversely affected by litigation.

The Company faces risks arising from various asserted and unasserted litigation matters. These matters include, but are not limited to, assertions of allegedly defective product design or manufacture, alleged failure to warn, purported class actions against firearms manufacturers, generally seeking relief such as medical expense reimbursement, property damages, and punitive damages arising from accidents involving firearms or the criminal misuse of firearms, and those lawsuits filed on behalf of municipalities alleging harm to the general public. Various factors or developments can lead to changes in current estimates of liabilities such as final adverse judgment, significant settlement or changes in applicable law. A future adverse outcome in any one or more of these matters could have a material adverse effect on the Company’s financial results. See Note 21 to the financial statements which are included in this Annual Report on Form 10-K.

 

The Company relies upon relationships with financial institutions.

The Company utilizes the services of numerous financial institutions, including banks, insurance carriers, transfer agents, and others. Anti-gun politicians, gun-control activists, and others may target these institutions and attempt to pressure them into ceasing to do business with the Company, or to use financial relationships to impose unacceptable and improper restrictions on the Company’s business, which could have a material adverse impact on our business, operating results, and financial condition.

 

Our insurance may be insufficient to protect us from claims or losses.

We maintain insurance coverage with third-party insurers. However, not every risk or liability is or can be protected by insurance, and, for those risks we insure, the limits of coverage we purchase or that are reasonably obtainable in the market may not be sufficient to cover all actual losses or liabilities incurred. Moreover, there is a risk that commercially available liability insurance will not continue to be available to us at a reasonable cost, if at all. If liability claims or losses exceed our current or available insurance coverage, our business and prospects may be harmed.

 

The Company’s results of operations could be adversely affected by a decrease in demand for Company products.

If demand for the Company’s products decreases significantly, the Company would be unable to efficiently utilize its capacity, and profitability would suffer. Decreased demand could result from a macroeconomic downturn, or could be specific to the firearms industry as a result of social, political, or other factors. If the decrease in demand occurs abruptly, the adverse impact would be even greater.

 

The financial health of our independent distributors is critical to our success.

Over 90% of our sales are made to 15 federally licensed, independent wholesale distributors. We review our distributors’ financial statements and have credit insurance for many of them. However, our credit evaluations of distributors and credit insurance may not be completely effective, especially if interest rate increases continue to exact an additional financial strain. If one or more independent distributors experience financial distress or liquidity issues, our sales could be adversely affected and we may not be able to collect our accounts receivable on a timely basis, which would have an adverse impact on our operating results and financial condition.

 

13 

The Company must comply with various laws and regulations pertaining to workplace safety and environment, environmental matters, and firearms manufacturing.

In the normal course of its manufacturing operations, the Company is subject to numerous federal, state and local laws and governmental regulations, and governmental proceedings and orders. These laws and regulations pertain to matters like workplace safety and environment, firearms serial number tracking and control, waste disposal, air emissions and water discharges into the environment. Noncompliance with any one or more of these laws and regulations could have a material adverse impact on the Company.

 

Misconduct of our employees or contractors could cause us to lose customers and could have a significant adverse impact on our business and reputation.

Misconduct, fraud or other improper activities by our employees or contractors could have a material adverse impact on our business and reputation. Such misconduct could include the failure to comply with federal, state, local or foreign government procurement regulations, regulations regarding the protection of personal information, laws and regulations relating to antitrust and any other applicable laws or regulations.

 

Product quality and performance is important to the Company’s success.

The Company has a long history of producing rugged, reliable firearms for the commercial market. While we believe our record of designing, manufacturing, and selling high-quality products demonstrates our commitment to safety and quality, we have occasionally identified design and/or manufacturing issues with respect to some firearms and, as a result, issued a product safety bulletin or initiated a product recall. Depending upon the volume of products we have shipped into the market, any future recall or safety bulletin could harm our reputation, cause us to lose business, and cause us to incur significant support and repair costs.

 

Business disruptions at one of the Company’s manufacturing facilities could adversely affect the Company’s financial results.

The Newport, New Hampshire, Prescott, Arizona, Mayodan, North Carolina, and Earth City, Missouri facilities are critical to the Company’s success. These facilities house the Company’s principal production, research, development, engineering, design, and shipping operations. Any event that causes a disruption of the operation of any of these facilities for even a relatively short period of time could have a material adverse effect on the Company’s ability to produce and ship products and to provide service to its customers.

 

We rely on our information and communications systems in our operations. Security breaches and other disruptions could adversely affect our business and results of operations.

Cyber-security threats are significant and evolving and include, among others, malicious software, attempts to gain unauthorized access to data, and other electronic security breaches that could lead to disruptions in mission critical systems, unauthorized release of confidential or otherwise protected information and corruption of data. In addition to security threats, we are also subject to other systems failures, including network, software or hardware failures, whether caused by us, third-party service providers, natural disasters, power shortages, terrorist attacks or other events. The unavailability of our information or communications systems, the failure of these systems to perform as anticipated or any significant breach of data security could cause loss of data, disrupt our operations, lead to financial losses from remedial actions, require significant management

14 

attention and resources, and negatively impact our reputation among our customers and the public, which could have a negative impact on our financial condition, results of operations and liquidity.

 

The lack of available raw materials or component parts could disrupt or even cease the Company’s manufacturing operations. Even if manufacturing operations are not disrupted, increased costs of raw materials and component parts could adversely affect the Company’s financial results.

Third parties supply the Company with various raw materials for its firearms and castings, such as fabricated steel components, walnut, birch, beech, maple and laminated lumber for rifle stocks, wax, ceramic material, metal alloys, various synthetic products and other component parts. There is a limited supply of these materials in the marketplace at any given time, which can cause the purchase prices to vary based upon numerous market factors. If market conditions result in a significant prolonged inflation of certain prices or if adequate quantities of raw materials cannot be obtained, the Company’s manufacturing processes could be interrupted and the Company’s financial condition or results of operations could be materially adversely affected.

 

We rely primarily on third parties for transportation of the products we manufacture as well as delivery of our raw materials.

Any increase in the cost of the transportation of our raw materials or products, as a result of increases in fuel or labor costs, higher demand for logistics services, consolidation in the transportation industry or otherwise, may adversely affect our results of operations. If any of these providers were to fail to deliver raw materials to us in a timely manner, we may be unable to manufacture and deliver our products in a timely manner. In addition, if any of these third parties were to cease operations or cease doing business with us, we may be unable to replace them at a reasonable cost. And such failure of a third-party transportation provider could harm our reputation, negatively affect our customer relationships and have a material adverse effect on our financial position and results of operations

 

The integration of Marlin branded firearms may be more difficult than anticipated.

If we are unable to execute our strategy related to the acquisition of Marlin assets and we are not able to manufacture Marlin branded firearms to the planned level of quality, quantity, cost effectiveness, or timeliness as planned, our financial condition, results of operations, and reputation would suffer.

 

Availability and retention of our labor force, especially our key management, is critical to the success of the Company.

We have observed an overall tightening and increasingly competitive labor market, which could inhibit our ability to recruit and retain the employees we require and could lead to increased costs, such as additional overtime to meet demand and increased wage rates to attract and retain employees. We rely on the knowledge, experience, and leadership skills of our senior management team. Our senior executives are not bound by employment agreements. The loss of the services of one or more of our senior executives or other key personnel could have a significant adverse impact on our business.

 

ITEM 1B—UNRESOLVED STAFF COMMENTS

 

None

15 

 

ITEM 2—PROPERTIES

 

The Company’s manufacturing operations are carried out at four facilities. The following table sets forth certain information regarding each of these facilities:

 

   Approximate
Aggregate
Usable
Square Feet
  Status  Segment
          
Newport, New Hampshire  350,000  Owned  Firearms/Castings
          
Prescott, Arizona  230,000  Leased  Firearms
          
Mayodan, North Carolina  220,000  Owned  Firearms
          
Earth City, Missouri    35,000  Leased  Castings

 

Each firearms facility contains enclosed ranges for testing firearms. The lease of the Prescott facility provides for rental payments which are approximately equivalent to estimated rates for real property taxes.

 

The Company has other facilities that were not used in its manufacturing operations in 2022:

 

   Approximate
Aggregate
Usable
Square
Feet
  Status  Segment
          
Southport, Connecticut  25,000  Owned  Corporate
          
Newport, New Hampshire(Dorr Woolen Building)  45,000  Owned  Firearms
          
Enfield, Connecticut  10,000  Leased  Firearms
          
Rochester, New Hampshire  2,000  Leased  Firearms
          
Fairport, New York  3,700  Leased  Corporate
          
Mayodan, North Carolina  225,000  Owned  Firearms
          
Madison, North Carolina  130,000  Leased  Firearms

 

There are no mortgages or any other major encumbrance on any of the real estate owned by the Company.

 

The Company’s principal executive offices are located in Southport, Connecticut.

16 

ITEM 3—LEGAL PROCEEDINGS

 

The nature of the legal proceedings against the Company is discussed at Note 21 to the financial statements, which are included in this Form 10-K.

 

The Company has reported all cases instituted against it through October 1, 2022, and the results of those cases, where terminated, to the SEC on its previous Form 10-Q and 10-K reports, to which reference is hereby made.

 

There were five lawsuits formally instituted against the Company during the three months ending December 31, 2022. As follows:

 

The City of Buffalo v. Smith & Wesson Brands, Inc., et al., filed in the Supreme Court of the State of New York for Erie County on December 20, 2022.

 

The City of Rochester v. Smith & Wesson Brands, Inc., et al., filed in the Supreme Court of the State of New York for Monroe County on December 21, 2022.

 

Rossiter v. Sturm, Ruger & Co., Inc., et al., filed in the Sullivan County Superior Court for the State of New Hampshire on December 13, 2022.

 

Jones v. Sturm, Ruger & Co., filed in the U.S. District Court for the District of Connecticut, on October 4, 2022.

 

Copeland v. Sturm, Ruger & Company, et al., filed in the U.S. District Court for the District of New Jersey, on October 27, 2022.

 

ITEM 4—MINE SAFETY DISCLOSURES – NOT APPLICABLE

17 

 

PART II

 

ITEM 5— MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

 

The Company’s common stock is traded on the New York Stock Exchange under the symbol “RGR.” At February 10, 2023, the Company had 1,826 stockholders of record.

 

Issuer Repurchase of Equity Securities

 

In 2022 the Company repurchased shares of its common stock. In 2020 and 2021, the Company did not repurchase any shares of its common stock. Details of the purchases in 2022 follow:

 

Period  Total
Number of
Shares
Purchased
  Average
Price Paid
per Share
  Total
Number of
Shares
Purchased
as Part of
Publicly
Announced
Program
  Maximum
Dollar
Value of
Shares that
May Yet Be
Purchased
Under the
Program
                     
Third Quarter 2022                    
July 3 to July 30   —      —      —        
July 31 to August 27   —      —      —        
August 28 to October 1   2,136   $49.97    2,136      
Fourth Quarter 2022                    
October 2 to October 29   —      —      —        
October 30 to November 26   2,304   $49.77    2,304      
November 27 to December 31   —      —      —        
Total   4,440   $49.87    4,440   $86,490,000 

 

All of these purchases were made with cash held by the Company and no debt was incurred.

 

At December 31, 2022 approximately $86.5 million remained authorized for share repurchases.

18 


Comparison of Five-Year Cumulative Total Return*
Sturm, Ruger & Co., Inc., Standard & Poor’s 500, Dow Jones US Recreational Products
TSM Index, Recreation, and Russell 2000 Index
(Performance Results Through 12/31/22)

 

 

   2017   2018   2019   2020   2021   2022 
Sturm, Ruger & Company, Inc.   100.00    97.15    87.30    131.09    143.24    120.97 
Standard & Poors 500   100.00    95.62    125.72    148.85    191.58    156.89 
Russell 2000 Index   100.00    88.99    111.70    134.00    153.85    122.41 
Dow Jones US Recreational Products TSM   100.00    70.31    99.63    134.26    175.68    115.37 
Recreation   100.00    82.25    102.86    111.23    104.15    63.34 

 

For the year ended December 31, 2022, the Company has provided the five year cumulative total return results for the Dow Jones US Recreational Products Index, a widely-published index tracking companies that provide recreational products, along with those of the Recreation index formerly used by the Company, which is comprised of companies in the broader recreation industry and was prepared by a former service provider of the Company that is no longer providing cumulative total return calculations. The five year results for both the former Recreation index and the Dow Jones US Recreational Products Index are presented above.

19 

ITEM 6—[RESERVED]

 

20 

ITEM 7— MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Company Overview

 

Sturm, Ruger & Company, Inc. (the “Company”) is principally engaged in the design, manufacture, and sale of firearms to domestic customers. Approximately 99% of sales are from firearms. Export sales represent approximately 6% of total sales. The Company’s design and manufacturing operations are located in the United States and almost all product content is domestic. The Company’s firearms are sold through a select number of independent wholesale distributors, principally to the commercial sporting market.

 

The Company also manufactures investment castings made from steel alloys and metal injection molding (“MIM”) parts for internal use in its firearms and for sale to unaffiliated, third-party customers. Less than 1% of sales are from the castings segment.

 

Orders of many models of firearms from the independent distributors tend to be stronger in the first quarter of the year and weaker in the third quarter of the year.

 

Impact of COVID-19

 

The global outbreak of the Coronavirus disease 2019 was declared a pandemic by the World Health Organization and a national emergency by the U.S. Government in March 2020. The COVID-19 pandemic has created significant uncertainty and adversely impacted many industries throughout the global economy. In 2022, the Company was able to mitigate the adverse impact on its business resulting from government restrictions on the movement of people, goods, and services. The impact of the COVID-19 pandemic is fluid and continues to evolve, and, therefore, the Company cannot predict the extent to which its business, results of operations, financial condition, or cash flows will ultimately be impacted. Management, with guidance from a dedicated Company COVID-19 Task Force, continues to monitor and assess the situation, take proactive steps to promote the health and safety of its employees, and prepare for potential implications for the Company’s business, supply chain and customer demand.

 

From a liquidity perspective, the Company believes it is currently well positioned to continue to manage through this global crisis. At the end of 2022, the Company was debt-free and had cash and short-term investments totaling $224.3 million.

 

The impact of COVID-19 in 2022 and future years on consumer demand and the Company’s business, operations, financial results financial condition, and cash flows is dependent on future developments, including the duration of the pandemic and the related impact on the global economy, which remains uncertain.

21 

Results of Operations - 2022

 

Product Demand

The estimated sell-through of the Company’s products from the independent distributors to retailers in 2022 decreased 25% from 2021. For the same period, adjusted NICS decreased 11%. These decreases are attributable to decreased consumer demand for firearms from the unprecedented levels of the surge that began in 2020 and remained for most of 2021.The greater reduction in the sell-through of the Company’s products relative to adjusted NICS background checks may be attributable to the following:

More aggressive promotions, discounts, rebates, and the extension of payment terms offered by our competitors,
An apparent increase in sales of used firearms at retail, which are included in the adjusted NICS checks, but are not distinguished from new gun sales, and
Decreased retailer inventories as the anticipation of further discounting may be encouraging cautious buying behavior by retailers.

Estimated sell-through from distributors to retailers and total adjusted NICS background checks:

 

   2022  2021  2020
                
Estimated Units Sold from Distributors to Retailers (1)   1,506,800    2,017,800    1,948,900 
                
Total Adjusted NICS Background Checks (2)   16,425,000    18,515,000    21,084,000 

 

(1)The estimates for each period were calculated by taking the beginning inventory at the distributors, plus shipments from the Company to distributors during the period, less the ending inventory at distributors. These estimates are only a proxy for actual market demand as they:

 

Rely on data provided by independent distributors that are not verified by the Company,
Do not consider potential timing issues within the distribution channel, including goods-in-transit, and
Do not consider fluctuations in inventory at retail.

 

(2)NICS background checks are performed when the ownership of most firearms, either new or used, is transferred by a Federal Firearms Licensee. NICS background checks are also performed for permit applications, permit renewals, and other administrative reasons.  

 

The adjusted NICS data presented above was derived by the NSSF by subtracting NICS checks that are not directly related to the sale of a firearm, including checks

22 

used for concealed carry (“CCW”) permit application checks as well as checks on active CCW permit databases.

 

Adjusted NICS data can be impacted by changes in state laws and regulations and any directives and interpretations issued by governmental agencies.

 

Orders Received and Ending Backlog

 

The Company uses the estimated unit sell-through of our products from the independent distributors to retailers, along with inventory levels at the independent distributors and at the Company, as the key metrics for planning production levels.

 

The units ordered, value of orders received and ending backlog, net of Federal Excise Tax, for the trailing three years are as follows (dollars in millions, except average sales price):

 

   2022  2021  2020
                
Orders Received  $451.2   $606.5   $992.9 
                
Average Sales Price of Orders Received  $416   $330   $326 
                
Ending Backlog  $314.4   $429.7   $516.6 
                
Average Sales Price of Ending Backlog  $486   $357   $342 

 

Production

 

The Company reviews the estimated sell-through from the independent distributors to retailers, as well as inventory levels at the independent distributors and at the Company, to plan production levels and manage inventories. These reviews resulted in a decrease in total unit production of 20% in 2022 compared to 2021.

23 

 

Annual Summary Unit Data

 

Firearms unit data for orders, production, and shipments follows:

 

   2022  2021  2020
                
Units Ordered   1,083,800    1,835,500    3,041,700 
                
Units Produced   1,733,200    2,154,600    1,659,100 
                
Units Shipped   1,641,000    2,142,900    1,717,700 
                
Average Sales Price  $362   $340   $329 
                
Units – Backlog   647,300    1,204,500    1,511,900 

 

Inventories

 

The Company’s finished goods inventory increased by 92,200 units during 2022.

 

Distributor inventories of the Company’s products increased by 134,200 units during 2022, and approximate a reasonable level to support rapid fulfillment of retailer demand for most product families.

 

Inventory data follows:

 

    2022    2021    2020 
Units – Company Inventory   112,800    20,600    8,800 
                
Units – Distributor Inventory (3)   298,400    164,200    39,200 
                
Total inventory (4)   411,200    184,800    48,000 
                

 

(3)Distributor ending inventory as provided by the independent distributors of the Company’s products. These numbers do not include goods-in-transit inventory that has been shipped from the Company but not yet received by the distributors.
(4)This total does not include inventory at retailers. The Company does not have access to data on retailer inventories.

24 

 

Year ended December 31, 2022, as compared to year ended December 31, 2021:

 

Net Sales, Cost of Products Sold, and Gross Profit

 

Net sales, cost of products sold, and gross profit data for the year ended (dollars in millions):

 

    December 31,
2022
    December 31,
2021
    Change   % Change
Net firearms sales  $593.3   $728.1   $(134.8)   (18.5)%
                     
Net casting sales   2.5    2.6    (0.1)   (1.6)%
                     
Total net sales   595.8    730.7    (134.9)   (18.5)%
                     
Cost of products sold   415.7    451.2    (35.5)   (7.8)%
                     
Gross profit  $180.1   $279.5   $(99.4)   (35.6)%
                     
Gross margin   30.2%    38.3%    (8.1)%   (29.7)%

 

Firearms sales and unit shipments decreased 18.5% and 23.4%, respectively, in 2022. New products represented $78.4 million or 14% of firearms sales in 2022, compared to $155.5 million or 22% of firearms sales in 2021. New product sales include only major new products that were introduced in the past two years. In 2022, new products included the MAX-9 pistol, LCP MAX, Marlin 1895 lever-action rifles, PC Charger, LC Carbine, and Small-Frame Autoloading Rifle.

 

The decreased gross profit for the year ended December 31, 2022 is attributable to the significant decrease in sales, as well as inflationary cost increases in materials, commodities, services, energy, fuel and transportation, which were partially offset by increased pricing.

 

The decrease in gross margin for the year ended December 31, 2022 is attributable to the aforementioned inflationary cost increases and unfavorable deleveraging of fixed costs resulting from decreased production and sales.

 

Selling, General and Administrative

 

Selling, general and administrative expenses were $76.6 million in 2022, a slight increase of $0.1 million from $76.5 million in 2021, and an increase from 10.5% of sales in 2021 to 12.9% of sales in 2022. The increase in these expenses was primarily attributable to increased shipping costs and to the resumption of trade show participation costs, travel expenditures, and advertising that had been deferred during the height of the COVID-19 restrictions, almost entirely offset by decreased

25 

incentive compensation expenses and decreased variable costs, such as shipping, as a result of the reduced sales volume.

 

Other Operating Income (Expense), Net

 

Other operating income (expense), net was de minimis in 2022 and an expense of $0.1 million in 2021.

 

Operating Income

 

Operating income was $103.5 million or 17.3% of sales in 2022. This is a decrease of $99.6 million from 2021 operating income of $203.1 million or 27.8% of sales.

 

Royalty Income

 

Royalty income was $0.8 million in 2022 and $2.0 million in 2021.

 

Interest Income

 

Interest income was $2.6 million in 2022, an increase from de minimis earnings in 2021, due to significantly increased interest rates earned on short-term investments beginning in the second quarter of 2022.

 

Interest Expense

 

Interest expense was $0.3 million in 2022 and $0.2 million and 2021.

 

Other Income, Net

 

Other income, net was $1.7 million in 2022, an increase of $0.1 million from $1.6 million in 2021.

 

Income Taxes and Net Income

 

The effective income tax rate was 18.4% in 2022 and 24.5% in 2021. The Company's 2022 and 2021 effective tax rate differs from the statutory federal tax rate due principally to the availability of research and development tax credits, state income taxes, and the nondeductibility of certain executive compensation. The decrease in the 2022 effective tax rate was primarily attributable to research and development tax credits, some of which related to amended prior year income tax returns. The impact related to research and development tax credits on the effective tax rate is expected to decline in future years.

 

As a result of the foregoing factors, consolidated net income was $88.3 million in 2022. This represents a decrease of $67.6 million from 2021 consolidated net income of $155.9 million.

26 

Non-GAAP Financial Measure

 

In an effort to provide investors with additional information regarding its results, the Company refers to various United States generally accepted accounting principles (“GAAP”) financial measures and two non-GAAP financial measures, EBITDA and EBITDA margin, which management believes provides useful information to investors. These non-GAAP measures may not be comparable to similarly titled measures being disclosed by other companies. In addition, the Company believes that the non-GAAP financial measures should be considered in addition to, and not in lieu of, GAAP financial measures. The Company believes that EBITDA and EBITDA margin are useful to understanding its operating results and the ongoing performance of its underlying business, as EBITDA provides information on the Company’s ability to meet its capital expenditure and working capital requirements, and is also an indicator of profitability. The Company believes that this reporting provides better transparency and comparability to its operating results. The Company uses both GAAP and non-GAAP financial measures to evaluate its financial performance.

 

Non-GAAP Reconciliation – EBITDA

 

EBITDA

(Unaudited, dollars in thousands)

 

Year ended December 31,  2022   2021 
           
Net income  $88,332   $155,899 
           
Income tax expense   19,947    50,695 
Depreciation and amortization expense   25,789    26,152 
Interest expense   256    164 
Interest income   (2,552)   (49)
EBITDA  $131,772   $232,861 
EBITDA margin   22.1%    31.9% 

 

EBITDA is defined as earnings before interest, taxes, and depreciation and amortization. The Company calculates this by adding the amount of interest expense, income tax expense and depreciation and amortization expenses that have been deducted from net income back into net income, and subtracting the amount of interest income that was included in net income from net income to arrive at EBITDA. The Company’s EBITDA calculation also excludes any one-time non-cash, non-operating expense.

27 

Quarterly Data

 

To supplement the summary annual unit data and discussion above, the same data for the last eight quarters follows:

 

   2022 
   Q4   Q3   Q2   Q1 
                     
Units Ordered   156,000    295,600    250,600    381,600 
                     
Units Produced   397,300    382,800    431,800    521,300 
                     
Units Shipped   393,100    373,800    382,600    491,500 
                     
Estimated Units Sold from Distributors to Retailers   397,800    343,500    354,300    411,200 
                     
Total Adjusted NICS Background Checks   4,531,000    3,764,000    3,917,000    4,213,000 
                     
Average Unit Sales Price  $378   $371   $366   $338 
                     
Units – Backlog   647,300    884,400    962,600    1,094,600 
                     
Units – Company Inventory   112,800    108,600    99,700    50,400 
                     
Units – Distributor Inventory (5)   298,400    303,100    272,800    244,600 

 

   2021 
   Q4   Q3   Q2   Q1 
                     
Units Ordered   373,000    218,800    453,400    790,300 
                     
Units Produced   512,100    525,200    575,400    541,900 
                     
Units Shipped   502,300    524,800    580,800    535,000 
                     
Estimated Units Sold from Distributors to Retailers   458,200    457,400    583,300    518,900 
                     
Total Adjusted NICS Background Checks   4,763,000    3,971,000    4,298,000    5,483,000 
                     
Average Unit Sales Price  $334   $338   $343   $343 
                     
Units – Backlog   1,204,500    1,333,800    1,639,800    1,767,200 
                     
Units – Company Inventory   20,600    10,900    10,400    15,700 
                     
Units – Distributor Inventory (5)   164,200    120,100    52,800    55,300 

28 

(5)Distributor ending inventory as provided by the independent distributors of the Company’s products.

 

(in millions except average sales price, net of Federal Excise Tax)

 

   2022 
   Q4   Q3   Q2   Q1 
                     
Orders Received  $81.0   $124.3   $98.9   $147.0 
                     
Average Sales Price of Orders Received  $519   $421   $395   $385 
                     
Ending Backlog  $314.4   $377.6   $389.6   $420.5 
                     
Average Sales Price of Ending Backlog  $486   $427   $405   $384 

 

   2021 
   Q4   Q3   Q2   Q1 
                     
Orders Received  $119.2   $61.1   $158.3   $267.9 
                     
Average Sales Price of Orders Received  $320   $279   $349   $339 
                     
Ending Backlog  $429.7   $471.7   $582.3   $612.3 
                     
Average Sales Price of Ending Backlog  $357   $354   $355   $346 

 

29 

 

Fourth Quarter Net Sales and Gross Profit Analysis

 

Net sales, cost of products sold, and gross profit data for the three months ended (dollars in millions):

 

    December 31,
2022
    December 31,
2021
    Change    % Change 
Net firearms sales  $148.7   $167.5   $(18.8)   (11.3)%
                     
Net casting sales   0.5    0.5        14.8% 
                     
Total net sales   149.2    168.0    (18.8)   (11.2)%
                     
Cost of products sold   109.6    104.6    5.0    4.8% 
                     
Gross profit  $39.6   $63.4   $(23.8)   (37.6)%
                     
Gross margin   26.5%    37.7%    (11.2)%   (21.1)%

 

30 

Results of Operations - 2021

 

Year ended December 31, 2021, as compared to year ended December 31, 2020:

 

Annual Summary Unit Data

 

Firearms unit data for orders, production, shipments and ending inventory, and castings setups (a measure of foundry production) are as follows:

 

   2021   2020   2019 
                
Units Ordered   1,835,500    3,041,700    1,361,100 
                
Units Produced   2,154,600    1,659,100    1,313,400 
                
Units Shipped   2,142,900    1,717,700    1,326,200 
                
Average Sales Price  $340   $329   $306 
                
Units – Backlog   1,204,500    1,511,900    187,900 
                
Units – Company Inventory   20,600    8,800    67,400 
                
Units – Distributor Inventory (1)   164,200    39,200    270,400 
                
Castings Setups   68,469    66,044    62,548 

 

Orders Received and Ending Backlog

 

(in millions except average sales price, net of Federal Excise Tax):

 

   2021   2020   2019 
                
Orders Received  $606.5   $992.9   $398.4 
                
Average Sales Price of Orders Received (2)  $330   $326   $293 
                
Ending Backlog  $429.7   $516.6   $57.8 
                
Average Sales Price of Ending Backlog (2)  $357   $342   $308 

 

(1)Distributor ending inventory as provided by the independent distributors of the Company’s products.

 

(2)Average sales price for orders received and ending backlog is net of Federal Excise Tax of 10% for handguns and 11% for long guns.

31 

Product Demand

The estimated sell-through of the Company’s products from the independent distributors to retailers in 2021 increased 3.5% from 2020. For the same period, adjusted NICS decreased 12%.

The increase in the sell-through of the Company’s products compared favorably to the decrease in adjusted NICS background checks in 2021 and may be attributable to the following:

 

Strong consumer demand for the Company’s products,
Increased production in 2021, and
The introduction of popular new products.

 

Estimated sell-through from distributors to retailers and total adjusted NICS background checks:

 

   2021   2020   2019 
                
Estimated Units Sold from Distributors to Retailers (1)   2,017,800    1,948,900    1,355,500 
                
Total Adjusted NICS Background Checks (2)   18,515,000    21,084,000    13,199,000 

 

(1)The estimates for each period were calculated by taking the beginning inventory at the distributors, plus shipments from the Company to distributors during the period, less the ending inventory at distributors. These estimates are only a proxy for actual market demand as they:

 

Rely on data provided by independent distributors that are not verified by the Company,
Do not consider potential timing issues within the distribution channel, including goods-in-transit, and
Do not consider fluctuations in inventory at retail.

 

(2)NICS background checks are performed when the ownership of most firearms, either new or used, is transferred by a Federal Firearms Licensee. NICS background checks are also performed for permit applications, permit renewals, and other administrative reasons.  

 

The adjusted NICS data presented above was derived by the NSSF by subtracting NICS checks that are not directly related to the sale of a firearm, including checks used for concealed carry (“CCW”) permit application checks as well as checks on active CCW permit databases.

 

Adjusted NICS data can be impacted by changes in state laws and regulations and any directives and interpretations issued by governmental agencies.

32 

Production

 

The Company reviews the estimated sell-through from the independent distributors to retailers, as well as inventory levels at the independent distributors and at the Company, to plan production levels and manage inventories. These reviews resulted in an increase in total unit production of 29.9% in 2021 compared to 2020.

 

Inventories

 

The Company’s finished goods inventory increased by 11,800 units during 2021, but remain significantly below pre-COVID-19 pandemic levels.

 

Distributor inventories of the Company’s products increased by 125,000 units during 2021, but remain significantly below the level needed to support rapid fulfillment of retailer demand for most product families.

 

Inventory data follows:

 

    2021    2020    2019 
Units – Company Inventory   20,600    8,800    67,400 
                
Units – Distributor Inventory (3)   164,200    39,200    270,400 
                
Total inventory (4)   184,800    48,000    337,800 
                

(3)Distributor ending inventory as provided by the independent distributors of the Company’s products. These numbers do not include goods-in-transit inventory that has been shipped from the Company but not yet received by the distributors.
(4)This total does not include inventory at retailers. The Company does not have access to data on retailer inventories.

33 

 

Quarterly Summary Unit Data

 

To supplement the summary annual unit data and discussion above, the same data for the last eight quarters follows:

 

   2021 
    Q4    Q3    Q2    Q1 
                     
Units Ordered   373,000    218,800    453,400    790,300 
                     
Units Produced   512,100    525,200    575,400    541,900 
                     
Units Shipped   502,300    524,800    580,800    535,000 
                     
Estimated Units Sold from Distributors to Retailers   458,200    457,400    583,300    518,900 
                     
Total Adjusted NICS Background Checks   4,763,000    3,971,000    4,298,000    5,483,000 
                     
Average Unit Sales Price  $334   $338   $343   $343 
                     
Units – Backlog   1,204,500    1,333,800    1,639,800    1,767,200 
                     
Units – Company Inventory   20,600    10,900    10,400    15,700 
                     
Units – Distributor Inventory (5)   164,200    120,100    52,800    55,300 

 

   2020 
   Q4   Q3   Q2   Q1 
                     
Units Ordered   733,200    935,200    746,600    626,700 
                     
Units Produced   491,000    430,400    374,400    363,300 
                     
Units Shipped   493,000    430,700    395,100    398,900 
                     
Estimated Units Sold from Distributors to Retailers   513,100    457,400    501,600    476,800 
                     
Total Adjusted NICS Background Checks   5,626,000    5,165,000    5,452,000    4,841,000 
                     
Average Unit Sales Price  $342   $337   $328   $285 
                     
Units – Backlog   1,511,900    1,271,700    767,200    415,700 
                     
Units – Company Inventory   8,800    10,700    11,100    31,900 
                     
Units – Distributor Inventory (5)   39,200    59,300    86,000    192,500 

 

34 

(5)Distributor ending inventory as provided by the independent distributors of the Company’s products.

 

(in millions except average sales price, net of Federal Excise Tax)

 

   2021 
   Q4   Q3   Q2   Q1 
                     
Orders Received  $119.2   $61.1   $158.3   $267.9 
                     
Average Sales Price of Orders Received  $320   $279   $349   $339 
                     
Ending Backlog  $429.7   $471.7   $582.3   $612.3 
                     
Average Sales Price of Ending Backlog  $357   $354   $355   $346 

 

   2020 
   Q4   Q3   Q2   Q1 
                     
Orders Received  $277.1   $284.0   $228.8   $203.0 
                     
Average Sales Price of Orders Received  $352   $304   $306   $324 
                     
Ending Backlog  $516.6   $410.1   $255.6   $142.7 
                     
Average Sales Price of Ending Backlog  $342   $322   $333   $343 

 

35 

 

Net Sales, Cost of Products Sold, and Gross Profit

 

Net sales, cost of products sold, and gross profit data for the year ended (dollars in millions):

 

    December 31,
2021
    December 31,
2020
    Change    % Change 
Net firearms sales  $728.1   $565.9   $162.2    28.7% 
                     
Net casting sales   2.6    3.0    (0.4)   (13.6)%
                     
Total net sales   730.7    568.9    161.8    28.5% 
                     
Cost of products sold   451.2    377.5    73.7    19.5% 
                     
Gross profit  $279.5   $191.4   $88.1    46.0% 
                     
Gross margin   38.3%    33.7%    4.6%    13.6% 

 

Firearms sales and unit shipments increased 28.7% and 24.8%, respectively, in 2021. New products represented $155.5 million or 22% of firearms sales in 2021, compared to $111.2 million or 22% of firearms sales in 2020. New product sales include only major new products that were introduced in the past two years. In 2021, new products included the Ruger-57 pistol, the PC Charger, the MAX-9 pistol, the LCP II in .22 LR pistol, the LCP MAX pistol, the Wrangler revolver, and the Marlin 1895 lever-action rifle.

 

The increased gross profit for the year ended December 31, 2021 is attributable to the significant increase in sales and profitability.

 

The increase in gross margin for the year ended December 31, 2021 is attributable to favorable leveraging of fixed costs, including depreciation, engineering and other indirect labor, resulting from the increased sales and production, labor efficiencies, and reduced sales promotional activities.

 

Selling, General and Administrative

 

Selling, general and administrative expenses were $76.5 million in 2021, an increase of $4.2 million from $72.3 million in 2020, and a decrease from 12.7% of sales in 2020 to 10.5% of sales in 2021. The increase in expense was primarily attributable to increased sales and incentive compensation expenses and the decrease in the percentage of sales was attributable to the significant increase in sales.

36 

Other Operating Income, net

 

Other operating income, net was $0.1 million in 2021 and was de minimis in 2020.

 

Operating Income

 

Operating income was $203.1 million or 27.8% of sales in 2021. This is an increase of $84.0 million from 2020 operating income of $119.1 million or 20.9% of sales.

 

Royalty Income

 

Royalty income was $2.0 million in 2021 and $0.8 million in 2020.

 

Interest Income

 

Interest income was de minimis in 2021, a decrease from $1.1 million in 2020, due to significantly decreased interest rates earned on short-term investments in 2021.

 

Interest Expense

 

Interest expense was $0.2 million in 2021 and 2020.

 

Other Income, Net

 

Other income, net was $1.6 million in 2021, an increase of $1.5 million from $0.1 million in 2020.

 

Income Taxes and Net Income

 

The effective income tax rate was 24.5% in 2021 and 25.3% in 2020. The Company's 2021 effective tax rate differs from the statutory federal tax rate due principally to state income taxes and the nondeductibility of certain executive compensation. The Company's 2020 effective tax rate differs from the statutory federal tax rate due principally to state income taxes.

 

As a result of the foregoing factors, consolidated net income was $155.9 million in 2021. This represents an increase of $65.5 million from 2020 consolidated net income of $90.4 million.

 

Non-GAAP Financial Measure

 

In an effort to provide investors with additional information regarding its results, the Company refers to various United States generally accepted accounting principles (“GAAP”) financial measures and two non-GAAP financial measures, EBITDA and EBITDA margin, which management believes provides useful information to investors. These non-GAAP measures may not be comparable to similarly titled measures being disclosed by other companies. In addition, the Company believes that the non-GAAP financial measures should be considered in addition to, and not in lieu of, GAAP financial measures. The Company believes that EBITDA and EBITDA margin are useful to understanding its operating results and the ongoing performance of its

37 

underlying business, as EBITDA provides information on the Company’s ability to meet its capital expenditure and working capital requirements, and is also an indicator of profitability. The Company believes that this reporting provides better transparency and comparability to its operating results. The Company uses both GAAP and non-GAAP financial measures to evaluate its financial performance.

 

Non-GAAP Reconciliation – EBITDA

 

EBITDA

(Unaudited, dollars in thousands)

 

Year ended December 31,  2021   2020 
           
Net income  $155,899   $90,398 
           
Income tax expense   50,695    30,583 
Depreciation and amortization expense   26,152    27,576 
Interest expense   164    191 
Interest income   (49)   (1,126)
EBITDA  $232,861   $147,622 
EBITDA margin   31.9%    26.0% 

 

EBITDA is defined as earnings before interest, taxes, and depreciation and amortization. The Company calculates this by adding the amount of interest expense, income tax expense and depreciation and amortization expenses that have been deducted from net income back into net income, and subtracting the amount of interest income that was included in net income from net income to arrive at EBITDA. The Company’s EBITDA calculation also excludes any one-time non-cash, non-operating expense.

 

 

Financial Condition

 

Liquidity

 

At December 31, 2022, the Company had cash and cash equivalents of $65.2 million and $159.1 million in short term investments. Our pre-LIFO working capital of $258.3 million, less the LIFO reserve of $59.5 million, resulted in working capital of $198.7 million and a current ratio of 2.2 to 1. The Company’s current ratio is lower than previous years primarily due to the dividends payable of $88 million related to the $5.00 per share special dividend that was declared on November 30, 2022 and paid on January 5, 2023. The Company also has access to a $40 million unsecured revolving line of credit that is currently undrawn.

 

Capital Resources

 

The Company believes that its cash flow from operations, current cash position, and access to capital markets will continue to be sufficient to meet its anticipated cash requirements and

38 

contractual obligations, which includes funding the Company’s capital expenditures, acquisitions, dividend payments, and share repurchases.

 

Operations

 

Cash provided by operating activities was $77.2 million, $172.3 million, and $143.8 million in 2022, 2021, and 2020, respectively. The decrease in cash provided in 2022 compared to 2021 is primarily attributable to significantly decreased earnings in 2022 and increased inventories in 2022.

 

The increase in cash provided in 2021 compared to 2020 is primarily attributable to significantly increased earnings in 2021.

 

Third parties supply the Company with various raw materials for its firearms and castings, such as fabricated steel components, walnut, birch, beech, maple and laminated lumber for rifle stocks, wax, ceramic material, metal alloys, various synthetic products and other component parts. There is a limited supply of these materials in the marketplace at any given time, which can cause the purchase prices to vary based upon numerous market factors. If market conditions result in a significant prolonged inflation of certain prices or if adequate quantities of raw materials cannot be obtained, the Company’s manufacturing processes could be interrupted and the Company’s financial condition or results of operations could be materially adversely affected.

 

Investing and Financing

 

Capital expenditures were $27.7 million, $28.8 million, and $24.2 million in 2022, 2021, and 2020, respectively. In 2023, the Company expects capital expenditures to approximate $20 million, much of which will relate to tooling and fixtures for new product introductions and to upgrade and modernize manufacturing equipment. Due to market conditions and business circumstances, actual capital expenditures could vary significantly from the budgeted amount. The Company finances, and intends to continue to finance, all of these activities with funds provided by operations and current cash.

 

Included in capital expenditures amount noted above, on October 3, 2022 the Company purchased a 225,000 square foot facility, which it had previously been leasing, in Mayodan, North Carolina for $8.3 million for use in its manufacturing and warehousing operations.

 

On November 23, 2020, the Company acquired substantially all of the Marlin Firearms assets, consisting of inventory, machinery and equipment, and intangible assets. The agreement to purchase these assets emanated from the Remington Outdoor Company, Inc. bankruptcy and was approved by the United States Bankruptcy Court for the Northern District of Alabama on September 30, 2020. The purchase price of approximately $28.3 million was paid with available cash on hand. Shipments of Ruger-made, Marlin lever-action rifles commenced in the fourth quarter of 2021.

 

As of December 31, 2022, the Company had $107.0 million of United States Treasury instruments which mature within one year. The Company also invests available cash in a bank-managed

39 

money market fund that invests exclusively in United States Treasury instruments which mature within one year. At December 31, 2022, the Company’s investment in this money market fund totaled $52.1 million.

 

In 2022, the Company repurchased 4,440 shares of its common stock for $0.2 million in the open market. The average price per share purchased was $49.87. These purchases were funded with cash on hand. No shares were repurchased in 2020 or 2021.

 

At December 31, 2022, approximately $86.5 million remained authorized for future share repurchases.

 

The Company paid dividends totaling $42.7 million, $59.1 million, and $113.9 million in 2022, 2021, and 2020, respectively. The increased dividends paid in 2020 were attributable to a $5.00 per share special dividend paid in August 2020. The quarterly dividend varies every quarter because the Company pays a percentage of earnings rather than a fixed amount per share. The Company’s practice is to pay a dividend of approximately 40% of net income.

 

On January 5, 2023, the Company paid a $5.00 per share special dividend to shareholders of record on December 15, 2022. On February 17, 2023, the Company’s Board of Directors authorized a dividend of 42¢ per share to shareholders of record on March 10, 2023. The payment of future dividends depends on many factors, including internal estimates of future performance, then-current cash, and the Company’s need for funds.

 

The Company provides supplemental discretionary contributions to substantially all employees’ individual 401(k) accounts.

 

Based on its unencumbered assets, the Company believes it has the ability to raise cash through issuance of short-term or long-term debt.

 

Contractual Obligations

 

At December 31, 2022, the Company had approximately $84.6 million in agreements to purchase goods or services that are enforceable and legally binding on the Company, all of which are expected to be settled in less than one year. Additionally, the Company has approximately $4.4 million in operating lease obligations, which will be payable through 2034. The Company expects to fund all of these commitments with cash flows from operations and current cash.

 

Firearms Legislation and Litigation

 

See Item 1A - Risk Factors and Note 21 to the financial statements which are included in the Annual Report on Form 10-K for a discussion of firearms legislation and litigation.

 

Other Operational Matters

 

In the normal course of its manufacturing operations, the Company is subject to occasional governmental proceedings and orders pertaining to workplace safety, firearms serial number tracking and control, waste disposal, air emissions and water discharges into the environment. The

40 

Company believes that it is generally in compliance with applicable Bureau of Alcohol, Tobacco, Firearms & Explosives, environmental, and safety regulations and the outcome of any proceedings or orders will not have a material adverse effect on the financial position or results of operations of the Company. If these regulations become more stringent in the future and we are not able to comply with them, such noncompliance could have a material adverse impact on the Company.

 

Currently, there are 15 domestic distributors. Additionally, the Company has 45 and 25 distributors servicing the export and law enforcement markets, respectively.

 

The Company self-insures a significant amount of its product liability, workers’ compensation, medical, and other insurance. It also carries significant deductible amounts on various insurance policies.

 

The Company expects to realize its deferred tax assets through tax deductions against future taxable income.

 

Critical Accounting Policies and Estimates

 

The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make assumptions and estimates that affect the reported amounts of assets and liabilities as of the balance sheet date and net sales and expenses recognized and incurred during the reporting period then ended. The Company bases estimates on prior experience, facts and circumstances, and other assumptions, including those reviewed with actuarial consultants and independent counsel, when applicable, that are believed to be reasonable. However, actual results may differ from these estimates.


The Company believes that the assumptions and judgments involved in the accounting estimates below have the greatest potential impact on its financial statements, so the Company believes these to be its critical accounting estimates. The methodologies applied for determining the estimates related to the below critical accounting estimates have not changed from the prior year.

 

Product Liability Accrual

 

The Company believes the determination of its product liability accrual is a critical accounting policy. The Company’s management reviews every lawsuit and claim and is in contact with independent and corporate counsel on an ongoing basis. The provision for product liability claims is based upon many factors, which vary for each case. These factors include the type of claim, nature and extent of injuries, historical settlement ranges, jurisdiction where filed, and advice of counsel. An accrual is established for each lawsuit and claim, when appropriate, based on the nature of each such lawsuit or claim.

 

Amounts are charged to product liability expense in the period in which the Company becomes aware that a claim or, in some instances a threat of a claim, has been made when potential losses or costs of defense are probable and can be reasonably estimated. Such amounts are determined based on the Company’s experience in defending similar claims. Occasionally, charges are made for claims made in prior periods because the cumulative actual costs incurred for that claim, or reasonably expected to be incurred in the future, exceed amounts already provided with respect to

41 

such claims. Likewise, credits may be taken if cumulative actual costs incurred for that claim, or reasonably expected to be incurred in the future, are less than amounts previously provided.

 

While it is not possible to forecast the outcome of litigation or the timing of related costs, in the opinion of management, after consultation with independent and corporate counsel, there is a remote likelihood that litigation, including punitive damage claims, will have a material adverse effect on the financial position of the Company, but such litigation may have a material impact on the Company’s financial results and cash flows for a particular period.

 

Inventory Valuation and Reserves

 

The Company believes the valuation of its inventory and the related excess and obsolescence reserve is also a critical accounting policy. Inventories are carried at the lower of cost, principally determined by the last-in, first-out (LIFO) method, or market. An actual valuation of inventory under the LIFO method is made at the end of each year based on the inventory levels and the Company’s estimates of the prevailing costs of the many components of inventory existing at that time.

 

The Company determines its excess and obsolescence reserve by projecting the year in which inventory will be consumed into a finished product. Given ever-changing market conditions, customer preferences and the anticipated introduction of new products, projecting the future usage of inventory is subjective. As such, it does not seem prudent to carry inventory at full cost beyond what the Company projects to be needed during the next 36 months.

 

Recent Accounting Pronouncements

 

None.

 

Forward-Looking Statements and Projections

 

The Company may, from time to time, make forward-looking statements and projections concerning future expectations. Such statements are based on current expectations and are subject to certain qualifying risks and uncertainties, such as market demand, sales levels of firearms, anticipated castings sales and earnings, the need for external financing for operations or capital expenditures, the results of pending litigation against the Company, the impact of future firearms control and environmental legislation and accounting estimates, any one or more of which could cause actual results to differ materially from those projected. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “will,” “should,” “could” and other words and terms of similar meaning, typically identify such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company undertakes no obligation to publish revised forward-looking statements to reflect events or circumstances after the date such forward-looking statements are made or to reflect the occurrence of subsequent unanticipated events.

42 

 

ITEM 7A—QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The Company is exposed to changing interest rates on its investments, which consist primarily of United States Treasury instruments with short-term (less than one year) maturities and cash. The interest rate market risk implicit in the Company's investments at any given time is low, as the investments mature within short periods and the Company does not have significant exposure to changing interest rates on invested cash.

 

The Company has not undertaken any actions to cover interest rate market risk and is not a party to any interest rate market risk management activities.

 

A hypothetical 100 basis point change in market interest rates over the next year would not materially impact the Company’s earnings or cash flows. A hypothetical 100 basis point change in market interest rates would not have a material effect on the fair value of the Company’s investments.

 

43 

 

ITEM 8—FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

 

Reports of Independent Registered Public Accounting Firm (PCAOB ID 49) 45
   
Consolidated Balance Sheets at December 31, 2022 and 2021 48
   
Consolidated Statements of Income and Comprehensive Income for the years ended December 31, 2022, 2021 and 2020 50
   
Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2022, 2021 and 2020 51
   
Consolidated Statements of Cash Flows for the years ended December 31, 2022, 2021 and 2020 52
   
Notes to Consolidated Financial Statements 53

 

44 

Report of Independent Registered Public Accounting Firm

 

To the Stockholders and the Board of Directors of Sturm, Ruger & Company, Inc. and Subsidiary

 

Opinion on the Internal Control Over Financial Reporting

We have audited Sturm, Ruger & Company, Inc. and Subsidiary's (the Company) internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission in 2013. In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission in 2013.

 

We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2022 and 2021, and the related consolidated statements of income and comprehensive income, stockholders’ equity, and cash flows for each of the three years in the period ended December 31, 2022, and our report dated February 22, 2023 expressed an unqualified opinion.

 

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting in the accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company's internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

 

Definition and Limitations of Internal Control Over Financial Reporting

A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

/s/RSM US LLP

Stamford, Connecticut

February 22, 2023

 

45 

Report of Independent Registered Public Accounting Firm

 

To the Stockholders and the Board of Directors of Sturm, Ruger & Company, Inc. and Subsidiary

 

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of Sturm, Ruger & Company, Inc. and Subsidiary (the Company) as of December 31, 2022 and 2021, the related consolidated statements of income and comprehensive income, stockholders’ equity and cash flows for each of the three years in the period ended December 31, 2022, and the related notes to the consolidated financial statements and schedule (collectively, the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2022, in conformity with accounting principles generally accepted in the United States of America.

 

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission in 2013, and our report dated February 22, 2023 expressed an unqualified opinion on the effectiveness of the Company’s internal control over financial reporting.

 

Basis for Opinion

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Critical Audit Matters
The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matters or on the accounts or disclosures to which it relates.

46 

Last-In, First-Out Inventory Reserve
As described in Notes 1 and 5 to the financial statements, substantially all of the Company’s inventories are valued at the lower of cost, which is principally determined by the last-in, first-out (LIFO) method, or net realizable value, and the Company's consolidated net inventories balance of $65.0 million as of December 31, 2022, included a LIFO inventory reserve of $59.5 million. The Company records its net inventories under the LIFO method at the end of each year based on the inventory levels at the measurement date and the prevailing inventory costs existing at that time which are estimated using a complex manual calculation.

 

We identified the LIFO inventory reserve as a critical audit matter because of the complexities of the manual calculations performed by management to estimate the prevailing inventory costs, which includes calculations to estimate current year price level changes through the development of a prior year and a current year cumulative price index. Auditing management’s estimate of the LIFO inventory reserve was complex and required a high degree of auditor judgement and increased audit effort due to the complexities of management’s manual calculations.

Our audit procedures related to the Company’s LIFO inventory reserve included the following, among others:

We obtained an understanding of the relevant controls related to the LIFO inventory reserve and tested such controls for design and operating effectiveness, including controls related to the review of the calculations related to the estimate of the current year price level changes, the calculation of the cumulative price indexes, and the estimate of the LIFO inventory reserve.
We tested the completeness, accuracy, and relevance of the underlying data used in management's estimate of the current year price level changes, the calculation of cumulative price index and the LIFO inventory reserve.
We tested the mathematical accuracy of the Company’s calculation to estimate the LIFO inventory reserve.
We evaluated the appropriateness of management’s methodologies to develop the estimate of the LIFO inventory reserve.
We evaluated the reasonableness of management’s estimate of the current year price level changes by comparing management’s estimate to external market data.

 

/s/RSM US LLP

 

We have served as the Company's auditor since 2005.

 

Stamford, Connecticut

February 22, 2023

47 

 

Consolidated Balance Sheets

(Dollars in thousands, except per share data)

 

December 31,  2022   2021 
           
Assets          
           
Current Assets          
Cash and cash equivalents  $65,173   $21,044 
Short-term investments   159,132    199,971 
Trade receivables, net   65,449    57,036 
           
Gross inventories   129,294    100,023 
Less LIFO reserve   (59,489)   (51,826)
Less excess and obsolescence reserve   (4,812)   (4,347)
Net inventories   64,993    43,850 
           
Prepaid expenses and other current assets   7,091    6,832 
Total Current Assets   361,838    328,733 
           
Property, Plant, and Equipment   447,126    421,282 
Less allowances for depreciation   (370,273)   (347,651)
Net property, plant and equipment   76,853    73,631 
           
Deferred income taxes   6,109    536 
Other assets   39,963    39,443 
Total Assets  $484,763   $442,343 

 

See accompanying notes to consolidated financial statements.

48 

December 31,  2022   2021 
         
Liabilities and Stockholders’ Equity          
           
Current Liabilities          
           
Trade accounts payable and accrued expenses  $35,658   $36,400 
Dividends Payable   88,343     
Contract liabilities with customers (Note 3)   1,031    
 
Product liability   235    795 
Employee compensation and benefits   30,160    33,154 
Workers’ compensation   6,469    6,760 
Income taxes payable   1,171     
Total Current Liabilities   163,067    77,109 
           
Lease liability (Note 8)   3,039    1,476 
Employee compensation   1,846     
Product liability accrual   73    97 
           
Contingent liabilities (Note 21)   
    
 
           
Stockholders’ Equity          
Common stock, non-voting, par value $1:          
Authorized shares – 50,000; none issued
   
 
    
 
 
Common stock, par value $1:          
Authorized shares – 40,000,000          
2022 – 24,378,568 issued,          
17,664,230 outstanding          
2021 – 24,306,486 issued,          
17,596,588 outstanding
   24,378    24,306 
Additional paid-in capital   45,075    46,847 
Retained earnings   393,097    438,098 
Less: Treasury stock – at cost          
2022 – 6,714,338 shares          
2021 – 6,709,898 shares
   (145,812)   (145,590)
Total Stockholders’ Equity   316,738    363,661 
Total Liabilities and Stockholders’ Equity  $484,763   $442,343 

 

See accompanying notes to consolidated financial statements.

49 

Consolidated Statements of Income and Comprehensive Income

(In thousands, except per share data)

 

Year ended December 31,  2022   2021   2020 
                
Net firearms sales  $593,289   $728,141   $565,863 
Net castings sales   2,553    2,595    3,005 
Total net sales   595,842    730,736    568,868 
                
Cost of products sold   415,757    451,179    377,427 
                
Gross profit   180,085    279,557    191,441 
                
Operating Expenses (Incomes):               
Selling   36,114    33,259    33,332 
General and administrative   40,551    43,289    39,013 
Other operating expense (income), net   (36)   (127)   (52)
Total operating expenses   76,629    76,421    72,293 
                
Operating income   103,456    203,136    119,148 
                
Other income:               
Royalty income   837    1,975    814 
Interest income   2,552    49    1,126 
Interest expense   (256)   (164)   (191)
Other income, net   1,690    1,598    84 
Total other income, net   4,823    3,458    1,833 
                
Income before income taxes   108,279    206,594    120,981 
                
Income taxes   19,947    50,695    30,583 
                
Net income and comprehensive income  $88,332   $155,899   $90,398 
                
                
Basic Earnings Per Share  $5.00   $8.87   $5.17 
                
Diluted Earnings Per Share  $4.96   $8.78   $5.09 
                
Weighted average number of common shares outstanding – Basic   17,648,850    17,585,604    17,486,054 
                
Weighted average number of common shares outstanding – Diluted   17,793,348    17,757,834    17,769,856 
                
Cash Dividends Per Share  $2.42   $3.36   $6.51 

 

See accompanying notes to consolidated financial statements.

50 

Consolidated Statements of Stockholders’ Equity

(Dollars in thousands)

 

   Common
Stock
   Additional
Paid-in
Capital
   Retained
Earnings
   Treasury
Stock
   Total 
Balance at December 31, 2019  $24,160   $38,683   $368,205   $(145,590)  $285,458 
Net income             90,398         90,398 
Dividends paid             (113,896)        (113,896)
Stock-based compensation        6,128              6,128 
Vesting of RSU’s        (1,297)             (1,297)
Common stock issued – compensation plans   46    (46)             
 
Unpaid dividends accrued             (2,092)        (2,092)
Balance at December 31, 2020   24,206    43,468    342,615    (145,590)   264,699 
Net income             155,899         155,899 
Dividends paid             (59,104)        (59,104)
Stock-based compensation        8,280              8,280 
Vesting of RSU’s        (4,801)             (4,801)
Common stock issued – compensation plans   100    (100)             
 
Unpaid dividends accrued             (1,312)        (1,312)
Balance at December 31, 2021   24,306    46,847    438,098    (145,590)   363,661 
Net income             88,332         88,332 
Dividends paid             (42,718)        (42,718)
Stock-based compensation        1,671              1,671 
Vesting of RSU’s        (3,371)             (3,371)
Common stock issued – compensation plans   72    (72)             
 
Unpaid dividends accrued             (90,615)        (90,615)
Repurchase of 4,440 shares of common stock                  (222)   (222)
Balance at December 31, 2022  $24,378   $45,075   $393,097   $(145,812)  $316,738 

 

See accompanying notes to consolidated financial statements.

51 

Consolidated Statements of Cash Flows

(In thousands)

 

Year ended December 31,  2022   2021   2020 
             
Operating Activities               
Net income  $88,332   $155,899   $90,398 
Adjustments to reconcile net income to cash provided by operating activities, net of effects of acquisition:               
Depreciation and amortization   25,789    26,152    27,576 
Stock-based compensation   1,671    8,280    6,128 
Excess and obsolescence inventory reserve   501    953    
 
Gain on sale of assets   (36)   (127)   (52)
Deferred income taxes   (5,573)   994    3,863 
Changes in operating assets and liabilities:               
Trade receivables   (8,413)   840    (5,236)
Inventories   (21,644)   (15,726)   10,624 
Trade accounts payable and accrued expenses   (640)   (392)   7,954 
Contract liability with customers   1,031    (84)   (9,539)
Employee compensation and benefits   (3,420)   (5,433)   20,910 
Product liability   (584)   (234)   308 
Prepaid expenses, other assets and other liabilities   (954)   1,217    (7,905)
Income taxes receivable/payable   1,171    
    (1,223)
Cash provided by operating activities   77,231    172,339    143,806 
                
Investing Activities               
Property, plant, and equipment additions   (27,730)   (28,776)   (24,229)
Purchase of Marlin assets   
    
    (28,316)
Purchases of short-term investments   (365,480)   (681,940)   (369,439)
Proceeds from maturity of short-term investments   406,319    602,976    377,920 
Net proceeds from sale of assets   100    203    178 
Cash provided by (used for) investing activities   13,209    (107,537)   (43,886)
                
Financing Activities               
Dividends paid   (42,718)   (59,104)   (113,896)
Repurchase of common stock   (222)   
    
 
Payment of employee withholding tax related to  share-based compensation   (3,371)   (4,801)   (1,297)
Cash used for financing activities   (46,311)   (63,905)   (115,193)
                
Increase (decrease) in cash and cash equivalents   44,129    897    (15,273)
Cash and cash equivalents at beginning of year   21,044    20,147    35,420 
Cash and cash equivalents at end of year  $65,173   $21,044   $20,147 

 

See accompanying notes to consolidated financial statements.

52 

Notes to Consolidated Financial Statements

(Dollars in thousands, except per share)

 

1.        Summary of Significant Accounting Policies

 

Organization

 

Sturm, Ruger & Company, Inc. (the “Company”) is principally engaged in the design, manufacture, and sale of firearms to domestic customers. Approximately 99% of sales were from firearms. Export sales represented approximately 6% of firearms sales. The Company’s design and manufacturing operations are located in the United States and almost all product content is domestic. The Company’s firearms are sold through a select number of independent wholesale distributors principally to the commercial sporting market.

 

The Company manufactures investment castings made from steel alloys and metal injection molding (“MIM”) parts for internal use in its firearms and utilizes available capacity to manufacture and sell investment castings and MIM parts to unaffiliated, third-party customers. Castings were less than 1% of the Company’s total sales for the year ended December 31, 2022.

 

Preparation of Financial Statements

 

The Company follows United States generally accepted accounting principles (“GAAP”). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.

 

The significant accounting policies described below, together with the notes that follow, are an integral part of the consolidated financial statements.

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All significant intercompany accounts and transactions have been eliminated.

 

Revenue Recognition

 

The Company recognizes revenue in accordance with the provisions of Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (“ASC 606”), which became effective January 1, 2018. Substantially all product sales are sold FOB (free on board) shipping point. Customary payment terms are 2% 30 days, net 40 days. Generally, all performance obligations are satisfied when product is shipped and the customer takes ownership and assumes the risk of loss. In some instances, sales include multiple performance obligations. The most common of these instances relates to sales promotion programs under which downstream customers are entitled to receive no charge products based on their purchases of certain of the Company’s products from the independent distributors. The fulfillment of these no charge products

53 

is the Company’s responsibility. In such instances, the Company allocates the revenue of the promotional sales based on the estimated level of participation in the sales promotional program and the timing of the shipment of all of the firearms included in the promotional program, including the no charge firearms. Revenue is recognized proportionally as each performance obligation is satisfied, based on the relative customary price of each product. Customary prices are generally determined based on the prices charged to the independent distributors. The net change in contract liabilities for a given period is reported as an increase or decrease to sales. The Company accounts for cash sales discounts as a reduction in sales. Amounts billed to customers for shipping and handling fees are included in net sales and costs incurred by the Company for the delivery of goods are classified as selling expenses. Federal excise taxes are excluded from net sales.

 

Business Combination

 

On September 26, 2020, the Company entered into an Asset Purchase Agreement (the "Agreement") with the Remington Outdoor Company, Inc. and each of the subsidiaries of the Remington Outdoor Company, Inc. (collectively, “Remington”) to purchase substantially all of the assets (the “Marlin Assets”) used to manufacture Marlin Firearms (the “Marlin Acquisition”). The agreement to purchase these assets emanated from the Remington Outdoor Company, Inc. bankruptcy and was approved by the United States Bankruptcy Court for the Northern District of Alabama on September 30, 2020. The Marlin Acquisition was conducted through a Bankruptcy Court-supervised process, subject to Bankruptcy Court-approved bidding procedures, approval of the transactions by the Bankruptcy Court, and the satisfaction of certain closing conditions. The Company closed on the Marlin Acquisition on November 23, 2020.

 

The Agreement provided that, upon the terms and subject to the conditions set forth therein, Remington sold, transferred and assigned to the Company the Marlin Assets (as defined in the Agreement) for a purchase price of $28.3 million in cash. The Marlin Assets include the following assets, among other things, equipment, inventory, and all intellectual property related to Marlin, including the Marlin names and marks, and all derivatives thereof.

  

The primary purpose of the Marlin Acquisition was to manufacture and sell Marlin branded firearms and generate shareholder value. The Marlin brand aligns with the Ruger brand and the Marlin product portfolio will widen the Company’s diverse product offerings. The transaction was funded by the Company with cash on hand and has been accounted for in accordance with ASC 805 - Business Combinations. ASC 805 requires, among other things, an assignment of the acquisition consideration transferred to the sellers for the tangible and intangible assets acquired, using the bottom up approach, to estimate their value at acquisition date. Any excess of the fair value of the purchase consideration over these identified net assets was recorded as goodwill. Our estimates of fair value were based upon assumptions believed to be reasonable, yet were inherently uncertain. During the measurement period, which did not exceed one year from the date of acquisition, we recorded adjustments totaling $2.2 million to the estimated fair values of the assets acquired and liabilities assumed with a corresponding adjustment to goodwill. These adjustments were recorded in the year ended December 31, 2021.

54 

Cash and Cash Equivalents

 

The Company considers interest-bearing deposits with financial institutions with remaining maturities of three months or less at the time of acquisition to be cash equivalents.

 

Fair Value Measurements of Short-term Investments

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the principal or most advantageous market at the measurement date. Fair value is established according to a hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below:

 

Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.

 

Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.

 

Level 3: Unobservable inputs are used when little or no market data is available. Level 3 inputs are given the lowest priority in the fair value hierarchy.

 

The asset or liability’s fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs.

 

As of December 31, 2022, the Company’s short-term investments consist of U.S. Treasury instruments (Level 1), maturing within one year, and investments in a bank-managed money market fund that invests exclusively in United States Treasury obligations and is valued at the net asset value ("NAV") daily closing price, as reported by the fund, based on the amortized cost of the fund’s securities (Level 2). For the bank-managed money market fund, the NAV is used as a practical expedient to estimate fair value. This practical expedient is not used when it is determined to be probable that the fund will sell the investment for an amount different than the reported NAV. Such securities are classified as held to maturity, since the Company has the intent and ability to do so, and are carried at cost plus accrued interest, which approximates fair value.

 

The fair value of inventory acquired as part of business combination is based on a third-party valuation utilizing the comparable sales method which is based on Level 2 and Level 3 inputs. The fair value of property, plant and equipment acquired as part of business combination is based on a third-party valuation utilizing the indirect method of cost approach, which is based on Level 2 and Level 3 inputs. The fair value of patents acquired as part of business combination is based on a third-party valuation utilizing the replacement cost method, which is based on Level 2 and Level 3 inputs. The fair value of the remaining intangible assets as part of business combination are based on a third-party valuation utilizing discounted cash flow methods that involves inputs, which are not observable in the market (Level 3).

55 

Accounts Receivable

 

The Company establishes an allowance for doubtful accounts based on the creditworthiness of its customers and historical experience. While the Company uses the best information available to make its evaluation, future adjustments to the allowance for doubtful accounts may be necessary if there are significant changes in economic and industry conditions or any other factors considered in the Company’s evaluation. Bad debt expense has been immaterial during each of the last three years. The Company mitigates its credit risk by maintaining credit insurance on most of its significant customers.

 

Inventories

 

Substantially all of the Company’s inventories are valued at the lower of cost, principally determined by the last-in, first-out (LIFO) method, or net realizable value. Elements of cost in inventories include raw materials, direct labor and manufacturing overhead.

 

Property, Plant, and Equipment

 

Property, plant, and equipment are carried at cost. Depreciation is computed over useful lives using the straight-line and declining balance methods predominately over 15 years for buildings, 7 years for machinery and equipment and 3 years for tools and dies. When assets are retired, sold or otherwise disposed of, their gross carrying values and related accumulated depreciation are removed from the accounts and a gain or loss on such disposals is recognized when appropriate.

 

Maintenance and repairs are charged to operations; replacements and improvements are capitalized.

 

Long-lived Assets

 

The Company evaluates the carrying value of long-lived assets to be held and used when events or changes in circumstances indicate the carrying value may not be recoverable. In performing this review, the carrying value of the assets is compared to the projected undiscounted cash flows to be generated from the assets. If the sum of the undiscounted expected future cash flows is less than the carrying value of the assets, the assets are considered to be impaired. Impairment losses are measured as the amount by which the carrying value of the assets exceeds their fair value. The Company bases fair value of the assets on quoted market prices if available or, if not available, quoted market prices of similar assets. Where quoted market prices are not available, the Company estimates fair value using the estimated future cash flows generated by the assets discounted at a rate commensurate with the risks associated with the recovery of the assets. As of December 31, 2022, the Company does not believe there are any indications of impairment related to long-lived assets.

 

Goodwill

 

Our goodwill represents the excess of the purchase price of business combinations over the fair value of the net assets acquired. We assess goodwill for impairment on an annual basis during the fourth quarter of each year, and between annual tests whenever events or changes in circumstances

56 

indicate that the carrying amount may not be recoverable. An impairment exists by the amount the fair value of a reporting unit to which goodwill has been allocated is less than their respective carrying values. The impairment for goodwill is limited to the total amount of goodwill allocated to the reporting unit. Goodwill impairment testing requires significant judgment and management estimates, including, but not limited to, the determination of (i) the number of reporting units, (ii) the goodwill and other assets and liabilities to be allocated to the reporting units and (iii) the fair values of the reporting units. The estimates and assumptions described above, along with other factors such as discount rates, will significantly affect the outcome of the impairment tests and the amounts of any resulting impairment losses. As of December 31, 2022, the Company does not believe there are any indications of impairment related to goodwill.

 

Income Taxes

 

Income taxes are accounted for using the asset and liability method. Under this method, deferred income taxes are recognized for the tax consequences of “temporary differences” by applying enacted statutory rates applicable to future years to temporary differences between the financial statement carrying amounts and the tax basis of the Company’s assets and liabilities.

 

Product Liability

 

The Company provides for product liability claims including estimated legal costs to be incurred defending such claims. The provision for product liability claims is charged to cost of products sold.

 

Advertising Costs

 

The Company includes advertising costs in selling expenses and these costs are expensed as incurred. Advertising costs for 2022, 2021, and 2020, were $2.4 million, $2.6 million, and $2.7 million, respectively.

 

Shipping Costs

 

Costs incurred related to the shipment of products are included in selling expense. Such costs totaled $4.7 million, $4.2 million, and $3.9 million in 2022, 2021, and 2020, respectively.

 

Research and Development

 

In 2022, 2021, and 2020, the Company spent approximately $9.6 million, $11.7 million, and $8.0 million, respectively, on research and development activities relating to new products and the improvement of existing products. These costs are included in costs of products sold and are expensed as incurred.

 

Earnings per Share

 

Basic earnings per share is based upon the weighted-average number of shares of common stock outstanding during the year. Diluted earnings per share reflect the impact of options, restricted stock units, and deferred stock outstanding using the treasury stock method.

57 

2.       Acquisition of Marlin Assets

 

As described in Note 1, the Company closed on the Marlin Acquisition on November 23, 2020. The Company paid $28.3 million dollars in cash for the Marlin Assets from Remington.

 

The Marlin Acquisition was accounted for in accordance with ASC Topic 805, Business Combinations. Accordingly, the total purchase price has been allocated to tangible assets based on their fair value and the intangibles and goodwill have been allocated on a provisional basis at the date of acquisition. The Company assumed no liabilities in this transaction. These allocations reflect various provisional estimates that were available at the time and are subject to change during the purchase price allocation period until the valuations are finalized.

 

The Company recorded measurement period adjustments in accordance with FASB’s guidance regarding business combinations in the fourth quarter of 2021 based on its valuation and purchase price allocation procedures, to better reflect the facts and circumstances that existed at the acquisition date. The measurement period adjustments, which were completed during the fourth quarter of 2021, resulted in an increase to goodwill of $2.4 million, primarily due to a decrease in the estimated fair value of inventory received.

 

The following table summarizes the Company's allocation of the purchase price:

 

    Initial Purchase
Price Allocation
    Measurement
Period
Adjustments
    Final Purchase
Price Allocation
 
Purchase Price               
Cash paid to sellers  $28,316   $
   $28,316 
Purchase Price Allocation               
Assets Acquired               
Inventory  $11,400   $(2,414)  $8,986 
Machinery and equipment   5,000    (25)   4,975 
Tradename and trademarks   7,800         7,800 
Patents   2,500         2,500 
Customer Relationships   1,000         1,000 
Goodwill   616    2,439    3,055 
Net Assets Acquired  $28,316   $
   $28,316 

 

Identifiable assets acquired were recorded at their estimated fair values based on the methodology described under “Fair Value Measurements” in Note 1 - Significant Accounting Policies.

 

The Machinery and Equipment acquired in the Marlin Acquisition were classified as deposits on capital items in Other Assets on the Company’s Consolidated Balance Sheet at December 31,

58 

2021. Certain of these items were reclassified as Machinery and Equipment when they were placed in service in 2022 and 2021.

 

Intangible assets acquired in the Marlin Acquisition are reflected in Other Assets on the Company’s Consolidated Balance Sheet at December 31, 2022. Intangible assets are amortized over their estimated remaining useful lives using a straight-line methodology.

 

   Remaining Economic
Useful Life
Tradename and trademarks  20 years
Patents  20 years
Customer Relationships  15 years

 

The excess purchase price over the fair value of the assets acquired was recorded as goodwill in the amount of $3.1 million. The Company incurred acquisition related costs of $1.7 million, which are included in selling, general and administrative expenses in the Company’s Consolidated Statements of Income and Comprehensive Income for the fiscal year ended December 31, 2020.

 

The pro forma impact of the acquisition and the results of operations attributable to Marlin in 2019 and 2020 have not been presented, as they are not material to the Company’s consolidated results of operations. The impact on sales and gross margin was no more than 5% of the reported amounts in either period, the trend in annual sales growth was unchanged, and the impact on gross margin percentage was less than 1%, in both periods.

 

3.       Revenue Recognition and Contracts with Customers

 

The impact of ASC 606 on revenue recognized during the years ended December 31, 2022, December 31, 2021, and December 31, 2020 is as follows:

    2022    2021    2020 
Contract liabilities with customers at January 1,  $
   $84   $9,623 
                
Revenue recognized   
    (84)   (14,570)
                
Revenue deferred   1,031    
    5,031 
                
Contract liabilities with customers at December 31,  $1,031   $
   $84 

 

During the year ended December 31, 2022, the Company deferred $1.0 million of revenue. There was no offset for the recognition from previously deferred revenue as the Company did not satisfy any performance obligations relating to the shipment of free products during the year. This resulted in a net decrease in firearms sales for the year ended December 31, 2022 of $1.0 million and a deferred contract revenue liability at December 31, 2022 of $1.0 million. The Company

59 

estimates that revenue from this deferred contract liability will be recognized in the first half of 2023.

 

During the year ended December 31, 2021, there were no promotions giving rise to deferred contract liabilities and, therefore, there was no additional deferred revenue. Previously deferred revenue of $0.1 million was recognized in the first quarter of 2021. The Company did not have a deferred contract revenue liability at December 31, 2021.

 

During the year ended December 31, 2020, the Company deferred $5.0 million of revenue, offset by the recognition of $14.6 million of revenue previously deferred as the performance obligations relating to the shipment of free products were satisfied. This resulted in a net increase in firearms sales for the year ended December 31, 2020 of $9.6 million and a deferred contract revenue liability at December 31, 2020 of $0.1 million. The deferred revenue balance was significantly reduced due to the absence of promotions in the fourth quarter of 2020.

 

Practical Expedients and Exemptions

 

The Company has elected to account for shipping and handling activities that occur after control of the related product transfers to the customer as fulfillment activities that are recognized upon shipment of the goods.

 

4.       Trade Receivables, Net

 

Trade receivables consist of the following:

 

December 31,  2022   2021 
         
Trade receivables  $67,183   $58,605 
Allowance for doubtful accounts   (400)   (400)
Allowance for discounts   (1,334)   (1,169)
   $65,449   $57,036 

 

In 2022, the largest individual trade receivable balances accounted for 26%, 23%, and 18% of total trade receivables, respectively.

 

In 2021, the largest individual trade receivable balances accounted for 34%, 17%, and 17% of total trade receivables, respectively.

60 

5.       Inventories

 

Inventories consist of the following:

 

December 31,  2022   2021 
Inventory at FIFO          
Finished goods  $23,573   $7,322 
Materials and products in process   105,721    92,701 
Gross inventories   129,294    100,023 
Less:  LIFO reserve   (59,489)   (51,826)
Less:  excess and obsolescence reserve   (4,812)   (4,347)
Net Inventories  $64,993   $43,850 

 

6.       Property, Plant and Equipment

 

Property, plant and equipment consist of the following:

 

December 31,  2022   2021 
         
Land and improvements  $2,826   $2,686 
Buildings and improvements   72,788    62,781 
Machinery and equipment   314,032    302,241 
Dies and tools   57,480    53,574 
Property, plant and equipment   447,126    421,282 
Less allowances for depreciation   (370,273)   (347,651)
Net property, plant and equipment  $76,853   $73,631 

 

Depreciation expense totaled $24.4 million, $25.8 million, and $27.3 million in 2022, 2021, and 2020, respectively.

 

7.       Other Assets

Other assets consist of the following:

 

December 31,  2022   2021 
         
Patents, at cost  $10,126   $10,024 
Accumulated amortization   (6,318)   (5,360)
Deposits on capital items   17,106    18,026 
Marlin trade name   7,800    7,800 
Other   11,249    8,953 
   $39,963   $39,443 

 

The capitalized cost of patents is amortized using the straight-line method over their useful lives. Expenses related to patent amortization was $0.4 million in 2022 and $0.3 million in 2021, and 2020. The estimated annual patent amortization expense for each of the next five years is $0.2

61 

million. Costs incurred to maintain existing patents are charged to expense in the year incurred. The Marlin trade name will be amortized using the straight-line method over its useful life. The estimated annual trade name amortization cost for each of the next five years is $0.4 million. The intangible asset related to Marlin customer relationships are included in Other above and will be amortized using the straight-line method over its useful life. The estimated annual customer relationship name amortization expense for each of the next five years is $0.1 million.

 

8.       Leased Assets

 

The Company leases certain of its real estate and equipment. The Company has evaluated all its leases and determined that all are operating leases under the definitions of the guidance of ASU 2016-02. The Company’s lease agreements generally do not require material variable lease payments, residual value guarantees or restrictive covenants.

 

The Company adopted the provisions of ASU 2016-02 using the effective interest method on January 1, 2019 and recorded right-of-use assets equal to the present value of the contractual liability for future lease payments. The table below presents the right-of-use assets and related lease liabilities recognized on the condensed consolidated balance sheet as of December 31, 2022:

 

   Balance Sheet Line
Item
  December 31,
2022
   December 31,
2021
 
Right-of-use assets  Other assets  $3,681   $1,694 
              
Operating lease liabilities             
              
Current portion  Trade accounts payable and accrued expenses  $642   $249 
              
Noncurrent portion  Lease liabilities   3,039    1,476 
              
Total operating lease liabilities     $3,681   $1,725 

 

The depreciable lives of right-of-use assets are limited by the lease term and are amortized on a straight line basis over the life of the lease.

62 

 

The Company’s leases generally do not provide an implicit interest rate, and therefore the Company calculates an incremental borrowing rate to determine the present value of its operating lease liabilities. The following table reconciles the undiscounted future minimum lease payments to the total operating lease liabilities recognized on the condensed consolidated balance sheet as of December 31, 2022:

 

2023  $803 
2024   808 
2025   702 
2026   705 
2027   229 
Thereafter   1,120 
Total undiscounted future minimum lease payments   4,367 
Less: Difference between undiscounted lease payments & the present value of future lease payments   (686)
Total operating lease liabilities  $3,681 

 

Certain of the Company’s lease agreements contain renewal options at the Company’s discretion. The Company does not recognize right-of-use assets or lease liabilities for leases of one year or less or for renewal periods unless it is reasonably certain that the Company will exercise the renewal option at the inception of the lease or when a triggering event occurs. The Company’s weighted average remaining lease term for operating leases as of December 31, 2022 is 8.9 years.

 

9.       Trade Accounts Payable and Accrued Expenses

Trade accounts payable and accrued expenses consist of the following:

 

December 31,  2022   2021 
           
Trade accounts payable  $13,281   $12,209 
Federal excise taxes payable   13,635    15,734 
Accrued other   8,742    8,457 
   $35,658   $36,400 

 

10.       Accrued Dividends

On November 30, 2022, the Company’s Board of Directors declared a $5.00 per share special dividend payable on January 5, 2023 to stockholders of record as of December 15, 2022. The dividend, which totaled $88.3 million, was paid on January 5, 2023.

 

11.       Line of Credit

During 2021 the Company had a $40 million unsecured revolving line of credit with a bank. This facility terminated on September 30, 2021. On January 7, 2022, the Company entered into a new $40 million unsecured revolving line of credit agreement with a different bank that expires January 7, 2025. Borrowings under this new facility bear interest at either 1) the Bloomberg short-Term

63 

Bank Yield Index – 1 month plus 150 basis points, or 2) a fluctuating rate per annum equal to the greater of (i) the Bank’s prime rate or (ii) the federal funds rate plus 50 basis points. The Company is also charged one-quarter of a percent (0.25%) per year on the unused portion. At December 31, 2022, the Company was in compliance with the terms and covenants of the credit facility.

 

12.       Employee Benefit Plans

 

The Company sponsors a qualified defined-contribution 401(k) plan that covers substantially all of its employees. Under the terms of the 401(k) plan, the Company matches a certain portion of employee contributions to their individual 401(k) accounts using the “safe harbor” guidelines provided in the Internal Revenue Code. Expenses related to matching employee contributions to the 401(k) plan were $4.1 million, $4.0 million, and $3.3 million in 2022, 2021, and 2020, respectively.

 

Additionally, in 2022, 2021, and 2020 the Company provided discretionary supplemental contributions to the individual 401(k) accounts of substantially all employees. Each employee received a supplemental contribution to their account based on a uniform percentage of qualifying compensation established annually. The cost of these supplemental contributions totaled $7.4 million, $7.4 million, and $5.6 million in 2022, 2021, and 2020, respectively.

 

13.       Other Operating Income, Net

 

Other operating income, net consists of the following:

 

Year ended December 31,  2022   2021   2020 
                
Gain on sale of operating assets  $36   $127   $52 

 

14.       Income Taxes

 

The Company files income tax returns in the U.S. federal jurisdiction and various state jurisdictions. With few exceptions, the Company is no longer subject to U.S. federal and state income tax examinations by tax authorities for years before 2017.

 

The federal and state income tax provision consisted of the following:

 

Year ended December 31,  2022   2021   2020 
   Current   Deferred   Current   Deferred   Current   Deferred 
Federal  $21,741   $(4,694)  $42,422   $863   $20,201   $3,696 
State   3,779    (879)   7,279    131    6,519    167 
   $25,520   $(5,573)  $49,701   $994   $26,720   $3,863 

64 

 

The effective income tax rate varied from the statutory federal income tax rate as follows:

 

Year ended December 31,  2022   2021   2020 
Statutory federal income tax rate   21.0%    21.0%    21.0% 
State income taxes, net of federal tax benefit   2.7    3.4    4.4 
Research and development tax credits   (4.2)   (0.4)   
 
Other   (1.1)   0.5    (0.1)
Effective income tax rate   18.4%    24.5%    25.3% 

 

The Company estimates that its effective tax rate in 2023 will approximate 22.4%.

 

Significant components of the Company’s deferred tax assets and liabilities are as follows:

 

December 31,  2022   2021 
Deferred tax assets          
Product Liability  $69   $224 
Capitalized research and development costs   4,838    
 
Employee compensation and benefits   2,316    2,643 
Allowances for doubtful accounts and discounts   637    418 
Inventories   1,196    1,224 
Stock-based compensation   1,661    1,538 
Other   1,636    1,538 
Total deferred tax assets   12,353    7,585 
Deferred tax liabilities:          
Depreciation   5,070    6,235 
Other   1,174    814 
Total deferred tax liabilities   6,244    7,049 
Net deferred tax assets  $6,109   $536 

 

Prior to 2022, the Company expensed research and development costs in the period in which they were incurred for both financial accounting and income tax purposes. In 2022 the Company adopted the provisions of the Tax Cuts and Jobs Act of 2017 that relate to IRS Code Section 174. Under these provisions, research and development costs must be capitalized and amortized over five years for income tax purposes. The Company continues to expense these costs in the period incurred for financial accounting purposes.

 

The Company made income tax payments of approximately $28.7 million, $49.5 million, and $30.6 million, during 2022, 2021, and 2020, respectively. The Company expects to realize its deferred tax assets through tax deductions against future taxable income.

 

The Company does not believe it has included any “uncertain tax positions” in its federal income tax return or any of the state income tax returns it is currently filing. The Company has made an evaluation of the potential impact of additional state taxes being assessed by jurisdictions in which the Company does not currently consider itself liable. The Company does not anticipate that such additional taxes, if any, would result in a material change to its financial position.

 

65 

15.       Earnings Per Share

Set forth below is a reconciliation of the numerator and denominator for the basic and diluted earnings per share calculations for the periods indicated:

 

Year ended December 31,  2022   2021   2020 
                
Numerator:               
Net income  $88,332   $155,899   $90,398 
Denominator:               
Weighted average number of common shares outstanding – Basic   17,648,850    17,585,604    17,486,054 
Dilutive effect of options and restricted stock units outstanding under the Company’s employee compensation plans   144,498    172,230    283,802 
Weighted average number of common shares outstanding – Diluted   17,793,348    17,757,834    17,769,856 

 

16.       Stock Repurchases

In 2022 the Company repurchased shares of its common stock. Details of these purchases are as follows:

 

Period  Total
Number of
Shares
Purchased
  Average
Price Paid
per Share
  Total
Number of
Shares
Purchased
as Part of
Publicly
Announced
Program
  Maximum
Dollar
Value of
Shares that
May Yet Be
Purchased
Under the
Program
                     
Third Quarter 2022                    
July 3 to July 30   
—  
    
—  
    
—  
    
 
 
July 31 to August 27   
—  
    
—  
    
—  
    
 
 
August 28 to October 1   2,136   $49.97    2,136    
 
 
Fourth Quarter 2022                    
October 2 to October 29   
—  
    
—  
    
—  
    
 
 
October 30 to November 26   2,304   $49.77    2,304    
 
 
November 27 to December 31   
—  
    
—  
    
—  
    
 
 
Total   4,440   $49.87    4,440   $86,490,000 

 

All of these purchases were made with cash held by the Company and no debt was incurred. No shares were repurchased in 2020 and 2021.

66 

At December 31, 2022, approximately $86.5 million remained authorized for share repurchases.

 

17.       Compensation Plans

 

In May 2017, the Company’s shareholders approved the 2017 Stock Incentive Plan (the “2017 SIP”) under which employees, independent contractors, and non-employee directors may be granted stock options, restricted stock, deferred stock awards, and stock appreciation rights, any of which may or may not require the satisfaction of performance objectives. Vesting requirements are determined by the Compensation Committee of the Board of Directors. The Company has reserved 750,000 shares for issuance under the 2017 SIP, of which approximately 120,000 shares remain available for future grants as of December 31, 2022.

 

Compensation expense related to deferred stock, restricted stock, and restricted stock units is recognized based on the grant-date fair value of the Company’s common stock, using either the actual share price or an estimated value using the Monte Carlo valuation model. The total stock-based compensation cost included in the Statements of Income was $5.7 million, $8.3 million, and $6.1 million in 2022, 2021, and 2020, respectively.

 

Deferred Stock

 

Deferred stock awards vest based on the passage of time or the Company’s attainment of performance objectives. Upon vesting, these awards convert one-for-one to common stock.

 

In 2022, 5,953 deferred stock awards were issued to non-employee directors that will vest in May 2023, 7,688 deferred stock awards were issued to non-employee directors that will vest in May 2025 and a 1,478 deferred stock award was issued to a non-employee director that will vest in June 2027.

 

In 2021, 5,113 deferred stock awards were issued to non-employee directors that vested in May 2022 and 6,615 deferred stock awards were issued to non-employee directors that will vest in May 2024.

 

In 2020, 6,244 deferred stock awards were issued to non-employee directors that vested in May 2021 and 8,078 deferred stock awards were issued to non-employee directors that will vest in May 2023.

 

Compensation expense related to these awards is amortized ratably over the vesting period. Compensation expense related to these awards was $0.8 million in 2022, $0.8 million in 2021, and $0.8 in 2020.

 

At December 31, 2022, there was $0.9 million of unrecognized compensation cost related to deferred stock that is expected to be recognized over a period of three years.

 

67 

Restricted Stock Units

 

The Company grants restricted stock units (RSU’s) to senior employees. Some of these RSU’s are retention awards and have only time-based vesting. Other RSU’s have a vesting “double trigger.” The vesting of these RSU’s is dependent on the achievement of corporate objectives established by the Compensation Committee of the Board of Directors, including stock performance relative to industry indices, return on net operating assets, and the passage of time.

 

During 2022, 82,000 restricted stock units were issued. Compensation costs related to these restricted stock units was $6.0 million, of which $1.7 million was recognized in 2022. The costs are being recognized ratably over the remaining periods required before the units vest, which range from 24 to 26 months.

 

During 2021, 82,000 restricted stock units were issued. Compensation costs related to these restricted stock units was $5.6 million, of which $1.6 million was recognized in 2021. The costs are being recognized ratably over the remaining periods required before the units vest, which range from 24 to 26 months.

 

During 2020, 95,000 restricted stock units were issued. Compensation costs related to these restricted stock units was $5.7 million, of which $1.1 million was recognized in 2020. The costs are being recognized ratably over the remaining periods required before the units vest, which range from 24 to 26 months.

 

At December 31, 2022, there was $8.1 million of unrecognized compensation cost related to restricted stock units that is expected to be recognized over a period of 3.3 years.

 

18.       Operating Segment Information

 

The Company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors primarily located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts.

 

Corporate segment income relates to interest income, the sale of non-operating assets, and other non-operating activities. Corporate segment assets consist of cash and other non-operating assets.

 

The Company evaluates performance and allocates resources, in part, based on income (loss) before taxes. The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies (see Note 1). Intersegment sales are recorded at the Company’s cost plus a fixed profit percentage.

 

68 

Year ended December 31,  2022   2021   2020 
Net Sales               
Firearms  $593,289   $728,141   $565,863 
Castings               
Unaffiliated   2,553    2,595    3,005 
Intersegment   21,306    24,711    22,254 
    23,859    27,306    25,259 
Eliminations   (21,306)   (24,711)   (22,254)
   $595,842   $730,736   $568,868 
Income (Loss) Before Income Taxes               
Firearms  $108,610   $207,657   $120,732 
Castings   (3,338)   (2,732)   (1,000)
Corporate   3,007    1,669    1,249 
   $108,279   $206,594   $120,981 
Identifiable Assets               
Firearms  $223,301   $188,290   $174,500 
Castings   11,910    13,889    11,959 
Corporate   249,552    240,164    161,799 
   $484,763   $442,343   $348,258 
Goodwill               
Firearms  $3,055   $3,055   $616 
Castings   209    209    209 
   $3,264   $3,264   $825 
Depreciation               
Firearms  $21,992   $22,842   $25,126 
Castings   2,452    2,959    2,158 
   $24,444   $25,801   $27,284 
Capital Expenditures               
Firearms  $26,598   $25,239   $19,253 
Castings   1,175    3,537    4,976 
   $27,773   $28,776   $24,229 

 

In 2022, the Company’s largest customers and the percent of firearms sales they represented were as follows: Lipsey’s - 23%; Davidson’s - 23%; and Sports South - 21%.

 

In 2021, the Company’s largest customers and the percent of firearms sales they represented were as follows: Lipsey’s - 21%; Sports South - 19%; and Davidson’s - 19%.

 

In 2020, the Company’s largest customers and the percent of firearms sales they represented were as follows: Sports South - 22%; Lipsey’s - 22%; and Davidson’s - 18%.

 

The Company’s assets are located entirely in the United States and domestic sales represented at least 94% of total sales in 2022, 2021, and 2020.

69 

19.       Quarterly Results of Operations (Unaudited)

 

The following is a tabulation of the unaudited quarterly results of operations for the two years ended December 31, 2022:

 

   Three Months Ended 
    4/2/22    7/2/22    10/1/22    12/31/22 
Net Sales  $166,575   $140,653   $139,390   $149,224 
Gross profit   58,108    43,554    38,869    39,554 
Net income   30,232    20,757    18,389    18,954 
Basic earnings per share   1.72    1.18    1.04    1.07 
Diluted earnings per share  $1.70   $1.17   $1.03   $1.06 

 

 

   Three Months Ended 
    4/3/21    7/3/21    10/2/21    12/31/21 
Net Sales  $184,377   $200,072   $178,246   $168,041 
Gross profit   72,566    78,757    64,802    63,432 
Net income   38,192    44,384    35,202    38,121 
Basic earnings per share   2.18    2.52    2.00    2.17 
Diluted earnings per share  $2.16   $2.50   $1.98   $2.14 

 

20.       Related Party Transactions

 

From time to time, the Company contracts with the National Rifle Association (“NRA”) for some of its promotional and advertising activities. The Company paid the NRA $0.7 million, $0.5 million and $0.6 million in 2022, 2021 and 2020, respectively. One of the Company’s Directors also serves as a Director on the Board of the NRA.

 

The Company is a member of the National Shooting Sports Foundation (“NSSF”), the firearm industry trade association. The Company paid the NSSF $0.3 million, $0.4 million and $0.5 million in 2022, 2021 and 2020, respectively. One of the Company’s Directors also serves on the Board of the NSSF.

 

21.       Contingent Liabilities

 

As of December 31, 2022, the Company was a defendant in eight (8) lawsuits and is aware of certain other such claims. The lawsuits generally fall into three categories: traditional product liability litigation, municipal litigation and negligence. Each is discussed in turn below.

 

Traditional Product Liability Litigation

 

One lawsuit mentioned above involves a claim for damages related to an allegedly defective product due to its design and/or manufacture. The lawsuit stems from a specific incident of personal injury and is based on traditional product liability theories such as strict liability, negligence, and/or breach of warranty.

70 

The Company management believes that the allegations in these cases are unfounded, that the incidents are unrelated to the design or manufacture of the firearms involved, and that there should be no recovery against the Company.

 

Municipal Litigation

 

Municipal litigation generally includes those cases brought by cities or other governmental entities against firearms manufacturers, distributors and retailers seeking to recover damages allegedly arising out of the misuse of firearms by third parties. There are four (4) lawsuits of this type, as follows:

 

(i) City of Gary v. Smith & Wesson Corp., et al, filed in Indiana State Court in 1999; (ii) Estados Unidos Mexicanos v. Smith & Wesson Brands, Inc., et al., filed in August 2021 in the U.S. District Court for the District of Massachusetts; (iii) The City of Buffalo v. Smith & Wesson Brands, Inc., et al., filed in December 2022 in the New York State Supreme Court for Erie County, New York and presently pending in the U.S. District Court for the Western District of New York; and (iv) The City of Rochester v. Smith & Wesson Brands, Inc., et al., filed in December 2022 in the New York State Supreme Court for Monroe County, New York and presently pending in the U.S. District Court for the Western District of New York.

 

The Complaint in City of Gary v. Smith & Wesson Corp., et al. was filed in 1999 and seeks damages, among other things, for the costs of medical care, police and emergency services, public health services, and other services as well as punitive damages. In addition, nuisance abatement and/or injunctive relief is sought to change the design, manufacture, marketing and distribution practices of the various defendants. The suit alleges, among other claims, negligence in the design of products, public nuisance, negligent distribution and marketing, negligence per se and deceptive advertising. The case does not allege a specific injury to a specific individual as a result of the misuse or use of any of the Company's products.

 

After a long procedural history, the case was scheduled for trial on June 15, 2009. The case was not tried on that date and was largely dormant until a status conference was held on July 27, 2015. At that time, the court entered a scheduling order setting deadlines for plaintiff to file a Second Amended Complaint, for defendants to answer, and for defendants to file dispositive motions. The plaintiff did not file a Second Amended Complaint by the deadline.

 

In 2015, Indiana passed a new law such that Indiana Code §34-12-3-1 became applicable to the City's case. The defendants filed a joint motion for judgment on the pleadings, asserting immunity under §34-12-3-1 and asking the court to revisit the Court of Appeals' decision holding the Protection of Lawful Commerce in Arms Act inapplicable to the City's claims.

 

On September 29, 2016, the court entered an order staying the case pending a decision by the Indiana Supreme Court in KS&E Sports v. Runnels, which presented related issues. The Indiana Supreme Court decided KS&E Sports on April 24, 2017, and the City of Gary court lifted the stay. The City of Gary court also entered an order setting a supplemental briefing schedule under which the parties addressed the impact of the KS&E Sports decision on defendants' motion for judgment on the pleadings.

 

71 

A hearing on the motion for judgment on the pleadings was held on December 12, 2017. On January 2, 2018, the court issued an order granting defendants’ motion for judgment on the pleadings, but denying defendants’ request for attorney’s fees and costs. On January 8, 2018, the court entered judgment for the defendants. The City filed a Notice of Appeal on February 1, 2018. Defendants cross-appealed the order denying attorney’s fees and costs.

 

Briefing in the Indiana Court of Appeals was completed on the City’s appeal and Defendants’ cross appeal on September 10, 2018. The Court of Appeals issued its ruling on May 23, 2019, affirming dismissal of the City’s negligent design and warnings count on the basis that the City had not alleged that Manufacturer Defendants’ conduct was unlawful. However, the court reversed dismissal of the City’s negligent sale and distribution and related public nuisance counts for damages and injunctive relief.

 

The Manufacturer Defendants filed a Petition to Transfer the case to the Indiana Supreme Court on July 8, 2019. The Petition was denied on November 26, 2019. The case was remanded to the trial court for further proceedings.

 

During the quarter ended April 3, 2021, the City initiated discovery and the Manufacturer Defendants reciprocated. Discovery is ongoing.

 

Estados Unidos Mexicanos v. Smith & Wesson Brands, Inc., et al. was filed by the Country of Mexico and names seven defendants, mostly U.S.-based firearms manufacturers, including the Company. The Complaint advances a variety of legal theories including negligence, public nuisance, unjust enrichment, restitution, and others. Plaintiff essentially alleges that the defendants design, manufacture, distribute, market and sell firearms in a way that they know results in the illegal trafficking of firearms into Mexico, where they are used by Mexican drug cartels for criminal activities. Plaintiff seeks injunctive relief and monetary damages.

 

On November 22, 2021, Defendants filed a joint Rule 12(b)(6) motion to dismiss the Mexican Government’s complaint based on the Government’s lack of Article III standing, Protection of Lawful Commerce in Arms Act immunity, and lack of proximate cause. The Company, along with other non-Massachusetts defendants, also filed a Rule 12(b)(2) motion to dismiss based on lack of specific personal jurisdiction. The motions were fully briefed and the court heard oral argument on April 12, 2022. On September 30, 2022, the court entered an order granting the defendants’ joint Rule 12(b)(6) motion. The Company’s Rule 12(b)(2) motion was denied as moot, without prejudice. On October 26, 2022, the plaintiff filed a Notice of Appeal and the Court has entered a briefing schedule.

 

On December 20, 2022, the City of Buffalo, New York filed a lawsuit captioned The City of Buffalo v. Smith & Wesson Brands, Inc., et al. in the New York State Supreme Court for Erie County, New York. The suit names a number of firearm manufacturers, distributors, and retailers as defendants, including the Company, and purports to state causes of action for violations of Sections 898, 349 and 350 of the New York General Business Law, as well as common law public nuisance. Generally, plaintiff alleges that the criminal misuse of firearms in the City of Buffalo is the result of the manufacturing, sales, marketing, and distribution practices of the defendants. The

72 

defendants timely removed the matter to the U.S. District Court for the Western District of New York.

 

On December 21, 2022, the City of Rochester, New York filed a lawsuit captioned The City of Rochester v. Smith & Wesson Brands, Inc., et al. in the New York State Supreme Court for Monroe County, New York. The suit names a number of firearm manufacturers, distributors, and retailers as defendants, including the Company, and purports to state causes of action for violations of Sections 898, 349 and 350 of the New York General Business Law, as well as common law public nuisance. The allegations essentially mirror those in The City of Buffalo, discussed in the preceding paragraph, as plaintiff claims that the criminal misuse of firearms in Rochester, New York is the result of the manufacturing, sales, marketing, and distribution practices of the defendants. The defendants timely removed the matter to the U.S. District Court for the Western District of New York.

 

Negligence

 

Rossiter v. Sturm, Ruger, et al. is a lawsuit arising out of a slip and fall accident by a contract security officer in December 2019. The Complaint was filed in the Superior Court for Sullivan County, New Hampshire on December 13, 2022 and names Pine Hill Construction, a snow removal contractor, as a co-defendant. The Company has tendered the defense of this matter to its insurance carrier and is assisting as required.

 

The Company was named in two purported class action lawsuits arising out of a data breach at Freestyle Solutions, Inc., the vendor who was hosting the Company ShopRuger.com website at the time of the breach. Jones v. Sturm, Ruger & Co., was filed in the U.S. District Court for Connecticut on October 4, 2022 and Copeland v. Sturm, Ruger & Company, et al. was filed in the U.S. District Court for New Jersey on October 27, 2022. Copeland also named Freestyle Solutions, Inc. as a defendant. By agreement of the parties, Copeland was dismissed, without prejudice, and consolidated with Jones in the pending Connecticut case. On January 20, 2023, five plaintiffs filed an Amended Complaint naming the Company and Freestyle Software, Inc. as defendants. The Complaint alleges causes of action for negligence, breach of implied warranties, and unjust enrichment.

 

Summary of Claimed Damages and Explanation of Product Liability Accruals

 

Punitive damages, as well as compensatory damages, are demanded in certain of the lawsuits and claims. In many instances, the plaintiff does not seek a specified amount of money, though aggregate amounts ultimately sought may exceed product liability accruals and applicable insurance coverage. For product liability claims made after July 10, 2000, coverage is provided on an annual basis for losses exceeding $5 million per claim, or an aggregate maximum loss of $10 million annually, except for certain new claims which might be brought by governments or municipalities after July 10, 2000, which are excluded from coverage.

 

The Company management monitors the status of known claims and the product liability accrual, which includes amounts for asserted and unasserted claims. While it is not possible to forecast the outcome of litigation or the timing of costs, in the opinion of management, after

73 

consultation with special and corporate counsel, it is not probable and is unlikely that litigation, including punitive damage claims, will have a material adverse effect on the financial position of the Company, but may have a material impact on the Company’s financial results for a particular period.

 

Product liability claim payments are made when appropriate if, as, and when claimants and the Company reach agreement upon an amount to finally resolve all claims. Legal costs are paid as the lawsuits and claims develop, the timing of which may vary greatly from case to case.

 

A time schedule cannot be determined in advance with any reliability concerning when payments will be made in any given case.

 

Provision is made for product liability claims based upon many factors related to the severity of the alleged injury and potential liability exposure, based upon prior claim experience. Because the Company's experience in defending these lawsuits and claims is that unfavorable outcomes are typically not probable or estimable, only in rare cases is an accrual established for such costs.

 

In most cases, an accrual is established only for estimated legal defense costs. Product liability accruals are periodically reviewed to reflect then-current estimates of possible liabilities and expenses incurred to date and reasonably anticipated in the future. Threatened product liability claims are reflected in the Company's product liability accrual on the same basis as actual claims; i.e., an accrual is made for reasonably anticipated possible liability and claims handling expenses on an ongoing basis.

 

A range of reasonably possible losses relating to unfavorable outcomes cannot be made. However, in product liability cases in which a dollar amount of damages is claimed, the amount of damages claimed, which totaled $1.1 million at December 31, 2021, is set forth as an indication of possible maximum liability the Company might be required to incur in these cases (regardless of the likelihood or reasonable probability of any or all of this amount being awarded to claimants) as a result of adverse judgments that are sustained on appeal. At December 31, 2022, the total amount claimed specifically in these cases was de minimis.

 

During 2022, no traditional product liability lawsuit was filed against the Company and one (1) was resolved. As of December 31, 2022, the Company was a defendant five lawsuits involving its products, including one (1) traditional product liability lawsuit and four (4) municipal lawsuits. The Company also was a defendant in three (3) negligence lawsuits though, as discussed above, that number has since been reduced to two (2) lawsuits with the consolidation of the Jones and Copeland matters.

 

During 2021, one (1) traditional product liability lawsuit was filed against the Company.  As of December 31, 2021, the Company was a defendant in four (4) lawsuits involving its products, including two (2) traditional lawsuits and two (2) municipal lawsuits.

 

During 2020, one (1) traditional product liability lawsuit was filed against the Company and one (1) was resolved.  As of December 31, 2020, the Company was a defendant in three (3) lawsuits involving its products, including two (2) traditional lawsuits and one (1) municipal lawsuit.

 

74 

The Company’s product liability expense was $1.3 million in 2022, $1.1 million in 2021, and $1.1 million in 2020. This expense includes the cost of outside legal fees, and other expenses incurred in the management and defense of product liability matters.

 

A roll-forward of the product liability reserve and detail of product liability expense for the three years ended December 31, 2022 follows:

 

Balance Sheet Roll-forward for Product Liability Reserve

  

           Cash Payments     
   Balance
Beginning
of Year (a)
   Accrued
Legal
Expense
(Income)
(b)
   Legal Fees
(c)
   Settlements
(d)
   Balance
End of
Year (a)
 
                          
2020  $818    800    (492)   
   $1,126 
                          
2021  $1,126    (7)   (227)   
   $892 
                          
2022  $892    (417)   (167)   
   $308 

 

Income Statement Detail for Product Liability Expense

 

   Accrued
Legal
Expense
(b)
   Insurance
Premium
Expense
(e)
   Total
Product
Liability
Expense
 
                
2020  $800    839   $1,639 
                
2021  $(7)   1,119   $1,112 
                
2022  $(417)   1,524   $1,107 

 

Notes

 

(a)The beginning and ending liability balances represent accrued legal fees only. Settlements and administrative costs are expensed as incurred. Only in rare instances is an accrual established for settlements.

 

(b)The expense accrued in the liability is for legal fees only. In 2022 and 2021, the costs incurred related to cases that were settled or dismissed were less than the amounts accrued for these cases in prior years.

 

(c) Legal fees represent payments to outside counsel related to product liability matters.

 

(d)Settlements represent payments made to plaintiffs or allegedly injured parties in exchange for a full and complete release of liability.

 

75 

(e) Insurance expense represents the cost of insurance premiums.

 

There were no insurance recoveries during any of the above years.

 

22.       Financial Instruments

The Company does not hold or issue financial instruments for trading or hedging purposes, nor does it hold interest rate, leveraged, or other types of derivative financial instruments. Fair values of accounts receivable, accounts payable, accrued expenses and income taxes payable reflected in the December 31, 2022 and 2021 balance sheets approximate carrying values at those dates.

 

23.       Subsequent Events

 

On February 17, 2023, the Company’s Board of Directors authorized a dividend of 42¢ per share to shareholders of record on March 10, 2023.

 

The Company’s management has evaluated transactions occurring subsequent to December 31, 2022 and determined that there were no events or transactions during that period that would have a material impact on the Company’s results of operations or financial position.

76 

ITEM 9— CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 

None.

 

ITEM 9A—CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

The Company conducted an evaluation, with the participation of its Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, as of December 31, 2022. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that as of December 31, 2022, the Company’s disclosure controls and procedures over financial reporting were effective.

 

Management’s Report on Internal Control over Financial Reporting

 

The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

The Company conducted an evaluation, with the participation of its Chief Executive Officer and Chief Financial Officer, of the effectiveness of its internal control over financial reporting as of December 31, 2022. This evaluation was performed based on the criteria established in “Internal Control — Integrated Framework” issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) in 2013.

 

Management has concluded that the Company maintained effective internal control over financial reporting as of December 31, 2022, based on criteria established in “Internal Control — Integrated Framework” issued by the COSO in 2013.

 

The effectiveness of the Company’s internal control over financial reporting as of December 31, 2022 has been audited by RSM US LLP, an independent registered public accounting firm, as stated in their report which is included in this Form 10-K.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting that occurred during our most recently completed fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

77 

New York Stock Exchange Certification

Pursuant to Section 303A.12(a) of the New York Stock Exchange Listed Company Manual, the Company submitted an unqualified certification of our Chief Executive Officer to the New York Stock Exchange in 2022. The Company has also filed, as exhibits to this Annual Report on Form 10-K, the Chief Executive Officer and Chief Financial Officer Certifications required under the Sarbanes-Oxley Act of 2002.

 

ITEM 9B—OTHER INFORMATION

 

None.

 

ITEM 9C—DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

 

Not applicable.

 

PART III

 

ITEM 10—DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 

Information concerning the Company’s directors, including the Company’s separately designated standing audit committee, and on the Company’s code of business conduct and ethics required by this Item is incorporated by reference from the Company’s Proxy Statement relating to the 2023 Annual Meeting of Stockholders scheduled to be held June 1, 2023, which will be filed with the SEC in April 2023.

 

Information concerning the Company’s executive officers required by this Item is set forth in Item 1 of this Annual Report on Form 10-K under the caption “Executive Officers of the Company.”

 

Information concerning beneficial ownership reporting compliance required by this Item is incorporated by reference from the Company’s Proxy Statement relating to the 2023 Annual Meeting of Stockholders scheduled to be held June 1, 2023, which will be filed with the SEC in April 2023.

 

ITEM 11—EXECUTIVE COMPENSATION

 

Information concerning director and executive compensation required by this Item is incorporated by reference from the Company’s Proxy Statement relating to the 2023 Annual Meeting of Stockholders scheduled to be held June 1, 2023, which will be filed with the SEC in April 2023.

78 

ITEM 12— SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 

Information concerning the security ownership of certain beneficial owners and management and related stockholder matters required by this Item is incorporated by reference from the Company’s Proxy Statement relating to the 2023 Annual Meeting of Stockholders scheduled to be held June 1, 2023, which will be filed with the SEC in April 2023.

 

Securities Authorized for Issuance Under Equity Compensation Plans

 

The following table provides information regarding compensation plans under which equity securities of the Company are authorized for issuance as of December 31, 2022:

 

Equity Compensation Plan Information
Plan category Number of securities to
be issued upon exercise of
outstanding options,
warrants and rights

(a)
Weighted-average
exercise price of
outstanding options,
warrants and rights

(b) *
Number of securities
remaining available for
future issuance under
equity compensation
plans (excluding
securities reflected in
column (a))

(c)
Equity compensation plans approved by security holders      
      -
2017 Stock Incentive Plan 288,586 - 121,034
       
Equity compensation plans not approved by security holders      
       
None.      
Total 288,586 - 121,034

 

*Restricted stock units are settled in shares of common stock or the cash equivalent. Accordingly, the weighted-average exercise price is not applicable.

 

ITEM 13—CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE

 

Information concerning certain relationships and related transactions required by this Item is incorporated by reference from the Company’s Proxy Statement relating to the 2023 Annual Meeting of Stockholders scheduled to be held June 1, 2023.

79 

 

ITEM 14—PRINCIPAL ACCOUNTANT FEES AND SERVICES

 

Information concerning the Company’s principal accountant fees and services and the pre-approval policies and procedures of the audit committee of the board of directors required by this Item is incorporated by reference from the Company’s Proxy Statement relating to the 2023 Annual Meeting of Stockholders scheduled to be held June 1, 2023, which will be filed with the SEC in April 2023.

 

 

 

 

80 

 

PART IV

 

ITEM 15—EXHIBITS AND FINANCIAL STATEMENT SCHEDULE

 

(a)Exhibits and Financial Statement Schedule

 

(1)Financial Statements can be found under Item 8 of Part II of this Form 10-K

 

(2)Schedule can be found on Page 94 of this Form 10-K

 

(3)Listing of Exhibits:

 

Exhibit 3.1 Certificate of Incorporation of the Company, as amended (Incorporated by reference to Exhibits 4.1 and 4.2 to the Form S-3 Registration Statement previously filed by the Company File No. 33-62702).
   
Exhibit 3.2 Bylaws of the Company, as amended through November 12, 2019.
   
Exhibit 4.1 Description of the Company’s Securities.
   
Exhibit 10.1 Severance Agreement, dated as of April 10, 2008, by and between the Company and Thomas A. Dineen (Incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed with the SEC on April 11, 2008).
   
Exhibit 10.2 Severance Agreement, dated as of April 10, 2008, by and between the Company and Thomas P. Sullivan (Incorporated by reference to Exhibit 10.6 to the Company's Current Report on Form 8-K filed with the SEC on April 11, 2008).
   
Exhibit 10.3 Severance Agreement, dated as of May 2, 2008 by and between the Company and Kevin B. Reid, Sr. (Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the SEC on May 5, 2008).
   
Exhibit 10.4 Transition Services and Consulting Agreement, dated August 1, 2016, by and between the Company and Michael O. Fifer (Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the SEC on August 2, 2016).
   
Exhibit 10.5 Amended and Restated Agreement, dated November 10, 2020, by and between the Company and Christopher J. Killoy (Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K/A filed with the SEC on November 12, 2020).

 

81 

Exhibit 10.6 Executive Severance Agreement, dated August 1, 2016, by and between the Company and Shawn C. Leska (Incorporated by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K filed with the SEC on August 2, 2016).
   
Exhibit 10.7 Loan Agreement, dated January 7, 2022 between Sturm, Ruger & Company, Inc. and Regions Bank. (Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the SEC on January 11, 2022), as amended by that certain Amendment to Credit Agreement, dated November 3, 2022, between Sturm, Ruger & Company, Inc. and Regions Bank (Incorporated by reference to Exhibit 99.1 to the Company’s Current Report on Form 8-K filed with the SEC on November 4, 2022).
   
Exhibit 10.8 The Sturm, Ruger & Company, Inc. 2017 Stock Incentive Plan (incorporated by reference to Annex A of the Company’s Definitive Proxy Statement of Schedule 14A, filed with the SEC on March 27, 2017)
   
Exhibit 23.1 Consent of RSM US LLP
   
Exhibit 31.1 Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) of the Exchange Act.
   
Exhibit 31.2 Certification of Treasurer and Chief Financial Officer Pursuant to Rule 13a-14(a) of the Exchange Act.
   
Exhibit 32.1 Certification of the Chief Executive Officer Pursuant to Rule 13a-14(b) of the Exchange Act and 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
Exhibit 32.2 Certification of the Treasurer and Chief Financial Officer Pursuant to Rule 13a-14(b) of the Exchange Act and 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
Exhibit 101.INS* XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
   
Exhibit 101.SCH* Inline XBRL Taxonomy Extension Schema Document
   
Exhibit 101.CAL* Inline XBRL Taxonomy Extension Calculation Linkbase Document
   
Exhibit 101.DEF* Inline XBRL Taxonomy Extension Definition Linkbase Document
   
Exhibit 101.LAB* Inline XBRL Taxonomy Extension Label Linkbase Document
   

82 

Exhibit 101.PRE* Inline XBRL Taxonomy Extension Presentation Linkbase Document
   
Exhibit 104* Cover Page Interactive Data File – the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
   
*Filed herewith  

83 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  STURM, RUGER & COMPANY, INC.
  (Registrant)
   
   
  S/THOMAS A. DINEEN
  Thomas A. Dineen
  Principal Financial Officer
  Principal Accounting Officer, Senior Vice President,
  Treasurer, and Chief Financial Officer
   
   
  February 22, 2023
  Date

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

S/CHRISTOPHER J. KILLOY 2/22/23   S/RONALD C. WHITAKER 2/22/23
Christopher J. Killoy
Chief Executive Officer, Director
(Principal Executive Officer)
    Ronald C. Whitaker
Director
 
         
S/JOHN A. COSENTINO, JR. 2/22/23   S/PHILLIP C. WIDMAN 2/22/23
John A. Cosentino, Jr.
Director
    Phillip C. Widman
Director
 
         
S/AMIR P. ROSENTHAL 2/22/23   S/SANDRA S. FROMAN 2/22/23
Amir P. Rosenthal
Director
    Sandra S. Froman
Director
 
         
S/TERRENCE G. O’CONNOR 2/22/23   S/REBECCA S. HALSTEAD 2/22/23
Terrence G. O’Connor
Director
    Rebecca S. Halstead
Director
 
         
S/MICHAEL O. FIFER 2/22/23   S/THOMAS A. DINEEN 2/22/23
Michael O. Fifer
Director
    Thomas A. Dineen
Principal Financial Officer
Principal Accounting Officer, Senior Vice
President, Treasurer, and Chief Financial Officer

84 

EXHIBIT INDEX

 

    Page
No.
Exhibit 3.1 Certificate of Incorporation of the Company, as amended (Incorporated by reference to Exhibits 4.1 and 4.2 to the Form S-3 Registration Statement previously filed by the Company File No. 33-62702).  
     
Exhibit 3.2 Bylaws of the Company, as amended through November 12, 2019.  
     
Exhibit 4.1 Description of the Company’s Securities.  
     
Exhibit 10.1 Severance Agreement, dated as of April 10, 2008, by and between the Company and Thomas A. Dineen (Incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed with the SEC on April 11, 2008).  
     
Exhibit 10.2 Severance Agreement, dated as of April 10, 2008, by and between the Company and Thomas P. Sullivan (Incorporated by reference to Exhibit 10.6 to the Company's Current Report on Form 8-K filed with the SEC on April 11, 2008).  
     
Exhibit 10.3 Severance Agreement, dated as of May 2, 2008 by and between the Company and Kevin B. Reid, Sr. (Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the SEC on May 2, 2008).  
     
Exhibit 10.4 Transition Services and Consulting Agreement, dated August 1, 2016, by and between the Company and Michael O. Fifer (Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the SEC on August 2, 2016).  
     
Exhibit 10.5 Amended and Restated Agreement, dated November 10, 2020, by and between the Company and Christopher J. Killoy (Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K/A filed with the SEC on November 12, 2020).  
     
Exhibit 10.6 Executive Severance Agreement, dated August 1, 2016, by and between the Company and Shawn C. Leska (Incorporated by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K filed with the SEC on August 2, 2016).  
     
Exhibit 10.7 Loan Agreement, dated January 7, 2022 between Sturm, Ruger & Company, Inc. and Regions Bank. (Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the SEC on January 11, 2022) , as amended by that certain Amendment to Credit Agreement, dated November 3, 2022, between Sturm, Ruger & Company, Inc. and Regions Bank (Incorporated by reference to Exhibit 99.1 to the Company’s Current Report on Form 8-K filed with the SEC on November 4, 2022).  

 

85 

EXHIBIT INDEX (continued)

 

Exhibit 10.8 The Sturm, Ruger & Company, Inc. 2017 Stock Incentive Plan (incorporated by reference to Annex A of the Company’s Definitive Proxy Statement of Schedule 14A, filed with the SEC on March 27, 2017)  
     
Exhibit 23.1 Consent of RSM US LLP 89
     
Exhibit 31.1 Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) of the Exchange Act. 90
     
Exhibit 31.2 Certification of Treasurer and Chief Financial Officer Pursuant to Rule 13a-14(a) of the Exchange Act. 92
     
Exhibit 32.1 Certification of the Chief Executive Officer Pursuant to Rule 13a-14(b) of the Exchange Act and 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 94
     
Exhibit 32.2 Certification of the Treasurer and Chief Financial Officer Pursuant to Rule 13a-14(b) of the Exchange Act and 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 95
     
Exhibit 101.INS* Inline XBRL Instance Document– the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.  
     
Exhibit 101.SCH* Inline XBRL Taxonomy Extension Schema Document  
     
Exhibit 101.CAL* Inline XBRL Taxonomy Extension Calculation Linkbase Document  
     
Exhibit 101.DEF* Inline XBRL Taxonomy Extension Definition Linkbase Document  
     
Exhibit 101.LAB* Inline XBRL Taxonomy Extension Label Linkbase Document  
     
Exhibit 101.PRE* Inline XBRL Taxonomy Extension Presentation Linkbase Document  
     
Exhibit 104* Cover Page Interactive Data File – the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.  
     
*Filed herewith    

86 

YEAR ENDED DECEMBER 31, 2022

STURM, RUGER & COMPANY, INC.



ITEMS 15(a)
FINANCIAL STATEMENT SCHEDULE

 

87 

 

Sturm, Ruger & Company, Inc.

 

Item 15(a)--Financial Statement Schedule

 

Schedule II—Valuation and Qualifying Accounts

 

(In Thousands)

 

 

COL. A  COL. B   COL. C   COL. D   COL. E 
       ADDITIONS         
Description  Balance at
Beginning
of Period
   (1)
Charged
(Credited) to
Costs and
Expenses
   (2)
Charged to
Other
Accounts
–Describe
   Deductions   Balance
at End
of
Period
 
                     
Deductions from asset accounts:                         
Allowance for doubtful accounts:                         
Year ended December 31, 2022  $400   $        $   $400 
Year ended December 31, 2021  $400   $        $   $400 
Year ended December 31, 2020  $400   $        $   $400 
                          
Allowance for discounts:                         
Year ended December 31, 2022  $1,169   $13,849        $13,684(a)  $1,334 
Year ended December 31, 2021  $1,166   $16,116        $16,113(a)  $1,169 
Year ended December 31, 2020  $1,070   $12,482        $12,386(a)  $1,166 
                          
Excess and obsolete inventory reserve:                         
Year ended December 31, 2022  $4,347   $465        $(b)  $4,812 
Year ended December 31, 2021  $3,394   $953        $(b)  $4,347 
Year ended December 31, 2020  $3,573   $(179)       $(b)  $3,394 

 

(a)Discounts taken
(b)Inventory written off

 

88 

STURM RUGER & CO INC Yes No Yes Yes 1 1 17664230 24306486 24378568 40000000 40000000 1 1 6714338 The beginning and ending liability balances represent accrued legal fees only. Settlements and administrative costs are expensed as incurred. Only in rare instances is an accrual established for settlements. The expense accrued in the liability is for legal fees only. In 2022 and 2021, the costs incurred related to cases that were settled or dismissed were less than the amounts accrued for these cases in prior years. Legal fees represent payments to outside counsel related to product liability matters. Settlements represent payments made to plaintiffs or allegedly injured parties in exchange for a full and complete release of liability. Insurance expense represents the cost of insurance premiums. false FY 0000095029 0000095029 2022-01-01 2022-12-31 0000095029 2022-06-30 0000095029 2023-02-15 0000095029 2022-12-31 0000095029 2021-12-31 0000095029 us-gaap:NonvotingCommonStockMember 2022-12-31 0000095029 us-gaap:NonvotingCommonStockMember 2021-12-31 0000095029 us-gaap:CommonStockMember 2022-12-31 0000095029 us-gaap:CommonStockMember 2021-12-31 0000095029 rgr:FirearmsMember 2022-01-01 2022-12-31 0000095029 rgr:FirearmsMember 2021-01-01 2021-12-31 0000095029 rgr:FirearmsMember 2020-01-01 2020-12-31 0000095029 rgr:UnaffiliatedCastingsMember 2022-01-01 2022-12-31 0000095029 rgr:UnaffiliatedCastingsMember 2021-01-01 2021-12-31 0000095029 rgr:UnaffiliatedCastingsMember 2020-01-01 2020-12-31 0000095029 2021-01-01 2021-12-31 0000095029 2020-01-01 2020-12-31 0000095029 us-gaap:CommonStockMember 2019-12-31 0000095029 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000095029 us-gaap:RetainedEarningsMember 2019-12-31 0000095029 us-gaap:TreasuryStockMember 2019-12-31 0000095029 2019-12-31 0000095029 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0000095029 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0000095029 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0000095029 us-gaap:CommonStockMember 2020-12-31 0000095029 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000095029 us-gaap:RetainedEarningsMember 2020-12-31 0000095029 us-gaap:TreasuryStockMember 2020-12-31 0000095029 2020-12-31 0000095029 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0000095029 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0000095029 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0000095029 us-gaap:CommonStockMember 2021-12-31 0000095029 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000095029 us-gaap:RetainedEarningsMember 2021-12-31 0000095029 us-gaap:TreasuryStockMember 2021-12-31 0000095029 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0000095029 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0000095029 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0000095029 us-gaap:TreasuryStockMember 2022-01-01 2022-12-31 0000095029 us-gaap:CommonStockMember 2022-12-31 0000095029 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000095029 us-gaap:RetainedEarningsMember 2022-12-31 0000095029 us-gaap:TreasuryStockMember 2022-12-31 0000095029 us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember rgr:FirearmsMember 2022-01-01 2022-12-31 0000095029 us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember rgr:UnaffiliatedCastingsMember 2022-01-01 2022-12-31 0000095029 srt:MinimumMember us-gaap:SalesMember us-gaap:NonUsMember 2022-01-01 2022-12-31 0000095029 rgr:RemingtonOutdoorCompanyMembeMember 2022-01-01 2022-12-31 0000095029 us-gaap:BuildingMember 2022-01-01 2022-12-31 0000095029 us-gaap:MachineryAndEquipmentMember 2022-01-01 2022-12-31 0000095029 us-gaap:ToolsDiesAndMoldsMember 2022-01-01 2022-12-31 0000095029 rgr:InitialPurchasePriceAcquisitionMember 2020-01-01 2020-12-31 0000095029 rgr:InitialPurchasePriceAllocationMember 2021-10-31 2021-12-31 0000095029 rgr:MarlinAcquisitionMember 2020-01-01 2020-12-31 0000095029 srt:MaximumMember rgr:MarlinAcquisitionMember 2020-01-01 2020-12-31 0000095029 srt:MinimumMember rgr:MarlinAcquisitionMember 2020-01-01 2020-12-31 0000095029 rgr:InitialPurchasePriceAllocationMember 2020-01-01 2020-12-31 0000095029 rgr:MeasurementPeriodAdjustmentsMember 2021-01-01 2021-12-31 0000095029 rgr:FinalPurchasePriceAllocationMember 2020-01-01 2020-12-31 0000095029 rgr:InitialPurchasePriceAllocationMember rgr:InventoryMember 2020-12-31 0000095029 rgr:MeasurementPeriodAdjustmentsMember rgr:InventoryMember 2021-12-31 0000095029 rgr:FinalPurchasePriceAllocationMember rgr:InventoryMember 2020-12-31 0000095029 rgr:InitialPurchasePriceAllocationMember us-gaap:MachineryAndEquipmentMember 2020-12-31 0000095029 rgr:MeasurementPeriodAdjustmentsMember us-gaap:MachineryAndEquipmentMember 2021-12-31 0000095029 rgr:FinalPurchasePriceAllocationMember us-gaap:MachineryAndEquipmentMember 2020-12-31 0000095029 rgr:InitialPurchasePriceAllocationMember us-gaap:TrademarksAndTradeNamesMember 2020-12-31 0000095029 rgr:FinalPurchasePriceAllocationMember us-gaap:TrademarksAndTradeNamesMember 2020-12-31 0000095029 rgr:InitialPurchasePriceAllocationMember us-gaap:PatentsMember 2020-12-31 0000095029 rgr:FinalPurchasePriceAllocationMember us-gaap:PatentsMember 2020-12-31 0000095029 rgr:InitialPurchasePriceAllocationMember us-gaap:CustomerRelationshipsMember 2020-12-31 0000095029 rgr:FinalPurchasePriceAllocationMember us-gaap:CustomerRelationshipsMember 2020-12-31 0000095029 rgr:InitialPurchasePriceAllocationMember us-gaap:GoodwillMember 2020-12-31 0000095029 rgr:MeasurementPeriodAdjustmentsMember us-gaap:GoodwillMember 2021-12-31 0000095029 rgr:FinalPurchasePriceAllocationMember us-gaap:GoodwillMember 2020-12-31 0000095029 rgr:InitialPurchasePriceAllocationMember 2020-12-31 0000095029 rgr:MeasurementPeriodAdjustmentsMember 2021-12-31 0000095029 rgr:FinalPurchasePriceAllocationMember 2020-12-31 0000095029 rgr:MarlinAcquisitionMember us-gaap:TrademarksAndTradeNamesMember 2022-01-01 2022-12-31 0000095029 rgr:MarlinAcquisitionMember us-gaap:PatentsMember 2022-01-01 2022-12-31 0000095029 rgr:MarlinAcquisitionMember us-gaap:CustomerRelationshipsMember 2022-01-01 2022-12-31 0000095029 2021-01-01 2021-03-31 0000095029 rgr:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0000095029 rgr:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0000095029 rgr:CustomerThreeMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0000095029 rgr:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0000095029 rgr:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0000095029 rgr:CustomerThreeMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0000095029 us-gaap:LandAndLandImprovementsMember 2022-12-31 0000095029 us-gaap:LandAndLandImprovementsMember 2021-12-31 0000095029 us-gaap:BuildingAndBuildingImprovementsMember 2022-12-31 0000095029 us-gaap:BuildingAndBuildingImprovementsMember 2021-12-31 0000095029 us-gaap:MachineryAndEquipmentMember 2022-12-31 0000095029 us-gaap:MachineryAndEquipmentMember 2021-12-31 0000095029 us-gaap:ToolsDiesAndMoldsMember 2022-12-31 0000095029 us-gaap:ToolsDiesAndMoldsMember 2021-12-31 0000095029 us-gaap:PatentsMember 2022-12-31 0000095029 rgr:TradeNameMember 2022-12-31 0000095029 us-gaap:CustomerRelationshipsMember 2022-12-31 0000095029 us-gaap:OtherAssetsMember 2022-12-31 0000095029 us-gaap:OtherAssetsMember 2021-12-31 0000095029 rgr:TradeAccountsPayableAndAccruedExpensesMember 2022-12-31 0000095029 rgr:TradeAccountsPayableAndAccruedExpensesMember 2021-12-31 0000095029 rgr:LeaseLiabilitiesMember 2022-12-31 0000095029 rgr:LeaseLiabilitiesMember 2021-12-31 0000095029 rgr:OperatingLeaseMember 2022-12-31 0000095029 2022-11-30 0000095029 us-gaap:SubsequentEventMember 2023-01-05 0000095029 us-gaap:LineOfCreditMember 2021-12-31 0000095029 us-gaap:LineOfCreditMember 2022-01-07 0000095029 us-gaap:LineOfCreditMember 2022-01-01 2022-01-07 0000095029 us-gaap:LineOfCreditMember 2022-01-01 2022-12-31 0000095029 srt:ScenarioForecastMember 2023-01-01 2023-12-31 0000095029 srt:WeightedAverageMember 2022-01-01 2022-12-31 0000095029 srt:WeightedAverageMember 2021-01-01 2021-12-31 0000095029 srt:WeightedAverageMember 2020-01-01 2020-12-31 0000095029 rgr:July3ToJuly30Member 2022-12-31 0000095029 rgr:July3ToJuly30Member 2022-01-01 2022-12-31 0000095029 rgr:July31ToAugust27Member 2022-12-31 0000095029 rgr:July31ToAugust27Member 2022-01-01 2022-12-31 0000095029 rgr:August28ToOctober1Member 2022-12-31 0000095029 rgr:August28ToOctober1Member 2022-01-01 2022-12-31 0000095029 rgr:October2ToOctober29Member 2022-12-31 0000095029 rgr:October2ToOctober29Member 2022-01-01 2022-12-31 0000095029 rgr:October3ToNovember26Member 2022-12-31 0000095029 rgr:October3ToNovember26Member 2022-01-01 2022-12-31 0000095029 rgr:November27ToDecember31Member 2022-12-31 0000095029 rgr:November27ToDecember31Member 2022-01-01 2022-12-31 0000095029 rgr:StockIncentivePlan2017Member 2022-12-31 0000095029 rgr:VestInMay2023Member srt:DirectorMember rgr:DeferredStockMember 2022-01-01 2022-12-31 0000095029 rgr:VestingInMay2025Member srt:DirectorMember rgr:DeferredStockMember 2022-01-01 2022-12-31 0000095029 rgr:VestInJune2027Member srt:DirectorMember rgr:DeferredStockMember 2022-01-01 2022-12-31 0000095029 rgr:VestingMayTwoThousandTwentyTwoMember srt:DirectorMember rgr:DeferredStockMember 2021-01-01 2021-12-31 0000095029 rgr:VestingMayTwoThousandTwentyThreeMember srt:DirectorMember rgr:DeferredStockMember 2021-01-01 2021-12-31 0000095029 rgr:VestingMayTwoThousandTwentyOneMember srt:DirectorMember rgr:DeferredStockMember 2020-01-01 2020-12-31 0000095029 rgr:VestingMayTwoThousandTwentyThreeMember srt:DirectorMember rgr:DeferredStockMember 2020-01-01 2020-12-31 0000095029 rgr:DeferredStockMember 2022-01-01 2022-12-31 0000095029 rgr:DeferredStockMember 2021-01-01 2021-12-31 0000095029 rgr:DeferredStockMember 2020-01-01 2020-12-31 0000095029 rgr:DeferredStockMember 2022-12-31 0000095029 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0000095029 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0000095029 srt:MinimumMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0000095029 srt:MaximumMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0000095029 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0000095029 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0000095029 srt:MinimumMember us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0000095029 srt:MaximumMember us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0000095029 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-12-31 0000095029 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0000095029 srt:MinimumMember us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-12-31 0000095029 srt:MaximumMember us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-12-31 0000095029 rgr:LipseysMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0000095029 rgr:DavidsonsMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0000095029 rgr:SportsSouthMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0000095029 rgr:LipseysMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0000095029 rgr:SportsSouthMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0000095029 rgr:DavidsonsMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0000095029 rgr:SportsSouthMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0000095029 rgr:LipseysMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0000095029 rgr:DavidsonsMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0000095029 country:US us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0000095029 country:US us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0000095029 country:US us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:FirearmsMember 2022-01-01 2022-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:FirearmsMember 2021-01-01 2021-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:FirearmsMember 2020-01-01 2020-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:UnaffiliatedCastingsMember 2022-01-01 2022-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:UnaffiliatedCastingsMember 2021-01-01 2021-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:UnaffiliatedCastingsMember 2020-01-01 2020-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:IntersegmentMember 2022-01-01 2022-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:IntersegmentMember 2021-01-01 2021-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:IntersegmentMember 2020-01-01 2020-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:CastingsMember 2022-01-01 2022-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:CastingsMember 2021-01-01 2021-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:CastingsMember 2020-01-01 2020-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:EliminationsMember 2022-01-01 2022-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:EliminationsMember 2021-01-01 2021-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:EliminationsMember 2020-01-01 2020-12-31 0000095029 us-gaap:OperatingSegmentsMember 2022-01-01 2022-12-31 0000095029 us-gaap:OperatingSegmentsMember 2021-01-01 2021-12-31 0000095029 us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0000095029 us-gaap:OperatingSegmentsMember us-gaap:CorporateMember 2022-01-01 2022-12-31 0000095029 us-gaap:OperatingSegmentsMember us-gaap:CorporateMember 2021-01-01 2021-12-31 0000095029 us-gaap:OperatingSegmentsMember us-gaap:CorporateMember 2020-01-01 2020-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:FirearmsMember 2022-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:FirearmsMember 2021-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:FirearmsMember 2020-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:UnaffiliatedCastingsMember 2022-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:UnaffiliatedCastingsMember 2021-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:UnaffiliatedCastingsMember 2020-12-31 0000095029 us-gaap:OperatingSegmentsMember us-gaap:CorporateMember 2022-12-31 0000095029 us-gaap:OperatingSegmentsMember us-gaap:CorporateMember 2021-12-31 0000095029 us-gaap:OperatingSegmentsMember us-gaap:CorporateMember 2020-12-31 0000095029 us-gaap:OperatingSegmentsMember 2022-12-31 0000095029 us-gaap:OperatingSegmentsMember 2021-12-31 0000095029 us-gaap:OperatingSegmentsMember 2020-12-31 0000095029 2022-01-03 2022-04-02 0000095029 2022-04-03 2022-07-02 0000095029 2022-07-03 2022-10-01 0000095029 2022-10-02 2022-12-31 0000095029 2021-01-04 2021-04-03 0000095029 2021-04-04 2021-07-03 0000095029 2021-07-04 2021-10-02 0000095029 2021-10-03 2021-12-31 0000095029 rgr:NationalRifleAssociationMember 2020-01-01 2020-12-31 0000095029 rgr:NationalRifleAssociationMember 2021-01-01 2021-12-31 0000095029 rgr:NationalRifleAssociationMember 2022-01-01 2022-12-31 0000095029 rgr:NationalShootingSportsFoundationMember 2022-01-01 2022-12-31 0000095029 rgr:NationalShootingSportsFoundationMember 2021-01-01 2021-12-31 0000095029 rgr:NationalShootingSportsFoundationMember 2020-01-01 2020-12-31 0000095029 rgr:TraditionalLawsuitsMember 2022-01-01 2022-12-31 0000095029 rgr:MunicipalLawsuitsMember 2022-01-01 2022-12-31 0000095029 rgr:NegligenceLawsuitsMember 2022-01-01 2022-12-31 0000095029 rgr:TraditionalLawsuitsMember 2021-01-01 2021-12-31 0000095029 rgr:MunicipalLawsuitsMember 2021-01-01 2021-12-31 0000095029 rgr:TraditionalLawsuitsMember 2020-01-01 2020-12-31 0000095029 rgr:MunicipalLawsuitsMember 2020-01-01 2020-12-31 0000095029 rgr:ProductLiabilityReserveMember 2019-12-31 0000095029 rgr:ProductLiabilityReserveMember 2020-01-01 2020-12-31 0000095029 rgr:ProductLiabilityReserveMember 2020-12-31 0000095029 rgr:ProductLiabilityReserveMember 2021-01-01 2021-12-31 0000095029 rgr:ProductLiabilityReserveMember 2021-12-31 0000095029 rgr:ProductLiabilityReserveMember 2022-01-01 2022-12-31 0000095029 rgr:ProductLiabilityReserveMember 2022-12-31 0000095029 rgr:AccruedLegalExpenseMember 2020-01-01 2020-12-31 0000095029 rgr:ProductInsurancePremiumExpenseMember 2020-01-01 2020-12-31 0000095029 rgr:TotalProductLiabilityExpenseMember 2020-12-31 0000095029 rgr:AccruedLegalExpenseMember 2021-01-01 2021-12-31 0000095029 rgr:ProductInsurancePremiumExpenseMember 2021-01-01 2021-12-31 0000095029 rgr:TotalProductLiabilityExpenseMember 2021-12-31 0000095029 rgr:AccruedLegalExpenseMember 2022-01-01 2022-12-31 0000095029 rgr:ProductInsurancePremiumExpenseMember 2022-01-01 2022-12-31 0000095029 rgr:TotalProductLiabilityExpenseMember 2022-12-31 0000095029 us-gaap:SubsequentEventMember 2023-02-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure
EX-23.1 2 ex23-1.htm EX-23.1

 

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

 

We consent to incorporation by reference in the Registration Statements (Nos. 333-84677 and 333-53234) on Form S-8 of Sturm, Ruger & Company, Inc. of our reports dated February 22, 2023 relating to the consolidated financial statements, the financial statement schedule and the effectiveness of internal control over financial reporting of Sturm, Ruger & Company, Inc., appearing in the Annual Report on Form 10-K of Sturm, Ruger & Company, Inc. for the year ended December 31, 2022.

 

 

 

/s/ RSM US LLP

Stamford, Connecticut

February 22, 2023

 

89 

 

EX-31.1 3 ex31-1.htm EX-31.1

EXHIBIT 31.1

 

CERTIFICATION

 

I, Christopher J. Killoy, certify that:

 

1.I have reviewed this Annual Report on Form 10-K (the “Report”) of Sturm, Ruger & Company, Inc. (the “Registrant”);

 

2.Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this Report, fairly present in all material respects, the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this Report;

 

4.The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

 

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this Report is being prepared;

 

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this Report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this Report based on such evaluation; and

 

d)Disclosed in this Report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting.

 

90 

 

5.The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of Registrant’s board of directors (or persons performing the equivalent functions):

 

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

 

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

 

 

Date: February 22, 2023

 

 

 

S/CHRISTOPHER J. KILLOY                

Christopher J. Killoy

Chief Executive Officer

91 

 

EX-31.2 4 ex31-2.htm EX-31.2

EXHIBIT 31.2

 

CERTIFICATION

 

I, Thomas A. Dineen, certify that:

 

1.I have reviewed this Annual Report on Form 10-K (the “Report”) of Sturm, Ruger & Company, Inc. (the “Registrant”);

 

2.Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this Report, fairly present in all material respects, the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this Report;

 

4.The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

 

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this Report is being prepared;

 

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this Report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this Report based on such evaluation; and

 

d)Disclosed in this Report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting.

 

92 

 

5.The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of Registrant’s board of directors (or persons performing the equivalent functions):

 

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

 

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

 

 

Date: February 22, 2023

 

 

 

S/THOMAS A. DINEEN                      

Thomas A. Dineen

Senior Vice President, Treasurer and

Chief Financial Officer

 

 

93 

 

EX-32.1 5 ex32-1.htm EX-32.1

EXHIBIT 32.1

 

 

Certification Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

 

 

In connection with the Annual Report on Form 10-K of Sturm, Ruger & Company, Inc. (the “Company”) for the period ended December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Christopher J. Killoy, Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

 

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)The information contained in the Report fairly presents, in all material respect, the financial condition and results of operations of the Company.

 

 

 

 

 

Date: February 22, 2023 S/CHRISTOPHER J. KILLOY
  Christopher J. Killoy
  Chief Executive Officer

 

 

 

 

 

 

 

A signed original of this statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

94 

 

EX-32.2 6 ex32-2.htm EX-32.2

EXHIBIT 32.2

 

 

 

Certification Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

 

In connection with the Annual Report on Form 10-K of Sturm, Ruger & Company, Inc. (the “Company”) for the period ended December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Thomas A. Dineen, Senior Vice President, Treasurer and Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

 

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)The information contained in the Report fairly presents, in all material respect, the financial condition and results of operations of the Company.

 

 

 

 

 

 

 

Date: February 22, 2023 S/THOMAS A. DINEEN
  Thomas A. Dineen
  Senior Vice President, Treasurer and
  Chief Financial Officer

 

 

 

 

 

 

A signed original of this statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

95 

 

GRAPHIC 7 image_003.jpg GRAPHIC begin 644 image_003.jpg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

!M7U+4+N M^@U&;5!LA@DCAU>WBAN1N#%F B55,9^4#JP8,&QP*H1>(=V?3I]/*6JQA9&C:*?RQN)"(3F1LAF^48P #T, 8 P**X+PQKVJ3^(+&RO MKG4Y9+NRDGN[>^TTVRVLJ&/*Q/Y:ATR[+]Z0\*=W.3WM !1110 4444 %%%% M !1110 5GZ[<7]KH-_<:9!Y]]' [018SN<#@8R,_3(STK0J.X@2YMY()#($D M4JQCD:-@#Z,I!!]P0: /.T\1:R&U*SL;S6;Z.*.UE:YNM),5W;I)(R2E(O)0 M285=RX1N=WWL;:W_ CK%Q?1:O%/<7=W%8W(CBN+RT-M,ZF)'PZ%$P06(R% M(V]>IT8?#&F6]E<6L0O%%RRM-/\ ;Y_/?;TS-O\ ,P.PW8Y/J:GL]#L+"WB@ MM4FC2.8SD_:)"TCD$$R,6S)G/\9/0>@P $[[4I+[4K'5+B^:6(12Q0Z@D N%1@1N)@ MC*EE.,$D8.>PJY%X.T*'[1MLW99XGA*27$KK'&YRRQJS$1 \<)MZ#T%7-+T. MPT=IGM$F,LV/,FN+F2XE8#H"\C,VT9.!G R>.30!HT444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !6?J>BV.K"-KF(B>+)AN(F*2Q'_9<Q'_+Q;H! MF1JI>79-=R0M*ELNUCN95YP2 N3P,Y- '8T5Y[)X\N3KFFV?]HZ5;VLEC;W% MQ=I:3W4+R2N5"K(K*L:G:<,_<@<\U8\.^-[W5]>LX9HK86&I?;#:"-&62+[/ M*$.\EB&W#)X"XZ<]: .KUC_CRC_Z^K?_ -')5^LO6KJW2*"W:>)9WN;@VZN@M)94:!K<)<74TRQQMC*1J[$1@X'"XZ#T%;]% ''Z=_PBL&K2Z=: MS:DU[-)Y!N9IKQ][1$OY2W+D@X(;**_9@1UJQHO_ C>H:Y/:9I+B$V'E,& :&(, M764\'=M4DO)DD$"M?0Y]8FU.^U35O#NHV]T8"D,?G6S1K&IR(U*S$EV)R68* M. .,9(!-9-X;T/Q!]CCEO&U&?$'G74ES<@$C>(A-(65"1\VS<">#CI6C9^(] M.O\ 4Y;"V^V2312/$[_89Q"&7[P\TILR/]ZLF^EU>^\46D4^@7YTFUD26.6* M6WQ)*1]Z3,H8*F3\H4DD9[ &"WTF[B\7QSZ9INJZ=;_:I9;Z6YOP]M=*RM_J MX1*^UBY5L[$P 1@]Z;!X7$?VZ2?6-2N[N[MOLINI3 M$KQ1_-@($C50FQ6UE:65G)):6UJ%18X=H#(%VA#D$@=#Q@\#G MKD Y!/&.J69U8WXMIOLEFUQ'&+*:S82!MNP>:294R1F15 '''( W-*O=9BUN M72M9DL;AC;+N;NE: NFWZWLC:A>BT@55QG=(58Y^8 *2>>@!- '145R6K^,9]*.G*+;3)WNXHW$: MZH/,F+$ K;)Y9,V,YR=@.1[XU_$6L-H>FB[ L0#($+W]Z+6% <\M(5;TP %) M)([9( -:BN8F\7/#X1M]8_LXM>7$;/%9>;@/M!)._;]S:"V[;TQQD@5T5K/] MILX9]NWS8U?;G.,C.* ):*** "BBB@ K%\3>'_\ A(]+^R+J5Y8.#E9;9^O& M"&4Y5UYZ$>XP:VJ* .3?X?Z:;.UL$O\ 4X],@CBB>P6<&&<1MN4L"I()/4H5 MSWS5O2_!NG:3K+:E!+4 M?_7U;_\ HY*OU0UC_CRC_P"OJW_]')5^@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **S]>"R@]2* /3Z*XG0;O2+;PKJ M$'VF.'2I)+M[) 3@VH^\T2J0QC!8XV] 1@@8K.\*?V';1^((A>Z3_9&R&2:_ MTAOL=BIP04&UR$< *6.\Y#KG' (!Z/17+_#Z^T^\\&6":==6L\=NGE,MO(K" M,@_=.WIP1Q744 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %8NL:->7FH6FI:9?06E];QR0[KBV,\;1OM+#:' M0YRBD'/KP@6VL1)I#6BVL\>6W"F=M[@)&X&S=C"$G@ $GJ>DTVQ33-,MK*-Y)%@C$8> M1V=C@=26))_$FK5% !1110 4444 %%%% !1110!0UC_CRC_Z^K?_ -')5^J& ML?\ 'E'_ -?5O_Z.2K] !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 4 M-8_X\H_^OJW_ /1R5?JAK'_'E'_U]6__ *.2K] !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 4-8_X\H_\ KZM__1R5?JAK'_'E'_U]6_\ Z.2K] !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110!YQXRUS7-&\=Z,TM[/8>'W>-!-# L MT.R(]S=;59F(9Q&KMM4L<$[0,G!.: +VM7"I!'$(KAW\^&3]U; MNXVK*I/*@CH#QUJ7^V+;_GE>_P#@#-_\14G]J:?_ &G_ &9]OM?[0V>9]E\Y M?-V?WMFJ65O';.L<[RW"((F(!"L2?E)!! /K0 ?VQ;? M\\KW_P 9O\ XBC^V+;_ )Y7O_@#-_\ $5+I^I6&K6HNM-O;:\MR2HEMI5D0 MD=1E215J@"A_;%M_SRO?_ &;_P"(H_MBV_YY7O\ X S?_$5?HH H?VQ;?\\K MW_P!F_\ B*/[8MO^>5[_ . ,W_Q%7Z* *']L6W_/*]_\ 9O_ (BC^V+;_GE> M_P#@#-_\15^B@"A_;%M_SRO?_ &;_P"(H_MBV_YY7O\ X S?_$5?HH H?VQ; M?\\KW_P!F_\ B*/[8MO^>5[_ . ,W_Q%7ZAN[NVL+62ZO+B*WMXANDEF<(B# MU)/ H K?VQ;?\\KW_P 9O\ XBHK?6HWC)GM[Q'WN !93'Y0Q"G[O=<'\:>W MB#14M;6Z?5[!;>[;9;2FY0),WHASAC["K;W=O'=1VKW$2W$JLT<1_\ @#-_\13K#5],U4S#3M1M M+PP-LE^SSK)Y;>C;2<'CH:NT 4/[8MO^>5[_ . ,W_Q%']L6W_/*]_\ &;_ M .(J_10!0_MBV_YY7O\ X S?_$4?VQ;?\\KW_P 9O\ XBK]% %#^V+;_GE> M_P#@#-_\11_;%M_SRO?_ !F_P#B*OT4 4/[8MO^>5[_ . ,W_Q%']L6W_/* M]_\ &;_ .(J_10!0_MBV_YY7O\ X S?_$4?VQ;?\\KW_P 9O\ XBK]% %# M^V+;_GE>_P#@#-_\142ZU&;J1&M[P0!%*/\ 8ILEB6W#&WL OYU-%K6E3WES M9PZG9R75J-UQ"DZEX1ZNH.5_&B#6=+NM,?4K?4K.:P0,S74_^ ,W_ ,13I=8TR&\MK.74;2.ZNANM MX6G4/,/5%SEOPJ[0!0_MBV_YY7O_ ( S?_$4?VQ;?\\KW_P!F_\ B*OT4 4/ M[8MO^>5[_P" ,W_Q%']L6W_/*]_\ 9O_ (BK]% %#^V+;_GE>_\ @#-_\11_ M;%M_SRO?_ &;_P"(J_10!0_MBV_YY7O_ ( S?_$4?VQ;?\\KW_P!F_\ B*OT M4 4/[8MO^>5[_P" ,W_Q%']L6W_/*]_\ 9O_ (BK]% %#^V+;_GE>_\ @#-_ M\145QK4:1@P6]X[[T!!LIA\I8!C]WLN3^%3W.KZ99WUO8W6HVD%W<_ZBWEG5 M9)?]U2L:9+_^ ,W_P 140\2Z"VEG5!K>FG3P^PW8ND\H-Z;\XS[9K31 MUD171@RL,A@<@CUH H_VQ;?\\KW_ , 9O_B*/[8MO^>5[_X S?\ Q%7Z* *' M]L6W_/*]_P# &;_XBC^V+;_GE>_^ ,W_ ,15^B@"A_;%M_SRO?\ P!F_^(H_ MMBV_YY7O_@#-_P#$5?HH H?VQ;?\\KW_ , 9O_B*/[8MO^>5[_X S?\ Q%7Z M* *']L6W_/*]_P# &;_XBC^V+;_GE>_^ ,W_ ,15^B@"A_;%M_SRO?\ P!F_ M^(H_MBV_YY7O_@#-_P#$59N[NVL+62ZO+B*WMXANDEF<(B#U)/ JHWB#14M; M6Z?5[!;>[;9;2FY0),WHASAC["@!EMK4;VL+W%O>1SLBF1!93$*V.1G;ZU+_ M &Q;?\\KW_P!F_\ B*=_:^F#51I?]HVG]HE=_P!D\]?-VXSG9G./?%3Q75O/ M--##<122P,%F1'!,9(! 8#H<$'GL: *W]L6W_/*]_P# &;_XBC^V+;_GE>_^ M ,W_ ,15^B@"A_;%M_SRO?\ P!F_^(H_MBV_YY7O_@#-_P#$5?HH H?VQ;?\ M\KW_ , 9O_B*/[8MO^>5[_X S?\ Q%7Z* *']L6W_/*]_P# &;_XBC^V+;_G ME>_^ ,W_ ,15^B@"A_;%M_SRO?\ P!F_^(H_MBV_YY7O_@#-_P#$5?HH H?V MQ;?\\KW_ , 9O_B*/[8MO^>5[_X S?\ Q%7ZS8O$.B7%M=7,.L:?)!:'%S*E MRA6$_P"V0<+^- $UI?&[NIE2&98$1"KRPO&68ELC# 9P OYU>OF[<9SLSG' MOB@"[1110 4444 %%%% !1110 5Y]\3I)YHK32K/29WEU%)+>XU6/3I+K[%; ML!Y@'EJS;GX '3C)Z9KT&B@#R>TT/4H_%4%HEM?%5UQ=02\>!@HM/L@C&7(P M&S\NT_-WQBK&C:9?>#=(\>_V387\DBS^98>8CRR7#F!/G!()?YR22.^:]0HH M R_#FCQ:#X?LM-BR3%&/,=CEI)#R[L>Y+$DGWK4HHH **** "BBB@ HHHH * M*** "L#QI>G3O"UU=1Z(^M3QE6@LDMS-ODW#:VT G"G#9[8]:WZ* /#YM U. M'1S+Y.HZE)J.EZA;R;=.FCV7L\B/_JW4,B'H'("_+DD9KIW\,7-C\0]-U2*V MNKNXFT:XBN99'8Q"15B5(\_=0$AC[Y8UZ310!YC\+M+O;"^E:XLKR-$TNUMW M>\MFA,4JE]T$>0-\:YR'^8G/+-7IU%% !1110 4444 %%%% !1110 4444 > M+:QI^H^*+[Q$EEI-WI2VMI=6NF6JZ;+"+MI"K2RM)L$?S[<*,Y.$_&MT;#4TAN)5N;"S\J2&2:2.V5/FBP&(WC@$17L%% 'DWB70;^74 MX8M/@O\ [1J$&G"7=8&2)?)E#968,!"5&XD..>-O->LT44 %%%% !1110 44 M44 %%%% !1110!YOXX$FH^++#1H]*NH+.0PSZAJ\.F2S-(L(=1T2]ODTR#5?MT9LRZW@FF#QHF1B7>.<#.,H6\FW3IH]E[/(C_ .K=0R(>@<@+\N21FO<** /+5@N;[Q]IVG3Z9=Z?9Z8T M<\MY'ILO_$QN_)*;C*J; B@X+,>>G3IL_#[P^?#NI^*;1+>Z2U;4$>"6Y+,9 M@84W/N;[V6W9/KFNYHH **** "BBB@ HHHH **** "BBB@!DQ589"Z%U"DE0 MNXD>F._TKQ6WLM1UA+G6QI%]IWD7=D(]&32YH?*L8)]V.4"R.Y@MO+\^>.+S'$:>8X7, C)JIX9\ M1ZFWPR9[2UFNM5TIS8RQO;L9/W; ;S$2C,?+(?9E2A45Y_>^,M3AT& MQU""\LGM6:=;O4UTJ=X8&0D*LD D$D70AF)8*5Y R*CO?&.OVL6L.DFE2_V? MJMK:J1;2 2PS>7W\PX8>9][D''W>> #T2BO-;/QIXKN/L#26NBI]JU>XTKRU M,K;2GF8DW\9 V8V[?FZ[DS@21^-_$%Y;VUA8:?#:V>YC,S.%:+S8WVQ'!& MTN&!W8SQSW% &=_;^C_VW_8O]IVG]J;=_P!D\Y?-QC/W-^S.-VWKC/&:\]E@M?#'B-Y+@1W^B7MUYX<8\RTGDN%Y)S\ MZ^;CD89^*/[4T_^T_[,^WVO]H;/,^R^^*\\E/^)L? M$VX-M&_S!>>4/_(/R_[O'2@#TF:Y@MVB6>>.)IG\N(.X4NV"=JYZG )P/0U+ M7+>,-5NM-O- 2WTZPN_M%ZR!KIB#&XAD92F%.TG!!;G )X.>.;T_QCXPU.PT MMX8]%2[U32YKVVB\B5P'C*?*3Y@SO#^VT_WJ /3:*X*3QKJ#:);:M8"VO8)( M+>$QI 4=KN9PH4;I0%"Y!*$YY W#J'/XA\8VNB23W^C?9I4NUC-RMH)]L!7) MD-M%.['#?*0LA.#NQP10!W=%>8KXLU6#7+_5SJ=G?:5:^'X;\P6\+JDQ/FH!(//L:FK@/#=G?6GQ5UXZ@VGR7 M$VF6TAELK5H!)\\@RZEW);C&=W0"NF\3ZVV@Z.+J-$::6>*VB\PX17D<(&;' M\(+9/KC'>@#9HKSS7/&7B/P\]YI\EOI=]?Q&TECG59+>)HII?*(*9._"=X+>+[49IXC/L&\IY#G;NZXRW$=P\G>((REI<]B H ]\#I0!T-Q=VUHC/$EENKCQ/9:SI%O;W4EYNNHXY/.MYT>)0I7*C^ ,".3 MD]\ ZJUN[:^MUN+.XBN(&SMEA<.IP<'!''4$4S^T+(26T?VNWWW0)MU\P9F M &3L&?FP.>*Y#PD39_#=(;-1$[7%Q;P"-<",MA MPQ!Q6C+<006SW,TT<=NB&1Y78!54#)8D\ 8YS7+>)_#.@ZA<6_G:+ITVH7]R MB-]E:TTF#3]/O[.U,:"1WDCF$ M?0Y 0CS,]&'\/;.3][#94@\'.L?&.J_83X@C6R M?1H]1-C):>4_VD 3>1YF_?MSNPVS9]W^+- '=U%;7,%Y;1W%K/'/!(-R2Q.& M5AZ@C@BN8M-0UCQ!')=QC3&T*22XMIK6:)_/VH7C+;]Q4DLO*%!@'[Q(KG_A M?K-YJF@:5IUA/;VUOIMI"MU%=6CF:;<,[HCO7"8X#E6!(.,@<@'IE%87B+6; MC3IM+L;/R4O-3N3;Q37"%HXL(SDLH*ECA2 ,C)/6N7N?&7B:'5[?1$MM*:\& MJ"PN+MA((R'A,J.D62?N]5+]5QGYMR@'H,\\5M!)/<2I%#$I>221@JHH&223 MP !WIZ.LB*Z,&5AD,#D$5@>*KR[TOP)JEV\%E?W-O9.\D]E:TTF#3]/O[.U,:"1WDCF$?0Y 0CS,]&'\/;<0#T2Y MNK>SA\ZZN(H(MRKOE<*,L0 ,GN20![FIJ\H\7WVH>)= 35%33%TNVUN&&**6 MV9KD;+E8S()-V$)8$;=GW3UYQ6]8^)O%.L:ONT_1E&CMQF3S= MPN-S?.O*>6IP3\W&2 =S17(^$]=UG5M4U"SU*;30^G,89TMH2#*Y9MLB'S6P MFT 8(SO#CC;774 11W,$TTT,4\;RP,%E17!:,D @,.Q((//8U+7FUQXLUNW\ M5W6G6.E:-$\^M)8O<,SEF4VPD5VP!O; ]1@ +SG<+VE^*]:UKR=+MVTZ#5@U MYYMQ);R/"1!,(OECWALMN4_?.WWS0!VPN8#=-:B>,W"H)&A#C>%)(#$=<$@C M/L:EKR;5=2U;P_XVN]2CBTR._DL--2_18G=)6>=XF*-E3D9&"P/"@8KN1ZU;KR"UFO?#R>+3-8:-=R'7[-)E6W,4&)!%^\6, MEOGRP/+?>RV3C!Z+Q-XM\0Z9K&N6]C;Z6MKI>EKJ(>?S)'EY?*X!4+G81G)Q MC/.<* =[17 ^*_&>IZ; .], M-4@.H)X;#:?.3][#94@\'(!ZC17G&H^-/$]GD]3M[ M18RTI:=)O+ R_1"-X.=K=<8XW---XTURWFN])%I;WFL+J0LH6M8@$*F 3[BD MDRY(&1CS!GKQT(!Z#17"7/B7Q;:V>@17&D6-K?ZAJ#V221@JHHZDD M\ 5P_P .[2[N+;4+S5)+&[EBU:\\F1+0I)&_F,KL&9VP", 8P."6K/\?7VH M>(/#7C"TM$TQ;#2HFBF2]MFEDED$8D+(0P$>T,NTD-DC/&* /1H+RUNGD2WN M896B($BQN&*9 89QTR""/8BE>Y@CN8K9YXUGE5FCB+@,X7&X@=2!D9],BO,K M+Q-K%C=7,PM]'M--M;^TM;Z1;9Y)6B>&/;*SAU&?F53E2%!ZL%YN:IXPOM(U MQ;[4;'3;C3A8WUW9S11,+D1QE,+DD@!N#N'48X&.0#T![JWCNH[5[B);B56: M.(N [A<9('4@9&?3(J:O*-7O=2T'QM8>(M8CTNXD30[R;;8P&)SM\L^6TC.V M\#/#?+U8[1FM"^\6^.-+TNXNKO0+11YULD$MPRPC]Y($92LI1N4L+0JA#11EG M$._+-@EBH?+'.#S0!ZA161X:U0ZQHD=VUY;W;EY$:6WMW@7*L1@QR$LC#&"" M>M:] !1110 4444 %%%% !1110 4444 9T.AV$&N3ZS&MP+ZXC6*1C=2E"J] M!Y9;8,9.,#N?4YH?\(7H@NK^Y5+Y)K]Q)<.FI7*EF!!!&)/E(P -N,#CIQ70 M44 8,G@[19+:.W,=XL:;\[-0N$:7>06\Q@X,F<#[Y:HM0\">'=3GFFN;*4&; MRRZPWY:[BSJET=LS? M>?F3DGG.?4^IR^/P'X>BMD@CM[M-EP]RDJZA<"5)'&'*R;]XW9Y .">2,UTE M% &))X3T>66%WAN-L2JHB%Y,(GVDL-\8?;("M";6TU M5K60RI(95A-Q(8!)G/F"+.S=GG..OS=>:M-X;TU_$2Z\5NO[15/+#B\F"!/[ MOE[]F.,XQC//7FM:B@#+/AW2CK']J&V)NMWF_;M\SR\[-^WC?C=CC-! M\.Z4=8_M0VQ-UN\SF5_+W[=OF>7G9OV\;\;L<9K4HH R=:\-Z9X@-J=12X8V MKF2$PWF3ZFJNG^"="TNYT^XL[>Z233XFAM=U].ZQHW)7 M:SD$'W!Z#T&.@HH S'\/:1)I%UI36$7V&Z:1YH1D!F=BS-GJ#N.<-3N1,3@@ R^9O*X)^7=CGI6Y10!BIX2T2*ZAN([(H\5M M]EVK-($DB^;Y9$W;9/O,?G!Y)/6H8_!7A^/2KC3'LI)[*>(0M%=7,LX6,=%0 MNQ* 8!&W&" >H%=!10!B:;X3TG2=4;4K47QO&B$+27&HW$^4!R%(D=A@$G'I MDXZUI:CIUGJVGSV%_;I<6LZE)(G&0P_SW[59HH YV;P/H-Q8/9S07GRV4 G6.7/F2&XD:5R1C<92V\MC #;L MC P>!5^B@#)TCPUI>AVD=K813I!'*9D22ZEEVN002-['@[B<=,G/7FC4/#>F MZIJMGJ=TMT;NS.;=H[R:-4/?Y5<*UADNXKIDS-$C(C9 M/ ;&>.G\(Y_Q-0ZKI=IK6F7&FWZ/):7"[)425HRR]QN4@X/?GD<5&ZS11,Y&"_EJX0/WW 9SSG/-0VG@?0+&33Y+6WNH7T^,Q6S)?S@K& M6#;"=_SID#Y6R.V,5T5% %'5='L-;LQ:ZA!YL0=9$(=D9'4Y5E92&5@>A!!K M.;P9H;BSS;W.ZSN#=1.+V<.92,%W;?F1L<92TN%V2HDK1EE[C_/(XK"_X5UX:^S3VYM[XQSRQS2@ZI=$N\8PA)\S/ M&!C_ '5]!CJ:* .9N_ 'AR]EN'EM;I!:.#4+B&.248Q(41PI?*@[L9)& MS_,BL&7C?PP8;MP^;))SDDEO_" ^&_)N8VLIW^TS1W$D MDE[.\GFQ\)(KE]RN!QN4@GN372T4 J75[MJJR:?$KVHLXK5'.N7EI+$$+_ 'O+W>=]_(W$'J,\YKK[&WDM-/MK M::Y>YEBB5'GD^](0,%C[GK5BB@#,CT#3HO$$VN)'.-0FB$+N;F0H4'0>7NV# M')Z=23W-9[>!/#SVMS:FTN!:W(,80D^9GC Q_NKZ#&_'IMG%J$E^D"B[EB2 M!YN2S(I)4$^Q8_G5JB@#"M_!VAVJSI!;3I',''E"\F\N/>26,2;]L1.3R@4\ MTU_!>AR6RPO#=.5G%P)VOYS.) I4'SM_F< D8W8P36_10!S5UX"\/7CWCSP7 MK&]G6XN,:E? ^@-]L+VUR[7DR7$KO?3L_FI]UU8 MOE&'3*D'''3BNBHH PY?"&C3K8B2*Z8V,QN('^W3[_,(QO9M^7..,L3QD=#4 M%IX&T"PFMYK:WNTEMYGGCD_M"X+!W(+Y)?+!BH)4Y!/4Z+<2+$TN,>88@VPOP/FVYR 4PPRF,-L8$=<@YP/05KT4 F-XTMI/(]W.ES*[WL[,)4 M^ZZ,7S&PZ I@XXZ<4ZW\$Z):I>+$NH WC(\\AU2Y:1F3&UMYDW C &00<#'2 MNAHH SK+0['3U@6V6X00L[C-U*QD9OO-(2Q\P^[[L=JT:** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** K"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$! end EX-101.SCH 8 rgr-20221231.xsd XBRL SCHEMA FILE 001 - Statement - Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Consolidated Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Consolidated Statements of Income and Comprehensive Income link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Consolidated Statements of Stockholders' Equity link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Consolidated Statements of Stockholders' Equity (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Acquisition of Marlin Assets link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Revenue Recognition and Contracts with Customers link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Trade Receivables, Net link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Inventories link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Property, Plant and Equipment link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Other Assets link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Leased Assets link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Trade Accounts Payable and Accrued Expenses link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Accrued Dividends link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Line of Credit link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Employee Benefit Plans link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Other Operating Income, Net link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Income Taxes link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Earnings Per Share link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Stock Repurchases link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Compensation Plans link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Operating Segment Information link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Quarterly Results of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Contingent Liabilities link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Financial Instruments link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Acquisition of Marlin Assets (Tables) link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Revenue Recognition and Contracts with Customers (Tables) link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Trade Receivables, Net (Tables) link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Inventories (Tables) link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Property, Plant and Equipment (Tables) link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - Other Assets (Tables) link:presentationLink link:definitionLink link:calculationLink 037 - Disclosure - Leased Assets (Tables) link:presentationLink link:definitionLink link:calculationLink 038 - Disclosure - Trade Accounts Payable and Accrued Expenses (Tables) link:presentationLink link:definitionLink link:calculationLink 039 - Disclosure - Other Operating Income, Net (Tables) link:presentationLink link:definitionLink link:calculationLink 040 - Disclosure - Income Taxes (Tables) link:presentationLink link:definitionLink link:calculationLink 041 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:definitionLink link:calculationLink 042 - Disclosure - Stock Repurchases (Tables) link:presentationLink link:definitionLink link:calculationLink 043 - Disclosure - Operating Segment Information (Tables) link:presentationLink link:definitionLink link:calculationLink 044 - Disclosure - Quarterly Results of Operations (Unaudited) (Tables) link:presentationLink link:definitionLink link:calculationLink 045 - Disclosure - Contingent Liabilities (Tables) link:presentationLink link:definitionLink link:calculationLink 046 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 047 - Disclosure - Acquisition of Marlin Assets (Details) link:presentationLink link:definitionLink link:calculationLink 048 - Disclosure - Acquisition of Marlin Assets (Details) - Schedule of allocation of purchase price consideration link:presentationLink link:definitionLink link:calculationLink 049 - Disclosure - Acquisition of Marlin Assets (Details) - Schedule of estimated remaining useful lives link:presentationLink link:definitionLink link:calculationLink 050 - Disclosure - Revenue Recognition and Contracts with Customers (Details) link:presentationLink link:definitionLink link:calculationLink 051 - Disclosure - Revenue Recognition and Contracts with Customers (Details) - Schedule of revenue recognized link:presentationLink link:definitionLink link:calculationLink 052 - Disclosure - Trade Receivables, Net (Details) link:presentationLink link:definitionLink link:calculationLink 053 - Disclosure - Trade Receivables, Net (Details) - Schedule of trade receivables link:presentationLink link:definitionLink link:calculationLink 054 - Disclosure - Inventories (Details) - Schedule of inventories link:presentationLink link:definitionLink link:calculationLink 055 - Disclosure - Property, Plant and Equipment (Details) link:presentationLink link:definitionLink link:calculationLink 056 - Disclosure - Property, Plant and Equipment (Details) - Schedule of property, plant and equipment link:presentationLink link:definitionLink link:calculationLink 057 - Disclosure - Other Assets (Details) link:presentationLink link:definitionLink link:calculationLink 058 - Disclosure - Other Assets (Details) - Schedule of Other Assets link:presentationLink link:definitionLink link:calculationLink 059 - Disclosure - Leased Assets (Details) link:presentationLink link:definitionLink link:calculationLink 060 - Disclosure - Leased Assets (Details) - Schedule of right-of-use assets and related lease liabilities link:presentationLink link:definitionLink link:calculationLink 061 - Disclosure - Leased Assets (Details) - Schedule of operating lease liabilities link:presentationLink link:definitionLink link:calculationLink 062 - Disclosure - Trade Accounts Payable and Accrued Expenses (Details) - Schedule of trade accounts payable and accrued expenses link:presentationLink link:definitionLink link:calculationLink 063 - Disclosure - Accrued Dividends (Details) link:presentationLink link:definitionLink link:calculationLink 064 - Disclosure - Line of Credit (Details) link:presentationLink link:definitionLink link:calculationLink 065 - Disclosure - Employee Benefit Plans (Details) link:presentationLink link:definitionLink link:calculationLink 066 - Disclosure - Other Operating Income, Net (Details) - Schedule of other operating income, net link:presentationLink link:definitionLink link:calculationLink 067 - Disclosure - Income Taxes (Details) link:presentationLink link:definitionLink link:calculationLink 068 - Disclosure - Income Taxes (Details) - Schedule of federal and state income tax provision link:presentationLink link:definitionLink link:calculationLink 069 - Disclosure - Income Taxes (Details) - Schedule of effective income tax rate reconciliation link:presentationLink link:definitionLink link:calculationLink 070 - Disclosure - Income Taxes (Details) - Schedule of deferred tax assets and liabilities link:presentationLink link:definitionLink link:calculationLink 071 - Disclosure - Earnings Per Share (Details) - Schedule of a reconciliation of the numerator and denominator for the basic and diluted earnings per share link:presentationLink link:definitionLink link:calculationLink 072 - Disclosure - Stock Repurchases (Details) link:presentationLink link:definitionLink link:calculationLink 073 - Disclosure - Stock Repurchases (Details) - Schedule of repurchased shares of its common stock link:presentationLink link:definitionLink link:calculationLink 074 - Disclosure - Compensation Plans (Details) link:presentationLink link:definitionLink link:calculationLink 075 - Disclosure - Operating Segment Information (Details) link:presentationLink link:definitionLink link:calculationLink 076 - Disclosure - Operating Segment Information (Details) - Schedule of operating segment financial information link:presentationLink link:definitionLink link:calculationLink 077 - Disclosure - Quarterly Results of Operations (Unaudited) (Details) - Schedule of quarterly financial information link:presentationLink link:definitionLink link:calculationLink 078 - Disclosure - Related Party Transactions (Details) link:presentationLink link:definitionLink link:calculationLink 079 - Disclosure - Contingent Liabilities (Details) link:presentationLink link:definitionLink link:calculationLink 080 - Disclosure - Contingent Liabilities (Details) - Schedule of roll-forward for product liability reserve link:presentationLink link:definitionLink link:calculationLink 081 - Disclosure - Contingent Liabilities (Details) - Schedule of product liability expense link:presentationLink link:definitionLink link:calculationLink 082 - Disclosure - Subsequent Events (Details) link:presentationLink link:definitionLink link:calculationLink 000 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 9 rgr-20221231_cal.xml XBRL CALCULATION FILE EX-101.DEF 10 rgr-20221231_def.xml XBRL DEFINITION FILE EX-101.LAB 11 rgr-20221231_lab.xml XBRL LABEL FILE EX-101.PRE 12 rgr-20221231_pre.xml XBRL PRESENTATION FILE XML 13 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Document And Entity Information - USD ($)
12 Months Ended
Dec. 31, 2022
Feb. 15, 2023
Jun. 30, 2022
Document Information Line Items      
Entity Registrant Name STURM RUGER & CO INC    
Trading Symbol RGR    
Document Type 10-K    
Current Fiscal Year End Date --12-31    
Entity Common Stock, Shares Outstanding   17,596,600  
Entity Public Float     $ 1,112,555,000
Amendment Flag false    
Entity Central Index Key 0000095029    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Filer Category Large Accelerated Filer    
Entity Well-known Seasoned Issuer Yes    
Document Period End Date Dec. 31, 2022    
Document Fiscal Year Focus 2022    
Document Fiscal Period Focus FY    
Entity Small Business false    
Entity Emerging Growth Company false    
Entity Shell Company false    
ICFR Auditor Attestation Flag true    
Document Annual Report true    
Document Transition Report false    
Entity File Number 0-4776    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 06-0633559    
Entity Address, Address Line One 1 Lacey Place    
Entity Address, City or Town Southport    
Entity Address, State or Province CT    
Entity Address, Postal Zip Code 06890    
City Area Code (203)    
Local Phone Number 259-7843    
Title of 12(b) Security Common Stock, $1 par value    
Security Exchange Name NYSE    
Entity Interactive Data Current Yes    
Auditor Firm ID 49    
Auditor Name RSM US LLP    
Auditor Location Stamford, Connecticut    
XML 14 R2.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current Assets    
Cash and cash equivalents $ 65,173 $ 21,044
Short-term investments 159,132 199,971
Trade receivables, net 65,449 57,036
Gross inventories 129,294 100,023
Less LIFO reserve (59,489) (51,826)
Less excess and obsolescence reserve (4,812) (4,347)
Net inventories 64,993 43,850
Prepaid expenses and other current assets 7,091 6,832
Total Current Assets 361,838 328,733
Property, Plant, and Equipment 447,126 421,282
Less allowances for depreciation (370,273) (347,651)
Net property, plant and equipment 76,853 73,631
Deferred income taxes 6,109 536
Other assets 39,963 39,443
Total Assets 484,763 442,343
Current Liabilities    
Trade accounts payable and accrued expenses 35,658 36,400
Dividends Payable 88,343  
Contract liabilities with customers (Note 3) 1,031
Product liability 235 795
Employee compensation and benefits 30,160 33,154
Workers’ compensation 6,469 6,760
Income taxes payable 1,171  
Total Current Liabilities 163,067 77,109
Lease liability (Note 8) 3,039 1,476
Employee compensation 1,846  
Product liability accrual 73 97
Contingent liabilities (Note 20)
Stockholders’ Equity    
Additional paid-in capital 45,075 46,847
Retained earnings 393,097 438,098
Less: Treasury stock – at cost 2021 – 6,709,898 shares 2020 – 6,709,898 shares (145,812) (145,590)
Total Stockholders’ Equity 316,738 363,661
Total Liabilities and Stockholders’ Equity 484,763 442,343
Nonvoting Common Stock    
Stockholders’ Equity    
Common stock
Common Stock    
Stockholders’ Equity    
Common stock $ 24,378 $ 24,306
XML 15 R3.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets (Parentheticals) - $ / shares
Dec. 31, 2022
Dec. 31, 2021
Treasury stock, shares 6,714,338 6,709,898
Nonvoting Common Stock    
Common stock, par value per share (in Dollars per share) $ 1 $ 1
Common stock, shares authorized 50,000 50,000
Common stock, shares issued
Common Stock    
Common stock, par value per share (in Dollars per share) $ 1 $ 1
Common stock, shares authorized 40,000,000 40,000,000
Common stock, shares issued 24,378,568 24,306,486
Common stock, shares outstanding 17,664,230 17,596,588
XML 16 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Income and Comprehensive Income - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Total net sales $ 595,842 $ 730,736 $ 568,868
Cost of products sold 415,757 451,179 377,427
Gross profit 180,085 279,557 191,441
Operating Expenses (Incomes):      
Selling 36,114 33,259 33,332
General and administrative 40,551 43,289 39,013
Other operating expense (income), net (36) (127) (52)
Total operating expenses 76,629 76,421 72,293
Operating income 103,456 203,136 119,148
Other income:      
Royalty income 837 1,975 814
Interest income 2,552 49 1,126
Interest expense (256) (164) (191)
Other income, net 1,690 1,598 84
Total other income, net 4,823 3,458 1,833
Income before income taxes 108,279 206,594 120,981
Income taxes 19,947 50,695 30,583
Net income and comprehensive income $ 88,332 $ 155,899 $ 90,398
Basic Earnings Per Share (in Dollars per share) $ 5 $ 8.87 $ 5.17
Diluted Earnings Per Share (in Dollars per share) $ 4.96 $ 8.78 $ 5.09
Weighted average number of common shares outstanding – Basic (in Shares) 17,648,850 17,585,604 17,486,054
Weighted average number of common shares outstanding – Diluted (in Shares) 17,793,348 17,757,834 17,769,856
Cash Dividends Per Share (in Dollars per share) $ 2.42 $ 3.36 $ 6.51
Net firearms sales      
Total net sales $ 593,289 $ 728,141 $ 565,863
Net castings sales      
Total net sales $ 2,553 $ 2,595 $ 3,005
XML 17 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Retained Earnings
Treasury Stock
Total
Balance at Dec. 31, 2019 $ 24,160 $ 38,683 $ 368,205 $ (145,590) $ 285,458
Net income     90,398   90,398
Dividends paid     (113,896)   (113,896)
Stock-based compensation   6,128     6,128
Vesting of RSU’s   (1,297)     (1,297)
Common stock issued – compensation plans 46 (46)    
Unpaid dividends accrued     (2,092)   (2,092)
Balance at Dec. 31, 2020 24,206 43,468 342,615 (145,590) 264,699
Net income     155,899   155,899
Dividends paid     (59,104)   (59,104)
Stock-based compensation   8,280     8,280
Vesting of RSU’s   (4,801)     (4,801)
Common stock issued – compensation plans 100 (100)    
Unpaid dividends accrued     (1,312)   (1,312)
Balance at Dec. 31, 2021 24,306 46,847 438,098 (145,590) 363,661
Net income     88,332   88,332
Dividends paid     (42,718)   (42,718)
Stock-based compensation   1,671     1,671
Vesting of RSU’s   (3,371)     (3,371)
Common stock issued – compensation plans 72 (72)    
Unpaid dividends accrued     (90,615)   (90,615)
Repurchase of 4,440 shares of common stock       (222) (222)
Balance at Dec. 31, 2022 $ 24,378 $ 45,075 $ 393,097 $ (145,812) $ 316,738
XML 18 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Stockholders' Equity (Parentheticals)
12 Months Ended
Dec. 31, 2022
shares
Statement of Stockholders' Equity [Abstract]  
Repurchase of common stock 4,440
XML 19 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Operating Activities      
Net income $ 88,332 $ 155,899 $ 90,398
Adjustments to reconcile net income to cash provided by operating activities, net of effects of acquisition:      
Depreciation and amortization 25,789 26,152 27,576
Stock-based compensation 1,671 8,280 6,128
Excess and obsolescence inventory reserve 501 953
Gain on sale of assets (36) (127) (52)
Deferred income taxes (5,573) 994 3,863
Changes in operating assets and liabilities:      
Trade receivables (8,413) 840 (5,236)
Inventories (21,644) (15,726) 10,624
Trade accounts payable and accrued expenses (640) (392) 7,954
Contract liability with customers 1,031 (84) (9,539)
Employee compensation and benefits (3,420) (5,433) 20,910
Product liability (584) (234) 308
Prepaid expenses, other assets and other liabilities (954) 1,217 (7,905)
Income taxes receivable/payable 1,171 (1,223)
Cash provided by operating activities 77,231 172,339 143,806
Investing Activities      
Property, plant, and equipment additions (27,730) (28,776) (24,229)
Purchase of Marlin assets (28,316)
Purchases of short-term investments (365,480) (681,940) (369,439)
Proceeds from maturity of short-term investments 406,319 602,976 377,920
Net proceeds from sale of assets 100 203 178
Cash provided by (used for) investing activities 13,209 (107,537) (43,886)
Financing Activities      
Dividends paid (42,718) (59,104) (113,896)
Repurchase of common stock (222)
Payment of employee withholding tax related to share-based compensation (3,371) (4,801) (1,297)
Cash used for financing activities (46,311) (63,905) (115,193)
Increase (decrease) in cash and cash equivalents 44,129 897 (15,273)
Cash and cash equivalents at beginning of year 21,044 20,147 35,420
Cash and cash equivalents at end of year $ 65,173 $ 21,044 $ 20,147
XML 20 R8.htm IDEA: XBRL DOCUMENT v3.22.4
Summary of Significant Accounting Policies
12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

1.        Summary of Significant Accounting Policies

 

Organization

 

Sturm, Ruger & Company, Inc. (the “Company”) is principally engaged in the design, manufacture, and sale of firearms to domestic customers. Approximately 99% of sales were from firearms. Export sales represented approximately 6% of firearms sales. The Company’s design and manufacturing operations are located in the United States and almost all product content is domestic. The Company’s firearms are sold through a select number of independent wholesale distributors principally to the commercial sporting market.

 

The Company manufactures investment castings made from steel alloys and metal injection molding (“MIM”) parts for internal use in its firearms and utilizes available capacity to manufacture and sell investment castings and MIM parts to unaffiliated, third-party customers. Castings were less than 1% of the Company’s total sales for the year ended December 31, 2022.

 

Preparation of Financial Statements

 

The Company follows United States generally accepted accounting principles (“GAAP”). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.

 

The significant accounting policies described below, together with the notes that follow, are an integral part of the consolidated financial statements.

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All significant intercompany accounts and transactions have been eliminated.

 

Revenue Recognition

 

The Company recognizes revenue in accordance with the provisions of Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (“ASC 606”), which became effective January 1, 2018. Substantially all product sales are sold FOB (free on board) shipping point. Customary payment terms are 2% 30 days, net 40 days. Generally, all performance obligations are satisfied when product is shipped and the customer takes ownership and assumes the risk of loss. In some instances, sales include multiple performance obligations. The most common of these instances relates to sales promotion programs under which downstream customers are entitled to receive no charge products based on their purchases of certain of the Company’s products from the independent distributors. The fulfillment of these no charge products

is the Company’s responsibility. In such instances, the Company allocates the revenue of the promotional sales based on the estimated level of participation in the sales promotional program and the timing of the shipment of all of the firearms included in the promotional program, including the no charge firearms. Revenue is recognized proportionally as each performance obligation is satisfied, based on the relative customary price of each product. Customary prices are generally determined based on the prices charged to the independent distributors. The net change in contract liabilities for a given period is reported as an increase or decrease to sales. The Company accounts for cash sales discounts as a reduction in sales. Amounts billed to customers for shipping and handling fees are included in net sales and costs incurred by the Company for the delivery of goods are classified as selling expenses. Federal excise taxes are excluded from net sales.

 

Business Combination

 

On September 26, 2020, the Company entered into an Asset Purchase Agreement (the "Agreement") with the Remington Outdoor Company, Inc. and each of the subsidiaries of the Remington Outdoor Company, Inc. (collectively, “Remington”) to purchase substantially all of the assets (the “Marlin Assets”) used to manufacture Marlin Firearms (the “Marlin Acquisition”). The agreement to purchase these assets emanated from the Remington Outdoor Company, Inc. bankruptcy and was approved by the United States Bankruptcy Court for the Northern District of Alabama on September 30, 2020. The Marlin Acquisition was conducted through a Bankruptcy Court-supervised process, subject to Bankruptcy Court-approved bidding procedures, approval of the transactions by the Bankruptcy Court, and the satisfaction of certain closing conditions. The Company closed on the Marlin Acquisition on November 23, 2020.

 

The Agreement provided that, upon the terms and subject to the conditions set forth therein, Remington sold, transferred and assigned to the Company the Marlin Assets (as defined in the Agreement) for a purchase price of $28.3 million in cash. The Marlin Assets include the following assets, among other things, equipment, inventory, and all intellectual property related to Marlin, including the Marlin names and marks, and all derivatives thereof.

  

The primary purpose of the Marlin Acquisition was to manufacture and sell Marlin branded firearms and generate shareholder value. The Marlin brand aligns with the Ruger brand and the Marlin product portfolio will widen the Company’s diverse product offerings. The transaction was funded by the Company with cash on hand and has been accounted for in accordance with ASC 805 - Business Combinations. ASC 805 requires, among other things, an assignment of the acquisition consideration transferred to the sellers for the tangible and intangible assets acquired, using the bottom up approach, to estimate their value at acquisition date. Any excess of the fair value of the purchase consideration over these identified net assets was recorded as goodwill. Our estimates of fair value were based upon assumptions believed to be reasonable, yet were inherently uncertain. During the measurement period, which did not exceed one year from the date of acquisition, we recorded adjustments totaling $2.2 million to the estimated fair values of the assets acquired and liabilities assumed with a corresponding adjustment to goodwill. These adjustments were recorded in the year ended December 31, 2021.

Cash and Cash Equivalents

 

The Company considers interest-bearing deposits with financial institutions with remaining maturities of three months or less at the time of acquisition to be cash equivalents.

 

Fair Value Measurements of Short-term Investments

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the principal or most advantageous market at the measurement date. Fair value is established according to a hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below:

 

Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.

 

Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.

 

Level 3: Unobservable inputs are used when little or no market data is available. Level 3 inputs are given the lowest priority in the fair value hierarchy.

 

The asset or liability’s fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs.

 

As of December 31, 2022, the Company’s short-term investments consist of U.S. Treasury instruments (Level 1), maturing within one year, and investments in a bank-managed money market fund that invests exclusively in United States Treasury obligations and is valued at the net asset value ("NAV") daily closing price, as reported by the fund, based on the amortized cost of the fund’s securities (Level 2). For the bank-managed money market fund, the NAV is used as a practical expedient to estimate fair value. This practical expedient is not used when it is determined to be probable that the fund will sell the investment for an amount different than the reported NAV. Such securities are classified as held to maturity, since the Company has the intent and ability to do so, and are carried at cost plus accrued interest, which approximates fair value.

 

The fair value of inventory acquired as part of business combination is based on a third-party valuation utilizing the comparable sales method which is based on Level 2 and Level 3 inputs. The fair value of property, plant and equipment acquired as part of business combination is based on a third-party valuation utilizing the indirect method of cost approach, which is based on Level 2 and Level 3 inputs. The fair value of patents acquired as part of business combination is based on a third-party valuation utilizing the replacement cost method, which is based on Level 2 and Level 3 inputs. The fair value of the remaining intangible assets as part of business combination are based on a third-party valuation utilizing discounted cash flow methods that involves inputs, which are not observable in the market (Level 3).

Accounts Receivable

 

The Company establishes an allowance for doubtful accounts based on the creditworthiness of its customers and historical experience. While the Company uses the best information available to make its evaluation, future adjustments to the allowance for doubtful accounts may be necessary if there are significant changes in economic and industry conditions or any other factors considered in the Company’s evaluation. Bad debt expense has been immaterial during each of the last three years. The Company mitigates its credit risk by maintaining credit insurance on most of its significant customers.

 

Inventories

 

Substantially all of the Company’s inventories are valued at the lower of cost, principally determined by the last-in, first-out (LIFO) method, or net realizable value. Elements of cost in inventories include raw materials, direct labor and manufacturing overhead.

 

Property, Plant, and Equipment

 

Property, plant, and equipment are carried at cost. Depreciation is computed over useful lives using the straight-line and declining balance methods predominately over 15 years for buildings, 7 years for machinery and equipment and 3 years for tools and dies. When assets are retired, sold or otherwise disposed of, their gross carrying values and related accumulated depreciation are removed from the accounts and a gain or loss on such disposals is recognized when appropriate.

 

Maintenance and repairs are charged to operations; replacements and improvements are capitalized.

 

Long-lived Assets

 

The Company evaluates the carrying value of long-lived assets to be held and used when events or changes in circumstances indicate the carrying value may not be recoverable. In performing this review, the carrying value of the assets is compared to the projected undiscounted cash flows to be generated from the assets. If the sum of the undiscounted expected future cash flows is less than the carrying value of the assets, the assets are considered to be impaired. Impairment losses are measured as the amount by which the carrying value of the assets exceeds their fair value. The Company bases fair value of the assets on quoted market prices if available or, if not available, quoted market prices of similar assets. Where quoted market prices are not available, the Company estimates fair value using the estimated future cash flows generated by the assets discounted at a rate commensurate with the risks associated with the recovery of the assets. As of December 31, 2022, the Company does not believe there are any indications of impairment related to long-lived assets.

 

Goodwill

 

Our goodwill represents the excess of the purchase price of business combinations over the fair value of the net assets acquired. We assess goodwill for impairment on an annual basis during the fourth quarter of each year, and between annual tests whenever events or changes in circumstances

indicate that the carrying amount may not be recoverable. An impairment exists by the amount the fair value of a reporting unit to which goodwill has been allocated is less than their respective carrying values. The impairment for goodwill is limited to the total amount of goodwill allocated to the reporting unit. Goodwill impairment testing requires significant judgment and management estimates, including, but not limited to, the determination of (i) the number of reporting units, (ii) the goodwill and other assets and liabilities to be allocated to the reporting units and (iii) the fair values of the reporting units. The estimates and assumptions described above, along with other factors such as discount rates, will significantly affect the outcome of the impairment tests and the amounts of any resulting impairment losses. As of December 31, 2022, the Company does not believe there are any indications of impairment related to goodwill.

 

Income Taxes

 

Income taxes are accounted for using the asset and liability method. Under this method, deferred income taxes are recognized for the tax consequences of “temporary differences” by applying enacted statutory rates applicable to future years to temporary differences between the financial statement carrying amounts and the tax basis of the Company’s assets and liabilities.

 

Product Liability

 

The Company provides for product liability claims including estimated legal costs to be incurred defending such claims. The provision for product liability claims is charged to cost of products sold.

 

Advertising Costs

 

The Company includes advertising costs in selling expenses and these costs are expensed as incurred. Advertising costs for 2022, 2021, and 2020, were $2.4 million, $2.6 million, and $2.7 million, respectively.

 

Shipping Costs

 

Costs incurred related to the shipment of products are included in selling expense. Such costs totaled $4.7 million, $4.2 million, and $3.9 million in 2022, 2021, and 2020, respectively.

 

Research and Development

 

In 2022, 2021, and 2020, the Company spent approximately $9.6 million, $11.7 million, and $8.0 million, respectively, on research and development activities relating to new products and the improvement of existing products. These costs are included in costs of products sold and are expensed as incurred.

 

Earnings per Share

 

Basic earnings per share is based upon the weighted-average number of shares of common stock outstanding during the year. Diluted earnings per share reflect the impact of options, restricted stock units, and deferred stock outstanding using the treasury stock method.

XML 21 R9.htm IDEA: XBRL DOCUMENT v3.22.4
Acquisition of Marlin Assets
12 Months Ended
Dec. 31, 2022
Acquisition of Marlin Assets [Abstract]  
Acquisition of Marlin Assets

2.       Acquisition of Marlin Assets

 

As described in Note 1, the Company closed on the Marlin Acquisition on November 23, 2020. The Company paid $28.3 million dollars in cash for the Marlin Assets from Remington.

 

The Marlin Acquisition was accounted for in accordance with ASC Topic 805, Business Combinations. Accordingly, the total purchase price has been allocated to tangible assets based on their fair value and the intangibles and goodwill have been allocated on a provisional basis at the date of acquisition. The Company assumed no liabilities in this transaction. These allocations reflect various provisional estimates that were available at the time and are subject to change during the purchase price allocation period until the valuations are finalized.

 

The Company recorded measurement period adjustments in accordance with FASB’s guidance regarding business combinations in the fourth quarter of 2021 based on its valuation and purchase price allocation procedures, to better reflect the facts and circumstances that existed at the acquisition date. The measurement period adjustments, which were completed during the fourth quarter of 2021, resulted in an increase to goodwill of $2.4 million, primarily due to a decrease in the estimated fair value of inventory received.

 

The following table summarizes the Company's allocation of the purchase price:

 

    Initial Purchase
Price Allocation
    Measurement
Period
Adjustments
    Final Purchase
Price Allocation
 
Purchase Price               
Cash paid to sellers  $28,316   $
   $28,316 
Purchase Price Allocation               
Assets Acquired               
Inventory  $11,400   $(2,414)  $8,986 
Machinery and equipment   5,000    (25)   4,975 
Tradename and trademarks   7,800         7,800 
Patents   2,500         2,500 
Customer Relationships   1,000         1,000 
Goodwill   616    2,439    3,055 
Net Assets Acquired  $28,316   $
   $28,316 

 

Identifiable assets acquired were recorded at their estimated fair values based on the methodology described under “Fair Value Measurements” in Note 1 - Significant Accounting Policies.

 

The Machinery and Equipment acquired in the Marlin Acquisition were classified as deposits on capital items in Other Assets on the Company’s Consolidated Balance Sheet at December 31,

2021. Certain of these items were reclassified as Machinery and Equipment when they were placed in service in 2022 and 2021.

 

Intangible assets acquired in the Marlin Acquisition are reflected in Other Assets on the Company’s Consolidated Balance Sheet at December 31, 2022. Intangible assets are amortized over their estimated remaining useful lives using a straight-line methodology.

 

   Remaining Economic
Useful Life
Tradename and trademarks  20 years
Patents  20 years
Customer Relationships  15 years

 

The excess purchase price over the fair value of the assets acquired was recorded as goodwill in the amount of $3.1 million. The Company incurred acquisition related costs of $1.7 million, which are included in selling, general and administrative expenses in the Company’s Consolidated Statements of Income and Comprehensive Income for the fiscal year ended December 31, 2020.

 

The pro forma impact of the acquisition and the results of operations attributable to Marlin in 2019 and 2020 have not been presented, as they are not material to the Company’s consolidated results of operations. The impact on sales and gross margin was no more than 5% of the reported amounts in either period, the trend in annual sales growth was unchanged, and the impact on gross margin percentage was less than 1%, in both periods.

XML 22 R10.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue Recognition and Contracts with Customers
12 Months Ended
Dec. 31, 2022
Revenue from Contracts with Customers [Abstract]  
Revenue Recognition and Contracts with Customers

3.       Revenue Recognition and Contracts with Customers

 

The impact of ASC 606 on revenue recognized during the years ended December 31, 2022, December 31, 2021, and December 31, 2020 is as follows:

    2022    2021    2020 
Contract liabilities with customers at January 1,  $
   $84   $9,623 
                
Revenue recognized   
    (84)   (14,570)
                
Revenue deferred   1,031    
    5,031 
                
Contract liabilities with customers at December 31,  $1,031   $
   $84 

 

During the year ended December 31, 2022, the Company deferred $1.0 million of revenue. There was no offset for the recognition from previously deferred revenue as the Company did not satisfy any performance obligations relating to the shipment of free products during the year. This resulted in a net decrease in firearms sales for the year ended December 31, 2022 of $1.0 million and a deferred contract revenue liability at December 31, 2022 of $1.0 million. The Company

estimates that revenue from this deferred contract liability will be recognized in the first half of 2023.

 

During the year ended December 31, 2021, there were no promotions giving rise to deferred contract liabilities and, therefore, there was no additional deferred revenue. Previously deferred revenue of $0.1 million was recognized in the first quarter of 2021. The Company did not have a deferred contract revenue liability at December 31, 2021.

 

During the year ended December 31, 2020, the Company deferred $5.0 million of revenue, offset by the recognition of $14.6 million of revenue previously deferred as the performance obligations relating to the shipment of free products were satisfied. This resulted in a net increase in firearms sales for the year ended December 31, 2020 of $9.6 million and a deferred contract revenue liability at December 31, 2020 of $0.1 million. The deferred revenue balance was significantly reduced due to the absence of promotions in the fourth quarter of 2020.

 

Practical Expedients and Exemptions

 

The Company has elected to account for shipping and handling activities that occur after control of the related product transfers to the customer as fulfillment activities that are recognized upon shipment of the goods.

XML 23 R11.htm IDEA: XBRL DOCUMENT v3.22.4
Trade Receivables, Net
12 Months Ended
Dec. 31, 2022
Trade Receivables, Net [Abstract]  
Trade Receivables, Net

4.       Trade Receivables, Net

 

Trade receivables consist of the following:

 

December 31,  2022   2021 
         
Trade receivables  $67,183   $58,605 
Allowance for doubtful accounts   (400)   (400)
Allowance for discounts   (1,334)   (1,169)
   $65,449   $57,036 

 

In 2022, the largest individual trade receivable balances accounted for 26%, 23%, and 18% of total trade receivables, respectively.

 

In 2021, the largest individual trade receivable balances accounted for 34%, 17%, and 17% of total trade receivables, respectively.

XML 24 R12.htm IDEA: XBRL DOCUMENT v3.22.4
Inventories
12 Months Ended
Dec. 31, 2022
Inventory Disclosure [Abstract]  
Inventories

5.       Inventories

 

Inventories consist of the following:

 

December 31,  2022   2021 
Inventory at FIFO          
Finished goods  $23,573   $7,322 
Materials and products in process   105,721    92,701 
Gross inventories   129,294    100,023 
Less:  LIFO reserve   (59,489)   (51,826)
Less:  excess and obsolescence reserve   (4,812)   (4,347)
Net Inventories  $64,993   $43,850 
XML 25 R13.htm IDEA: XBRL DOCUMENT v3.22.4
Property, Plant and Equipment
12 Months Ended
Dec. 31, 2022
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment

6.       Property, Plant and Equipment

 

Property, plant and equipment consist of the following:

 

December 31,  2022   2021 
         
Land and improvements  $2,826   $2,686 
Buildings and improvements   72,788    62,781 
Machinery and equipment   314,032    302,241 
Dies and tools   57,480    53,574 
Property, plant and equipment   447,126    421,282 
Less allowances for depreciation   (370,273)   (347,651)
Net property, plant and equipment  $76,853   $73,631 

 

Depreciation expense totaled $24.4 million, $25.8 million, and $27.3 million in 2022, 2021, and 2020, respectively.

XML 26 R14.htm IDEA: XBRL DOCUMENT v3.22.4
Other Assets
12 Months Ended
Dec. 31, 2022
Disclosure Text Block Supplement [Abstract]  
Other Assets

7.       Other Assets

Other assets consist of the following:

 

December 31,  2022   2021 
         
Patents, at cost  $10,126   $10,024 
Accumulated amortization   (6,318)   (5,360)
Deposits on capital items   17,106    18,026 
Marlin trade name   7,800    7,800 
Other   11,249    8,953 
   $39,963   $39,443 

 

The capitalized cost of patents is amortized using the straight-line method over their useful lives. Expenses related to patent amortization was $0.4 million in 2022 and $0.3 million in 2021, and 2020. The estimated annual patent amortization expense for each of the next five years is $0.2

million. Costs incurred to maintain existing patents are charged to expense in the year incurred. The Marlin trade name will be amortized using the straight-line method over its useful life. The estimated annual trade name amortization cost for each of the next five years is $0.4 million. The intangible asset related to Marlin customer relationships are included in Other above and will be amortized using the straight-line method over its useful life. The estimated annual customer relationship name amortization expense for each of the next five years is $0.1 million.

XML 27 R15.htm IDEA: XBRL DOCUMENT v3.22.4
Leased Assets
12 Months Ended
Dec. 31, 2022
Leased Assets [Abstract]  
Leased Assets

8.       Leased Assets

 

The Company leases certain of its real estate and equipment. The Company has evaluated all its leases and determined that all are operating leases under the definitions of the guidance of ASU 2016-02. The Company’s lease agreements generally do not require material variable lease payments, residual value guarantees or restrictive covenants.

 

The Company adopted the provisions of ASU 2016-02 using the effective interest method on January 1, 2019 and recorded right-of-use assets equal to the present value of the contractual liability for future lease payments. The table below presents the right-of-use assets and related lease liabilities recognized on the condensed consolidated balance sheet as of December 31, 2022:

 

   Balance Sheet Line
Item
  December 31,
2022
   December 31,
2021
 
Right-of-use assets  Other assets  $3,681   $1,694 
              
Operating lease liabilities             
              
Current portion  Trade accounts payable and accrued expenses  $642   $249 
              
Noncurrent portion  Lease liabilities   3,039    1,476 
              
Total operating lease liabilities     $3,681   $1,725 

 

The depreciable lives of right-of-use assets are limited by the lease term and are amortized on a straight line basis over the life of the lease.

The Company’s leases generally do not provide an implicit interest rate, and therefore the Company calculates an incremental borrowing rate to determine the present value of its operating lease liabilities. The following table reconciles the undiscounted future minimum lease payments to the total operating lease liabilities recognized on the condensed consolidated balance sheet as of December 31, 2022:

 

2023  $803 
2024   808 
2025   702 
2026   705 
2027   229 
Thereafter   1,120 
Total undiscounted future minimum lease payments   4,367 
Less: Difference between undiscounted lease payments & the present value of future lease payments   (686)
Total operating lease liabilities  $3,681 

 

Certain of the Company’s lease agreements contain renewal options at the Company’s discretion. The Company does not recognize right-of-use assets or lease liabilities for leases of one year or less or for renewal periods unless it is reasonably certain that the Company will exercise the renewal option at the inception of the lease or when a triggering event occurs. The Company’s weighted average remaining lease term for operating leases as of December 31, 2022 is 8.9 years.

XML 28 R16.htm IDEA: XBRL DOCUMENT v3.22.4
Trade Accounts Payable and Accrued Expenses
12 Months Ended
Dec. 31, 2022
Trade Accounts Payable and Accrued Expenses [Abstract]  
Trade Accounts Payable and Accrued Expenses

9.       Trade Accounts Payable and Accrued Expenses

Trade accounts payable and accrued expenses consist of the following:

 

December 31,  2022   2021 
           
Trade accounts payable  $13,281   $12,209 
Federal excise taxes payable   13,635    15,734 
Accrued other   8,742    8,457 
   $35,658   $36,400 
XML 29 R17.htm IDEA: XBRL DOCUMENT v3.22.4
Accrued Dividends
12 Months Ended
Dec. 31, 2022
Disclosure Text Block Supplement [Abstract]  
Accrued Dividends

10.       Accrued Dividends

On November 30, 2022, the Company’s Board of Directors declared a $5.00 per share special dividend payable on January 5, 2023 to stockholders of record as of December 15, 2022. The dividend, which totaled $88.3 million, was paid on January 5, 2023.

XML 30 R18.htm IDEA: XBRL DOCUMENT v3.22.4
Line of Credit
12 Months Ended
Dec. 31, 2022
Line of Credit [Abstract]  
Line of Credit

11.       Line of Credit

During 2021 the Company had a $40 million unsecured revolving line of credit with a bank. This facility terminated on September 30, 2021. On January 7, 2022, the Company entered into a new $40 million unsecured revolving line of credit agreement with a different bank that expires January 7, 2025. Borrowings under this new facility bear interest at either 1) the Bloomberg short-Term

Bank Yield Index – 1 month plus 150 basis points, or 2) a fluctuating rate per annum equal to the greater of (i) the Bank’s prime rate or (ii) the federal funds rate plus 50 basis points. The Company is also charged one-quarter of a percent (0.25%) per year on the unused portion. At December 31, 2022, the Company was in compliance with the terms and covenants of the credit facility.

XML 31 R19.htm IDEA: XBRL DOCUMENT v3.22.4
Employee Benefit Plans
12 Months Ended
Dec. 31, 2022
Employee Benefit Plans [Abstract]  
Employee Benefit Plans

12.       Employee Benefit Plans

 

The Company sponsors a qualified defined-contribution 401(k) plan that covers substantially all of its employees. Under the terms of the 401(k) plan, the Company matches a certain portion of employee contributions to their individual 401(k) accounts using the “safe harbor” guidelines provided in the Internal Revenue Code. Expenses related to matching employee contributions to the 401(k) plan were $4.1 million, $4.0 million, and $3.3 million in 2022, 2021, and 2020, respectively.

 

Additionally, in 2022, 2021, and 2020 the Company provided discretionary supplemental contributions to the individual 401(k) accounts of substantially all employees. Each employee received a supplemental contribution to their account based on a uniform percentage of qualifying compensation established annually. The cost of these supplemental contributions totaled $7.4 million, $7.4 million, and $5.6 million in 2022, 2021, and 2020, respectively.

XML 32 R20.htm IDEA: XBRL DOCUMENT v3.22.4
Other Operating Income, Net
12 Months Ended
Dec. 31, 2022
Other Operating Income, Net [Abstract]  
Other Operating Income, Net

13.       Other Operating Income, Net

 

Other operating income, net consists of the following:

 

Year ended December 31,  2022   2021   2020 
                
Gain on sale of operating assets  $36   $127   $52 
XML 33 R21.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes
12 Months Ended
Dec. 31, 2022
Income Taxes [Abstract]  
Income Taxes

14.       Income Taxes

 

The Company files income tax returns in the U.S. federal jurisdiction and various state jurisdictions. With few exceptions, the Company is no longer subject to U.S. federal and state income tax examinations by tax authorities for years before 2017.

 

The federal and state income tax provision consisted of the following:

 

Year ended December 31,  2022   2021   2020 
   Current   Deferred   Current   Deferred   Current   Deferred 
Federal  $21,741   $(4,694)  $42,422   $863   $20,201   $3,696 
State   3,779    (879)   7,279    131    6,519    167 
   $25,520   $(5,573)  $49,701   $994   $26,720   $3,863 

The effective income tax rate varied from the statutory federal income tax rate as follows:

 

Year ended December 31,  2022   2021   2020 
Statutory federal income tax rate   21.0%    21.0%    21.0% 
State income taxes, net of federal tax benefit   2.7    3.4    4.4 
Research and development tax credits   (4.2)   (0.4)   
 
Other   (1.1)   0.5    (0.1)
Effective income tax rate   18.4%    24.5%    25.3% 

 

The Company estimates that its effective tax rate in 2023 will approximate 22.4%.

 

Significant components of the Company’s deferred tax assets and liabilities are as follows:

 

December 31,  2022   2021 
Deferred tax assets          
Product Liability  $69   $224 
Capitalized research and development costs   4,838    
 
Employee compensation and benefits   2,316    2,643 
Allowances for doubtful accounts and discounts   637    418 
Inventories   1,196    1,224 
Stock-based compensation   1,661    1,538 
Other   1,636    1,538 
Total deferred tax assets   12,353    7,585 
Deferred tax liabilities:          
Depreciation   5,070    6,235 
Other   1,174    814 
Total deferred tax liabilities   6,244    7,049 
Net deferred tax assets  $6,109   $536 

 

Prior to 2022, the Company expensed research and development costs in the period in which they were incurred for both financial accounting and income tax purposes. In 2022 the Company adopted the provisions of the Tax Cuts and Jobs Act of 2017 that relate to IRS Code Section 174. Under these provisions, research and development costs must be capitalized and amortized over five years for income tax purposes. The Company continues to expense these costs in the period incurred for financial accounting purposes.

 

The Company made income tax payments of approximately $28.7 million, $49.5 million, and $30.6 million, during 2022, 2021, and 2020, respectively. The Company expects to realize its deferred tax assets through tax deductions against future taxable income.

 

The Company does not believe it has included any “uncertain tax positions” in its federal income tax return or any of the state income tax returns it is currently filing. The Company has made an evaluation of the potential impact of additional state taxes being assessed by jurisdictions in which the Company does not currently consider itself liable. The Company does not anticipate that such additional taxes, if any, would result in a material change to its financial position.

XML 34 R22.htm IDEA: XBRL DOCUMENT v3.22.4
Earnings Per Share
12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
Earnings Per Share

15.       Earnings Per Share

Set forth below is a reconciliation of the numerator and denominator for the basic and diluted earnings per share calculations for the periods indicated:

 

Year ended December 31,  2022   2021   2020 
                
Numerator:               
Net income  $88,332   $155,899   $90,398 
Denominator:               
Weighted average number of common shares outstanding – Basic   17,648,850    17,585,604    17,486,054 
Dilutive effect of options and restricted stock units outstanding under the Company’s employee compensation plans   144,498    172,230    283,802 
Weighted average number of common shares outstanding – Diluted   17,793,348    17,757,834    17,769,856 
XML 35 R23.htm IDEA: XBRL DOCUMENT v3.22.4
Stock Repurchases
12 Months Ended
Dec. 31, 2022
Stock Repurchases [Abstract]  
Stock Repurchases

16.       Stock Repurchases

In 2022 the Company repurchased shares of its common stock. Details of these purchases are as follows:

 

Period  Total
Number of
Shares
Purchased
  Average
Price Paid
per Share
  Total
Number of
Shares
Purchased
as Part of
Publicly
Announced
Program
  Maximum
Dollar
Value of
Shares that
May Yet Be
Purchased
Under the
Program
                     
Third Quarter 2022                    
July 3 to July 30   
—  
    
—  
    
—  
    
 
 
July 31 to August 27   
—  
    
—  
    
—  
    
 
 
August 28 to October 1   2,136   $49.97    2,136    
 
 
Fourth Quarter 2022                    
October 2 to October 29   
—  
    
—  
    
—  
    
 
 
October 30 to November 26   2,304   $49.77    2,304    
 
 
November 27 to December 31   
—  
    
—  
    
—  
    
 
 
Total   4,440   $49.87    4,440   $86,490,000 

 

All of these purchases were made with cash held by the Company and no debt was incurred. No shares were repurchased in 2020 and 2021.

At December 31, 2022, approximately $86.5 million remained authorized for share repurchases.

XML 36 R24.htm IDEA: XBRL DOCUMENT v3.22.4
Compensation Plans
12 Months Ended
Dec. 31, 2022
Compensation Plans [Abstract]  
Compensation Plans

17.       Compensation Plans

 

In May 2017, the Company’s shareholders approved the 2017 Stock Incentive Plan (the “2017 SIP”) under which employees, independent contractors, and non-employee directors may be granted stock options, restricted stock, deferred stock awards, and stock appreciation rights, any of which may or may not require the satisfaction of performance objectives. Vesting requirements are determined by the Compensation Committee of the Board of Directors. The Company has reserved 750,000 shares for issuance under the 2017 SIP, of which approximately 120,000 shares remain available for future grants as of December 31, 2022.

 

Compensation expense related to deferred stock, restricted stock, and restricted stock units is recognized based on the grant-date fair value of the Company’s common stock, using either the actual share price or an estimated value using the Monte Carlo valuation model. The total stock-based compensation cost included in the Statements of Income was $5.7 million, $8.3 million, and $6.1 million in 2022, 2021, and 2020, respectively.

 

Deferred Stock

 

Deferred stock awards vest based on the passage of time or the Company’s attainment of performance objectives. Upon vesting, these awards convert one-for-one to common stock.

 

In 2022, 5,953 deferred stock awards were issued to non-employee directors that will vest in May 2023, 7,688 deferred stock awards were issued to non-employee directors that will vest in May 2025 and a 1,478 deferred stock award was issued to a non-employee director that will vest in June 2027.

 

In 2021, 5,113 deferred stock awards were issued to non-employee directors that vested in May 2022 and 6,615 deferred stock awards were issued to non-employee directors that will vest in May 2024.

 

In 2020, 6,244 deferred stock awards were issued to non-employee directors that vested in May 2021 and 8,078 deferred stock awards were issued to non-employee directors that will vest in May 2023.

 

Compensation expense related to these awards is amortized ratably over the vesting period. Compensation expense related to these awards was $0.8 million in 2022, $0.8 million in 2021, and $0.8 in 2020.

 

At December 31, 2022, there was $0.9 million of unrecognized compensation cost related to deferred stock that is expected to be recognized over a period of three years.

 

Restricted Stock Units

 

The Company grants restricted stock units (RSU’s) to senior employees. Some of these RSU’s are retention awards and have only time-based vesting. Other RSU’s have a vesting “double trigger.” The vesting of these RSU’s is dependent on the achievement of corporate objectives established by the Compensation Committee of the Board of Directors, including stock performance relative to industry indices, return on net operating assets, and the passage of time.

 

During 2022, 82,000 restricted stock units were issued. Compensation costs related to these restricted stock units was $6.0 million, of which $1.7 million was recognized in 2022. The costs are being recognized ratably over the remaining periods required before the units vest, which range from 24 to 26 months.

 

During 2021, 82,000 restricted stock units were issued. Compensation costs related to these restricted stock units was $5.6 million, of which $1.6 million was recognized in 2021. The costs are being recognized ratably over the remaining periods required before the units vest, which range from 24 to 26 months.

 

During 2020, 95,000 restricted stock units were issued. Compensation costs related to these restricted stock units was $5.7 million, of which $1.1 million was recognized in 2020. The costs are being recognized ratably over the remaining periods required before the units vest, which range from 24 to 26 months.

 

At December 31, 2022, there was $8.1 million of unrecognized compensation cost related to restricted stock units that is expected to be recognized over a period of 3.3 years.

XML 37 R25.htm IDEA: XBRL DOCUMENT v3.22.4
Operating Segment Information
12 Months Ended
Dec. 31, 2022
Operating Segment Information [Abstract]  
Operating Segment Information

18.       Operating Segment Information

 

The Company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors primarily located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts.

 

Corporate segment income relates to interest income, the sale of non-operating assets, and other non-operating activities. Corporate segment assets consist of cash and other non-operating assets.

 

The Company evaluates performance and allocates resources, in part, based on income (loss) before taxes. The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies (see Note 1). Intersegment sales are recorded at the Company’s cost plus a fixed profit percentage.

 

Year ended December 31,  2022   2021   2020 
Net Sales               
Firearms  $593,289   $728,141   $565,863 
Castings               
Unaffiliated   2,553    2,595    3,005 
Intersegment   21,306    24,711    22,254 
    23,859    27,306    25,259 
Eliminations   (21,306)   (24,711)   (22,254)
   $595,842   $730,736   $568,868 
Income (Loss) Before Income Taxes               
Firearms  $108,610   $207,657   $120,732 
Castings   (3,338)   (2,732)   (1,000)
Corporate   3,007    1,669    1,249 
   $108,279   $206,594   $120,981 
Identifiable Assets               
Firearms  $223,301   $188,290   $174,500 
Castings   11,910    13,889    11,959 
Corporate   249,552    240,164    161,799 
   $484,763   $442,343   $348,258 
Goodwill               
Firearms  $3,055   $3,055   $616 
Castings   209    209    209 
   $3,264   $3,264   $825 
Depreciation               
Firearms  $21,992   $22,842   $25,126 
Castings   2,452    2,959    2,158 
   $24,444   $25,801   $27,284 
Capital Expenditures               
Firearms  $26,598   $25,239   $19,253 
Castings   1,175    3,537    4,976 
   $27,773   $28,776   $24,229 

 

In 2022, the Company’s largest customers and the percent of firearms sales they represented were as follows: Lipsey’s - 23%; Davidson’s - 23%; and Sports South - 21%.

 

In 2021, the Company’s largest customers and the percent of firearms sales they represented were as follows: Lipsey’s - 21%; Sports South - 19%; and Davidson’s - 19%.

 

In 2020, the Company’s largest customers and the percent of firearms sales they represented were as follows: Sports South - 22%; Lipsey’s - 22%; and Davidson’s - 18%.

 

The Company’s assets are located entirely in the United States and domestic sales represented at least 94% of total sales in 2022, 2021, and 2020.

XML 38 R26.htm IDEA: XBRL DOCUMENT v3.22.4
Quarterly Results of Operations (Unaudited)
12 Months Ended
Dec. 31, 2022
Quarterly Results of Operations [Abstract]  
Quarterly Results of Operations (Unaudited)

19.       Quarterly Results of Operations (Unaudited)

 

The following is a tabulation of the unaudited quarterly results of operations for the two years ended December 31, 2022:

 

   Three Months Ended 
    4/2/22    7/2/22    10/1/22    12/31/22 
Net Sales  $166,575   $140,653   $139,390   $149,224 
Gross profit   58,108    43,554    38,869    39,554 
Net income   30,232    20,757    18,389    18,954 
Basic earnings per share   1.72    1.18    1.04    1.07 
Diluted earnings per share  $1.70   $1.17   $1.03   $1.06 

 

   Three Months Ended 
    4/3/21    7/3/21    10/2/21    12/31/21 
Net Sales  $184,377   $200,072   $178,246   $168,041 
Gross profit   72,566    78,757    64,802    63,432 
Net income   38,192    44,384    35,202    38,121 
Basic earnings per share   2.18    2.52    2.00    2.17 
Diluted earnings per share  $2.16   $2.50   $1.98   $2.14 
XML 39 R27.htm IDEA: XBRL DOCUMENT v3.22.4
Related Party Transactions
12 Months Ended
Dec. 31, 2022
Related Party Transactions [Abstract]  
Related Party Transactions

20.       Related Party Transactions

 

From time to time, the Company contracts with the National Rifle Association (“NRA”) for some of its promotional and advertising activities. The Company paid the NRA $0.7 million, $0.5 million and $0.6 million in 2022, 2021 and 2020, respectively. One of the Company’s Directors also serves as a Director on the Board of the NRA.

 

The Company is a member of the National Shooting Sports Foundation (“NSSF”), the firearm industry trade association. The Company paid the NSSF $0.3 million, $0.4 million and $0.5 million in 2022, 2021 and 2020, respectively. One of the Company’s Directors also serves on the Board of the NSSF.

XML 40 R28.htm IDEA: XBRL DOCUMENT v3.22.4
Contingent Liabilities
12 Months Ended
Dec. 31, 2022
Contingent Liabilities [Abstract]  
Contingent Liabilities

21.       Contingent Liabilities

 

As of December 31, 2022, the Company was a defendant in eight (8) lawsuits and is aware of certain other such claims. The lawsuits generally fall into three categories: traditional product liability litigation, municipal litigation and negligence. Each is discussed in turn below.

 

Traditional Product Liability Litigation

 

One lawsuit mentioned above involves a claim for damages related to an allegedly defective product due to its design and/or manufacture. The lawsuit stems from a specific incident of personal injury and is based on traditional product liability theories such as strict liability, negligence, and/or breach of warranty.

The Company management believes that the allegations in these cases are unfounded, that the incidents are unrelated to the design or manufacture of the firearms involved, and that there should be no recovery against the Company.

 

Municipal Litigation

 

Municipal litigation generally includes those cases brought by cities or other governmental entities against firearms manufacturers, distributors and retailers seeking to recover damages allegedly arising out of the misuse of firearms by third parties. There are four (4) lawsuits of this type, as follows:

 

(i) City of Gary v. Smith & Wesson Corp., et al, filed in Indiana State Court in 1999; (ii) Estados Unidos Mexicanos v. Smith & Wesson Brands, Inc., et al., filed in August 2021 in the U.S. District Court for the District of Massachusetts; (iii) The City of Buffalo v. Smith & Wesson Brands, Inc., et al., filed in December 2022 in the New York State Supreme Court for Erie County, New York and presently pending in the U.S. District Court for the Western District of New York; and (iv) The City of Rochester v. Smith & Wesson Brands, Inc., et al., filed in December 2022 in the New York State Supreme Court for Monroe County, New York and presently pending in the U.S. District Court for the Western District of New York.

 

The Complaint in City of Gary v. Smith & Wesson Corp., et al. was filed in 1999 and seeks damages, among other things, for the costs of medical care, police and emergency services, public health services, and other services as well as punitive damages. In addition, nuisance abatement and/or injunctive relief is sought to change the design, manufacture, marketing and distribution practices of the various defendants. The suit alleges, among other claims, negligence in the design of products, public nuisance, negligent distribution and marketing, negligence per se and deceptive advertising. The case does not allege a specific injury to a specific individual as a result of the misuse or use of any of the Company's products.

 

After a long procedural history, the case was scheduled for trial on June 15, 2009. The case was not tried on that date and was largely dormant until a status conference was held on July 27, 2015. At that time, the court entered a scheduling order setting deadlines for plaintiff to file a Second Amended Complaint, for defendants to answer, and for defendants to file dispositive motions. The plaintiff did not file a Second Amended Complaint by the deadline.

 

In 2015, Indiana passed a new law such that Indiana Code §34-12-3-1 became applicable to the City's case. The defendants filed a joint motion for judgment on the pleadings, asserting immunity under §34-12-3-1 and asking the court to revisit the Court of Appeals' decision holding the Protection of Lawful Commerce in Arms Act inapplicable to the City's claims.

 

On September 29, 2016, the court entered an order staying the case pending a decision by the Indiana Supreme Court in KS&E Sports v. Runnels, which presented related issues. The Indiana Supreme Court decided KS&E Sports on April 24, 2017, and the City of Gary court lifted the stay. The City of Gary court also entered an order setting a supplemental briefing schedule under which the parties addressed the impact of the KS&E Sports decision on defendants' motion for judgment on the pleadings.

 

A hearing on the motion for judgment on the pleadings was held on December 12, 2017. On January 2, 2018, the court issued an order granting defendants’ motion for judgment on the pleadings, but denying defendants’ request for attorney’s fees and costs. On January 8, 2018, the court entered judgment for the defendants. The City filed a Notice of Appeal on February 1, 2018. Defendants cross-appealed the order denying attorney’s fees and costs.

 

Briefing in the Indiana Court of Appeals was completed on the City’s appeal and Defendants’ cross appeal on September 10, 2018. The Court of Appeals issued its ruling on May 23, 2019, affirming dismissal of the City’s negligent design and warnings count on the basis that the City had not alleged that Manufacturer Defendants’ conduct was unlawful. However, the court reversed dismissal of the City’s negligent sale and distribution and related public nuisance counts for damages and injunctive relief.

 

The Manufacturer Defendants filed a Petition to Transfer the case to the Indiana Supreme Court on July 8, 2019. The Petition was denied on November 26, 2019. The case was remanded to the trial court for further proceedings.

 

During the quarter ended April 3, 2021, the City initiated discovery and the Manufacturer Defendants reciprocated. Discovery is ongoing.

 

Estados Unidos Mexicanos v. Smith & Wesson Brands, Inc., et al. was filed by the Country of Mexico and names seven defendants, mostly U.S.-based firearms manufacturers, including the Company. The Complaint advances a variety of legal theories including negligence, public nuisance, unjust enrichment, restitution, and others. Plaintiff essentially alleges that the defendants design, manufacture, distribute, market and sell firearms in a way that they know results in the illegal trafficking of firearms into Mexico, where they are used by Mexican drug cartels for criminal activities. Plaintiff seeks injunctive relief and monetary damages.

 

On November 22, 2021, Defendants filed a joint Rule 12(b)(6) motion to dismiss the Mexican Government’s complaint based on the Government’s lack of Article III standing, Protection of Lawful Commerce in Arms Act immunity, and lack of proximate cause. The Company, along with other non-Massachusetts defendants, also filed a Rule 12(b)(2) motion to dismiss based on lack of specific personal jurisdiction. The motions were fully briefed and the court heard oral argument on April 12, 2022. On September 30, 2022, the court entered an order granting the defendants’ joint Rule 12(b)(6) motion. The Company’s Rule 12(b)(2) motion was denied as moot, without prejudice. On October 26, 2022, the plaintiff filed a Notice of Appeal and the Court has entered a briefing schedule.

 

On December 20, 2022, the City of Buffalo, New York filed a lawsuit captioned The City of Buffalo v. Smith & Wesson Brands, Inc., et al. in the New York State Supreme Court for Erie County, New York. The suit names a number of firearm manufacturers, distributors, and retailers as defendants, including the Company, and purports to state causes of action for violations of Sections 898, 349 and 350 of the New York General Business Law, as well as common law public nuisance. Generally, plaintiff alleges that the criminal misuse of firearms in the City of Buffalo is the result of the manufacturing, sales, marketing, and distribution practices of the defendants. The

defendants timely removed the matter to the U.S. District Court for the Western District of New York.

 

On December 21, 2022, the City of Rochester, New York filed a lawsuit captioned The City of Rochester v. Smith & Wesson Brands, Inc., et al. in the New York State Supreme Court for Monroe County, New York. The suit names a number of firearm manufacturers, distributors, and retailers as defendants, including the Company, and purports to state causes of action for violations of Sections 898, 349 and 350 of the New York General Business Law, as well as common law public nuisance. The allegations essentially mirror those in The City of Buffalo, discussed in the preceding paragraph, as plaintiff claims that the criminal misuse of firearms in Rochester, New York is the result of the manufacturing, sales, marketing, and distribution practices of the defendants. The defendants timely removed the matter to the U.S. District Court for the Western District of New York.

 

Negligence

 

Rossiter v. Sturm, Ruger, et al. is a lawsuit arising out of a slip and fall accident by a contract security officer in December 2019. The Complaint was filed in the Superior Court for Sullivan County, New Hampshire on December 13, 2022 and names Pine Hill Construction, a snow removal contractor, as a co-defendant. The Company has tendered the defense of this matter to its insurance carrier and is assisting as required.

 

The Company was named in two purported class action lawsuits arising out of a data breach at Freestyle Solutions, Inc., the vendor who was hosting the Company ShopRuger.com website at the time of the breach. Jones v. Sturm, Ruger & Co., was filed in the U.S. District Court for Connecticut on October 4, 2022 and Copeland v. Sturm, Ruger & Company, et al. was filed in the U.S. District Court for New Jersey on October 27, 2022. Copeland also named Freestyle Solutions, Inc. as a defendant. By agreement of the parties, Copeland was dismissed, without prejudice, and consolidated with Jones in the pending Connecticut case. On January 20, 2023, five plaintiffs filed an Amended Complaint naming the Company and Freestyle Software, Inc. as defendants. The Complaint alleges causes of action for negligence, breach of implied warranties, and unjust enrichment.

 

Summary of Claimed Damages and Explanation of Product Liability Accruals

 

Punitive damages, as well as compensatory damages, are demanded in certain of the lawsuits and claims. In many instances, the plaintiff does not seek a specified amount of money, though aggregate amounts ultimately sought may exceed product liability accruals and applicable insurance coverage. For product liability claims made after July 10, 2000, coverage is provided on an annual basis for losses exceeding $5 million per claim, or an aggregate maximum loss of $10 million annually, except for certain new claims which might be brought by governments or municipalities after July 10, 2000, which are excluded from coverage.

 

The Company management monitors the status of known claims and the product liability accrual, which includes amounts for asserted and unasserted claims. While it is not possible to forecast the outcome of litigation or the timing of costs, in the opinion of management, after

consultation with special and corporate counsel, it is not probable and is unlikely that litigation, including punitive damage claims, will have a material adverse effect on the financial position of the Company, but may have a material impact on the Company’s financial results for a particular period.

 

Product liability claim payments are made when appropriate if, as, and when claimants and the Company reach agreement upon an amount to finally resolve all claims. Legal costs are paid as the lawsuits and claims develop, the timing of which may vary greatly from case to case.

A time schedule cannot be determined in advance with any reliability concerning when payments will be made in any given case.

 

Provision is made for product liability claims based upon many factors related to the severity of the alleged injury and potential liability exposure, based upon prior claim experience. Because the Company's experience in defending these lawsuits and claims is that unfavorable outcomes are typically not probable or estimable, only in rare cases is an accrual established for such costs.

 

In most cases, an accrual is established only for estimated legal defense costs. Product liability accruals are periodically reviewed to reflect then-current estimates of possible liabilities and expenses incurred to date and reasonably anticipated in the future. Threatened product liability claims are reflected in the Company's product liability accrual on the same basis as actual claims; i.e., an accrual is made for reasonably anticipated possible liability and claims handling expenses on an ongoing basis.

 

A range of reasonably possible losses relating to unfavorable outcomes cannot be made. However, in product liability cases in which a dollar amount of damages is claimed, the amount of damages claimed, which totaled $1.1 million at December 31, 2021, is set forth as an indication of possible maximum liability the Company might be required to incur in these cases (regardless of the likelihood or reasonable probability of any or all of this amount being awarded to claimants) as a result of adverse judgments that are sustained on appeal. At December 31, 2022, the total amount claimed specifically in these cases was de minimis.

 

During 2022, no traditional product liability lawsuit was filed against the Company and one (1) was resolved. As of December 31, 2022, the Company was a defendant five lawsuits involving its products, including one (1) traditional product liability lawsuit and four (4) municipal lawsuits. The Company also was a defendant in three (3) negligence lawsuits though, as discussed above, that number has since been reduced to two (2) lawsuits with the consolidation of the Jones and Copeland matters.

 

During 2021, one (1) traditional product liability lawsuit was filed against the Company.  As of December 31, 2021, the Company was a defendant in four (4) lawsuits involving its products, including two (2) traditional lawsuits and two (2) municipal lawsuits.

 

During 2020, one (1) traditional product liability lawsuit was filed against the Company and one (1) was resolved.  As of December 31, 2020, the Company was a defendant in three (3) lawsuits involving its products, including two (2) traditional lawsuits and one (1) municipal lawsuit.

 

The Company’s product liability expense was $1.3 million in 2022, $1.1 million in 2021, and $1.1 million in 2020. This expense includes the cost of outside legal fees, and other expenses incurred in the management and defense of product liability matters.

A roll-forward of the product liability reserve and detail of product liability expense for the three years ended December 31, 2022 follows:

 

Balance Sheet Roll-forward for Product Liability Reserve

  

           Cash Payments     
   Balance
Beginning
of Year (a)
   Accrued
Legal
Expense
(Income)
(b)
   Legal Fees
(c)
   Settlements
(d)
   Balance
End of
Year (a)
 
                          
2020  $818    800    (492)   
   $1,126 
                          
2021  $1,126    (7)   (227)   
   $892 
                          
2022  $892    (417)   (167)   
   $308 

 

Income Statement Detail for Product Liability Expense

 

   Accrued
Legal
Expense
(b)
   Insurance
Premium
Expense
(e)
   Total
Product
Liability
Expense
 
                
2020  $800    839   $1,639 
                
2021  $(7)   1,119   $1,112 
                
2022  $(417)   1,524   $1,107 

 

Notes

 

(a)The beginning and ending liability balances represent accrued legal fees only. Settlements and administrative costs are expensed as incurred. Only in rare instances is an accrual established for settlements.

 

(b)The expense accrued in the liability is for legal fees only. In 2022 and 2021, the costs incurred related to cases that were settled or dismissed were less than the amounts accrued for these cases in prior years.

 

(c) Legal fees represent payments to outside counsel related to product liability matters.

 

(d)Settlements represent payments made to plaintiffs or allegedly injured parties in exchange for a full and complete release of liability.

 

(e) Insurance expense represents the cost of insurance premiums.

 

There were no insurance recoveries during any of the above years.

XML 41 R29.htm IDEA: XBRL DOCUMENT v3.22.4
Financial Instruments
12 Months Ended
Dec. 31, 2022
Financial Instruments [Abstract]  
Financial Instruments

22.       Financial Instruments

The Company does not hold or issue financial instruments for trading or hedging purposes, nor does it hold interest rate, leveraged, or other types of derivative financial instruments. Fair values of accounts receivable, accounts payable, accrued expenses and income taxes payable reflected in the December 31, 2022 and 2021 balance sheets approximate carrying values at those dates.

XML 42 R30.htm IDEA: XBRL DOCUMENT v3.22.4
Subsequent Events
12 Months Ended
Dec. 31, 2022
Subsequent Events [Abstract]  
Subsequent Events

23.       Subsequent Events

 

On February 17, 2023, the Company’s Board of Directors authorized a dividend of 42¢ per share to shareholders of record on March 10, 2023.

 

The Company’s management has evaluated transactions occurring subsequent to December 31, 2022 and determined that there were no events or transactions during that period that would have a material impact on the Company’s results of operations or financial position.

XML 43 R31.htm IDEA: XBRL DOCUMENT v3.22.4
Accounting Policies, by Policy (Policies)
12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Organization

Organization

 

Sturm, Ruger & Company, Inc. (the “Company”) is principally engaged in the design, manufacture, and sale of firearms to domestic customers. Approximately 99% of sales were from firearms. Export sales represented approximately 6% of firearms sales. The Company’s design and manufacturing operations are located in the United States and almost all product content is domestic. The Company’s firearms are sold through a select number of independent wholesale distributors principally to the commercial sporting market.

 

The Company manufactures investment castings made from steel alloys and metal injection molding (“MIM”) parts for internal use in its firearms and utilizes available capacity to manufacture and sell investment castings and MIM parts to unaffiliated, third-party customers. Castings were less than 1% of the Company’s total sales for the year ended December 31, 2022.

 

Preparation of Financial Statements

Preparation of Financial Statements

 

The Company follows United States generally accepted accounting principles (“GAAP”). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.

 

The significant accounting policies described below, together with the notes that follow, are an integral part of the consolidated financial statements.

 

Principles of Consolidation

Principles of Consolidation

 

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All significant intercompany accounts and transactions have been eliminated.

 

Revenue Recognition

Revenue Recognition

 

The Company recognizes revenue in accordance with the provisions of Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (“ASC 606”), which became effective January 1, 2018. Substantially all product sales are sold FOB (free on board) shipping point. Customary payment terms are 2% 30 days, net 40 days. Generally, all performance obligations are satisfied when product is shipped and the customer takes ownership and assumes the risk of loss. In some instances, sales include multiple performance obligations. The most common of these instances relates to sales promotion programs under which downstream customers are entitled to receive no charge products based on their purchases of certain of the Company’s products from the independent distributors. The fulfillment of these no charge products

is the Company’s responsibility. In such instances, the Company allocates the revenue of the promotional sales based on the estimated level of participation in the sales promotional program and the timing of the shipment of all of the firearms included in the promotional program, including the no charge firearms. Revenue is recognized proportionally as each performance obligation is satisfied, based on the relative customary price of each product. Customary prices are generally determined based on the prices charged to the independent distributors. The net change in contract liabilities for a given period is reported as an increase or decrease to sales. The Company accounts for cash sales discounts as a reduction in sales. Amounts billed to customers for shipping and handling fees are included in net sales and costs incurred by the Company for the delivery of goods are classified as selling expenses. Federal excise taxes are excluded from net sales.

 

Business Combination

Business Combination

 

On September 26, 2020, the Company entered into an Asset Purchase Agreement (the "Agreement") with the Remington Outdoor Company, Inc. and each of the subsidiaries of the Remington Outdoor Company, Inc. (collectively, “Remington”) to purchase substantially all of the assets (the “Marlin Assets”) used to manufacture Marlin Firearms (the “Marlin Acquisition”). The agreement to purchase these assets emanated from the Remington Outdoor Company, Inc. bankruptcy and was approved by the United States Bankruptcy Court for the Northern District of Alabama on September 30, 2020. The Marlin Acquisition was conducted through a Bankruptcy Court-supervised process, subject to Bankruptcy Court-approved bidding procedures, approval of the transactions by the Bankruptcy Court, and the satisfaction of certain closing conditions. The Company closed on the Marlin Acquisition on November 23, 2020.

 

The Agreement provided that, upon the terms and subject to the conditions set forth therein, Remington sold, transferred and assigned to the Company the Marlin Assets (as defined in the Agreement) for a purchase price of $28.3 million in cash. The Marlin Assets include the following assets, among other things, equipment, inventory, and all intellectual property related to Marlin, including the Marlin names and marks, and all derivatives thereof.

  

The primary purpose of the Marlin Acquisition was to manufacture and sell Marlin branded firearms and generate shareholder value. The Marlin brand aligns with the Ruger brand and the Marlin product portfolio will widen the Company’s diverse product offerings. The transaction was funded by the Company with cash on hand and has been accounted for in accordance with ASC 805 - Business Combinations. ASC 805 requires, among other things, an assignment of the acquisition consideration transferred to the sellers for the tangible and intangible assets acquired, using the bottom up approach, to estimate their value at acquisition date. Any excess of the fair value of the purchase consideration over these identified net assets was recorded as goodwill. Our estimates of fair value were based upon assumptions believed to be reasonable, yet were inherently uncertain. During the measurement period, which did not exceed one year from the date of acquisition, we recorded adjustments totaling $2.2 million to the estimated fair values of the assets acquired and liabilities assumed with a corresponding adjustment to goodwill. These adjustments were recorded in the year ended December 31, 2021.

Cash and Cash Equivalents

Cash and Cash Equivalents

 

The Company considers interest-bearing deposits with financial institutions with remaining maturities of three months or less at the time of acquisition to be cash equivalents.

 

Fair Value Measurements of Short-term Investments

Fair Value Measurements of Short-term Investments

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the principal or most advantageous market at the measurement date. Fair value is established according to a hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below:

 

Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.

 

Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.

 

Level 3: Unobservable inputs are used when little or no market data is available. Level 3 inputs are given the lowest priority in the fair value hierarchy.

 

The asset or liability’s fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs.

 

As of December 31, 2022, the Company’s short-term investments consist of U.S. Treasury instruments (Level 1), maturing within one year, and investments in a bank-managed money market fund that invests exclusively in United States Treasury obligations and is valued at the net asset value ("NAV") daily closing price, as reported by the fund, based on the amortized cost of the fund’s securities (Level 2). For the bank-managed money market fund, the NAV is used as a practical expedient to estimate fair value. This practical expedient is not used when it is determined to be probable that the fund will sell the investment for an amount different than the reported NAV. Such securities are classified as held to maturity, since the Company has the intent and ability to do so, and are carried at cost plus accrued interest, which approximates fair value.

 

The fair value of inventory acquired as part of business combination is based on a third-party valuation utilizing the comparable sales method which is based on Level 2 and Level 3 inputs. The fair value of property, plant and equipment acquired as part of business combination is based on a third-party valuation utilizing the indirect method of cost approach, which is based on Level 2 and Level 3 inputs. The fair value of patents acquired as part of business combination is based on a third-party valuation utilizing the replacement cost method, which is based on Level 2 and Level 3 inputs. The fair value of the remaining intangible assets as part of business combination are based on a third-party valuation utilizing discounted cash flow methods that involves inputs, which are not observable in the market (Level 3).

Accounts Receivable

Accounts Receivable

 

The Company establishes an allowance for doubtful accounts based on the creditworthiness of its customers and historical experience. While the Company uses the best information available to make its evaluation, future adjustments to the allowance for doubtful accounts may be necessary if there are significant changes in economic and industry conditions or any other factors considered in the Company’s evaluation. Bad debt expense has been immaterial during each of the last three years. The Company mitigates its credit risk by maintaining credit insurance on most of its significant customers.

 

Inventories

Inventories

 

Substantially all of the Company’s inventories are valued at the lower of cost, principally determined by the last-in, first-out (LIFO) method, or net realizable value. Elements of cost in inventories include raw materials, direct labor and manufacturing overhead.

 

Property, Plant, and Equipment

Property, Plant, and Equipment

 

Property, plant, and equipment are carried at cost. Depreciation is computed over useful lives using the straight-line and declining balance methods predominately over 15 years for buildings, 7 years for machinery and equipment and 3 years for tools and dies. When assets are retired, sold or otherwise disposed of, their gross carrying values and related accumulated depreciation are removed from the accounts and a gain or loss on such disposals is recognized when appropriate.

 

Maintenance and repairs are charged to operations; replacements and improvements are capitalized.

 

Long-lived Assets

Long-lived Assets

 

The Company evaluates the carrying value of long-lived assets to be held and used when events or changes in circumstances indicate the carrying value may not be recoverable. In performing this review, the carrying value of the assets is compared to the projected undiscounted cash flows to be generated from the assets. If the sum of the undiscounted expected future cash flows is less than the carrying value of the assets, the assets are considered to be impaired. Impairment losses are measured as the amount by which the carrying value of the assets exceeds their fair value. The Company bases fair value of the assets on quoted market prices if available or, if not available, quoted market prices of similar assets. Where quoted market prices are not available, the Company estimates fair value using the estimated future cash flows generated by the assets discounted at a rate commensurate with the risks associated with the recovery of the assets. As of December 31, 2022, the Company does not believe there are any indications of impairment related to long-lived assets.

 

Goodwill

Goodwill

 

Our goodwill represents the excess of the purchase price of business combinations over the fair value of the net assets acquired. We assess goodwill for impairment on an annual basis during the fourth quarter of each year, and between annual tests whenever events or changes in circumstances

indicate that the carrying amount may not be recoverable. An impairment exists by the amount the fair value of a reporting unit to which goodwill has been allocated is less than their respective carrying values. The impairment for goodwill is limited to the total amount of goodwill allocated to the reporting unit. Goodwill impairment testing requires significant judgment and management estimates, including, but not limited to, the determination of (i) the number of reporting units, (ii) the goodwill and other assets and liabilities to be allocated to the reporting units and (iii) the fair values of the reporting units. The estimates and assumptions described above, along with other factors such as discount rates, will significantly affect the outcome of the impairment tests and the amounts of any resulting impairment losses. As of December 31, 2022, the Company does not believe there are any indications of impairment related to goodwill.

 

Income Taxes

Income Taxes

 

Income taxes are accounted for using the asset and liability method. Under this method, deferred income taxes are recognized for the tax consequences of “temporary differences” by applying enacted statutory rates applicable to future years to temporary differences between the financial statement carrying amounts and the tax basis of the Company’s assets and liabilities.

 

Product Liability

Product Liability

 

The Company provides for product liability claims including estimated legal costs to be incurred defending such claims. The provision for product liability claims is charged to cost of products sold.

 

Advertising Costs

Advertising Costs

 

The Company includes advertising costs in selling expenses and these costs are expensed as incurred. Advertising costs for 2022, 2021, and 2020, were $2.4 million, $2.6 million, and $2.7 million, respectively.

 

Shipping Costs

Shipping Costs

 

Costs incurred related to the shipment of products are included in selling expense. Such costs totaled $4.7 million, $4.2 million, and $3.9 million in 2022, 2021, and 2020, respectively.

 

Research and Development

Research and Development

 

In 2022, 2021, and 2020, the Company spent approximately $9.6 million, $11.7 million, and $8.0 million, respectively, on research and development activities relating to new products and the improvement of existing products. These costs are included in costs of products sold and are expensed as incurred.

 

Earnings per Share

Earnings per Share

 

Basic earnings per share is based upon the weighted-average number of shares of common stock outstanding during the year. Diluted earnings per share reflect the impact of options, restricted stock units, and deferred stock outstanding using the treasury stock method.

XML 44 R32.htm IDEA: XBRL DOCUMENT v3.22.4
Acquisition of Marlin Assets (Tables)
12 Months Ended
Dec. 31, 2022
Acquisition of Marlin Assets [Abstract]  
Schedule of allocation of purchase price consideration
    Initial Purchase
Price Allocation
    Measurement
Period
Adjustments
    Final Purchase
Price Allocation
 
Purchase Price               
Cash paid to sellers  $28,316   $
   $28,316 
Purchase Price Allocation               
Assets Acquired               
Inventory  $11,400   $(2,414)  $8,986 
Machinery and equipment   5,000    (25)   4,975 
Tradename and trademarks   7,800         7,800 
Patents   2,500         2,500 
Customer Relationships   1,000         1,000 
Goodwill   616    2,439    3,055 
Net Assets Acquired  $28,316   $
   $28,316 

 

Schedule of estimated remaining useful lives
   Remaining Economic
Useful Life
Tradename and trademarks  20 years
Patents  20 years
Customer Relationships  15 years

 

XML 45 R33.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue Recognition and Contracts with Customers (Tables)
12 Months Ended
Dec. 31, 2022
Revenue from Contracts with Customers [Abstract]  
Schedule of revenue recognized
    2022    2021    2020 
Contract liabilities with customers at January 1,  $
   $84   $9,623 
                
Revenue recognized   
    (84)   (14,570)
                
Revenue deferred   1,031    
    5,031 
                
Contract liabilities with customers at December 31,  $1,031   $
   $84 

 

XML 46 R34.htm IDEA: XBRL DOCUMENT v3.22.4
Trade Receivables, Net (Tables)
12 Months Ended
Dec. 31, 2022
Trade Receivables, Net [Abstract]  
Schedule of trade receivables
December 31,  2022   2021 
         
Trade receivables  $67,183   $58,605 
Allowance for doubtful accounts   (400)   (400)
Allowance for discounts   (1,334)   (1,169)
   $65,449   $57,036 

 

XML 47 R35.htm IDEA: XBRL DOCUMENT v3.22.4
Inventories (Tables)
12 Months Ended
Dec. 31, 2022
Inventory Disclosure [Abstract]  
Schedule of inventories
December 31,  2022   2021 
Inventory at FIFO          
Finished goods  $23,573   $7,322 
Materials and products in process   105,721    92,701 
Gross inventories   129,294    100,023 
Less:  LIFO reserve   (59,489)   (51,826)
Less:  excess and obsolescence reserve   (4,812)   (4,347)
Net Inventories  $64,993   $43,850 
XML 48 R36.htm IDEA: XBRL DOCUMENT v3.22.4
Property, Plant and Equipment (Tables)
12 Months Ended
Dec. 31, 2022
Property, Plant and Equipment [Abstract]  
Schedule of property, plant and equipment

Property, plant and equipment consist of the following:

 

December 31,  2022   2021 
         
Land and improvements  $2,826   $2,686 
Buildings and improvements   72,788    62,781 
Machinery and equipment   314,032    302,241 
Dies and tools   57,480    53,574 
Property, plant and equipment   447,126    421,282 
Less allowances for depreciation   (370,273)   (347,651)
Net property, plant and equipment  $76,853   $73,631 

 

XML 49 R37.htm IDEA: XBRL DOCUMENT v3.22.4
Other Assets (Tables)
12 Months Ended
Dec. 31, 2022
Disclosure Text Block Supplement [Abstract]  
Schedule of Other Assets
December 31,  2022   2021 
         
Patents, at cost  $10,126   $10,024 
Accumulated amortization   (6,318)   (5,360)
Deposits on capital items   17,106    18,026 
Marlin trade name   7,800    7,800 
Other   11,249    8,953 
   $39,963   $39,443 

 

XML 50 R38.htm IDEA: XBRL DOCUMENT v3.22.4
Leased Assets (Tables)
12 Months Ended
Dec. 31, 2022
Leased Assets [Abstract]  
Schedule of right-of-use assets and related lease liabilities
   Balance Sheet Line
Item
  December 31,
2022
   December 31,
2021
 
Right-of-use assets  Other assets  $3,681   $1,694 
              
Operating lease liabilities             
              
Current portion  Trade accounts payable and accrued expenses  $642   $249 
              
Noncurrent portion  Lease liabilities   3,039    1,476 
              
Total operating lease liabilities     $3,681   $1,725 

 

Schedule of operating lease liabilities
2023  $803 
2024   808 
2025   702 
2026   705 
2027   229 
Thereafter   1,120 
Total undiscounted future minimum lease payments   4,367 
Less: Difference between undiscounted lease payments & the present value of future lease payments   (686)
Total operating lease liabilities  $3,681 

 

XML 51 R39.htm IDEA: XBRL DOCUMENT v3.22.4
Trade Accounts Payable and Accrued Expenses (Tables)
12 Months Ended
Dec. 31, 2022
Trade Accounts Payable and Accrued Expenses [Abstract]  
Schedule of trade accounts payable and accrued expenses
December 31,  2022   2021 
           
Trade accounts payable  $13,281   $12,209 
Federal excise taxes payable   13,635    15,734 
Accrued other   8,742    8,457 
   $35,658   $36,400 
XML 52 R40.htm IDEA: XBRL DOCUMENT v3.22.4
Other Operating Income, Net (Tables)
12 Months Ended
Dec. 31, 2022
Other Operating Income, Net [Abstract]  
Schedule of other operating income, net
Year ended December 31,  2022   2021   2020 
                
Gain on sale of operating assets  $36   $127   $52 
XML 53 R41.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Taxes [Abstract]  
Schedule of federal and state income tax provision
Year ended December 31,  2022   2021   2020 
   Current   Deferred   Current   Deferred   Current   Deferred 
Federal  $21,741   $(4,694)  $42,422   $863   $20,201   $3,696 
State   3,779    (879)   7,279    131    6,519    167 
   $25,520   $(5,573)  $49,701   $994   $26,720   $3,863 

Schedule of effective income tax rate reconciliation
Year ended December 31,  2022   2021   2020 
Statutory federal income tax rate   21.0%    21.0%    21.0% 
State income taxes, net of federal tax benefit   2.7    3.4    4.4 
Research and development tax credits   (4.2)   (0.4)   
 
Other   (1.1)   0.5    (0.1)
Effective income tax rate   18.4%    24.5%    25.3% 

 

Schedule of deferred tax assets and liabilities
December 31,  2022   2021 
Deferred tax assets          
Product Liability  $69   $224 
Capitalized research and development costs   4,838    
 
Employee compensation and benefits   2,316    2,643 
Allowances for doubtful accounts and discounts   637    418 
Inventories   1,196    1,224 
Stock-based compensation   1,661    1,538 
Other   1,636    1,538 
Total deferred tax assets   12,353    7,585 
Deferred tax liabilities:          
Depreciation   5,070    6,235 
Other   1,174    814 
Total deferred tax liabilities   6,244    7,049 
Net deferred tax assets  $6,109   $536 

 

XML 54 R42.htm IDEA: XBRL DOCUMENT v3.22.4
Earnings Per Share (Tables)
12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
Schedule of a reconciliation of the numerator and denominator for the basic and diluted earnings per share
Year ended December 31,  2022   2021   2020 
                
Numerator:               
Net income  $88,332   $155,899   $90,398 
Denominator:               
Weighted average number of common shares outstanding – Basic   17,648,850    17,585,604    17,486,054 
Dilutive effect of options and restricted stock units outstanding under the Company’s employee compensation plans   144,498    172,230    283,802 
Weighted average number of common shares outstanding – Diluted   17,793,348    17,757,834    17,769,856 
XML 55 R43.htm IDEA: XBRL DOCUMENT v3.22.4
Stock Repurchases (Tables)
12 Months Ended
Dec. 31, 2022
Stock Repurchases [Abstract]  
Schedule of repurchased shares of its common stock
Period  Total
Number of
Shares
Purchased
  Average
Price Paid
per Share
  Total
Number of
Shares
Purchased
as Part of
Publicly
Announced
Program
  Maximum
Dollar
Value of
Shares that
May Yet Be
Purchased
Under the
Program
                     
Third Quarter 2022                    
July 3 to July 30   
—  
    
—  
    
—  
    
 
 
July 31 to August 27   
—  
    
—  
    
—  
    
 
 
August 28 to October 1   2,136   $49.97    2,136    
 
 
Fourth Quarter 2022                    
October 2 to October 29   
—  
    
—  
    
—  
    
 
 
October 30 to November 26   2,304   $49.77    2,304    
 
 
November 27 to December 31   
—  
    
—  
    
—  
    
 
 
Total   4,440   $49.87    4,440   $86,490,000 

 

XML 56 R44.htm IDEA: XBRL DOCUMENT v3.22.4
Operating Segment Information (Tables)
12 Months Ended
Dec. 31, 2022
Operating Segment Information [Abstract]  
Schedule of Operating Segment Financial Information
Year ended December 31,  2022   2021   2020 
Net Sales               
Firearms  $593,289   $728,141   $565,863 
Castings               
Unaffiliated   2,553    2,595    3,005 
Intersegment   21,306    24,711    22,254 
    23,859    27,306    25,259 
Eliminations   (21,306)   (24,711)   (22,254)
   $595,842   $730,736   $568,868 
Income (Loss) Before Income Taxes               
Firearms  $108,610   $207,657   $120,732 
Castings   (3,338)   (2,732)   (1,000)
Corporate   3,007    1,669    1,249 
   $108,279   $206,594   $120,981 
Identifiable Assets               
Firearms  $223,301   $188,290   $174,500 
Castings   11,910    13,889    11,959 
Corporate   249,552    240,164    161,799 
   $484,763   $442,343   $348,258 
Goodwill               
Firearms  $3,055   $3,055   $616 
Castings   209    209    209 
   $3,264   $3,264   $825 
Depreciation               
Firearms  $21,992   $22,842   $25,126 
Castings   2,452    2,959    2,158 
   $24,444   $25,801   $27,284 
Capital Expenditures               
Firearms  $26,598   $25,239   $19,253 
Castings   1,175    3,537    4,976 
   $27,773   $28,776   $24,229 

 

XML 57 R45.htm IDEA: XBRL DOCUMENT v3.22.4
Quarterly Results of Operations (Unaudited) (Tables)
12 Months Ended
Dec. 31, 2022
Quarterly Results of Operations [Abstract]  
Schedule of quarterly financial information
   Three Months Ended 
    4/2/22    7/2/22    10/1/22    12/31/22 
Net Sales  $166,575   $140,653   $139,390   $149,224 
Gross profit   58,108    43,554    38,869    39,554 
Net income   30,232    20,757    18,389    18,954 
Basic earnings per share   1.72    1.18    1.04    1.07 
Diluted earnings per share  $1.70   $1.17   $1.03   $1.06 

 

   Three Months Ended 
    4/3/21    7/3/21    10/2/21    12/31/21 
Net Sales  $184,377   $200,072   $178,246   $168,041 
Gross profit   72,566    78,757    64,802    63,432 
Net income   38,192    44,384    35,202    38,121 
Basic earnings per share   2.18    2.52    2.00    2.17 
Diluted earnings per share  $2.16   $2.50   $1.98   $2.14 
XML 58 R46.htm IDEA: XBRL DOCUMENT v3.22.4
Contingent Liabilities (Tables)
12 Months Ended
Dec. 31, 2022
Contingent Liabilities [Abstract]  
Schedule of roll-forward for product liability reserve
           Cash Payments     
   Balance
Beginning
of Year (a)
   Accrued
Legal
Expense
(Income)
(b)
   Legal Fees
(c)
   Settlements
(d)
   Balance
End of
Year (a)
 
                          
2020  $818    800    (492)   
   $1,126 
                          
2021  $1,126    (7)   (227)   
   $892 
                          
2022  $892    (417)   (167)   
   $308 

 

Schedule of product liability expense
   Accrued
Legal
Expense
(b)
   Insurance
Premium
Expense
(e)
   Total
Product
Liability
Expense
 
                
2020  $800    839   $1,639 
                
2021  $(7)   1,119   $1,112 
                
2022  $(417)   1,524   $1,107 

 

XML 59 R47.htm IDEA: XBRL DOCUMENT v3.22.4
Summary of Significant Accounting Policies (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Summary of Significant Accounting Policies (Details) [Line Items]      
Customer payment description Customary payment terms are 2% 30 days    
Advertising expenses $ 2.4 $ 2.6 $ 2.7
Shipping costs 4.7 4.2 3.9
Research and development $ 9.6 $ 11.7 $ 8.0
Sales [Member] | Customer Concentration Risk [Member] | Firearms [Member]      
Summary of Significant Accounting Policies (Details) [Line Items]      
Percentage of sales 99.00%    
Sales [Member] | Customer Concentration Risk [Member] | Unaffiliated Castings [Member]      
Summary of Significant Accounting Policies (Details) [Line Items]      
Percentage of sales 6.00%    
Sales [Member] | Non-US [Member] | Minimum [Member]      
Summary of Significant Accounting Policies (Details) [Line Items]      
Percentage of sales 1.00%    
Building [Member]      
Summary of Significant Accounting Policies (Details) [Line Items]      
Useful life 15 years    
Machinery and Equipment [Member]      
Summary of Significant Accounting Policies (Details) [Line Items]      
Useful life 7 years    
Tools, Dies and Molds [Member]      
Summary of Significant Accounting Policies (Details) [Line Items]      
Useful life 3 years    
Remington Outdoor Company, Inc. [Member]      
Summary of Significant Accounting Policies (Details) [Line Items]      
Purchase price $ 28.3    
XML 60 R48.htm IDEA: XBRL DOCUMENT v3.22.4
Acquisition of Marlin Assets (Details) - USD ($)
$ in Millions
2 Months Ended 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Initial Purchase Price Acquisition [Member]    
Acquisition of Marlin Assets (Details) [Line Items]    
Cash paid   $ 28.3
Initial Purchase Price Acquisition [Member]    
Acquisition of Marlin Assets (Details) [Line Items]    
Increase to goodwill $ 2.4  
Marlin Acquisition [Member]    
Acquisition of Marlin Assets (Details) [Line Items]    
Excess purchase price of goodwill   3.1
Acquisition related costs   $ 1.7
Marlin Acquisition [Member] | Maximum [Member]    
Acquisition of Marlin Assets (Details) [Line Items]    
Sales and gross margin percentage   5.00%
Marlin Acquisition [Member] | Minimum [Member]    
Acquisition of Marlin Assets (Details) [Line Items]    
Sales and gross margin percentage   1.00%
XML 61 R49.htm IDEA: XBRL DOCUMENT v3.22.4
Acquisition of Marlin Assets (Details) - Schedule of allocation of purchase price consideration - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Initial Purchase Price Allocation[Member]    
Purchase Price    
Cash paid to sellers   $ 28,316
Assets Acquired    
Net Assets Acquired   28,316
Initial Purchase Price Allocation[Member] | Inventory [Member]    
Assets Acquired    
Net Assets Acquired   11,400
Initial Purchase Price Allocation[Member] | Machinery and Equipment [Member]    
Assets Acquired    
Net Assets Acquired   5,000
Initial Purchase Price Allocation[Member] | Tradename and trademarks [Member]    
Assets Acquired    
Net Assets Acquired   7,800
Initial Purchase Price Allocation[Member] | Patents [Member]    
Assets Acquired    
Net Assets Acquired   2,500
Initial Purchase Price Allocation[Member] | Customer Relationships [Member]    
Assets Acquired    
Net Assets Acquired   1,000
Initial Purchase Price Allocation[Member] | Goodwill [Member]    
Assets Acquired    
Net Assets Acquired   616
Measurement Period Adjustments [Member]    
Purchase Price    
Cash paid to sellers  
Assets Acquired    
Net Assets Acquired  
Measurement Period Adjustments [Member] | Inventory [Member]    
Assets Acquired    
Net Assets Acquired (2,414)  
Measurement Period Adjustments [Member] | Machinery and Equipment [Member]    
Assets Acquired    
Net Assets Acquired (25)  
Measurement Period Adjustments [Member] | Goodwill [Member]    
Assets Acquired    
Net Assets Acquired $ 2,439  
Final Purchase Price Allocation [Member]    
Purchase Price    
Cash paid to sellers   28,316
Assets Acquired    
Net Assets Acquired   28,316
Final Purchase Price Allocation [Member] | Inventory [Member]    
Assets Acquired    
Net Assets Acquired   8,986
Final Purchase Price Allocation [Member] | Machinery and Equipment [Member]    
Assets Acquired    
Net Assets Acquired   4,975
Final Purchase Price Allocation [Member] | Tradename and trademarks [Member]    
Assets Acquired    
Net Assets Acquired   7,800
Final Purchase Price Allocation [Member] | Patents [Member]    
Assets Acquired    
Net Assets Acquired   2,500
Final Purchase Price Allocation [Member] | Customer Relationships [Member]    
Assets Acquired    
Net Assets Acquired   1,000
Final Purchase Price Allocation [Member] | Goodwill [Member]    
Assets Acquired    
Net Assets Acquired   $ 3,055
XML 62 R50.htm IDEA: XBRL DOCUMENT v3.22.4
Acquisition of Marlin Assets (Details) - Schedule of estimated remaining useful lives - Marlin Acquisition [Member]
12 Months Ended
Dec. 31, 2022
Trademarks and Trade Names [Member]  
Acquired Finite-Lived Intangible Assets [Line Items]  
Intangible assets useful life 20 years
Patents [Member]  
Acquired Finite-Lived Intangible Assets [Line Items]  
Intangible assets useful life 20 years
Customer Relationships [Member]  
Acquired Finite-Lived Intangible Assets [Line Items]  
Intangible assets useful life 15 years
XML 63 R51.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue Recognition and Contracts with Customers (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Revenue from Contracts with Customers [Abstract]        
Company deferred revenue   $ 1,000   $ 5,000
Net decrease in firearms sales   1,000   9,600
Deferred contract revenue liability   1,000   100
Recognized deferred revenue $ 100 $ 84 $ 14,570
XML 64 R52.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue Recognition and Contracts with Customers (Details) - Schedule of revenue recognized - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Schedule Of Revenue Recognized Abstract        
Contract liabilities with customers at January 1, $ 84 $ 84 $ 9,623
Revenue recognized $ (100) (84) (14,570)
Revenue deferred   1,031 5,031
Contract liabilities with customers at December 31,   $ 1,031 $ 84
XML 65 R53.htm IDEA: XBRL DOCUMENT v3.22.4
Trade Receivables, Net (Details) - Accounts Receivable [Member] - Customer Concentration Risk [Member]
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Customer One [Member]    
Trade Receivables, Net (Details) [Line Items]    
Total trade receivables 26.00% 34.00%
Customer Two [Member]    
Trade Receivables, Net (Details) [Line Items]    
Total trade receivables 23.00% 17.00%
Customer Three [Member]    
Trade Receivables, Net (Details) [Line Items]    
Total trade receivables 18.00% 17.00%
XML 66 R54.htm IDEA: XBRL DOCUMENT v3.22.4
Trade Receivables, Net (Details) - Schedule of trade receivables - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Schedule of trade receivables [Abstract]    
Trade receivables $ 67,183 $ 58,605
Allowance for doubtful accounts (400) (400)
Allowance for discounts (1,334) (1,169)
Trade receivables, net $ 65,449 $ 57,036
XML 67 R55.htm IDEA: XBRL DOCUMENT v3.22.4
Inventories (Details) - Schedule of inventories - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Inventory at FIFO    
Finished goods $ 23,573 $ 7,322
Materials and products in process 105,721 92,701
Gross inventories 129,294 100,023
Less: LIFO reserve (59,489) (51,826)
Less: excess and obsolescence reserve (4,812) (4,347)
Net Inventories $ 64,993 $ 43,850
XML 68 R56.htm IDEA: XBRL DOCUMENT v3.22.4
Property, Plant and Equipment (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Property, Plant and Equipment [Abstract] [Standard Label]      
Depreciation expense $ 24.4 $ 25.8 $ 27.3
XML 69 R57.htm IDEA: XBRL DOCUMENT v3.22.4
Property, Plant and Equipment (Details) - Schedule of property, plant and equipment - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]    
Property, plant and equipment $ 447,126 $ 421,282
Less allowances for depreciation (370,273) (347,651)
Net property, plant and equipment 76,853 73,631
Land and improvements [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment 2,826 2,686
Buildings and improvements [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment 72,788 62,781
Machinery and equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment 314,032 302,241
Dies and tools [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment $ 57,480 $ 53,574
XML 70 R58.htm IDEA: XBRL DOCUMENT v3.22.4
Other Assets (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Other Assets (Details) [Line Items]      
Amortization expenses $ 0.4 $ 0.3 $ 0.3
Patents [Member]      
Other Assets (Details) [Line Items]      
Estimated annual patent amortization expense 2023 0.2    
Estimated annual patent amortization expense 2024 0.2    
Estimated annual patent amortization expense 2025 0.2    
Estimated annual patent amortization expense 2026 0.2    
Estimated annual patent amortization expense 2027 0.2    
Trade name [Member]      
Other Assets (Details) [Line Items]      
Estimated annual patent amortization expense 2023 0.4    
Estimated annual patent amortization expense 2024 0.4    
Estimated annual patent amortization expense 2025 0.4    
Estimated annual patent amortization expense 2026 0.4    
Estimated annual patent amortization expense 2027 0.4    
Customer Relationships [Member]      
Other Assets (Details) [Line Items]      
Estimated annual patent amortization expense 2023 0.1    
Estimated annual patent amortization expense 2024 0.1    
Estimated annual patent amortization expense 2025 0.1    
Estimated annual patent amortization expense 2026 0.1    
Estimated annual patent amortization expense 2027 $ 0.1    
XML 71 R59.htm IDEA: XBRL DOCUMENT v3.22.4
Other Assets (Details) - Schedule of Other Assets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Schedule Of Other Assets Abstract    
Patents, at cost $ 10,126 $ 10,024
Accumulated amortization (6,318) (5,360)
Deposits on capital items 17,106 18,026
Marlin trade name 7,800 7,800
Other 11,249 8,953
Other assets $ 39,963 $ 39,443
XML 72 R60.htm IDEA: XBRL DOCUMENT v3.22.4
Leased Assets (Details)
Dec. 31, 2022
Disclosure Text Block [Abstract]  
Lease term 8 years 10 months 24 days
XML 73 R61.htm IDEA: XBRL DOCUMENT v3.22.4
Leased Assets (Details) - Schedule of right-of-use assets and related lease liabilities - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Leased Assets (Details) - Schedule of right-of-use assets and related lease liabilities [Line Items]    
Total operating lease liabilities $ 3,681 $ 1,725
Other Assets [Member]    
Leased Assets (Details) - Schedule of right-of-use assets and related lease liabilities [Line Items]    
Right-of-use assets 3,681 1,694
Trade accounts payable and accrued expenses [Member]    
Leased Assets (Details) - Schedule of right-of-use assets and related lease liabilities [Line Items]    
Current portion 642 249
Lease liabilities [Member]    
Leased Assets (Details) - Schedule of right-of-use assets and related lease liabilities [Line Items]    
Noncurrent portion $ 3,039 $ 1,476
XML 74 R62.htm IDEA: XBRL DOCUMENT v3.22.4
Leased Assets (Details) - Schedule of operating lease liabilities - Operating lease [Member]
$ in Thousands
Dec. 31, 2022
USD ($)
Leased Assets (Details) - Schedule of operating lease liabilities [Line Items]  
2023 $ 803
2024 808
2025 702
2026 705
2027 229
Thereafter 1,120
Total undiscounted future minimum lease payments 4,367
Less: Difference between undiscounted lease payments & the present value of future lease payments (686)
Total operating lease liabilities $ 3,681
XML 75 R63.htm IDEA: XBRL DOCUMENT v3.22.4
Trade Accounts Payable and Accrued Expenses (Details) - Schedule of trade accounts payable and accrued expenses - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Schedule of trade accounts payable and accrued expenses [Abstract]    
Trade accounts payable $ 13,281 $ 12,209
Federal excise taxes payable 13,635 15,734
Accrued other 8,742 8,457
Total trade accounts payable and accrued expenses $ 35,658 $ 36,400
XML 76 R64.htm IDEA: XBRL DOCUMENT v3.22.4
Accrued Dividends (Details) - USD ($)
$ / shares in Units, $ in Millions
Feb. 17, 2023
Jan. 05, 2023
Nov. 30, 2022
Accrued Dividends (Details) [Line Items]      
Dividend per share     $ 5
Subsequent Event [Member]      
Accrued Dividends (Details) [Line Items]      
Dividend per share $ 0.42    
Dividend payable   $ 88.3  
XML 77 R65.htm IDEA: XBRL DOCUMENT v3.22.4
Line of Credit (Details) - Line of Credit [Member] - USD ($)
$ in Millions
12 Months Ended
Jan. 07, 2022
Dec. 31, 2022
Dec. 31, 2021
Line of Credit (Details) [Line Items]      
Credit facility with a bank $ 40   $ 40
Revolving credit facility, expiration date Jan. 07, 2025    
Line of credit unused portion per year   0.25%  
XML 78 R66.htm IDEA: XBRL DOCUMENT v3.22.4
Employee Benefit Plans (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Retirement Benefits [Abstract]      
Expenses related to matching employee contributions $ 4.1 $ 4.0 $ 3.3
Supplemental contributions total $ 7.4 $ 7.4 $ 5.6
XML 79 R67.htm IDEA: XBRL DOCUMENT v3.22.4
Other Operating Income, Net (Details) - Schedule of other operating income, net - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Schedule of other operating income, net [Abstract]      
Gain on sale of operating assets $ 36 $ 127 $ 52
XML 80 R68.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Taxes (Details) [Line Items]        
Capitalized and amortized over for income tax purposes   5 years    
Income tax payments   $ 28.7 $ 49.5 $ 30.6
Forecast [Member]        
Income Taxes (Details) [Line Items]        
Effective tax rate, percentage 22.40%      
XML 81 R69.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes (Details) - Schedule of federal and state income tax provision - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Schedule of federal and state income tax provision [Abstract]      
Federal, current $ 21,741 $ 42,422 $ 20,201
Federal, deferred (4,694) 863 3,696
State, current 3,779 7,279 6,519
State, deferred (879) 131 167
Current 25,520 49,701 26,720
Deferred $ (5,573) $ 994 $ 3,863
XML 82 R70.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes (Details) - Schedule of effective income tax rate reconciliation
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Schedule of effective income tax rate reconciliation [Abstract]      
Statutory federal income tax rate 21.00% 21.00% 21.00%
State income taxes, net of federal tax benefit 2.70% 3.40% 4.40%
Research and development tax credits (4.20%) (0.40%)
Other (1.10%) 0.50% (0.10%)
Effective income tax rate 18.40% 24.50% 25.30%
XML 83 R71.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes (Details) - Schedule of deferred tax assets and liabilities - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Deferred tax assets    
Product Liability $ 69 $ 224
Capitalized research and development costs 4,838
Employee compensation and benefits 2,316 2,643
Allowances for doubtful accounts and discounts 637 418
Inventories 1,196 1,224
Stock-based compensation 1,661 1,538
Other 1,636 1,538
Total deferred tax assets 12,353 7,585
Deferred tax liabilities:    
Depreciation 5,070 6,235
Other 1,174 814
Total deferred tax liabilities 6,244 7,049
Net deferred tax assets $ 6,109 $ 536
XML 84 R72.htm IDEA: XBRL DOCUMENT v3.22.4
Earnings Per Share (Details) - Schedule of a reconciliation of the numerator and denominator for the basic and diluted earnings per share - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Numerator:      
Net income (in Dollars) $ 88,332 $ 155,899 $ 90,398
Denominator:      
Weighted average number of common shares outstanding – Basic 17,648,850 17,585,604 17,486,054
Dilutive effect of options and restricted stock units outstanding under the Company’s employee compensation plans 144,498 172,230 283,802
Weighted average number of common shares outstanding – Diluted 17,793,348 17,757,834 17,769,856
Weighted Average [Member]      
Denominator:      
Weighted average number of common shares outstanding – Basic 17,648,850 17,585,604 17,486,054
Weighted average number of common shares outstanding – Diluted 17,793,348 17,757,834 17,769,856
XML 85 R73.htm IDEA: XBRL DOCUMENT v3.22.4
Stock Repurchases (Details)
$ in Millions
Dec. 31, 2022
USD ($)
Stock Repurchases Abstract  
Share repurchase authorization $ 86.5
XML 86 R74.htm IDEA: XBRL DOCUMENT v3.22.4
Stock Repurchases (Details) - Schedule of repurchased shares of its common stock
12 Months Ended
Dec. 31, 2022
USD ($)
$ / shares
shares
Third Quarter 2022  
Total Number of Shares Purchased 4,440
Average Price Paid per Share (in Dollars per share) | $ / shares $ 49.87
Total Number of Shares Purchased as Part of Publicly Announced Program 4,440
Maximum Dollar Value of Shares that May Yet Be Purchased Under the Program (in Dollars) | $ $ 86,490,000
July 3 to July 30 [Member]  
Third Quarter 2022  
Total Number of Shares Purchased
Average Price Paid per Share (in Dollars per share) | $ / shares
Total Number of Shares Purchased as Part of Publicly Announced Program
Maximum Dollar Value of Shares that May Yet Be Purchased Under the Program (in Dollars) | $
July 31 to August 27 [Member]  
Third Quarter 2022  
Total Number of Shares Purchased
Average Price Paid per Share (in Dollars per share) | $ / shares
Total Number of Shares Purchased as Part of Publicly Announced Program
Maximum Dollar Value of Shares that May Yet Be Purchased Under the Program (in Dollars) | $
August 28 to October 1 [Member]  
Third Quarter 2022  
Total Number of Shares Purchased 2,136
Average Price Paid per Share (in Dollars per share) | $ / shares $ 49.97
Total Number of Shares Purchased as Part of Publicly Announced Program 2,136
Maximum Dollar Value of Shares that May Yet Be Purchased Under the Program (in Dollars) | $
October 2 to October 29 [Member]  
Third Quarter 2022  
Total Number of Shares Purchased
Average Price Paid per Share (in Dollars per share) | $ / shares
Total Number of Shares Purchased as Part of Publicly Announced Program
Maximum Dollar Value of Shares that May Yet Be Purchased Under the Program (in Dollars) | $
October 3 to November 26 [Member]  
Third Quarter 2022  
Total Number of Shares Purchased 2,304
Average Price Paid per Share (in Dollars per share) | $ / shares $ 49.77
Total Number of Shares Purchased as Part of Publicly Announced Program 2,304
Maximum Dollar Value of Shares that May Yet Be Purchased Under the Program (in Dollars) | $
November 27 to December 31 [Member]  
Third Quarter 2022  
Total Number of Shares Purchased
Average Price Paid per Share (in Dollars per share) | $ / shares
Total Number of Shares Purchased as Part of Publicly Announced Program
Maximum Dollar Value of Shares that May Yet Be Purchased Under the Program (in Dollars) | $
XML 87 R75.htm IDEA: XBRL DOCUMENT v3.22.4
Compensation Plans (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Compensation Plans (Details) [Line Items]      
Total stock-based compensation $ 5.7 $ 8.3 $ 6.1
Cost of issuances restricted stock units 6.0 5.6 5.7
Unrecognized compensation cost $ 8.1    
Stock Incentive Plan 2017 [Member]      
Compensation Plans (Details) [Line Items]      
Shares reserved for future issuance (in Shares) 750,000    
Shares available for future grants (in Shares) 120,000    
Deferred Stock [Member]      
Compensation Plans (Details) [Line Items]      
Compensation expense $ 0.8 $ 0.8 $ 0.8
Unrecognized compensation cost $ 0.9    
Restricted Stock Units (RSUs) [Member]      
Compensation Plans (Details) [Line Items]      
Restricted stock units issued (in Shares) 82,000 82,000 95,000
Recognized costs of restricted stock units $ 1.7 $ 1.6 $ 1.1
Vesting period 3 years 3 months 18 days    
Restricted Stock Units (RSUs) [Member] | Minimum [Member]      
Compensation Plans (Details) [Line Items]      
Vesting period 24 months 24 months 24 months
Restricted Stock Units (RSUs) [Member] | Maximum [Member]      
Compensation Plans (Details) [Line Items]      
Vesting period 26 months 26 months 26 months
Director [Member] | Deferred Stock [Member] | Vest in May 2023 [Member]      
Compensation Plans (Details) [Line Items]      
Deferred stock awards amount (in Shares) 5,953    
Director [Member] | Deferred Stock [Member] | Vesting in May 2025 [Member]      
Compensation Plans (Details) [Line Items]      
Deferred stock awards amount (in Shares) 7,688    
Director [Member] | Deferred Stock [Member] | Vest in June 2027 [Member]      
Compensation Plans (Details) [Line Items]      
Deferred stock awards amount (in Shares) 1,478    
Director [Member] | Deferred Stock [Member] | Vesting in May 2022 [Member]      
Compensation Plans (Details) [Line Items]      
Deferred stock awards amount (in Shares)   5,113  
Director [Member] | Deferred Stock [Member] | Vesting in May 2023 [Member]      
Compensation Plans (Details) [Line Items]      
Deferred stock awards amount (in Shares)   6,615 8,078
Director [Member] | Deferred Stock [Member] | Vesting in May 2021 [Member]      
Compensation Plans (Details) [Line Items]      
Deferred stock awards amount (in Shares)     6,244
XML 88 R76.htm IDEA: XBRL DOCUMENT v3.22.4
Operating Segment Information (Details)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Operating Segment Information (Details) [Line Items]      
Number of Operating Segments 2    
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Lipseys [Member]      
Operating Segment Information (Details) [Line Items]      
Percentage of sales 23.00% 21.00% 22.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Davidsons [Member]      
Operating Segment Information (Details) [Line Items]      
Percentage of sales 23.00% 19.00% 18.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Sports South [Member]      
Operating Segment Information (Details) [Line Items]      
Percentage of sales 21.00% 19.00% 22.00%
United States [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]      
Operating Segment Information (Details) [Line Items]      
Percentage of sales 94.00% 94.00% 94.00%
XML 89 R77.htm IDEA: XBRL DOCUMENT v3.22.4
Operating Segment Information (Details) - Schedule of operating segment financial information - Operating Segments [Member] - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Net Sales      
Net Sales $ 595,842 $ 730,736 $ 568,868
Income (Loss) Before Income Taxes      
Income (Loss) Before Income Taxes 108,279 206,594 120,981
Identifiable Assets      
Identifiable Assets 484,763 442,343 348,258
Goodwill      
Goodwill 3,264 3,264 825
Depreciation      
Depreciation 24,444 25,801 27,284
Capital Expenditures      
Capital Expenditures 27,773 28,776 24,229
Firearms [Member]      
Net Sales      
Net Sales 593,289 728,141 565,863
Income (Loss) Before Income Taxes      
Income (Loss) Before Income Taxes 108,610 207,657 120,732
Identifiable Assets      
Identifiable Assets 223,301 188,290 174,500
Goodwill      
Goodwill 3,055 3,055 616
Depreciation      
Depreciation 21,992 22,842 25,126
Capital Expenditures      
Capital Expenditures 26,598 25,239 19,253
Unaffiliated Castings [Member]      
Net Sales      
Net Sales 2,553 2,595 3,005
Income (Loss) Before Income Taxes      
Income (Loss) Before Income Taxes (3,338) (2,732) (1,000)
Identifiable Assets      
Identifiable Assets 11,910 13,889 11,959
Goodwill      
Goodwill 209 209 209
Depreciation      
Depreciation 2,452 2,959 2,158
Capital Expenditures      
Capital Expenditures 1,175 3,537 4,976
Intersegment [Member]      
Net Sales      
Net Sales 21,306 24,711 22,254
Castings [Member]      
Net Sales      
Net Sales 23,859 27,306 25,259
Eliminations [Member]      
Net Sales      
Net Sales (21,306) (24,711) (22,254)
Corporate Segment [Member]      
Income (Loss) Before Income Taxes      
Income (Loss) Before Income Taxes 3,007 1,669 1,249
Identifiable Assets      
Identifiable Assets $ 249,552 $ 240,164 $ 161,799
XML 90 R78.htm IDEA: XBRL DOCUMENT v3.22.4
Quarterly Results of Operations (Unaudited) (Details) - Schedule of quarterly financial information - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2022
Oct. 01, 2022
Jul. 02, 2022
Apr. 02, 2022
Dec. 31, 2021
Oct. 02, 2021
Jul. 03, 2021
Apr. 03, 2021
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Schedule Of Quarterly Financial Information Abstract                      
Net Sales $ 149,224 $ 139,390 $ 140,653 $ 166,575 $ 168,041 $ 178,246 $ 200,072 $ 184,377 $ 595,842 $ 730,736 $ 568,868
Gross profit 39,554 38,869 43,554 58,108 63,432 64,802 78,757 72,566 180,085 279,557 191,441
Net income $ 18,954 $ 18,389 $ 20,757 $ 30,232 $ 38,121 $ 35,202 $ 44,384 $ 38,192 $ 88,332 $ 155,899 $ 90,398
Basic earnings per share (in Dollars per share) $ 1.07 $ 1.04 $ 1.18 $ 1.72 $ 2.17 $ 2 $ 2.52 $ 2.18 $ 5 $ 8.87 $ 5.17
Diluted earnings per share (in Dollars per share) $ 1.06 $ 1.03 $ 1.17 $ 1.7 $ 2.14 $ 1.98 $ 2.5 $ 2.16 $ 4.96 $ 8.78 $ 5.09
XML 91 R79.htm IDEA: XBRL DOCUMENT v3.22.4
Related Party Transactions (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
National Rifle Association [Member]      
Related Party Transactions (Details) [Line Items]      
Amount paid $ 0.6 $ 0.5 $ 0.7
National Shooting Sports Foundation [Member]      
Related Party Transactions (Details) [Line Items]      
Amount paid $ 0.3 $ 0.4 $ 0.5
XML 92 R80.htm IDEA: XBRL DOCUMENT v3.22.4
Contingent Liabilities (Details)
$ in Millions
12 Months Ended
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Contingent Liabilities (Details) [Line Items]      
Minimum limit of per claim for providing insurance coverage on annual basis (in Dollars) $ 5.0    
Maximum limit of aggregate loss incurred annually for providing insurance coverage on annual basis (in Dollars) $ 10.0    
Total amount of damages claimed (in Dollars)   $ 1.1  
Number of settled lawsuits 1   1
Number of new lawsuits   1 1
Number of lawsuits   4 3
Total Product Liability Expense (in Dollars) $ 1.3 $ 1.1 $ 1.1
Traditional Lawsuits [Member]      
Contingent Liabilities (Details) [Line Items]      
Number of new lawsuits 1 2 2
Municipal Lawsuits [Member]      
Contingent Liabilities (Details) [Line Items]      
Number of new lawsuits 4 2 1
Negligence Lawsuits [Member]      
Contingent Liabilities (Details) [Line Items]      
Number of new lawsuits 3    
XML 93 R81.htm IDEA: XBRL DOCUMENT v3.22.4
Contingent Liabilities (Details) - Schedule of roll-forward for product liability reserve - Product Liability Reserve [Member] - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Product Warranty Liability [Line Items]      
Balance Beginning of Year [1] $ 892 $ 1,126 $ 818
Accrued Legal Expense (Income) [2] (417) (7) 800
Legal Fees [3] (167) (227) (492)
Settlements [4]
Balance End of Year [1] $ 308 $ 892 $ 1,126
[1] The beginning and ending liability balances represent accrued legal fees only. Settlements and administrative costs are expensed as incurred. Only in rare instances is an accrual established for settlements.
[2] The expense accrued in the liability is for legal fees only. In 2022 and 2021, the costs incurred related to cases that were settled or dismissed were less than the amounts accrued for these cases in prior years.
[3] Legal fees represent payments to outside counsel related to product liability matters.
[4] Settlements represent payments made to plaintiffs or allegedly injured parties in exchange for a full and complete release of liability.
XML 94 R82.htm IDEA: XBRL DOCUMENT v3.22.4
Contingent Liabilities (Details) - Schedule of product liability expense - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Accrued Legal Expense [Member]      
Product Liability Contingency [Line Items]      
Accrued Legal Expense [1] $ (417) $ (7) $ 800
Insurance Premium Expense [Member]      
Product Liability Contingency [Line Items]      
Insurance Premium Expense [2] 1,524 1,119 839
Total Product Liability Expense [Member]      
Product Liability Contingency [Line Items]      
Total Product Liability Expense $ 1,107 $ 1,112 $ 1,639
[1] The expense accrued in the liability is for legal fees only. In 2022 and 2021, the costs incurred related to cases that were settled or dismissed were less than the amounts accrued for these cases in prior years.
[2] Insurance expense represents the cost of insurance premiums.
XML 95 R83.htm IDEA: XBRL DOCUMENT v3.22.4
Subsequent Events (Details)
Feb. 17, 2023
$ / shares
Subsequent Event [Member]  
Subsequent Events (Details) [Line Items]  
Dividend authorized $ 0.42
XML 96 rgr-20221231_htm.xml IDEA: XBRL DOCUMENT 0000095029 2022-01-01 2022-12-31 0000095029 2022-06-30 0000095029 2023-02-15 0000095029 2022-12-31 0000095029 2021-12-31 0000095029 us-gaap:NonvotingCommonStockMember 2022-12-31 0000095029 us-gaap:NonvotingCommonStockMember 2021-12-31 0000095029 us-gaap:CommonStockMember 2022-12-31 0000095029 us-gaap:CommonStockMember 2021-12-31 0000095029 rgr:FirearmsMember 2022-01-01 2022-12-31 0000095029 rgr:FirearmsMember 2021-01-01 2021-12-31 0000095029 rgr:FirearmsMember 2020-01-01 2020-12-31 0000095029 rgr:UnaffiliatedCastingsMember 2022-01-01 2022-12-31 0000095029 rgr:UnaffiliatedCastingsMember 2021-01-01 2021-12-31 0000095029 rgr:UnaffiliatedCastingsMember 2020-01-01 2020-12-31 0000095029 2021-01-01 2021-12-31 0000095029 2020-01-01 2020-12-31 0000095029 us-gaap:CommonStockMember 2019-12-31 0000095029 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000095029 us-gaap:RetainedEarningsMember 2019-12-31 0000095029 us-gaap:TreasuryStockMember 2019-12-31 0000095029 2019-12-31 0000095029 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0000095029 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0000095029 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0000095029 us-gaap:CommonStockMember 2020-12-31 0000095029 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000095029 us-gaap:RetainedEarningsMember 2020-12-31 0000095029 us-gaap:TreasuryStockMember 2020-12-31 0000095029 2020-12-31 0000095029 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0000095029 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0000095029 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0000095029 us-gaap:CommonStockMember 2021-12-31 0000095029 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000095029 us-gaap:RetainedEarningsMember 2021-12-31 0000095029 us-gaap:TreasuryStockMember 2021-12-31 0000095029 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0000095029 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0000095029 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0000095029 us-gaap:TreasuryStockMember 2022-01-01 2022-12-31 0000095029 us-gaap:CommonStockMember 2022-12-31 0000095029 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000095029 us-gaap:RetainedEarningsMember 2022-12-31 0000095029 us-gaap:TreasuryStockMember 2022-12-31 0000095029 us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember rgr:FirearmsMember 2022-01-01 2022-12-31 0000095029 us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember rgr:UnaffiliatedCastingsMember 2022-01-01 2022-12-31 0000095029 srt:MinimumMember us-gaap:SalesMember us-gaap:NonUsMember 2022-01-01 2022-12-31 0000095029 rgr:RemingtonOutdoorCompanyMembeMember 2022-01-01 2022-12-31 0000095029 us-gaap:BuildingMember 2022-01-01 2022-12-31 0000095029 us-gaap:MachineryAndEquipmentMember 2022-01-01 2022-12-31 0000095029 us-gaap:ToolsDiesAndMoldsMember 2022-01-01 2022-12-31 0000095029 rgr:InitialPurchasePriceAcquisitionMember 2020-01-01 2020-12-31 0000095029 rgr:InitialPurchasePriceAllocationMember 2021-10-31 2021-12-31 0000095029 rgr:MarlinAcquisitionMember 2020-01-01 2020-12-31 0000095029 srt:MaximumMember rgr:MarlinAcquisitionMember 2020-01-01 2020-12-31 0000095029 srt:MinimumMember rgr:MarlinAcquisitionMember 2020-01-01 2020-12-31 0000095029 rgr:InitialPurchasePriceAllocationMember 2020-01-01 2020-12-31 0000095029 rgr:MeasurementPeriodAdjustmentsMember 2021-01-01 2021-12-31 0000095029 rgr:FinalPurchasePriceAllocationMember 2020-01-01 2020-12-31 0000095029 rgr:InitialPurchasePriceAllocationMember rgr:InventoryMember 2020-12-31 0000095029 rgr:MeasurementPeriodAdjustmentsMember rgr:InventoryMember 2021-12-31 0000095029 rgr:FinalPurchasePriceAllocationMember rgr:InventoryMember 2020-12-31 0000095029 rgr:InitialPurchasePriceAllocationMember us-gaap:MachineryAndEquipmentMember 2020-12-31 0000095029 rgr:MeasurementPeriodAdjustmentsMember us-gaap:MachineryAndEquipmentMember 2021-12-31 0000095029 rgr:FinalPurchasePriceAllocationMember us-gaap:MachineryAndEquipmentMember 2020-12-31 0000095029 rgr:InitialPurchasePriceAllocationMember us-gaap:TrademarksAndTradeNamesMember 2020-12-31 0000095029 rgr:FinalPurchasePriceAllocationMember us-gaap:TrademarksAndTradeNamesMember 2020-12-31 0000095029 rgr:InitialPurchasePriceAllocationMember us-gaap:PatentsMember 2020-12-31 0000095029 rgr:FinalPurchasePriceAllocationMember us-gaap:PatentsMember 2020-12-31 0000095029 rgr:InitialPurchasePriceAllocationMember us-gaap:CustomerRelationshipsMember 2020-12-31 0000095029 rgr:FinalPurchasePriceAllocationMember us-gaap:CustomerRelationshipsMember 2020-12-31 0000095029 rgr:InitialPurchasePriceAllocationMember us-gaap:GoodwillMember 2020-12-31 0000095029 rgr:MeasurementPeriodAdjustmentsMember us-gaap:GoodwillMember 2021-12-31 0000095029 rgr:FinalPurchasePriceAllocationMember us-gaap:GoodwillMember 2020-12-31 0000095029 rgr:InitialPurchasePriceAllocationMember 2020-12-31 0000095029 rgr:MeasurementPeriodAdjustmentsMember 2021-12-31 0000095029 rgr:FinalPurchasePriceAllocationMember 2020-12-31 0000095029 rgr:MarlinAcquisitionMember us-gaap:TrademarksAndTradeNamesMember 2022-01-01 2022-12-31 0000095029 rgr:MarlinAcquisitionMember us-gaap:PatentsMember 2022-01-01 2022-12-31 0000095029 rgr:MarlinAcquisitionMember us-gaap:CustomerRelationshipsMember 2022-01-01 2022-12-31 0000095029 2021-01-01 2021-03-31 0000095029 rgr:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0000095029 rgr:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0000095029 rgr:CustomerThreeMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0000095029 rgr:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0000095029 rgr:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0000095029 rgr:CustomerThreeMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0000095029 us-gaap:LandAndLandImprovementsMember 2022-12-31 0000095029 us-gaap:LandAndLandImprovementsMember 2021-12-31 0000095029 us-gaap:BuildingAndBuildingImprovementsMember 2022-12-31 0000095029 us-gaap:BuildingAndBuildingImprovementsMember 2021-12-31 0000095029 us-gaap:MachineryAndEquipmentMember 2022-12-31 0000095029 us-gaap:MachineryAndEquipmentMember 2021-12-31 0000095029 us-gaap:ToolsDiesAndMoldsMember 2022-12-31 0000095029 us-gaap:ToolsDiesAndMoldsMember 2021-12-31 0000095029 us-gaap:PatentsMember 2022-12-31 0000095029 rgr:TradeNameMember 2022-12-31 0000095029 us-gaap:CustomerRelationshipsMember 2022-12-31 0000095029 us-gaap:OtherAssetsMember 2022-12-31 0000095029 us-gaap:OtherAssetsMember 2021-12-31 0000095029 rgr:TradeAccountsPayableAndAccruedExpensesMember 2022-12-31 0000095029 rgr:TradeAccountsPayableAndAccruedExpensesMember 2021-12-31 0000095029 rgr:LeaseLiabilitiesMember 2022-12-31 0000095029 rgr:LeaseLiabilitiesMember 2021-12-31 0000095029 rgr:OperatingLeaseMember 2022-12-31 0000095029 2022-11-30 0000095029 us-gaap:SubsequentEventMember 2023-01-05 0000095029 us-gaap:LineOfCreditMember 2021-12-31 0000095029 us-gaap:LineOfCreditMember 2022-01-07 0000095029 us-gaap:LineOfCreditMember 2022-01-01 2022-01-07 0000095029 us-gaap:LineOfCreditMember 2022-01-01 2022-12-31 0000095029 srt:ScenarioForecastMember 2023-01-01 2023-12-31 0000095029 srt:WeightedAverageMember 2022-01-01 2022-12-31 0000095029 srt:WeightedAverageMember 2021-01-01 2021-12-31 0000095029 srt:WeightedAverageMember 2020-01-01 2020-12-31 0000095029 rgr:July3ToJuly30Member 2022-12-31 0000095029 rgr:July3ToJuly30Member 2022-01-01 2022-12-31 0000095029 rgr:July31ToAugust27Member 2022-12-31 0000095029 rgr:July31ToAugust27Member 2022-01-01 2022-12-31 0000095029 rgr:August28ToOctober1Member 2022-12-31 0000095029 rgr:August28ToOctober1Member 2022-01-01 2022-12-31 0000095029 rgr:October2ToOctober29Member 2022-12-31 0000095029 rgr:October2ToOctober29Member 2022-01-01 2022-12-31 0000095029 rgr:October3ToNovember26Member 2022-12-31 0000095029 rgr:October3ToNovember26Member 2022-01-01 2022-12-31 0000095029 rgr:November27ToDecember31Member 2022-12-31 0000095029 rgr:November27ToDecember31Member 2022-01-01 2022-12-31 0000095029 rgr:StockIncentivePlan2017Member 2022-12-31 0000095029 srt:DirectorMember rgr:DeferredStockMember rgr:VestInMay2023Member 2022-01-01 2022-12-31 0000095029 srt:DirectorMember rgr:DeferredStockMember rgr:VestingInMay2025Member 2022-01-01 2022-12-31 0000095029 srt:DirectorMember rgr:DeferredStockMember rgr:VestInJune2027Member 2022-01-01 2022-12-31 0000095029 srt:DirectorMember rgr:DeferredStockMember rgr:VestingMayTwoThousandTwentyTwoMember 2021-01-01 2021-12-31 0000095029 srt:DirectorMember rgr:DeferredStockMember rgr:VestingMayTwoThousandTwentyThreeMember 2021-01-01 2021-12-31 0000095029 srt:DirectorMember rgr:DeferredStockMember rgr:VestingMayTwoThousandTwentyOneMember 2020-01-01 2020-12-31 0000095029 srt:DirectorMember rgr:DeferredStockMember rgr:VestingMayTwoThousandTwentyThreeMember 2020-01-01 2020-12-31 0000095029 rgr:DeferredStockMember 2022-01-01 2022-12-31 0000095029 rgr:DeferredStockMember 2021-01-01 2021-12-31 0000095029 rgr:DeferredStockMember 2020-01-01 2020-12-31 0000095029 rgr:DeferredStockMember 2022-12-31 0000095029 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0000095029 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0000095029 srt:MinimumMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0000095029 srt:MaximumMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0000095029 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0000095029 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0000095029 srt:MinimumMember us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0000095029 srt:MaximumMember us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0000095029 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-12-31 0000095029 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0000095029 srt:MinimumMember us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-12-31 0000095029 srt:MaximumMember us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-12-31 0000095029 rgr:LipseysMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0000095029 rgr:DavidsonsMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0000095029 rgr:SportsSouthMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0000095029 rgr:LipseysMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0000095029 rgr:SportsSouthMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0000095029 rgr:DavidsonsMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0000095029 rgr:SportsSouthMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0000095029 rgr:LipseysMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0000095029 rgr:DavidsonsMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0000095029 country:US us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0000095029 country:US us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0000095029 country:US us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:FirearmsMember 2022-01-01 2022-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:FirearmsMember 2021-01-01 2021-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:FirearmsMember 2020-01-01 2020-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:UnaffiliatedCastingsMember 2022-01-01 2022-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:UnaffiliatedCastingsMember 2021-01-01 2021-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:UnaffiliatedCastingsMember 2020-01-01 2020-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:IntersegmentMember 2022-01-01 2022-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:IntersegmentMember 2021-01-01 2021-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:IntersegmentMember 2020-01-01 2020-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:CastingsMember 2022-01-01 2022-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:CastingsMember 2021-01-01 2021-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:CastingsMember 2020-01-01 2020-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:EliminationsMember 2022-01-01 2022-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:EliminationsMember 2021-01-01 2021-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:EliminationsMember 2020-01-01 2020-12-31 0000095029 us-gaap:OperatingSegmentsMember 2022-01-01 2022-12-31 0000095029 us-gaap:OperatingSegmentsMember 2021-01-01 2021-12-31 0000095029 us-gaap:OperatingSegmentsMember 2020-01-01 2020-12-31 0000095029 us-gaap:OperatingSegmentsMember us-gaap:CorporateMember 2022-01-01 2022-12-31 0000095029 us-gaap:OperatingSegmentsMember us-gaap:CorporateMember 2021-01-01 2021-12-31 0000095029 us-gaap:OperatingSegmentsMember us-gaap:CorporateMember 2020-01-01 2020-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:FirearmsMember 2022-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:FirearmsMember 2021-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:FirearmsMember 2020-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:UnaffiliatedCastingsMember 2022-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:UnaffiliatedCastingsMember 2021-12-31 0000095029 us-gaap:OperatingSegmentsMember rgr:UnaffiliatedCastingsMember 2020-12-31 0000095029 us-gaap:OperatingSegmentsMember us-gaap:CorporateMember 2022-12-31 0000095029 us-gaap:OperatingSegmentsMember us-gaap:CorporateMember 2021-12-31 0000095029 us-gaap:OperatingSegmentsMember us-gaap:CorporateMember 2020-12-31 0000095029 us-gaap:OperatingSegmentsMember 2022-12-31 0000095029 us-gaap:OperatingSegmentsMember 2021-12-31 0000095029 us-gaap:OperatingSegmentsMember 2020-12-31 0000095029 2022-01-03 2022-04-02 0000095029 2022-04-03 2022-07-02 0000095029 2022-07-03 2022-10-01 0000095029 2022-10-02 2022-12-31 0000095029 2021-01-04 2021-04-03 0000095029 2021-04-04 2021-07-03 0000095029 2021-07-04 2021-10-02 0000095029 2021-10-03 2021-12-31 0000095029 rgr:NationalRifleAssociationMember 2020-01-01 2020-12-31 0000095029 rgr:NationalRifleAssociationMember 2021-01-01 2021-12-31 0000095029 rgr:NationalRifleAssociationMember 2022-01-01 2022-12-31 0000095029 rgr:NationalShootingSportsFoundationMember 2022-01-01 2022-12-31 0000095029 rgr:NationalShootingSportsFoundationMember 2021-01-01 2021-12-31 0000095029 rgr:NationalShootingSportsFoundationMember 2020-01-01 2020-12-31 0000095029 rgr:TraditionalLawsuitsMember 2022-01-01 2022-12-31 0000095029 rgr:MunicipalLawsuitsMember 2022-01-01 2022-12-31 0000095029 rgr:NegligenceLawsuitsMember 2022-01-01 2022-12-31 0000095029 rgr:TraditionalLawsuitsMember 2021-01-01 2021-12-31 0000095029 rgr:MunicipalLawsuitsMember 2021-01-01 2021-12-31 0000095029 rgr:TraditionalLawsuitsMember 2020-01-01 2020-12-31 0000095029 rgr:MunicipalLawsuitsMember 2020-01-01 2020-12-31 0000095029 rgr:ProductLiabilityReserveMember 2019-12-31 0000095029 rgr:ProductLiabilityReserveMember 2020-01-01 2020-12-31 0000095029 rgr:ProductLiabilityReserveMember 2020-12-31 0000095029 rgr:ProductLiabilityReserveMember 2021-01-01 2021-12-31 0000095029 rgr:ProductLiabilityReserveMember 2021-12-31 0000095029 rgr:ProductLiabilityReserveMember 2022-01-01 2022-12-31 0000095029 rgr:ProductLiabilityReserveMember 2022-12-31 0000095029 rgr:AccruedLegalExpenseMember 2020-01-01 2020-12-31 0000095029 rgr:ProductInsurancePremiumExpenseMember 2020-01-01 2020-12-31 0000095029 rgr:TotalProductLiabilityExpenseMember 2020-12-31 0000095029 rgr:AccruedLegalExpenseMember 2021-01-01 2021-12-31 0000095029 rgr:ProductInsurancePremiumExpenseMember 2021-01-01 2021-12-31 0000095029 rgr:TotalProductLiabilityExpenseMember 2021-12-31 0000095029 rgr:AccruedLegalExpenseMember 2022-01-01 2022-12-31 0000095029 rgr:ProductInsurancePremiumExpenseMember 2022-01-01 2022-12-31 0000095029 rgr:TotalProductLiabilityExpenseMember 2022-12-31 0000095029 us-gaap:SubsequentEventMember 2023-02-17 iso4217:USD shares iso4217:USD shares pure 10-K true 2022-12-31 --12-31 2022 false 0-4776 DE 06-0633559 1 Lacey Place Southport CT 06890 (203) 259-7843 Common Stock, $1 par value RGR NYSE Large Accelerated Filer false false true false 1112555000 17596600 49 RSM US LLP Stamford, Connecticut 65173000 21044000 159132000 199971000 65449000 57036000 129294000 100023000 59489000 51826000 4812000 4347000 64993000 43850000 7091000 6832000 361838000 328733000 447126000 421282000 370273000 347651000 76853000 73631000 6109000 536000 39963000 39443000 484763000 442343000 35658000 36400000 88343000 1031000 235000 795000 30160000 33154000 6469000 6760000 1171000 163067000 77109000 3039000 1476000 1846000 73000 97000 50000 50000 17596588 24378000 24306000 45075000 46847000 393097000 438098000 6709898 145812000 145590000 316738000 363661000 484763000 442343000 593289000 728141000 565863000 2553000 2595000 3005000 595842000 730736000 568868000 415757000 451179000 377427000 180085000 279557000 191441000 36114000 33259000 33332000 40551000 43289000 39013000 36000 127000 52000 76629000 76421000 72293000 103456000 203136000 119148000 837000 1975000 814000 2552000 49000 1126000 256000 164000 191000 1690000 1598000 84000 4823000 3458000 1833000 108279000 206594000 120981000 19947000 50695000 30583000 88332000 155899000 90398000 5 8.87 5.17 4.96 8.78 5.09 17648850 17585604 17486054 17793348 17757834 17769856 2.42 3.36 6.51 24160000 38683000 368205000 -145590000 285458000 90398000 90398000 113896000 113896000 6128000 6128000 -1297000 -1297000 46000 -46000 2092000 2092000 24206000 43468000 342615000 -145590000 264699000 155899000 155899000 59104000 59104000 8280000 8280000 -4801000 -4801000 100000 -100000 1312000 1312000 24306000 46847000 438098000 -145590000 363661000 88332000 88332000 42718000 42718000 1671000 1671000 -3371000 -3371000 72000 -72000 90615000 90615000 4440 222000 222000 24378000 45075000 393097000 -145812000 316738000 88332000 155899000 90398000 25789000 26152000 27576000 1671000 8280000 6128000 501000 953000 36000 127000 52000 -5573000 994000 3863000 8413000 -840000 5236000 21644000 15726000 -10624000 -640000 -392000 7954000 1031000 -84000 -9539000 -3420000 -5433000 20910000 -584000 -234000 308000 954000 -1217000 7905000 1171000 -1223000 77231000 172339000 143806000 27730000 28776000 24229000 -28316000 365480000 681940000 369439000 406319000 602976000 377920000 100000 203000 178000 13209000 -107537000 -43886000 42718000 59104000 113896000 222000 3371000 4801000 1297000 -46311000 -63905000 -115193000 44129000 897000 -15273000 21044000 20147000 35420000 65173000 21044000 20147000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>1.        Summary of Significant Accounting Policies</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Organization</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Sturm, Ruger &amp; Company, Inc. (the “Company”) is principally engaged in the design, manufacture, and sale of firearms to domestic customers. Approximately 99% of sales were from firearms. Export sales represented approximately 6% of firearms sales. The Company’s design and manufacturing operations are located in the United States and almost all product content is domestic. The Company’s firearms are sold through a select number of independent wholesale distributors principally to the commercial sporting market.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company manufactures investment castings made from steel alloys and metal injection molding (“MIM”) parts for internal use in its firearms and utilizes available capacity to manufacture and sell investment castings and MIM parts to unaffiliated, third-party customers. Castings were less than 1% of the Company’s total sales for the year ended December 31, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-weight: normal"><span style="text-decoration: underline">Preparation of Financial Statements</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company follows United States generally accepted accounting principles (“GAAP”). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The significant accounting policies described below, together with the notes that follow, are an integral part of the consolidated financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-weight: normal"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-weight: normal"><span style="text-decoration: underline">Principles of Consolidation</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All significant intercompany accounts and transactions have been eliminated.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-weight: normal"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-weight: normal"><span style="text-decoration: underline">Revenue Recognition</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognizes revenue in accordance with the provisions of Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (“ASC 606”), which became effective January 1, 2018. Substantially all product sales are sold FOB (free on board) shipping point. Customary payment terms are 2% 30 days, net 40 days. Generally, all performance obligations are satisfied when product is shipped and the customer takes ownership and assumes the risk of loss. In some instances, sales include multiple performance obligations. The most common of these instances relates to sales promotion programs under which downstream customers are entitled to receive no charge products based on their purchases of certain of the Company’s products from the independent distributors. The fulfillment of these no charge products </p><div> </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">is the Company’s responsibility. In such instances, the Company allocates the revenue of the promotional sales based on the estimated level of participation in the sales promotional program and the timing of the shipment of all of the firearms included in the promotional program, including the no charge firearms. Revenue is recognized proportionally as each performance obligation is satisfied, based on the relative customary price of each product. Customary prices are generally determined based on the prices charged to the independent distributors. The net change in contract liabilities for a given period is reported as an increase or decrease to sales. The Company accounts for cash sales discounts as a reduction in sales. Amounts billed to customers for shipping and handling fees are included in net sales and costs incurred by the Company for the delivery of goods are classified as selling expenses. Federal excise taxes are excluded from net sales.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline">Business Combination</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 26, 2020, the Company entered into an Asset Purchase Agreement (the "Agreement") with the Remington Outdoor Company, Inc. and each of the subsidiaries of the Remington Outdoor Company, Inc. (collectively, “Remington”) to purchase substantially all of the assets (the “Marlin Assets”) used to manufacture Marlin Firearms (the “Marlin Acquisition”). The agreement to purchase these assets emanated from the Remington Outdoor Company, Inc. bankruptcy and was approved by the United States Bankruptcy Court for the Northern District of Alabama on September 30, 2020. The Marlin Acquisition was conducted through a Bankruptcy Court-supervised process, subject to Bankruptcy Court-approved bidding procedures, approval of the transactions by the Bankruptcy Court, and the satisfaction of certain closing conditions. The Company closed on the Marlin Acquisition on November 23, 2020.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Agreement provided that, upon the terms and subject to the conditions set forth therein, Remington sold, transferred and assigned to the Company the Marlin Assets (as defined in the Agreement) for a purchase price of $28.3 million in cash. The Marlin Assets include the following assets, among other things, equipment, inventory, and all intellectual property related to Marlin, including the Marlin names and marks, and all derivatives thereof.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">  </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The primary purpose of the Marlin Acquisition was to manufacture and sell Marlin branded firearms and generate shareholder value. The Marlin brand aligns with the Ruger brand and the Marlin product portfolio will widen the Company’s diverse product offerings. The transaction was funded by the Company with cash on hand and has been accounted for in accordance with ASC 805 - <i>Business Combinations</i>. ASC 805 requires, among other things, an assignment of the acquisition consideration transferred to the sellers for the tangible and intangible assets acquired, using the bottom up approach, to estimate their value at acquisition date. Any excess of the fair value of the purchase consideration over these identified net assets was recorded as goodwill. Our estimates of fair value were based upon assumptions believed to be reasonable, yet were inherently uncertain. During the measurement period, which did not exceed one year from the date of acquisition, we recorded adjustments totaling $2.2 million to the estimated fair values of the assets acquired and liabilities assumed with a corresponding adjustment to goodwill. These adjustments were recorded in the year ended December 31, 2021.</p><div> </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0pt 0pt; text-align: justify"><span style="font-weight: normal"><span style="text-decoration: underline">Cash and Cash Equivalents</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company considers interest-bearing deposits with financial institutions with remaining maturities of three months or less at the time of acquisition to be cash equivalents.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-weight: normal"><span style="text-decoration: underline">Fair Value Measurements of Short-term Investments</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the principal or most advantageous market at the measurement date. Fair value is established according to a hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Level 3: Unobservable inputs are used when little or no market data is available. Level 3 inputs are given the lowest priority in the fair value hierarchy.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The asset or liability’s fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As of December 31, 2022, the Company’s short-term investments consist of U.S. Treasury instruments (Level 1), maturing within one year, and </span>investments in a bank-managed money market fund that invests exclusively in United States Treasury obligations and is valued at the net asset value ("NAV") daily closing price, as reported by the fund, based on the amortized cost of the fund’s securities (Level 2)<span style="font-family: Times New Roman, Times, Serif">. For the bank-managed money market fund, t</span>he NAV is used as a practical expedient to estimate fair value. This practical expedient is not used when it is determined to be probable that the fund will sell the investment for an amount different than the reported NAV<span style="font-family: Times New Roman, Times, Serif">. Such securities are classified as held to maturity, since the Company has the intent and ability to do so, and are carried at cost plus accrued interest, which approximates fair value.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of inventory acquired as part of business combination is based on a third-party valuation utilizing the comparable sales method which is based on Level 2 and Level 3 inputs. The fair value of property, plant and equipment acquired as part of business combination is based on a third-party valuation utilizing the indirect method of cost approach, which is based on Level 2 and Level 3 inputs. The fair value of patents acquired as part of business combination is based on a third-party valuation utilizing the replacement cost method, which is based on Level 2 and Level 3 inputs. The fair value of the remaining intangible assets as part of business combination are based on a third-party valuation utilizing discounted cash flow methods that involves inputs, which are not observable in the market (Level 3).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0pt 0pt"><span style="text-decoration: underline">Accounts Receivable</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company establishes an allowance for doubtful accounts based on the creditworthiness of its customers and historical experience. While the Company uses the best information available to make its evaluation, future adjustments to the allowance for doubtful accounts may be necessary if there are significant changes in economic and industry conditions or any other factors considered in the Company’s evaluation. Bad debt expense has been immaterial during each of the last three years. The Company mitigates its credit risk by maintaining credit insurance on most of its significant customers.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-weight: normal"><span style="text-decoration: underline">Inventories</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Substantially all of the Company’s inventories are valued at the lower of cost, principally determined by the last-in, first-out (LIFO) method, or net realizable value. Elements of cost in inventories include raw materials, direct labor and manufacturing overhead.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-weight: normal"><span style="text-decoration: underline">Property, Plant, and Equipment</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property, plant, and equipment are carried at cost. Depreciation is computed over useful lives using the straight-line and declining balance methods predominately over 15 years for buildings, 7 years for machinery and equipment and 3 years for tools and dies. When assets are retired, sold or otherwise disposed of, their gross carrying values and related accumulated depreciation are removed from the accounts and a gain or loss on such disposals is recognized when appropriate.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Maintenance and repairs are charged to operations; replacements and improvements are capitalized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Long-lived Assets</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates the carrying value of long-lived assets to be held and used when events or changes in circumstances indicate the carrying value may not be recoverable. In performing this review, the carrying value of the assets is compared to the projected undiscounted cash flows to be generated from the assets. If the sum of the undiscounted expected future cash flows is less than the carrying value of the assets, the assets are considered to be impaired. Impairment losses are measured as the amount by which the carrying value of the assets exceeds their fair value. The Company bases fair value of the assets on quoted market prices if available or, if not available, quoted market prices of similar assets. Where quoted market prices are not available, the Company estimates fair value using the estimated future cash flows generated by the assets discounted at a rate commensurate with the risks associated with the recovery of the assets. As of December 31, 2022, the Company does not believe there are any indications of impairment related to long-lived assets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline">Goodwill</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our goodwill represents the excess of the purchase price of business combinations over the fair value of the net assets acquired. We assess goodwill for impairment on an annual basis during the fourth quarter of each year, and between annual tests whenever events or changes in circumstances </p><div> </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">indicate that the carrying amount may not be recoverable. An impairment exists by the amount the fair value of a reporting unit to which goodwill has been allocated is less than their respective carrying values. The impairment for goodwill is limited to the total amount of goodwill allocated to the reporting unit. Goodwill impairment testing requires significant judgment and management estimates, including, but not limited to, the determination of (i) the number of reporting units, (ii) the goodwill and other assets and liabilities to be allocated to the reporting units and (iii) the fair values of the reporting units. The estimates and assumptions described above, along with other factors such as discount rates, will significantly affect the outcome of the impairment tests and the amounts of any resulting impairment losses. As of December 31, 2022, the Company does not believe there are any indications of impairment related to goodwill.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-weight: normal"><span style="text-decoration: underline">Income Taxes</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Income taxes are accounted for using the asset and liability method. Under this method, deferred income taxes are recognized for the tax consequences of “temporary differences” by applying enacted statutory rates applicable to future years to temporary differences between the financial statement carrying amounts and the tax basis of the Company’s assets and liabilities.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-weight: normal"><span style="text-decoration: underline">Product Liability</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company provides for product liability claims including estimated legal costs to be incurred defending such claims. The provision for product liability claims is charged to cost of products sold.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Advertising Costs</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company includes advertising costs in selling expenses and these costs are expensed as incurred. Advertising costs for 2022, 2021, and 2020, were $2.4 million, $2.6 million, and $2.7 million, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-weight: normal"><span style="text-decoration: underline">Shipping Costs</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Costs incurred related to the shipment of products are included in selling expense. Such costs totaled $4.7 million, $4.2 million, and $3.9 million in 2022, 2021, and 2020, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Research and Development</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In 2022, 2021, and 2020, the Company spent approximately $9.6 million, $11.7 million, and $8.0 million, respectively, on research and development activities relating to new products and the improvement of existing products. These costs are included in costs of products sold and are expensed as incurred.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Earnings per Share</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Basic earnings per share is based upon the weighted-average number of shares of common stock outstanding during the year. Diluted earnings per share reflect the impact of options, restricted stock units, and deferred stock outstanding using the treasury stock method.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Organization</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Sturm, Ruger &amp; Company, Inc. (the “Company”) is principally engaged in the design, manufacture, and sale of firearms to domestic customers. Approximately 99% of sales were from firearms. Export sales represented approximately 6% of firearms sales. The Company’s design and manufacturing operations are located in the United States and almost all product content is domestic. The Company’s firearms are sold through a select number of independent wholesale distributors principally to the commercial sporting market.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company manufactures investment castings made from steel alloys and metal injection molding (“MIM”) parts for internal use in its firearms and utilizes available capacity to manufacture and sell investment castings and MIM parts to unaffiliated, third-party customers. Castings were less than 1% of the Company’s total sales for the year ended December 31, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> 0.99 0.06 0.01 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-weight: normal"><span style="text-decoration: underline">Preparation of Financial Statements</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company follows United States generally accepted accounting principles (“GAAP”). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The significant accounting policies described below, together with the notes that follow, are an integral part of the consolidated financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-weight: normal"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-weight: normal"><span style="text-decoration: underline">Principles of Consolidation</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All significant intercompany accounts and transactions have been eliminated.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-weight: normal"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-weight: normal"><span style="text-decoration: underline">Revenue Recognition</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognizes revenue in accordance with the provisions of Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (“ASC 606”), which became effective January 1, 2018. Substantially all product sales are sold FOB (free on board) shipping point. Customary payment terms are 2% 30 days, net 40 days. Generally, all performance obligations are satisfied when product is shipped and the customer takes ownership and assumes the risk of loss. In some instances, sales include multiple performance obligations. The most common of these instances relates to sales promotion programs under which downstream customers are entitled to receive no charge products based on their purchases of certain of the Company’s products from the independent distributors. The fulfillment of these no charge products </p><div> </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">is the Company’s responsibility. In such instances, the Company allocates the revenue of the promotional sales based on the estimated level of participation in the sales promotional program and the timing of the shipment of all of the firearms included in the promotional program, including the no charge firearms. Revenue is recognized proportionally as each performance obligation is satisfied, based on the relative customary price of each product. Customary prices are generally determined based on the prices charged to the independent distributors. The net change in contract liabilities for a given period is reported as an increase or decrease to sales. The Company accounts for cash sales discounts as a reduction in sales. Amounts billed to customers for shipping and handling fees are included in net sales and costs incurred by the Company for the delivery of goods are classified as selling expenses. Federal excise taxes are excluded from net sales.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> Customary payment terms are 2% 30 days <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline">Business Combination</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 26, 2020, the Company entered into an Asset Purchase Agreement (the "Agreement") with the Remington Outdoor Company, Inc. and each of the subsidiaries of the Remington Outdoor Company, Inc. (collectively, “Remington”) to purchase substantially all of the assets (the “Marlin Assets”) used to manufacture Marlin Firearms (the “Marlin Acquisition”). The agreement to purchase these assets emanated from the Remington Outdoor Company, Inc. bankruptcy and was approved by the United States Bankruptcy Court for the Northern District of Alabama on September 30, 2020. The Marlin Acquisition was conducted through a Bankruptcy Court-supervised process, subject to Bankruptcy Court-approved bidding procedures, approval of the transactions by the Bankruptcy Court, and the satisfaction of certain closing conditions. The Company closed on the Marlin Acquisition on November 23, 2020.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Agreement provided that, upon the terms and subject to the conditions set forth therein, Remington sold, transferred and assigned to the Company the Marlin Assets (as defined in the Agreement) for a purchase price of $28.3 million in cash. The Marlin Assets include the following assets, among other things, equipment, inventory, and all intellectual property related to Marlin, including the Marlin names and marks, and all derivatives thereof.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">  </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The primary purpose of the Marlin Acquisition was to manufacture and sell Marlin branded firearms and generate shareholder value. The Marlin brand aligns with the Ruger brand and the Marlin product portfolio will widen the Company’s diverse product offerings. The transaction was funded by the Company with cash on hand and has been accounted for in accordance with ASC 805 - <i>Business Combinations</i>. ASC 805 requires, among other things, an assignment of the acquisition consideration transferred to the sellers for the tangible and intangible assets acquired, using the bottom up approach, to estimate their value at acquisition date. Any excess of the fair value of the purchase consideration over these identified net assets was recorded as goodwill. Our estimates of fair value were based upon assumptions believed to be reasonable, yet were inherently uncertain. During the measurement period, which did not exceed one year from the date of acquisition, we recorded adjustments totaling $2.2 million to the estimated fair values of the assets acquired and liabilities assumed with a corresponding adjustment to goodwill. These adjustments were recorded in the year ended December 31, 2021.</p><div> </div> 28300000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0pt 0pt; text-align: justify"><span style="font-weight: normal"><span style="text-decoration: underline">Cash and Cash Equivalents</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company considers interest-bearing deposits with financial institutions with remaining maturities of three months or less at the time of acquisition to be cash equivalents.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-weight: normal"><span style="text-decoration: underline">Fair Value Measurements of Short-term Investments</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the principal or most advantageous market at the measurement date. Fair value is established according to a hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Level 3: Unobservable inputs are used when little or no market data is available. Level 3 inputs are given the lowest priority in the fair value hierarchy.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The asset or liability’s fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As of December 31, 2022, the Company’s short-term investments consist of U.S. Treasury instruments (Level 1), maturing within one year, and </span>investments in a bank-managed money market fund that invests exclusively in United States Treasury obligations and is valued at the net asset value ("NAV") daily closing price, as reported by the fund, based on the amortized cost of the fund’s securities (Level 2)<span style="font-family: Times New Roman, Times, Serif">. For the bank-managed money market fund, t</span>he NAV is used as a practical expedient to estimate fair value. This practical expedient is not used when it is determined to be probable that the fund will sell the investment for an amount different than the reported NAV<span style="font-family: Times New Roman, Times, Serif">. Such securities are classified as held to maturity, since the Company has the intent and ability to do so, and are carried at cost plus accrued interest, which approximates fair value.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of inventory acquired as part of business combination is based on a third-party valuation utilizing the comparable sales method which is based on Level 2 and Level 3 inputs. The fair value of property, plant and equipment acquired as part of business combination is based on a third-party valuation utilizing the indirect method of cost approach, which is based on Level 2 and Level 3 inputs. The fair value of patents acquired as part of business combination is based on a third-party valuation utilizing the replacement cost method, which is based on Level 2 and Level 3 inputs. The fair value of the remaining intangible assets as part of business combination are based on a third-party valuation utilizing discounted cash flow methods that involves inputs, which are not observable in the market (Level 3).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0pt 0pt"><span style="text-decoration: underline">Accounts Receivable</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company establishes an allowance for doubtful accounts based on the creditworthiness of its customers and historical experience. While the Company uses the best information available to make its evaluation, future adjustments to the allowance for doubtful accounts may be necessary if there are significant changes in economic and industry conditions or any other factors considered in the Company’s evaluation. Bad debt expense has been immaterial during each of the last three years. The Company mitigates its credit risk by maintaining credit insurance on most of its significant customers.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-weight: normal"><span style="text-decoration: underline">Inventories</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Substantially all of the Company’s inventories are valued at the lower of cost, principally determined by the last-in, first-out (LIFO) method, or net realizable value. Elements of cost in inventories include raw materials, direct labor and manufacturing overhead.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-weight: normal"><span style="text-decoration: underline">Property, Plant, and Equipment</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property, plant, and equipment are carried at cost. Depreciation is computed over useful lives using the straight-line and declining balance methods predominately over 15 years for buildings, 7 years for machinery and equipment and 3 years for tools and dies. When assets are retired, sold or otherwise disposed of, their gross carrying values and related accumulated depreciation are removed from the accounts and a gain or loss on such disposals is recognized when appropriate.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Maintenance and repairs are charged to operations; replacements and improvements are capitalized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> P15Y P7Y P3Y <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Long-lived Assets</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates the carrying value of long-lived assets to be held and used when events or changes in circumstances indicate the carrying value may not be recoverable. In performing this review, the carrying value of the assets is compared to the projected undiscounted cash flows to be generated from the assets. If the sum of the undiscounted expected future cash flows is less than the carrying value of the assets, the assets are considered to be impaired. Impairment losses are measured as the amount by which the carrying value of the assets exceeds their fair value. The Company bases fair value of the assets on quoted market prices if available or, if not available, quoted market prices of similar assets. Where quoted market prices are not available, the Company estimates fair value using the estimated future cash flows generated by the assets discounted at a rate commensurate with the risks associated with the recovery of the assets. As of December 31, 2022, the Company does not believe there are any indications of impairment related to long-lived assets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline">Goodwill</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our goodwill represents the excess of the purchase price of business combinations over the fair value of the net assets acquired. We assess goodwill for impairment on an annual basis during the fourth quarter of each year, and between annual tests whenever events or changes in circumstances </p><div> </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">indicate that the carrying amount may not be recoverable. An impairment exists by the amount the fair value of a reporting unit to which goodwill has been allocated is less than their respective carrying values. The impairment for goodwill is limited to the total amount of goodwill allocated to the reporting unit. Goodwill impairment testing requires significant judgment and management estimates, including, but not limited to, the determination of (i) the number of reporting units, (ii) the goodwill and other assets and liabilities to be allocated to the reporting units and (iii) the fair values of the reporting units. The estimates and assumptions described above, along with other factors such as discount rates, will significantly affect the outcome of the impairment tests and the amounts of any resulting impairment losses. As of December 31, 2022, the Company does not believe there are any indications of impairment related to goodwill.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-weight: normal"><span style="text-decoration: underline">Income Taxes</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Income taxes are accounted for using the asset and liability method. Under this method, deferred income taxes are recognized for the tax consequences of “temporary differences” by applying enacted statutory rates applicable to future years to temporary differences between the financial statement carrying amounts and the tax basis of the Company’s assets and liabilities.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-weight: normal"><span style="text-decoration: underline">Product Liability</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company provides for product liability claims including estimated legal costs to be incurred defending such claims. The provision for product liability claims is charged to cost of products sold.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Advertising Costs</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company includes advertising costs in selling expenses and these costs are expensed as incurred. Advertising costs for 2022, 2021, and 2020, were $2.4 million, $2.6 million, and $2.7 million, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> 2400000 2600000 2700000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-weight: normal"><span style="text-decoration: underline">Shipping Costs</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Costs incurred related to the shipment of products are included in selling expense. Such costs totaled $4.7 million, $4.2 million, and $3.9 million in 2022, 2021, and 2020, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> 4700000 4200000 3900000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Research and Development</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In 2022, 2021, and 2020, the Company spent approximately $9.6 million, $11.7 million, and $8.0 million, respectively, on research and development activities relating to new products and the improvement of existing products. These costs are included in costs of products sold and are expensed as incurred.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> 9600000 11700000 8000000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Earnings per Share</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Basic earnings per share is based upon the weighted-average number of shares of common stock outstanding during the year. Diluted earnings per share reflect the impact of options, restricted stock units, and deferred stock outstanding using the treasury stock method.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>2.       Acquisition of Marlin Assets</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As described in Note 1, the Company closed on the Marlin Acquisition on November 23, 2020. The Company paid $28.3 million dollars in cash for the Marlin Assets from Remington.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Marlin Acquisition was accounted for in accordance with ASC Topic 805, Business Combinations. Accordingly, the total purchase price has been allocated to tangible assets based on their fair value and the intangibles and goodwill have been allocated on a provisional basis at the date of acquisition. The Company assumed no liabilities in this transaction. These allocations reflect various provisional estimates that were available at the time and are subject to change during the purchase price allocation period until the valuations are finalized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recorded measurement period adjustments in accordance with FASB’s guidance regarding business combinations in the fourth quarter of 2021 based on its valuation and purchase price allocation procedures, to better reflect the facts and circumstances that existed at the acquisition date. The measurement period adjustments, which were completed during the fourth quarter of 2021, resulted in an increase to goodwill of $2.4 million, primarily due to a decrease in the estimated fair value of inventory received.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table summarizes the Company's allocation of the purchase price:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White; font-size: 8pt; font-weight: bold"> <td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt"> </td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"> </td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Initial Purchase <br/> Price Allocation</span></td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; white-space: nowrap; text-align: center"> </td><td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"> </td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"> </td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Measurement <br/> Period<br/> Adjustments</span></td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; white-space: nowrap; text-align: center"> </td><td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"> </td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"> </td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Final Purchase <br/> Price Allocation</span></td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; white-space: nowrap; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Purchase Price</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 61%; text-align: left; padding-bottom: 2.5pt; padding-left: 9pt">Cash paid to sellers</td><td style="border-bottom: Black 2.5pt double; width: 1%"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right">28,316</td><td style="border-bottom: Black 2.5pt double; white-space: nowrap; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; width: 1%"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-31">—</div></td><td style="border-bottom: Black 2.5pt double; white-space: nowrap; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; width: 1%"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right">28,316</td><td style="border-bottom: Black 2.5pt double; white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 2.4pt">Purchase Price Allocation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 9pt">Assets Acquired</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.25in">Inventory</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">11,400</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(2,414</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">8,986</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.25in">Machinery and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,000</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(25</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,975</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 15.5pt">Tradename and trademarks</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,800</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,800</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.25in">Patents</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,500</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,500</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.25in">Customer Relationships</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; padding-left: 0.25in">Goodwill</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">616</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,439</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,055</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.25in">Net Assets Acquired</td><td style="border-bottom: Black 2.5pt double"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">28,316</td><td style="border-bottom: Black 2.5pt double; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 2.5pt double"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-32">—</div></td><td style="border-bottom: Black 2.5pt double; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 2.5pt double"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">28,316</td><td style="border-bottom: Black 2.5pt double; white-space: nowrap; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Identifiable assets acquired were recorded at their estimated fair values based on the methodology described under “Fair Value Measurements” in Note 1 - Significant Accounting Policies.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Machinery and Equipment acquired in the Marlin Acquisition were classified as deposits on capital items in Other Assets on the Company’s Consolidated Balance Sheet at December 31, </p><div> </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">2021. Certain of these items were reclassified as Machinery and Equipment when they were placed in service in 2022 and 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Intangible assets acquired in the Marlin Acquisition are reflected in Other Assets on the Company’s Consolidated Balance Sheet at December 31, 2022. Intangible assets are amortized over their estimated remaining useful lives using a straight-line methodology.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White; font-size: 8pt; font-weight: bold"> <td style="padding-bottom: 1pt"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center; padding-bottom: 1pt">Remaining Economic<br/> Useful Life</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 879%; text-align: left">Tradename and trademarks</td><td style="width: 1%"> </td> <td style="width: 20%; text-align: center">20 years</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Patents</td><td> </td> <td style="text-align: center">20 years</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer Relationships</td><td> </td> <td style="text-align: center">15 years</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The excess purchase price over the fair value of the assets acquired was recorded as goodwill in the amount of $3.1 million. The Company incurred acquisition related costs of $1.7 million, which are included in selling, general and administrative expenses in the Company’s Consolidated Statements of Income and Comprehensive Income for the fiscal year ended December 31, 2020.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The pro forma impact of the acquisition and the results of operations attributable to Marlin in 2019 and 2020 have not been presented, as they are not material to the Company’s consolidated results of operations. The impact on sales and gross margin was no more than 5% of the reported amounts in either period, the trend in annual sales growth was unchanged, and the impact on gross margin percentage was less than 1%, in both periods.</p> 28300000 2400000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White; font-size: 8pt; font-weight: bold"> <td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt"> </td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"> </td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Initial Purchase <br/> Price Allocation</span></td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; white-space: nowrap; text-align: center"> </td><td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"> </td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"> </td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Measurement <br/> Period<br/> Adjustments</span></td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; white-space: nowrap; text-align: center"> </td><td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"> </td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"> </td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Final Purchase <br/> Price Allocation</span></td><td style="border-bottom: Black 1pt solid; vertical-align: bottom; white-space: nowrap; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Purchase Price</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 61%; text-align: left; padding-bottom: 2.5pt; padding-left: 9pt">Cash paid to sellers</td><td style="border-bottom: Black 2.5pt double; width: 1%"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right">28,316</td><td style="border-bottom: Black 2.5pt double; white-space: nowrap; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; width: 1%"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-31">—</div></td><td style="border-bottom: Black 2.5pt double; white-space: nowrap; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; width: 1%"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right">28,316</td><td style="border-bottom: Black 2.5pt double; white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 2.4pt">Purchase Price Allocation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 9pt">Assets Acquired</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.25in">Inventory</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">11,400</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(2,414</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">8,986</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.25in">Machinery and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,000</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(25</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,975</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 15.5pt">Tradename and trademarks</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,800</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,800</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.25in">Patents</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,500</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,500</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.25in">Customer Relationships</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; padding-left: 0.25in">Goodwill</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">616</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,439</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,055</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.25in">Net Assets Acquired</td><td style="border-bottom: Black 2.5pt double"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">28,316</td><td style="border-bottom: Black 2.5pt double; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 2.5pt double"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-32">—</div></td><td style="border-bottom: Black 2.5pt double; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 2.5pt double"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">28,316</td><td style="border-bottom: Black 2.5pt double; white-space: nowrap; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> 28316000 28316000 11400000 -2414000 8986000 5000000 -25000 4975000 7800000 7800000 2500000 2500000 1000000 1000000 616000 2439000 3055000 28316000 28316000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White; font-size: 8pt; font-weight: bold"> <td style="padding-bottom: 1pt"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center; padding-bottom: 1pt">Remaining Economic<br/> Useful Life</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 879%; text-align: left">Tradename and trademarks</td><td style="width: 1%"> </td> <td style="width: 20%; text-align: center">20 years</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Patents</td><td> </td> <td style="text-align: center">20 years</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer Relationships</td><td> </td> <td style="text-align: center">15 years</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> P20Y P20Y P15Y 3100000 1700000 0.05 0.01 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>3.       Revenue Recognition and Contracts with Customers</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">The impact of ASC 60<span style="font-family: Times New Roman, Times, Serif">6 on revenue recognized during the years ended December 31, 2022, December 31, 2021, and</span> December 31, 2020 is as follows:</p><div> </div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-indent: -0.3in; padding-left: 0.3in"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right">2022</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">2021</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">2020</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left; text-indent: -0.3in; padding-left: 0.3in">Contract liabilities with customers at January 1,</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-33">—</div></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">84</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">9,623</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.3in; padding-left: 0.3in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Revenue recognized</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-34">—</div></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(84</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(14,570</td><td style="white-space: nowrap; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid; text-align: left">Revenue deferred</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,031</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-35">—</div></td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5,031</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid; text-align: left">Contract liabilities with customers at December 31,</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,031</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-36">—</div></td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">84</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended December 31, 2022, the Company deferred $1.0 million of revenue. There was no offset for the recognition from previously deferred revenue as the Company did not satisfy any performance obligations relating to the shipment of free products during the year. This resulted in a net decrease in firearms sales for the year ended December 31, 2022 of $1.0 million and a deferred contract revenue liability at December 31, 2022 of $1.0 million. The Company </p><div> </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">estimates that revenue from this deferred contract liability will be recognized in the first half of 2023.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended December 31, 2021, there were no promotions giving rise to deferred contract liabilities and, therefore, there was no additional deferred revenue. Previously deferred revenue of $0.1 million was recognized in the first quarter of 2021. The Company did not have a deferred contract revenue liability at December 31, 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended December 31, 2020, the Company deferred $5.0 million of revenue, offset by the recognition of $14.6 million of revenue previously deferred as the performance obligations relating to the shipment of free products were satisfied. This resulted in a net increase in firearms sales for the year ended December 31, 2020 of $9.6 million and a deferred contract revenue liability at December 31, 2020 of $0.1 million. The deferred revenue balance was significantly reduced due to the absence of promotions in the fourth quarter of 2020.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Practical Expedients and Exemptions</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has elected to account for shipping and handling activities that occur after control of the related product transfers to the customer as fulfillment activities that are recognized upon shipment of the goods.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-indent: -0.3in; padding-left: 0.3in"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right">2022</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">2021</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right">2020</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: left; text-indent: -0.3in; padding-left: 0.3in">Contract liabilities with customers at January 1,</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-33">—</div></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">84</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">9,623</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.3in; padding-left: 0.3in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Revenue recognized</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-34">—</div></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(84</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(14,570</td><td style="white-space: nowrap; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid; text-align: left">Revenue deferred</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,031</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-35">—</div></td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5,031</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid; text-align: left">Contract liabilities with customers at December 31,</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,031</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-36">—</div></td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">84</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> 84000 9623000 84000 14570000 1031000 5031000 1031000 84000 1000000 1000000 1000000 100000 5000000 14600000 9600000 100000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>4.       Trade Receivables, Net</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Trade receivables consist of the following:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: italic 8pt Times New Roman, Times, Serif; white-space: nowrap">December 31,</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; text-align: right">2022</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; text-align: right">2021</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-weight: bold; text-align: justify"> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 74%; text-align: left">Trade receivables</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">67,183</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">58,605</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Allowance for doubtful accounts</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(400</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(400</td><td style="white-space: nowrap; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; text-align: left">Allowance for discounts</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,334</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">)</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,169</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">65,449</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">57,036</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In 2022, the largest individual trade receivable balances accounted for 26%, 23%, and 18% of total trade receivables, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In 2021, the largest individual trade receivable balances accounted for 34%, 17%, and 17% of total trade receivables, respectively.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: italic 8pt Times New Roman, Times, Serif; white-space: nowrap">December 31,</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; text-align: right">2022</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; text-align: right">2021</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-weight: bold; text-align: justify"> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 74%; text-align: left">Trade receivables</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">67,183</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">58,605</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Allowance for doubtful accounts</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(400</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(400</td><td style="white-space: nowrap; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; text-align: left">Allowance for discounts</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,334</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">)</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,169</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">65,449</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">57,036</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> 67183000 58605000 400000 400000 1334000 1169000 65449000 57036000 0.26 0.23 0.18 0.34 0.17 0.17 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>5.       Inventories</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventories consist of the following:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: italic 8pt Times New Roman, Times, Serif; white-space: nowrap">December 31,</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2022</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2021</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; text-align: justify">Inventory at FIFO</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left; padding-left: 21.8pt">Finished goods</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">23,573</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">7,322</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; text-align: left; padding-left: 21.8pt">Materials and products in process</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">105,721</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">92,701</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Gross inventories</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">129,294</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">100,023</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 21.8pt">Less:  LIFO reserve</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(59,489</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(51,826</td><td style="white-space: nowrap; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid; text-align: left; padding-left: 21.8pt">Less:  excess and obsolescence reserve</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(4,812</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">)</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(4,347</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; text-align: left">Net Inventories</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">64,993</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">43,850</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: italic 8pt Times New Roman, Times, Serif; white-space: nowrap">December 31,</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2022</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2021</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; text-align: justify">Inventory at FIFO</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left; padding-left: 21.8pt">Finished goods</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">23,573</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">7,322</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; text-align: left; padding-left: 21.8pt">Materials and products in process</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">105,721</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">92,701</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Gross inventories</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">129,294</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">100,023</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 21.8pt">Less:  LIFO reserve</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(59,489</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(51,826</td><td style="white-space: nowrap; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid; text-align: left; padding-left: 21.8pt">Less:  excess and obsolescence reserve</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(4,812</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">)</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(4,347</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; text-align: left">Net Inventories</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">64,993</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">43,850</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> </table> 23573000 7322000 105721000 92701000 129294000 100023000 59489000 51826000 4812000 4347000 64993000 43850000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>6.       Property, Plant and Equipment</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property, plant and equipment consist of the following:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: italic 8pt Times New Roman, Times, Serif; white-space: nowrap">December 31,</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2022</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2021</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-weight: bold; text-align: justify"> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 74%; text-align: left">Land and improvements</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">2,826</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">2,686</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Buildings and improvements</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">72,788</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">62,781</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Machinery and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">314,032</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">302,241</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid; text-align: left">Dies and tools</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">57,480</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">53,574</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Property, plant and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">447,126</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">421,282</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid; text-align: left">Less allowances for depreciation</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(370,273</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">)</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(347,651</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; text-align: left">Net property, plant and equipment</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">76,853</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">73,631</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Depreciation expense totaled $24.4 million, $25.8 million, and $27.3 million in 2022, 2021, and 2020, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property, plant and equipment consist of the following:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: italic 8pt Times New Roman, Times, Serif; white-space: nowrap">December 31,</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2022</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2021</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-weight: bold; text-align: justify"> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 74%; text-align: left">Land and improvements</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">2,826</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">2,686</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Buildings and improvements</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">72,788</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">62,781</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Machinery and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">314,032</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">302,241</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid; text-align: left">Dies and tools</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">57,480</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">53,574</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Property, plant and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">447,126</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">421,282</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid; text-align: left">Less allowances for depreciation</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(370,273</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">)</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(347,651</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; text-align: left">Net property, plant and equipment</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">76,853</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">73,631</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> 2826000 2686000 72788000 62781000 314032000 302241000 57480000 53574000 447126000 421282000 370273000 347651000 76853000 73631000 24400000 25800000 27300000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><b>7.       Other Assets</b></p><div> </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Other assets consist of the following:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: italic 8pt Times New Roman, Times, Serif; white-space: nowrap">December 31,</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2022</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2021</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-weight: bold; text-align: justify"> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 74%; text-align: left">Patents, at cost</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">10,126</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">10,024</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 14.8pt">Accumulated amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(6,318</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5,360</td><td style="white-space: nowrap; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Deposits on capital items</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,106</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,026</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Marlin trade name</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,800</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,800</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid">Other</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">11,249</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">8,953</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">39,963</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">39,443</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The capitalized cost of patents is amortized using the straight-line method over their useful lives. Expenses related to patent amortization was $0.4 million in 2022 and $0.3 million in 2021, and 2020. The estimated annual patent amortization expense for each of the next five years is $0.2 </p><div> </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">million. Costs incurred to maintain existing patents are charged to expense in the year incurred. The Marlin trade name will be amortized using the straight-line method over its useful life. The estimated annual trade name amortization cost for each of the next five years is $0.4 million. The intangible asset related to Marlin customer relationships are included in Other above and will be amortized using the straight-line method over its useful life. The estimated annual customer relationship name amortization expense for each of the next five years is $0.1 million.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: italic 8pt Times New Roman, Times, Serif; white-space: nowrap">December 31,</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2022</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2021</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; font-weight: bold; text-align: justify"> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 74%; text-align: left">Patents, at cost</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">10,126</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">10,024</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 14.8pt">Accumulated amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(6,318</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5,360</td><td style="white-space: nowrap; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Deposits on capital items</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,106</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,026</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Marlin trade name</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,800</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,800</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid">Other</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">11,249</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">8,953</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">39,963</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">39,443</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> 10126000 10024000 6318000 5360000 17106000 18026000 7800000 7800000 11249000 8953000 39963000 39443000 400000 300000 300000 200000 200000 200000 200000 200000 400000 400000 400000 400000 400000 100000 100000 100000 100000 100000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>8.       Leased Assets</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company leases certain of its real estate and equipment. The Company has evaluated all its leases and determined that all are operating leases under the definitions of the guidance of ASU 2016-02. The Company’s lease agreements generally do not require material variable lease payments, residual value guarantees or restrictive covenants.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company adopted the provisions of ASU 2016-02 using the effective interest method on January 1, 2019 and recorded right-of-use assets equal to the present value of the contractual liability for future lease payments. The table below presents the right-of-use assets and related lease liabilities recognized on the condensed consolidated balance sheet as of December 31, 2022:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: bold 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; text-align: center">Balance Sheet Line <br/> Item</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; text-align: center">December 31,<br/> 2022</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; text-align: center">December 31,<br/> 2021</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; text-align: left">Right-of-use assets</td><td style="width: 1%"> </td> <td style="vertical-align: bottom; width: 25%; text-align: center">Other assets</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">3,681</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,694</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: justify"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Operating lease liabilities</td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; padding-left: 18.55pt">Current portion</td><td> </td> <td style="vertical-align: top; text-align: center">Trade accounts payable and accrued expenses</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">642</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">249</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18.55pt"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 18.55pt">Noncurrent portion</td><td> </td> <td style="text-align: center; text-indent: 5.3pt">Lease liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,039</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,476</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; padding-left: 18.55pt"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 2.5pt double; text-align: left">Total operating lease liabilities</td><td style="border-bottom: Black 2.5pt double"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right"> </td><td style="border-bottom: Black 2.5pt double"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,681</td><td style="border-bottom: Black 2.5pt double; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 2.5pt double"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,725</td><td style="border-bottom: Black 2.5pt double; white-space: nowrap; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The depreciable lives of right-of-use assets are limited by the lease term and are amortized on a straight line basis over the life of the lease.</p><div> </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s leases generally do not provide an implicit interest rate, and therefore the Company calculates an incremental borrowing rate to determine the present value of its operating lease liabilities. The following table reconciles the undiscounted future minimum lease payments to the total operating lease liabilities recognized on the condensed consolidated balance sheet as of December 31, 2022:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; width: 85%; text-align: left; padding-left: 30.75pt">2023</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">803</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; text-align: left; padding-left: 30.75pt">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">808</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left; padding-left: 30.75pt">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">702</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; text-align: left; padding-left: 30.75pt">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">705</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left; padding-left: 30.75pt">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">229</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 30.75pt; vertical-align: bottom">Thereafter</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,120</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left; padding-left: 30.75pt">Total undiscounted future minimum lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,367</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; text-align: left; padding-bottom: 1pt; text-indent: -22.5pt; padding-left: 53.25pt">Less: Difference between undiscounted lease payments &amp; the present value of future lease payments</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(686</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left; padding-bottom: 2.5pt; padding-left: 30.75pt">Total operating lease liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,681</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain of the Company’s lease agreements contain renewal options at the Company’s discretion. The Company does not recognize right-of-use assets or lease liabilities for leases of one year or less or for renewal periods unless it is reasonably certain that the Company will exercise the renewal option at the inception of the lease or when a triggering event occurs. The Company’s weighted average remaining lease term for operating leases as of December 31, 2022 is 8.9 years.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: bold 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; text-align: center">Balance Sheet Line <br/> Item</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; text-align: center">December 31,<br/> 2022</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; text-align: center">December 31,<br/> 2021</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; text-align: left">Right-of-use assets</td><td style="width: 1%"> </td> <td style="vertical-align: bottom; width: 25%; text-align: center">Other assets</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">3,681</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,694</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: justify"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0pt">Operating lease liabilities</td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0pt"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-align: left; padding-left: 18.55pt">Current portion</td><td> </td> <td style="vertical-align: top; text-align: center">Trade accounts payable and accrued expenses</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">642</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">249</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 18.55pt"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 18.55pt">Noncurrent portion</td><td> </td> <td style="text-align: center; text-indent: 5.3pt">Lease liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,039</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,476</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; padding-left: 18.55pt"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 2.5pt double; text-align: left">Total operating lease liabilities</td><td style="border-bottom: Black 2.5pt double"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right"> </td><td style="border-bottom: Black 2.5pt double"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,681</td><td style="border-bottom: Black 2.5pt double; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 2.5pt double"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,725</td><td style="border-bottom: Black 2.5pt double; white-space: nowrap; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> 3681000 1694000 642000 249000 3039000 1476000 3681000 1725000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; width: 85%; text-align: left; padding-left: 30.75pt">2023</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">803</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; text-align: left; padding-left: 30.75pt">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">808</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left; padding-left: 30.75pt">2025</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">702</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; text-align: left; padding-left: 30.75pt">2026</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">705</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left; padding-left: 30.75pt">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">229</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 30.75pt; vertical-align: bottom">Thereafter</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,120</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left; padding-left: 30.75pt">Total undiscounted future minimum lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,367</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; text-align: left; padding-bottom: 1pt; text-indent: -22.5pt; padding-left: 53.25pt">Less: Difference between undiscounted lease payments &amp; the present value of future lease payments</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(686</td><td style="white-space: nowrap; padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: bottom; text-align: left; padding-bottom: 2.5pt; padding-left: 30.75pt">Total operating lease liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,681</td><td style="white-space: nowrap; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> 803000 808000 702000 705000 229000 1120000 4367000 686000 3681000 P8Y10M24D <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><b>9.</b>       <b>Trade Accounts Payable and Accrued Expenses</b></p><div> </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Trade accounts payable and accrued expenses consist of the following:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: italic 8pt Times New Roman, Times, Serif; white-space: nowrap">December 31,</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2022</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2021</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left">Trade accounts payable</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">13,281</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">12,209</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Federal excise taxes payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,635</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,734</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid; text-align: left">Accrued other</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">8,742</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">8,457</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">35,658</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">36,400</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: italic 8pt Times New Roman, Times, Serif; white-space: nowrap">December 31,</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2022</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2021</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left">Trade accounts payable</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">13,281</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">12,209</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Federal excise taxes payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,635</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">15,734</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid; text-align: left">Accrued other</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">8,742</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">8,457</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">35,658</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">36,400</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> </table> 13281000 12209000 13635000 15734000 8742000 8457000 35658000 36400000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><b>10.</b>       <b>Accrued Dividends</b></p><div> </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 30, 2022, the Company’s Board of Directors declared a $5.00 per share special dividend payable on January 5, 2023 to stockholders of record as of December 15, 2022. The dividend, which totaled $88.3 million, was paid on January 5, 2023.</p> 5 88300000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><b>11.</b>       <b>Line of Credit</b></p><div> </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During 2021 the Company had a <span style="font-size: 10pt">$40 million</span> unsecured revolving line of credit with a bank. This facility terminated on September 30, 2021. On January 7, 2022, the Company entered into a new $40 million unsecured revolving line of credit agreement with a different bank that expires January 7, 2025. Borrowings under this new facility bear interest at either 1) the Bloomberg short-Term </p><div> </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Bank Yield Index – 1 month plus 150 basis points, or 2) a fluctuating rate per annum equal to the greater of (i) the Bank’s prime rate or (ii) the federal funds rate plus 50 basis points. The Company is also charged one-quarter of a percent (0.25%) per year on the unused portion. At December 31, 2022, the Company was in compliance with the terms and covenants of the credit facility.</p> 40000000 40000000 2025-01-07 0.0025 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>12.       Employee Benefit Plans</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company sponsors a qualified defined-contribution 401(k) plan that covers substantially all of its employees. Under the terms of the 401(k) plan, the Company matches a certain portion of employee contributions to their individual 401(k) accounts using the “safe harbor” guidelines provided in the Internal Revenue Code. Expenses related to matching employee contributions to the 401(k) plan were $4.1 million, $4.0 million, and $3.3 million in 2022, 2021, and 2020, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Additionally, in 2022, 2021, and 2020 the Company provided discretionary supplemental contributions to the individual 401(k) accounts of substantially all employees. Each employee received a supplemental contribution to their account based on a uniform percentage of qualifying compensation established annually. The cost of these supplemental contributions totaled $7.4 million, $7.4 million, and $5.6 million in 2022, 2021, and 2020, respectively.</p> 4100000 4000000 3300000 7400000 7400000 5600000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>13.       Other Operating Income, Net</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Other operating income, net consists of the following:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: italic 8pt Times New Roman, Times, Serif; white-space: nowrap">Year ended December 31,</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2022</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2021</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2020</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 61%"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"> </td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"> </td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"> </td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid; text-align: left">Gain on sale of operating assets</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">36</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">127</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">52</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: italic 8pt Times New Roman, Times, Serif; white-space: nowrap">Year ended December 31,</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2022</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2021</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2020</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 61%"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"> </td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"> </td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"> </td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid; text-align: left">Gain on sale of operating assets</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">36</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">127</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">52</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> </table> 36000 127000 52000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>14.       Income Taxes </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company files income tax returns in the U.S. federal jurisdiction and various state jurisdictions. With few exceptions, the Company is no longer subject to U.S. federal and state income tax examinations by tax authorities for years before 2017.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The federal and state income tax provision consisted of the following:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: italic 8pt Times New Roman, Times, Serif; white-space: nowrap">Year ended December 31,</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">2022</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">2021</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">2020</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom"> </td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; text-align: center">Current</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; text-align: center">Deferred</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; text-align: center">Current</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; text-align: center">Deferred</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; text-align: center">Current</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; text-align: center">Deferred</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 34%">Federal</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">21,741</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">(4,694</td><td style="white-space: nowrap; width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">42,422</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">863</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">20,201</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">3,696</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid">State</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,779</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(879</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">)</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7,279</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">131</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,519</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">167</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">25,520</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(5,573</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">)</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">49,701</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">994</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">26,720</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">3,863</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The effective income tax rate varied from the statutory federal income tax rate as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: italic 8pt Times New Roman, Times, Serif; white-space: nowrap">Year ended December 31,</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2022</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2021</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2020</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; width: 67%; text-align: left; text-indent: -13.75pt; padding-left: 13.75pt">Statutory federal income tax rate</td><td style="border-bottom: Black 1pt solid; width: 1%"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 8%; text-align: right">21.0%</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 1%"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 8%; text-align: right">21.0%</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 1%"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 8%; text-align: right">21.0%</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid; text-align: left; text-indent: -13.75pt; padding-left: 13.75pt">State income taxes, net of federal tax benefit</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2.7</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3.4</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4.4</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; text-align: left">Research and development tax credits</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(4.2</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">)</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(0.4</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">)</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-37">—</div></td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid; text-indent: -13.75pt; padding-left: 13.75pt">Other</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1.1</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">)</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">0.5</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(0.1</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; text-align: left; text-indent: -13.75pt; padding-left: 13.75pt">Effective income tax rate</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">18.4%</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">24.5%</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">25.3%</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company estimates that its effective tax rate in 2023 will approximate 22.4%.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Significant components of the Company’s deferred tax assets and liabilities are as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: italic 8pt Times New Roman, Times, Serif; white-space: nowrap">December 31,</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2022</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2021</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Deferred tax assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left; padding-left: 22.5pt">Product Liability</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">69</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">224</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 22.5pt">Capitalized research and development costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,838</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-38">—</div></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 22.5pt">Employee compensation and benefits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,316</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,643</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 22.5pt">Allowances for doubtful accounts and discounts</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">637</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">418</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 22.5pt">Inventories</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,196</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,224</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 22.5pt">Stock-based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,661</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,538</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid; padding-left: 22.5pt">Other</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,636</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,538</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; text-align: left">Total deferred tax assets</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">12,353</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7,585</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Deferred tax liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -4.5pt; padding-left: 27pt">Depreciation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,070</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,235</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid; text-indent: -4.5pt; padding-left: 27pt">Other</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,174</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">814</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; text-align: left">Total deferred tax liabilities</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,244</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7,049</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid; text-align: left">Net deferred tax assets</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">6,109</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">536</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Prior to 2022, the Company expensed research and development costs in the period in which they were incurred for both financial accounting and income tax purposes. In 2022 the Company adopted the provisions of the Tax Cuts and Jobs Act of 2017 that relate to IRS Code Section 174. Under these provisions, research and development costs must be capitalized and amortized over five years for income tax purposes. The Company continues to expense these costs in the period incurred for financial accounting purposes.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company made income tax payments of approximately $28.7 million, $49.5 million, and $30.6 million, during 2022, 2021, and 2020, respectively. The Company expects to realize its deferred tax assets through tax deductions against future taxable income<i>. </i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company does not believe it has included any “uncertain tax positions” in its federal income tax return or any of the state income tax returns it is currently filing. The Company has made an evaluation of the potential impact of additional state taxes being assessed by jurisdictions in which the Company does not currently consider itself liable. The Company does not anticipate that such additional taxes, if any, would result in a material change to its financial position.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: italic 8pt Times New Roman, Times, Serif; white-space: nowrap">Year ended December 31,</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">2022</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">2021</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">2020</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom"> </td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; text-align: center">Current</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; text-align: center">Deferred</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; text-align: center">Current</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; text-align: center">Deferred</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; text-align: center">Current</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; white-space: nowrap; text-align: center">Deferred</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 34%">Federal</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">21,741</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">(4,694</td><td style="white-space: nowrap; width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">42,422</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">863</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">20,201</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">3,696</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid">State</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,779</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(879</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">)</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7,279</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">131</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,519</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">167</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">25,520</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(5,573</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">)</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">49,701</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">994</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">26,720</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">3,863</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> 21741000 -4694000 42422000 863000 20201000 3696000 3779000 -879000 7279000 131000 6519000 167000 25520000 -5573000 49701000 994000 26720000 3863000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: italic 8pt Times New Roman, Times, Serif; white-space: nowrap">Year ended December 31,</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2022</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2021</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2020</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; width: 67%; text-align: left; text-indent: -13.75pt; padding-left: 13.75pt">Statutory federal income tax rate</td><td style="border-bottom: Black 1pt solid; width: 1%"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 8%; text-align: right">21.0%</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 1%"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 8%; text-align: right">21.0%</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 1%"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 8%; text-align: right">21.0%</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid; text-align: left; text-indent: -13.75pt; padding-left: 13.75pt">State income taxes, net of federal tax benefit</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2.7</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3.4</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4.4</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; text-align: left">Research and development tax credits</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(4.2</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">)</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(0.4</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">)</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-37">—</div></td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid; text-indent: -13.75pt; padding-left: 13.75pt">Other</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1.1</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">)</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">0.5</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(0.1</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; text-align: left; text-indent: -13.75pt; padding-left: 13.75pt">Effective income tax rate</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">18.4%</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">24.5%</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">25.3%</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> 0.21 0.21 0.21 0.027 0.034 0.044 0.042 0.004 -0.011 0.005 -0.001 0.184 0.245 0.253 0.224 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: italic 8pt Times New Roman, Times, Serif; white-space: nowrap">December 31,</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2022</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2021</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Deferred tax assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 74%; text-align: left; padding-left: 22.5pt">Product Liability</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">69</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">224</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 22.5pt">Capitalized research and development costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,838</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-38">—</div></td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 22.5pt">Employee compensation and benefits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,316</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,643</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 22.5pt">Allowances for doubtful accounts and discounts</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">637</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">418</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 22.5pt">Inventories</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,196</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,224</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 22.5pt">Stock-based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,661</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,538</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid; padding-left: 22.5pt">Other</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,636</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,538</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; text-align: left">Total deferred tax assets</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">12,353</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7,585</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Deferred tax liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -4.5pt; padding-left: 27pt">Depreciation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,070</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,235</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid; text-indent: -4.5pt; padding-left: 27pt">Other</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,174</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">814</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; text-align: left">Total deferred tax liabilities</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6,244</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7,049</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid; text-align: left">Net deferred tax assets</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">6,109</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">536</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> 69000 224000 4838000 2316000 2643000 637000 418000 1196000 1224000 1661000 1538000 1636000 1538000 12353000 7585000 5070000 6235000 1174000 814000 6244000 7049000 6109000 536000 P5Y 28700000 49500000 30600000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><b>15.       Earnings Per Share</b></p><div> </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Set forth below is a reconciliation of the numerator and denominator for the basic and diluted earnings per share calculations for the periods indicated:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: italic 8pt Times New Roman, Times, Serif; white-space: nowrap">Year ended December 31,</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2022</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2021</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2020</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 61%; text-align: left; text-indent: 17.9pt; padding-left: 0.1pt">Net income</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">88,332</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">155,899</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">90,398</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -9pt; padding-left: 27pt">Weighted average number of common shares outstanding – Basic</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,648,850</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,585,604</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,486,054</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid; text-align: left; text-indent: -9pt; padding-left: 27pt">Dilutive effect of options and restricted stock units outstanding under the Company’s employee compensation plans</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">144,498</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">172,230</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">283,802</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; text-indent: -27pt; padding-left: 27pt">Weighted average number of common shares outstanding – Diluted</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">17,793,348</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">17,757,834</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">17,769,856</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: italic 8pt Times New Roman, Times, Serif; white-space: nowrap">Year ended December 31,</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2022</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2021</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2020</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 61%; text-align: left; text-indent: 17.9pt; padding-left: 0.1pt">Net income</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">88,332</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">155,899</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">90,398</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -9pt; padding-left: 27pt">Weighted average number of common shares outstanding – Basic</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,648,850</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,585,604</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">17,486,054</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid; text-align: left; text-indent: -9pt; padding-left: 27pt">Dilutive effect of options and restricted stock units outstanding under the Company’s employee compensation plans</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">144,498</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">172,230</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">283,802</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; text-indent: -27pt; padding-left: 27pt">Weighted average number of common shares outstanding – Diluted</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">17,793,348</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">17,757,834</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">17,769,856</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> </table> 88332000 155899000 90398000 17648850 17585604 17486054 144498 172230 283802 17793348 17757834 17769856 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><b>16.       Stock Repurchases</b></p><div> </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In 2022 the Company repurchased shares of its common stock. Details of these purchases are as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; font-size: 8pt; font-weight: bold"> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid">Period</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid"> </td> <td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">Total <br/> Number of<br/> Shares <br/> Purchased</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid"> </td> <td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">Average<br/> Price Paid <br/> per Share</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid"> </td> <td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">Total <br/> Number of <br/> Shares <br/> Purchased <br/> as Part of <br/> Publicly <br/> Announced <br/> Program</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid"> </td> <td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">Maximum <br/> Dollar <br/> Value of <br/> Shares that <br/> May Yet Be <br/> Purchased <br/> Under the <br/> Program</td></tr> <tr style="vertical-align: bottom; background-color: White; font-size: 8pt; font-weight: bold"> <td style="border-bottom: Black 1pt solid"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="border-bottom: Black 1pt solid; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Third Quarter 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 21.35pt">July 3 to July 30</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-39">—  </div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-40">—  </div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-41">—  </div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-42"><div><div> </div></div></div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 21.35pt">July 31 to August 27</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-43">—  </div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-44">—  </div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-45">—  </div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-46"><div><div> </div></div></div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; width: 48%; padding-left: 21pt">August 28 to October 1</td><td style="border-bottom: Black 1pt solid; width: 1%"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right">2,136</td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 1%"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right">49.97</td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 1%"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right">2,136</td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 1%"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-47"><div><div> </div></div></div></td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Fourth Quarter 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 21.35pt">October 2 to October 29</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-48">—  </div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-49">—  </div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-50">—  </div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-51"><div><div> </div></div></div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 21.35pt">October 30 to November 26</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,304</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">49.77</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,304</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-52"><div><div> </div></div></div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; padding-left: 21pt">November 27 to December 31</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-53">—  </div></td><td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-54">—  </div></td><td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-55">—  </div></td><td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-56"><div><div> </div></div></div></td><td style="border-bottom: Black 1pt solid; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid">Total</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4,440</td><td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">49.87</td><td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4,440</td><td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">86,490,000</td><td style="border-bottom: Black 1pt solid; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All of these purchases were made with cash held by the Company and no debt was incurred. No shares were repurchased in 2020 and 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At December 31, 2022, approximately $86.5 million remained authorized for share repurchases.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; font-size: 8pt; font-weight: bold"> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid">Period</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid"> </td> <td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">Total <br/> Number of<br/> Shares <br/> Purchased</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid"> </td> <td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">Average<br/> Price Paid <br/> per Share</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid"> </td> <td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">Total <br/> Number of <br/> Shares <br/> Purchased <br/> as Part of <br/> Publicly <br/> Announced <br/> Program</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid"> </td> <td colspan="3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center">Maximum <br/> Dollar <br/> Value of <br/> Shares that <br/> May Yet Be <br/> Purchased <br/> Under the <br/> Program</td></tr> <tr style="vertical-align: bottom; background-color: White; font-size: 8pt; font-weight: bold"> <td style="border-bottom: Black 1pt solid"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="border-bottom: Black 1pt solid; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Third Quarter 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 21.35pt">July 3 to July 30</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-39">—  </div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-40">—  </div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-41">—  </div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-42"><div><div> </div></div></div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 21.35pt">July 31 to August 27</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-43">—  </div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-44">—  </div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-45">—  </div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-46"><div><div> </div></div></div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; width: 48%; padding-left: 21pt">August 28 to October 1</td><td style="border-bottom: Black 1pt solid; width: 1%"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right">2,136</td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 1%"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right">49.97</td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 1%"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right">2,136</td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 1%"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-47"><div><div> </div></div></div></td><td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Fourth Quarter 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 21.35pt">October 2 to October 29</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-48">—  </div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-49">—  </div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-50">—  </div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-51"><div><div> </div></div></div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 21.35pt">October 30 to November 26</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,304</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">49.77</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,304</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-52"><div><div> </div></div></div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; padding-left: 21pt">November 27 to December 31</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-53">—  </div></td><td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-54">—  </div></td><td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-55">—  </div></td><td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-56"><div><div> </div></div></div></td><td style="border-bottom: Black 1pt solid; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid">Total</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4,440</td><td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">49.87</td><td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4,440</td><td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">86,490,000</td><td style="border-bottom: Black 1pt solid; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> 2136 49.97 2136 2304 49.77 2304 4440 49.87 4440 86490000 86500000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>17.       Compensation Plans</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In May 2017, the Company’s shareholders approved the 2017 Stock Incentive Plan (the “2017 SIP”) under which employees, independent contractors, and non-employee directors may be granted stock options, restricted stock, deferred stock awards, and stock appreciation rights, any of which may or may not require the satisfaction of performance objectives. Vesting requirements are determined by the Compensation Committee of the Board of Directors<i>. </i>The Company has reserved 750,000 shares for issuance under the 2017 SIP, of which approximately 120,000 shares remain available for future grants as of December 31, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Compensation expense related to deferred stock, restricted stock, and restricted stock units is recognized based on the grant-date fair value of the Company’s common stock, using either the actual share price or an estimated value using the Monte Carlo valuation model. The total stock-based compensation cost included in the Statements of Income was $5.7 million, $8.3 million, and $6.1 million in 2022, 2021, and 2020, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Deferred Stock</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Deferred stock awards vest based on the passage of time or the Company’s attainment of performance objectives. Upon vesting, these awards convert one-for-one to common stock.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In 2022, 5,953 deferred stock awards were issued to non-employee directors that will vest in May 2023, 7,688 deferred stock awards were issued to non-employee directors that will vest in May 2025 and a 1,478 deferred stock award was issued to a non-employee director that will vest in June 2027.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In 2021, 5,113 deferred stock awards were issued to non-employee directors that vested in May 2022 and 6,615 deferred stock awards were issued to non-employee directors that will vest in May 2024.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In 2020, 6,244 deferred stock awards were issued to non-employee directors that vested in May 2021 and 8,078 deferred stock awards were issued to non-employee directors that will vest in May 2023.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Compensation expense related to these awards is amortized ratably over the vesting period. Compensation expense related to these awards was $0.8 million in 2022, $0.8 million in 2021, and $0.8 in 2020.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At December 31, 2022, there was $0.9 million of unrecognized compensation cost related to deferred stock that is expected to be recognized over a period of three years.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline">Restricted Stock Units</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company grants restricted stock units (RSU’s) to senior employees. Some of these RSU’s are retention awards and have only time-based vesting. Other RSU’s have a vesting “double trigger.” The vesting of these RSU’s is dependent on the achievement of corporate objectives established by the Compensation Committee of the Board of Directors, including stock performance relative to industry indices, return on net operating assets, and the passage of time.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During 2022, 82,000 restricted stock units were issued. Compensation costs related to these restricted stock units was $6.0 million, of which $1.7 million was recognized in 2022. The costs are being recognized ratably over the remaining periods required before the units vest, which range from 24 to 26 months.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During 2021, 82,000 restricted stock units were issued. Compensation costs related to these restricted stock units was $5.6 million, of which $1.6 million was recognized in 2021. The costs are being recognized ratably over the remaining periods required before the units vest, which range from 24 to 26 months.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During 2020, 95,000 restricted stock units were issued. Compensation costs related to these restricted stock units was $5.7 million, of which $1.1 million was recognized in 2020. The costs are being recognized ratably over the remaining periods required before the units vest, which range from 24 to 26 months.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At December 31, 2022, there was $8.1 million of unrecognized compensation cost related to restricted stock units that is expected to be recognized over a period of 3.3 years.</p> 750000 120000 5700000 8300000 6100000 5953 7688 1478 5113 6615 6244 8078 800000 800000 800000 900000 82000 6000000 1700000 P24M P26M 82000 5600000 1600000 P24M P26M 95000 5700000 1100000 P24M P26M 8100000 P3Y3M18D <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>18.       Operating Segment Information</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors primarily located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Corporate segment income relates to interest income, the sale of non-operating assets, and other non-operating activities. Corporate segment assets consist of cash and other non-operating assets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates performance and allocates resources, in part, based on income (loss) before taxes. The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies (see Note 1). Intersegment sales are recorded at the Company’s cost plus a fixed profit percentage.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: italic 8pt Times New Roman, Times, Serif; white-space: nowrap">Year ended December 31,</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2022</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2021</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2020</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; text-align: left">Net Sales</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; width: 61%">Firearms</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">593,289</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">728,141</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">565,863</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Castings</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt">Unaffiliated</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,553</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,595</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,005</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; padding-left: 20pt">Intersegment</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">21,306</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">24,711</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">22,254</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">23,859</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">27,306</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,259</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; padding-left: 10pt">Eliminations</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(21,306</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">)</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(24,711</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">)</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(22,254</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">595,842</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">730,736</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">568,868</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Income (Loss) Before Income Taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Firearms</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">108,610</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">207,657</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">120,732</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Castings</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,338</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,732</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,000</td><td style="white-space: nowrap; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid; padding-left: 10pt">Corporate</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,007</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,669</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,249</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">108,279</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">206,594</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">120,981</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Identifiable Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Firearms</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">223,301</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">188,290</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">174,500</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Castings</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,910</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,889</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,959</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; padding-left: 10pt">Corporate</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">249,552</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">240,164</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">161,799</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">484,763</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">442,343</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">348,258</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Goodwill</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Firearms</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">3,055</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">3,055</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">616</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; padding-left: 10pt">Castings</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">209</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">209</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">209</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">3,264</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">3,264</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">825</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Depreciation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Firearms</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">21,992</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">22,842</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">25,126</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; padding-left: 10pt">Castings</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,452</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,959</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,158</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">24,444</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">25,801</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">27,284</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Capital Expenditures</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Firearms</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">26,598</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">25,239</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">19,253</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; padding-left: 10pt">Castings</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,175</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,537</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4,976</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">27,773</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">28,776</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">24,229</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In 2022, the Company’s largest customers and the percent of firearms sales they represented were as follows: Lipsey’s - 23%; Davidson’s - 23%; and Sports South - 21%.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In 2021, the Company’s largest customers and the percent of firearms sales they represented were as follows: Lipsey’s - 21%; Sports South - 19%; and Davidson’s - 19%.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In 2020, the Company’s largest customers and the percent of firearms sales they represented were as follows: Sports South - 22%; Lipsey’s - 22%; and Davidson’s - 18%.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s assets are located entirely in the United States and domestic sales represented at least 94% of total sales in 2022, 2021, and 2020.</p> 2 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: italic 8pt Times New Roman, Times, Serif; white-space: nowrap">Year ended December 31,</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2022</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2021</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: right">2020</td><td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: normal; text-align: left">Net Sales</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; width: 61%">Firearms</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">593,289</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">728,141</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">565,863</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Castings</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt">Unaffiliated</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,553</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,595</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,005</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; padding-left: 20pt">Intersegment</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">21,306</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">24,711</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">22,254</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">23,859</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">27,306</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">25,259</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; padding-left: 10pt">Eliminations</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(21,306</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">)</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(24,711</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">)</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(22,254</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">595,842</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">730,736</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">568,868</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Income (Loss) Before Income Taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Firearms</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">108,610</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">207,657</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">120,732</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Castings</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,338</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,732</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,000</td><td style="white-space: nowrap; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid; padding-left: 10pt">Corporate</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,007</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,669</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,249</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">108,279</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">206,594</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">120,981</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Identifiable Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Firearms</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">223,301</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">188,290</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">174,500</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Castings</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,910</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">13,889</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,959</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; padding-left: 10pt">Corporate</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">249,552</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">240,164</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">161,799</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">484,763</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">442,343</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">348,258</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Goodwill</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Firearms</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">3,055</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">3,055</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">616</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; padding-left: 10pt">Castings</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">209</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">209</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">209</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">3,264</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">3,264</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">825</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Depreciation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Firearms</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">21,992</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">22,842</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">25,126</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; padding-left: 10pt">Castings</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,452</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,959</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,158</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">24,444</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">25,801</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">27,284</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Capital Expenditures</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Firearms</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">26,598</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">25,239</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">19,253</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; padding-left: 10pt">Castings</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,175</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">3,537</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4,976</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">27,773</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">28,776</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">24,229</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> 593289 728141 565863 2553 2595 3005 21306 24711 22254 23859 27306 25259 -21306 -24711 -22254 595842 730736 568868 108610 207657 120732 -3338 -2732 -1000 3007 1669 1249 108279 206594 120981 223301 188290 174500 11910 13889 11959 249552 240164 161799 484763 442343 348258 3055 3055 616 209 209 209 3264 3264 825 21992 22842 25126 2452 2959 2158 24444 25801 27284 26598 25239 19253 1175 3537 4976 27773 28776 24229 0.23 0.23 0.21 0.21 0.19 0.19 0.22 0.22 0.18 0.94 0.94 0.94 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>19.       Quarterly Results of Operations (Unaudited)</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following is a tabulation of the unaudited quarterly results of operations for the two years ended December 31, 2022:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 3in"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Three Months Ended</td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-indent: 0.5pt"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>4/2/22</b></span></td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>7/2/22</b></span></td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>10/1/22</b></span></td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>12/31/22</b></span></td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; font-weight: normal; text-align: left; text-indent: 0.5pt">Net Sales</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">166,575</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">140,653</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">139,390</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">149,224</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 0.5pt">Gross profit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">58,108</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">43,554</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">38,869</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">39,554</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 0.5pt">Net income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">30,232</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20,757</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,389</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,954</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 0.5pt">Basic earnings per share</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.72</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.18</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.04</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.07</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid; text-indent: 0.5pt">Diluted earnings per share</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1.70</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1.17</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1.03</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1.06</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap"> </td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Three Months Ended</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4/3/21</span></td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7/3/21</span></td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10/2/21</span></td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12/31/21</span></td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; font-weight: normal; text-align: left">Net Sales</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">184,377</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">200,072</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">178,246</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">168,041</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Gross profit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">72,566</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">78,757</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">64,802</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">63,432</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Net income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">38,192</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">44,384</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">35,202</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">38,121</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Basic earnings per share</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.18</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.52</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.00</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.17</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid">Diluted earnings per share</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">2.16</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">2.50</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1.98</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">2.14</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Three Months Ended</td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-indent: 0.5pt"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>4/2/22</b></span></td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>7/2/22</b></span></td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>10/1/22</b></span></td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><b>12/31/22</b></span></td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; font-weight: normal; text-align: left; text-indent: 0.5pt">Net Sales</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">166,575</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">140,653</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">139,390</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">149,224</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 0.5pt">Gross profit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">58,108</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">43,554</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">38,869</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">39,554</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 0.5pt">Net income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">30,232</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20,757</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,389</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,954</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: 0.5pt">Basic earnings per share</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.72</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.18</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.04</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.07</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid; text-indent: 0.5pt">Diluted earnings per share</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1.70</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1.17</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1.03</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1.06</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap"> </td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Three Months Ended</td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 8pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">4/3/21</span></td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7/3/21</span></td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10/2/21</span></td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12/31/21</span></td><td style="border-bottom: Black 1pt solid; font: 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; font-weight: normal; text-align: left">Net Sales</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">184,377</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">200,072</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">178,246</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">168,041</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Gross profit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">72,566</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">78,757</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">64,802</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">63,432</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Net income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">38,192</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">44,384</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">35,202</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">38,121</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Basic earnings per share</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.18</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.52</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.00</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.17</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid">Diluted earnings per share</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">2.16</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">2.50</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1.98</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">2.14</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> </table> 166575000 140653000 139390000 149224000 58108000 43554000 38869000 39554000 30232000 20757000 18389000 18954000 1.72 1.18 1.04 1.07 1.7 1.17 1.03 1.06 184377000 200072000 178246000 168041000 72566000 78757000 64802000 63432000 38192000 44384000 35202000 38121000 2.18 2.52 2 2.17 2.16 2.5 1.98 2.14 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>20.       Related Party Transactions </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">From time to time, the Company contracts with the National Rifle Association (“NRA”) for some of its promotional and advertising activities. The Company paid the NRA $0.7 million, $0.5 million and $0.6 million in 2022, 2021 and 2020, respectively. One of the Company’s Directors also serves as a Director on the Board of the NRA.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is a member of the National Shooting Sports Foundation (“NSSF”), the firearm industry trade association. The Company paid the NSSF $0.3 million, $0.4 million and $0.5 million in 2022, 2021 and 2020, respectively. One of the Company’s Directors also serves on the Board of the NSSF.</p> 700000 500000 600000 300000 400000 500000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>21.       Contingent Liabilities </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As of December 31, 2022, the Company was a defendant in eight (8) lawsuits and is aware of certain other such claims. The lawsuits</span> generally <span style="font-family: Times New Roman, Times, Serif">fall into three categories: traditional product liability litigation, municipal litigation</span> and negligence<span style="font-family: Times New Roman, Times, Serif">. Each is discussed in turn below.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Traditional Product Liability Litigation </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">One lawsuit mentioned above involves a claim for damages related to an allegedly defective product due to its design and/or manufacture. The lawsuit stems from a specific incident of personal injury and is based on traditional product liability theories such as strict liability, negligence, and/or breach of warranty.</p><div> </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company management believes that the allegations in these cases are unfounded, that the incidents are unrelated to the design or manufacture of the firearms involved, and that there should be no recovery against the Company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Municipal Litigation</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Municipal litigation generally includes those cases brought by cities or other governmental entities against firearms manufacturers, distributors and retailers seeking to recover damages allegedly arising out of the misuse of firearms by third parties. </span>There are four (4) lawsuits of this type, as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(i) <i>City of Gary v. Smith &amp; Wesson Corp., et al</i>, filed in Indiana State Court in 1999; (ii) <i>Estados Unidos Mexicanos v. Smith &amp; Wesson Brands, Inc., et al.</i>, filed in August 2021 in the U.S. District Court for the District of Massachusetts; (iii) <i>The City of Buffalo v. Smith &amp; Wesson Brands, Inc., et al.</i>, filed in December 2022 in the New York State Supreme Court for Erie County, New York and presently pending in the U.S. District Court for the Western District of New York; and (iv) <i>The City of Rochester v. Smith &amp; Wesson Brands, Inc., et al.</i>, filed in December 2022 in the New York State Supreme Court for Monroe County, New York and presently pending in the U.S. District Court for the Western District of New York.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Complaint in <i>City of Gary v. Smith &amp; Wesson Corp., et al</i>. was filed in 1999 and <span style="font-family: Times New Roman, Times, Serif">seeks damages, among other things, for the costs of medical care, police and emergency services, public health services, and other services as well as punitive damages. In addition, nuisance abatement and/or injunctive relief is sought to change the design, manufacture, marketing and distribution practices of the various defendants. The suit alleges, among other claims, negligence in the design of products, public nuisance, negligent distribution and marketing, negligence per se and deceptive advertising. The case does not allege a specific injury to a specific individual as a result of the misuse or use of any of the Company's products.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">After a long procedural history, the case was scheduled for trial on June 15, 2009. The case was not tried on that date and was largely dormant until a status conference was held on July 27, 2015. At that time, the court entered a scheduling order setting deadlines for plaintiff to file a Second Amended Complaint, for defendants to answer, and for defendants to file dispositive motions. The plaintiff did not file a Second Amended Complaint by the deadline.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In 2015, Indiana passed a new law such that Indiana Code §34-12-3-1 became applicable to the City's case. The defendants filed a joint motion for judgment on the pleadings, asserting immunity under §34-12-3-1 and asking the court to revisit the Court of Appeals' decision holding the Protection of Lawful Commerce in Arms Act inapplicable to the City's claims.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 29, 2016, the court entered an order staying the case pending a decision by the Indiana Supreme Court in <i>KS&amp;E Sports v. Runnels,</i> which presented related issues. The Indiana Supreme Court decided <i>KS&amp;E Sports</i> on April 24, 2017, and the <i>City of Gary</i> court lifted the stay. The <i>City of Gary</i> court also entered an order setting a supplemental briefing schedule under which the parties addressed the impact of the <i>KS&amp;E Sports</i> decision on defendants' motion for judgment on the pleadings.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A hearing on the motion for judgment on the pleadings was held on December 12, 2017. On January 2, 2018, the court issued an order granting defendants’ motion for judgment on the pleadings, but denying defendants’ request for attorney’s fees and costs. On January 8, 2018, the court entered judgment for the defendants. The City filed a Notice of Appeal on February 1, 2018. Defendants cross-appealed the order denying attorney’s fees and costs.</p><div>  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Briefing in the Indiana Court of Appeals was completed on the City’s appeal and Defendants’ cross appeal on September 10, 2018. The Court of Appeals issued its ruling on May 23, 2019, affirming dismissal of the City’s negligent design and warnings count on the basis that the City had not alleged that Manufacturer Defendants’ conduct was unlawful. However, the court reversed dismissal of the City’s negligent sale and distribution and related public nuisance counts for damages and injunctive relief.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Manufacturer Defendants filed a Petition to Transfer the case to the Indiana Supreme Court on July 8, 2019. The Petition was denied on November 26, 2019. The case was remanded to the trial court for further proceedings.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the quarter ended April 3, 2021, the City initiated discovery and the Manufacturer Defendants reciprocated. Discovery is ongoing.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Estados Unidos Mexicanos v. Smith &amp; Wesson Brands, Inc., et al.</i> was filed by the Country of Mexico and names seven defendants, mostly U.S.-based firearms manufacturers, including the Company. The Complaint advances a variety of legal theories including negligence, public nuisance, unjust enrichment, restitution, and others. Plaintiff essentially alleges that the defendants design, manufacture, distribute, market and sell firearms in a way that they know results in the illegal trafficking of firearms into Mexico, where they are used by Mexican drug cartels for criminal activities. Plaintiff seeks injunctive relief and monetary damages.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0">On November 22, 2021, Defendants filed a joint Rule 12(b)(6) motion to dismiss the Mexican Government’s complaint based on the Government’s lack of Article III standing, Protection of Lawful Commerce in Arms Act immunity, and lack of proximate cause. The Company, along with other non-Massachusetts defendants, also filed a Rule 12(b)(2) motion to dismiss based on lack of specific personal jurisdiction. The motions were fully briefed and the court heard oral argument on April 12, 2022. On September 30, 2022, the court entered an order granting the defendants’ joint Rule 12(b)(6) motion. The Company’s Rule 12(b)(2) motion was denied as moot, without prejudice. On October 26, 2022, the plaintiff filed a Notice of Appeal and the Court has entered a briefing schedule.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0">On December 20, 2022, the City of Buffalo, New York filed a lawsuit captioned <i>The City of Buffalo v. Smith &amp; Wesson Brands, Inc., et al.</i> in the New York State Supreme Court for Erie County, New York. The suit names a number of firearm manufacturers, distributors, and retailers as defendants, including the Company, and purports to state causes of action for violations of Sections 898, 349 and 350 of the New York General Business Law, as well as common law public nuisance. Generally, plaintiff alleges that the criminal misuse of firearms in the City of Buffalo is the result of the manufacturing, sales, marketing, and distribution practices of the defendants. The </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">defendants timely removed the matter to the U.S. District Court for the Western District of New York.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0">On December 21, 2022, the City of Rochester, New York filed a lawsuit captioned <i>The City of Rochester v. Smith &amp; Wesson Brands, Inc., et al. </i>in the New York State Supreme Court for Monroe County, New York. The suit names a number of firearm manufacturers, distributors, and retailers as defendants, including the Company, and purports to state causes of action for violations of Sections 898, 349 and 350 of the New York General Business Law, as well as common law public nuisance. The allegations essentially mirror those in <i>The City of Buffalo</i>, discussed in the preceding paragraph, as plaintiff claims that the criminal misuse of firearms in Rochester, New York is the result of the manufacturing, sales, marketing, and distribution practices of the defendants. The defendants timely removed the matter to the U.S. District Court for the Western District of New York.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline">Negligence</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><i>Rossiter v. Sturm, Ruger, et al.</i> is a lawsuit arising out of a slip and fall accident by a contract security officer in December 2019. The Complaint was filed in the Superior Court for Sullivan County, New Hampshire on December 13, 2022 and names Pine Hill Construction, a snow removal contractor, as a co-defendant. The Company has tendered the defense of this matter to its insurance carrier and is assisting as required.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0">The Company was named in two purported class action lawsuits arising out of a data breach at Freestyle Solutions, Inc., the vendor who was hosting the Company ShopRuger.com website at the time of the breach. <i>Jones v. Sturm, Ruger &amp; Co.,</i> was filed in the U.S. District Court for Connecticut on October 4, 2022 and <i>Copeland v. Sturm, Ruger &amp; Company, et al.</i> was filed in the U.S. District Court for New Jersey on October 27, 2022. <i>Copeland</i> also named Freestyle Solutions, Inc. as a defendant. By agreement of the parties, <i>Copeland</i> was dismissed, without prejudice, and consolidated with <i>Jones</i> in the pending Connecticut case. On January 20, 2023, five plaintiffs filed an Amended Complaint naming the Company and Freestyle Software, Inc. as defendants. The Complaint alleges causes of action for negligence, breach of implied warranties, and unjust enrichment.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Summary of Claimed Damages and Explanation of Product Liability Accruals</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Punitive damages, as well as compensatory damages, are demanded in certain of the lawsuits and claims. In many instances, the plaintiff does not seek a specified amount of money, though aggregate amounts ultimately sought may exceed product liability accruals and applicable insurance coverage. For product liability claims made after July 10, 2000, coverage is provided on an annual basis for losses exceeding $5 million per claim, or an aggregate maximum loss of $10 million annually, except for certain new claims which might be brought by governments or municipalities after July 10, 2000, which are excluded from coverage.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company management monitors the status of known claims and the product liability accrual, which includes amounts for asserted and unasserted claims. While it is not possible to forecast the outcome of litigation or the timing of costs, in the opinion of management, after </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">consultation with special and corporate counsel, it is not probable and is unlikely that litigation, including punitive damage claims, will have a material adverse effect on the financial position of the Company, but may have a material impact on the Company’s financial results for a particular period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Product liability claim payments are made when appropriate if, as, and when claimants and the Company reach agreement upon an amount to finally resolve all claims. Legal costs are paid as the lawsuits and claims develop, the timing of which may vary greatly from case to case. </p><div> </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A time schedule cannot be determined in advance with any reliability concerning when payments will be made in any given case.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Provision is made for product liability claims based upon many factors related to the severity of the alleged injury and potential liability exposure, based upon prior claim experience. Because the Company's experience in defending these lawsuits and claims is that unfavorable outcomes are typically not probable or estimable, only in rare cases is an accrual established for such costs.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In most cases, an accrual is established only for estimated legal defense costs. Product liability accruals are periodically reviewed to reflect then-current estimates of possible liabilities and expenses incurred to date and reasonably anticipated in the future. Threatened product liability claims are reflected in the Company's product liability accrual on the same basis as actual claims; <i>i.e.</i>, an accrual is made for reasonably anticipated possible liability and claims handling expenses on an ongoing basis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">A range of reasonably possible losses relating to unfavorable outcomes cannot be made. However, in product liability cases in which a dollar amount of damages is claimed, the amount of damages claimed, which totaled $1.1 million at December 31, 2021, is set forth as an indication of possible maximum liability the Company might be required to incur in these cases (regardless of the likelihood or reasonable probability of any or all of this amount being awarded to claimants) as a result of adverse judgments that are sustained on appeal. </span>At December 31, 2022, the total amount claimed specifically in these cases was de minimis.</p><div>  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During 2022, no traditional product liability lawsuit was filed against the Company and one (1) was resolved. As of December 31, 2022, the Company was a defendant five lawsuits involving its products, including one (1) traditional product liability lawsuit and four (4) municipal lawsuits. The Company also was a defendant in three (3) negligence lawsuits though, as discussed above, that number has since been reduced to two (2) lawsuits with the consolidation of the <i>Jones</i> and <i>Copeland</i> matters.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During 2021, one (1) traditional product liability lawsuit was filed against the Company.  As of December 31, 2021, the Company was a defendant in four (4) lawsuits involving its products, including two (2) traditional lawsuits and two (2) municipal lawsuits.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During 2020, one (1) traditional product liability lawsuit was filed against the Company and one (1) was resolved.  As of December 31, 2020, the Company was a defendant in three (3) lawsuits involving its products, including two (2) traditional lawsuits and one (1) municipal lawsuit.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company’s product liability expense was </span>$1.3 million in 2022, <span style="font-family: Times New Roman, Times, Serif">$1.1 million in 2021, and $1.1 million in 2020. This expense includes the cost of outside legal fees, and other expenses incurred in the management and defense of product liability matters.</span></p><div> </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-weight: normal">A roll-forward of the product liability reserve and detail of product liability expense for the three years ended December 31, 2022 follows:</span></p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Balance Sheet Roll-forward for Product Liability Reserve</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: bold 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"> </td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"> </td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"> </td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Cash Payments</td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"> </td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: bold 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Balance<br/> Beginning <br/> of Year (a<b>)</b></span></td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Accrued<br/> Legal<br/> Expense<br/> (Income) <br/> (b)</td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Legal Fees <br/> (c)</td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Settlements <br/> (d)</td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Balance <br/> End of <br/> Year (a)</td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%; text-align: justify">2020</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">818</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">800</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">(492</td><td style="white-space: nowrap; width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-57">—</div></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,126</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2021</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,126</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(7</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(227</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-58">—</div></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">892</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2022</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">892</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(417</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(167</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-59">—</div></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">308</td><td style="white-space: nowrap; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Income Statement Detail for Product Liability Expense</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: bold 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Accrued <br/> Legal<br/> Expense <br/> (b)</td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Insurance <br/> Premium<br/> Expense<br/> (e)</td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Total <br/> Product <br/> Liability <br/> Expense</td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: justify">2020</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">800</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">839</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,639</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2021</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(7</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,119</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,112</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2022</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(417</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,524</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,107</td><td style="white-space: nowrap; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Notes</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0" width="100%"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.5in">(a)</td><td style="text-align: justify">The beginning and ending liability balances represent accrued legal fees only. Settlements and administrative costs are expensed as incurred. Only in rare instances is an accrual established for settlements.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0" width="100%"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.5in">(b)</td><td style="text-align: justify">The expense accrued in the liability is for legal fees only. In 2022 and 2021, the costs incurred related to cases that were settled or dismissed were less than the amounts accrued for these cases in prior years.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="text-align: justify; width: 0.5in">(c)</td> <td style="text-align: justify">Legal fees represent payments to outside counsel related to product liability matters.</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0" width="100%"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 0.5in">(d)</td><td style="text-align: justify">Settlements represent payments made to plaintiffs or allegedly injured parties in exchange for a full and complete release of liability.</td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="text-align: justify; width: 0.5in">(e)</td> <td style="text-align: justify">Insurance expense represents the cost of insurance premiums.</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There were no insurance recoveries during any of the above years.</p> 5000000 10000000 1100000 1 1 4 3 1 4 2 2 1 1 3 2 1 1300000 1100000 1100000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: bold 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"> </td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"> </td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"> </td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Cash Payments</td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"> </td><td style="font: bold 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: bold 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Balance<br/> Beginning <br/> of Year (a<b>)</b></span></td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Accrued<br/> Legal<br/> Expense<br/> (Income) <br/> (b)</td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Legal Fees <br/> (c)</td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Settlements <br/> (d)</td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Balance <br/> End of <br/> Year (a)</td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%; text-align: justify">2020</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">818</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">800</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">(492</td><td style="white-space: nowrap; width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-57">—</div></td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,126</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2021</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,126</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(7</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(227</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-58">—</div></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">892</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2022</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">892</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(417</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(167</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-59">—</div></td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">308</td><td style="white-space: nowrap; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> 818000 800000 -492000 1126000 1126000 -7000 -227000 892000 892000 -417000 -167000 308000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: bold 8pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Accrued <br/> Legal<br/> Expense <br/> (b)</td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Insurance <br/> Premium<br/> Expense<br/> (e)</td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center">Total <br/> Product <br/> Liability <br/> Expense</td><td style="border-bottom: Black 1pt solid; font: bold 8pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 61%; text-align: justify">2020</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">800</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right">839</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1,639</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2021</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(7</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,119</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,112</td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">2022</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(417</td><td style="white-space: nowrap; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,524</td><td style="white-space: nowrap; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,107</td><td style="white-space: nowrap; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> 800000 839000 1639000 -7000 1119000 1112000 -417000 1524000 1107000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><b>22.       Financial Instruments</b></p><div> </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company does not hold or issue financial instruments for trading or hedging purposes, nor does it hold interest rate, leveraged, or other types of derivative financial instruments. Fair values of accounts receivable, accounts payable, accrued expenses and income taxes payable reflected in the December 31, 2022 and 2021 balance sheets approximate carrying values at those dates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>23.       Subsequent Events</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 17, 2023, the Company’s Board of Directors authorized a dividend of 42¢ per share to shareholders of record on March 10, 2023.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s management has evaluated transactions occurring subsequent to December 31, 2022 and determined that there were no events or transactions during that period that would have a material impact on the Company’s results of operations or financial position.</p> 0.42 STURM RUGER & CO INC Yes No Yes Yes 1 1 17664230 24306486 24378568 40000000 40000000 1 1 6714338 false FY 0000095029 The beginning and ending liability balances represent accrued legal fees only. Settlements and administrative costs are expensed as incurred. Only in rare instances is an accrual established for settlements. The expense accrued in the liability is for legal fees only. In 2022 and 2021, the costs incurred related to cases that were settled or dismissed were less than the amounts accrued for these cases in prior years. Legal fees represent payments to outside counsel related to product liability matters. Settlements represent payments made to plaintiffs or allegedly injured parties in exchange for a full and complete release of liability. Insurance expense represents the cost of insurance premiums. EXCEL 97 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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

?C(C[?"X3"*;^//,9]_T$28WCGQRT4_29&)8_OZ'_FCJOG'EB@L\B_R]O M(=?7G7$'+?B2;7UY'^U^X[E#@P1O'ODB_1_MLK:C00?-MT)&06ZL1A!X8?:7 MO>1$E S(>P8D-R 5 ^R^8^#D!LZQ!FYNX*;,9*ZD/% FV?0JCG8H3EHKM.1# M2F9JK=SWPN2Y/\A8?>LI.SF=18&:0H*E#^'.9Z% %Y1+YOGB(_J$'A\HNOCP M$7U 7HAN/=]7S<153ZJ>$_O>/._E)NN%O-,+)N@V"N5:H%_"!5^8 #TUY&+< MY&W<-\2*2/F\BQS\$R)]0FH&-#O>'->8T^/-^Q9OG.(I."F><\I3^/:':HV^ M2!Z(O^NHSZ#=>N@D;UR*#9OSZXY*#(+'S[PS_?$'/.S_7$<;)!@% C,H=0M* M71OZ],](,A^I^)E__Y0DA@6:ETBNXS'#&Z=X2;I\G@ZZHZO>_3;CKM,O M_\.F!=VW&'9U&\.U0>':P.K:+!(214OD";%EX9P+E8"%C+VY5%ZF'J-MZ,G: M.,V0!^7A5%S,6DP,&BIM:%V;4;U3P\*IH=6IQS#F\V@5>O]6'I6Z$++.E6'- MLZBP/[/VV70Z X$9](P*>D96>A[2Q_I%/>TP^:%,DX3*/GB$OMWRX(G'M:G! MBMDT-4""42 P@\MQP>6XO6P[AJ04$HP"@1F43@I*)_;IN69QEH<2X 52!2E: M;N4VYD660A>JA,C:?:PC=K*7F4:#)*%6(MHZCJ:4 8$9E.&^+KWZQY#&GM7, M8T\^+[.VBEDHQ2'.\@[*I&%20YI]($U9@T(S:2M5K-A*&^5+'L=JDF4YT9;_ M[$A-HQ44C4*AF2P2S2)I+PGFV%"\0J)1*#235UW)8VM5:_+*7Y+/O)9"9Z]\ MZ7?'U;@]HA$]T,CT0Y?/V%X_-Z_'\'ZIV^].JAY9>VW\K('03(YT'8[MA?B] M+KNS7/28E-WHXO[A,0DB6V*R C<.($@T"H5FDJIU !ZVF)@@"_X9*!J%0C-Y MU0("VQ7$?:U&3,LS=>M0H3':*S3&I*;..*H9K6DV&92;F2[JNAY;:USE8BEC M">6<$LG'2^,R%]G%Y&OV';KW0"[:! M-77;^VJ:8D#1*!2:R;.NS EN+W43T%H=%(U"H9F\ZEJ=6&O6(R+_ !Q\Y"O MI>IT6WJ:K4F#+JV)O;0^/HS9R^$P!GUM#HI&H=!,GG7I3]P6PQBRP)^!HE$H M-)-7+1>(72X<$<9V #*TA?'IMO0T6Y,&7> 3^YM^ZBEE*:.X'+'OO--1WR2D MI8N/[#59;7/L00U:_H.B42@TDW5=_I-1BT$-NI BD:AT$Q>M>8@=LU1S-Q, M7; =BQ<"L2#:AO*0JLJARSIH,!DX%_$G&U/$_ ML,<_I&J9@:)1*#1S@X'60$Z_Q2T&H)H'%(U"H9F\:LWC'+D:<4+\Y]#&FM=P M7'T);!] 8[K:D#*.EC*.71&<]N/_^U9-3Q7]]M5N>]>-9RGHJ@04FDE[:7]1 MFQN,8'<8P6XQ:D,J.5HJ.?95DK.BW]U?O'5'>]$/JH"@T$RZM )R[$+BW%]_ M8H]_T$454#0*A682KS67T^*BB@.JJD#1*!2:R:M658Y]4>6L^ <55<[^FLH MXXJ6H%!]FG1IL>0<$$MGQK]=_=L[;TPHJ.R"0C.)U[++F;08_Z"J"A2-0J&9 M>XRUJG+M*TOGQ+\=NBFM[OY6L.$0#ZJ[D?=;C?NC=S:+N%H$N0=$T)EQC:UQ M;>^\,5&@<@H*S21>RRFWQ5U<+JA> D6C4&@FKUHON?:EIK/B&E0N@:+1',W( M$L1U*_'?*YTG"GB\2L]E"31/O,^.Z!1WB[-?G],33Y7[-_B29B>X-$QVH.R6 MQ2M/S5:?+Q5DOYN&PO=V]R:W-H M965T\^Q[[&/:]_)EHM[F0(H]#W/ MF)PZJ5+%I>O*.(6 -/?++G(B=*O8N7*0@!)2E">N;[GC=R<4.:$D[+M M1H03OE8997 CD%SG.1$_9I#Q[=3!SD/#+5VERC2XX:0@*UB ^EC<"/WF-BP) MS8%)RAD2L)PZ;_!EA$<&4$9\HK"5>\_(I'+'^;UYN4JFCF=&!!G$RE 0_;&! M.6298=+C^%:3.DV?!KC__,#^3YF\3N:.2)CS[#--5#IU+AR4P)*L,W7+M_]" MG=#0\,4\D^5_M*UC/0?%:ZEX7H/U"'+*JD_RO19B#Z 3[0;X-< _! P> 00U M(#@6,*@!@U*9*I52AX@H$DX$WR)AHC6;>2C%+-$Z?CX5NF+5:C*S\B("16@F7TYNB6<5L?\(,?;1-6@M M2R!I$[AZE,U0_8>ASOQ>Q@CB,Q3@5\CW?+]C0//CX;@#'AT/]WJR"1KA@Y(O M^#/AT9=W&HBN%.3R:]:6]@ 6P.: 8M3O=??HR_78-3ZBOY#\W+'TT4+"#]DT=4G:.XI3%Z9-LL@264O]4:/^Z$EL/[*IKDVRR!)92]WS1MWS MWK5] \*L6GU@,=:7)(-.MU.[X["[:BH.VJW>[3RN&CRN/CK M'HW(AB:2LWZ7]H[CU'5DDRRR1-;2?]SH/WX2EXYMJFN3++)$UE(7>[M#IV?# MIS7+KXS:'8;'!TY]).RBVZIX[P2-_[I9%P472J*%OIFEO7[M'\NI2\HJ6V2+ MK3T/_FX>_"N6P MRA;98FM+O+MUX-YC]]'&'759;1R,6W^'-OX-4'0BJ$K;W:MS:0NNRGJA1#%? M,U75D9K6IB;YIJS$';3/3*VRK)_M:*I"YS41*ZK/S!DL-:5W=J[G352UP^I% M\:*LIMUQI?>!\C$%DH P ?K[)>?JX<5TT%1PP_\!4$L#!!0 ( ,"(5E8G MF#*PKP< "P[ 9 >&PO=V]R:W-H965TVX6=4JFZ^#EL68AF$T7F9Y.9I#DBH^,J;/*J M#&JUN!R](>=2\"Y@C?@C5X_-WNN@&\I-57WIWKR?7X["[HA4H69M1Y'I/P]J MJHJB8]+'\<^6=+3[GUW@_NMG]G?KP>O!W&2-FE;%G_F\O;L<):-@KA;9?=%^ MJAY_5ML!B8YO5A7-^G?PN,6&HV!VW[35#.4M0XR:[/)15T]!G6'UFS=B[68ZV@]_+SLYOVZ MK?6WN8YK)[^M5)VU>7D;7*M;/9]M\+[<9%,W*Z^D:K.\:+X/SH)KG7+S^T(% MU2*H=E'--FJ1EUDYR[,BR/?BSX(>?Q/\]4$M;U3]M_[V\[4,7GW[_<6XU4/I M#F@\VQ[VU>:PZEG,UMPG&6H.=$/19B"L*,DHU>QTP\D- M0TH]!S0]/IQXPN7QX2$P&K:;5K;F8P-\O^HKQG56J,8G[2:4^T.["\UYL\IF MZG*DKR2-JA_4:/+=-R0*?_3)@DDFD<@LR?A.,@ZQPY)M0J-U:'#>P&,Z1N;X$YXL\N]$7\C=-HUKO4&+,K, DDTADEGC)3KP$ MSHKCQ$MZ,\<3'D?,R0,/C%/&'9CLPQA/J!BX5J2[H:1@'OQ45?/'O"A\QY]B M3CXFF40BLQ0CH7%*(3C]D&;;4&N::.2M\F7<$!'/:4=DD%ILM'37247#B#TI'^Y=TKG_=Y>U_[;V,$U1ZBLDDL-EM"XQ );!&/EI![IC". MW3N #Y;$L>L6?3!.:3J0$,8N$M!"3=[EM$02 MO;S&(J#!/%DW3#:)Q6;K9BPH 4W: =WB7K*+E-'$==$>G+Y($MZ[FGKX(I'L MN3%[%,8+D@2_VB*@P3PY*S#9)!:;K:E 1B08FW1A(RO]7$49!_WGRQ&.R22PV6SKC5BGL5@]*)_HG/DE3 MMT/K@]%>(U?Z8(+0H00PGI'"GO'8"H*BVD=4-HG%9DMH[".%[>/1$O:='XU$ MFK@)X8$)RE(W(?HPDE(Q8".IL9$4[BE^+K/%(B]T7JMY,,V:;JD,KLA@PI-3 M ]5#8K'98AH/2>&N)EA94-2^)BJ;Q&*SUPJ-.V5P9Q->+>RW(ZD0;B_#BTK= MNZH'Q<)PH+?)C#=D<&_S1;4#0VUXHK))+#9;3^--&=SP?)F>_;[E&6/,O=[Z M8'2_PMHJX(&1<,AVL[UU<;@+>F09P7#7R'$7R;]&$Y09#\O@)NBQ"O:[EH2D MO,T<*B<8:NL3E4UBL=FR&1O+X/5Q4#;? K?; MOCL&) ^ [&,W_I'!2^"'"@F&NOB-RB:QV&SIC%EEL%D]*%U_L9IRX99@/M3^ MJ;P=J@=%AI:]F;&(#+:(QU8/#-4MHK))+#;[,2GC%CGL%H^5D/?-'B&QVX[Q MH)A@;F/6@^)I/%".'W2>< JCV$Y5-8K'9NAG[R6'[">OF<8TL M+>V>8],$$'2H\N'&A'.YBOBWR95ZNG=2!TP?5CJ*R22PV6T-C1SF\ M! ^G 6J;%)5-8K'9NAD/S.&E=EBW_A+XF??6X\/Y[CT^W/#-1Q@;*@[8T*I> M5776JMW.%>@T@LE.?M ==64=B\T6TIA@\16ZIP+5$*.R22PV6T]CB,57Z)Z* M?K^3A:%3!DT]*!)%;NGL0U$^<,L2QK *E-:I0&V=HK))+#9;0>.7!4KK=,NR MOS](3Y_H-5*\N)#T'BCWX$A$XM3-B/'>-L*EJF_7VS&;8%;=E^UF(]WNT]V6 MSS?KC8[.YU?D7&XV;AJ:S3[2#UE]FVO'4ZB%I@Q?QSI)Z\W6S,V;MEJM-RO> M5&U;+=&PO=V]R:W-H965T6Q1=KDF+>IAN2R6]6E*58R%OV9O$- M(WA9D-+$6:]#MR*),_+( -^F*68_[TA"=]V6W=H//,5O M:Y$/6+W.!K^19R)>-H],WEFURC).2<9CF@%&5MW6K7TS1SF^ /P3DQT_N 9Y M)J^4?LMO)LMN"^83(@E9B%P!RX]W2T_A>:;;JD#GQ\'JO/BQRE[F\ M8D[N:?)OO!3K;@NUP)*L\#813W0W)E4^?JZWH DO_H-=A84ML-AR0=.*+&>0 MQEGYB7]4ZW! D#IF@E,1')7@G2"X%<$]E^!5!.]<@E\1_',)044(SB6$%2$\ MEX J CJ7$%6$2"4$IXR#>^?@N3'LVFS-[9.4O=UVX;=5%E91E7TL<*_#Z ZP M'"_U\HNBM N^+,8XRYOP63#Y;2QYHO?7%C-!6/(3/!$N*Y<#N@(/&\)PWB0< M7+UD>+N,!5E>@ZL^$3A.^#7X I[E;K#<)B2'?Z\U5G&<6,$Q!GY0:1=]H7 M\/+?KL$G8 &^QHQP"0 O62SX9SDHK_]>TRW'V9)W+"'3RB=G+:H4[LH4 MG!,IN. KS<2:@T&V)$L#?]K,MYT& 4NN9[VHSGY1[YQ&Q3Y9M(%K?P8.=!S# MA.Z;Z0\+T0;P-+W?3)]N$TEW3M('S?3;#6ND#\_/W3;01^?D[IRDC\_)W3U) MGYR3^VGZ]&.^SSZV=//SZ;"ABMUZ:W +/?>$7MWB#ROP:YL8UBT^.6CQVU$FQT27%QI<4FUQ2;'I)L=DEQ>87$COJ8J_N8J])O?>G_"'_C!-B?+"6U*"@ MYC_7WWNV%SF.U['>#YO. ',C-X+'L+Y)#0:^>PP;&&!!X(?^,6QH@B'HV<>P MD0$6(L<+CF%C'29?4V#H',,F!C7DN6%X#)OJ,#_RD:>HS718Z,+05>8V-Z@% M" 6HAAT9[]?&^XW&CQCE'&P87<7&;;ED^P=1WL-*#FU2'%>1WFNIC70 M43ZR(5)\UU&!Z[G*THX,* ]!!37642$*?<7-B0'E^('BTE1'V0A"I)3M3(;U)X'_]OL<;:@*3$Y'AB*.](<-Z%Q M1[G04;T<&E#(=M1&-Z!\1W-<1WF>BY0<)\:(D:(UU5$(N>KL9X;U\GT4*0LV MUV$1=*,3/1[6?H>-?M]A'B\ P2R+LS?9[(25KU?@2KY2]6F28'8P>FTJBC) M>#C]-E1\O#>"E$7MFT"VTMT#$TC=A8>U( 6-H)OBM.F5"D'3XG)- M\)*P'""_7U$J]C=Y@/JXN?X ( $L+ 9 M >&PO=V]R:W-H965T+,-M#^^]E.R %QM3L)?'9]WV^^^)SSM\P M_BP2 (E>4IJ)@95(F=_8MH@22+&X9CED:F7!>(JE,OG2%CD''!M02FVGU?+L M%)/,"GPS-^&!SU:2D@PF'(E5FF+^.@+*-@.K;6TGIF292#UA!WZ.ES #^9A/ MN++LBB4F*62"L QQ6 RL8?LF[&M_X_"=P$;LC)'.9,[8LS8>XH'5T@$!A4AJ M!JQ>:[@%2C61"N-7R6E56VK@[GC+?F=R5[G,L8!;1G^06"8#JV^A&!9X1>64 M;>ZAS*>K^2)&A7FB3>'KJ1VCE9 L+<'*3DE6O/%+J<,.H.T= 3@EP#D$N$< MG1+0.1?@E@#7*%.D8G0(L<2!S]D&<>VMV/3 B&G0*GV2Z<\^DURM$H63P10H MEA"C">;R%7WC.!/8?!&!+D.0F%!QA3ZBQUF(+B^NT 4B&1H32K6';TL5@>:Q MHW*W4;&;+L&'IX/;YW(IE-]C8[ADS1E"PHH*$0+")F#CV-(9T#_UDG M^DE2?7'ZU/=8(U218V1+8GIEN)Z1KVSEN.]M,7 MA4(/$E)1*ZW;I+1-DH4-D>U)VZVD[9X\I\.4K3*)[VI1Y]/=]PGK?'J5SU[D7A6Y=UZ%S1+&),F6:)8S+@6Z4QG%?R^UD^S_ M>AZ:) L;(MM3M5>IVOO_I=9K4MHFR<*&R/:D[5?2]M]2:OV:$ND'0-$('\R/5*1:-W1^:HLT<8[XD MZM106"A*5>WJ"N!%ZU88DN6FF9DSJ5HC,TQ4MPM<.ZCUA:KJK:$WJ/KGX#=0 M2P,$% @ P(A65BK;V:]3! "!@ !D !X;"]W;W)K&ULM5A=;]LV%/TKA%8,+3!$'_Z(D]D&&JO#"L1#T+3=0[$'6KJV MB5*D1U)V\N]'2HIDV0IM#\R++4KW'O(<\E)''.^X^"G7 H]993)B;=6:G/K M^S)90X;E%=\ TT^67&18Z:98^7(C *=%4D;]* B&?H8)\Z;CXMZ#F(YYKBAA M\""0S+,,B^<[H'PW\4+OY<87LEHK<\.?CC=X!8^@OFT>A&[Y-4I*,F"2<(8$ M+"?>Q_ V#F],0A'QG%&5!JD/0X M_JU O;I/D[A__8+^1T%>DUE@"3-._R:I6D^\D8=26.*L19(25__BI$F(O(8I>28BJA.C#H6?(>$B=9HYJ(0L\C6] DS\_ZHA'Y*=)Z:SCA3A*V *71/\()0 MH@A(]#X&A0F5'] [1!B:$TKU+,FQKW2?)M-/*OR[$C]Z!3^,T%QWL9;H$TLA M;0/X>K#UB*.7$=]%5L08DBO4"W]#41!%Z-MCC-Z_^] QL-GY,*$%)CX?)NB& M:;'LU?/2*W![_W=>?MSK#/1902;_Z9J6$K[?#6]VDUNYP0E,/+U=2!!;\*:_ M_A(.@]^[I'0)%CL":\G:KV7MV]"G<\)(EF>(DHPHQ)=H P(E%),,Z3T4;03? MDE3KKA>]S 5F":"$;T'H+1"978JQ'%.ST1 ]%[HP8DXI%K)KX=R5(QD6(S'; M[W8Z&/O;?5FM8[U45D=@+5D'M:P#NZSXJ2TK7JT$K+ "1+F46LTD%P+22D#Z M[%[MP9':87 @MY7#I7([ FO)/:SE'EKE_LJ5U@5G/&>%VBG.M&2R7,A:Y5-: M6=$OW1M*L-&^\%=A6_G848-J17GTD4P.B5;;(MH,;VIF=Z< MR=3&THIQ*6@UIA?LK!60[272$1(=5ILMI,VA M<;_A"?N;,Y*0S=F5YM*@SIRBQ:[0VDHVAC<>B//.D*.*NTXY+6W6F,ZPQ.N$U:4Z.6A/VG.*S67MG+F%"UVA=:6 MLG&TX>B-2\VIU76*%KM":VO;>.CP7!-]LM1LUK92QJ79CEVAET>D&8A5 M<=2LOYC-)W1Y]EC?K8^S/Q:'N ?W[\PQ=W'TVL"49^1S+%:$241AJ2&#JVNM ME2B/G)9<;D&G((P ?KYDG/UTC =U(?_T_\ 4$L#!!0 ( M ,"(5E:&PO=V]R:W-H965T0'_/'R1^^35+PE+(%!,9D; 8>#?A]30,#,!& M_,E@K7;>B;$R%^*G^;A-!EY@% &'6!L*BH\7& /GA@EU_%.1>O68!KC[OF'_ M:LVCF3E5,!;\!TOT:N#U/)+ @A9#*_I)U%1MX)"Z4%FD% M1@4IR\HG?:T2L0,(VR< 406(#@'=$X!V!6@? CHG )T*T'DOX*("6.M^Z=TF M;D(U'?:E6!-IHI'-O-CL6S3FBV5FH3QIB;T,<7HX%IEFV1(R3>X8G3/.- -% MSB:@*>/J,SDG3[@XDX(#$0LB!>?GN#S75"8$GR27(BEB37@%?L/5HT"^ (? MJKZ[NN^QZIO=0SH'^8Q!WY\FY.S39_*)L(Q\6XE"T2Q1?5^C.2/1CRLCX])( M=,)(&)%[]+)29)HED.P3^)B5.C71)C7CJ)%Q G&+M,,O) JBR"%H\GYXZ(!/ MWP\/&MRTZXEN6[[V";[-9/R@4M(,YV([*[,[C"6W&E+U[$I\2=QQ$YN3[%KE M-(:!EU=S[PU__27L!K^YDO:19-,/(MM+:*=.:*>)?3BBG&8QD!$L69;A'C+[ MXR^@TB%TU$PU"YUY+T%="S('_LNP=X4+\64WG<'F0 M T?00&PF[AVX=05%TZ-<1 MU-E9.WN&+VO#EXVBL6C0'+!(T$['S>!9Q^FX$>3>P,1UJGP0S_3_\^REME>G MMO>NLP3_NII.D6:2$Z=([VCSMX/>P9HZCCDZ::;',7LGS9[O*^^@(0RV]4CP M7RZ^K8#,ZU,5RP$"66)>MT7&O$R8PFK#S@26+[0ZD;C=EPO)* MV1N9F =.-3ZU(#'6S0ICJ"9K0,VE%EQ8DB1,I4P9B[:'@[*!I1*:BL+FJ!)H MQ& [2BX947 N&3:^X?)$6^WGNZW4[3SD]*W,-4K!FXEBB1%;H'6^J_*X<,2J M7X,A[CSO3IF#.:7(:3@XWH0T6RR4,4@P4@#M&FV7RVIY=K:_DZQG8)L2CWY9WI'* M#RUR>PF8"XU7"ONZPGLE2!. _0LA].;##%#?5(?_ E!+ P04 " # B%96 M+= 1Q1($ K$0 &0 'AL+W=O2E M!*5[[)> [7D>9I[,& _#C9 _U I D]UW,3QE-G/+1S,SD>BDS'/(69)"I+$B:WMQ"+S- M.K@G)I2Y$#_,X"X:.9[Q"&((M:%@>'F!"<2Q84(__BU(G?*9!GAXOV/_TP:/ MP WAE NP"T3P&=,X!. >A<"N@6 !NZF\=NA9LR MS<9#*39$&FMD,S=6?8M&O7AJ$N512USEB-/CB4@U3Y>0:G+/V9S'7'-0Y.,4 M-..Q^D2^D$=,SBB+@8@%64L19:$F<6&[)?"*.:L [;X]3LG'#Y_(!\)3\K02 MF6)II(:N1C?-P]RP<&F2N^2?<8GZY &]6BD2I!%$QP0NQE<&Z>^"G/BUC%,( M6Z1-/Q/?\_T*AZ:7PVD%/+@<[M5$TR[_LK;EZYSANPE#F4%$[F')8A(4^C\_ M0#('^4^5WK5\9BNZ5FL6PLC!O4:!? %G_/MOM.?]4:55DV1!0V1'.G9*'3N6 MO7U&QUF1R_=E+I?%$&[)\SV:DSL-B:K4M-.DIDV2!0V1'6G:+37MOC\W*YR\ MK:=YII6:YZ">!9DWX,OX2X?VA^[+H9851B>5-D>!]\K >[4>WZ4J MDRP-@U/C\) MC?O1V\2ZI$AKF=^;4$V2!0V1'2E*O?W)T?N%95J0-R1KHVQ!4VS'PAXG_ M2=9*->F;5QJEWNFKL=**^B?E5V75.U> U)S!CV?VYUA:?Y#%M_S3"LH.@A5G M!^P>-$[O6PRN"';$)+9GB@5@>R+2>-LB=ZD]T!-L,^S1_+/%A4)IA21A)B6R M28B9QJL6),2&4J$-TV0#$H@"K6-<0NZ(JX0KA0.[$H.RAKDG+!%9BIP[!XTS M.(\NYXSH\%IRG-P"DZJ%^^-^M]T%)\&FBJ'9.6GZ*5X:KO-M6;6J4L@]:/ 2 MD$O;62MD0;_R V\Y6W;OM[9G/9F?F*Z^8OZ&^M=36H7 /Q%7;#OK[A^=?T9X M8'*)$:!<"W3#:_5QSY9Y9YX/M%C;UG,N-#:R]G8%+ )I#'!](83>#&PO=V]R:W-H965T MY'NI/N^^TXZ*>ZD>M E@$%/@E*NN1D:5@ BK-9(44[!/\:;Y: M1R[>!WQGT.F)C5PEF90/SKDI$APX0< A-XZ!VJF%*^#<$5D9CP,G'E,ZX-0^ MLE_[VFTM&=5P)?D/5I@RP1\P*F!/&V[N9/<%AGHN'%\NN?8CZOK8R&;,&VVD M&,#6%ZSJ9_HTG,,$$%Z\ @'0.AU]XF\R@TU-(V5[)!RT9;-&;Y4C[;B6.4N M96>4W6469])=DVEX;* RZ'-K1XW>;L!0QO6[F!B;P(61?"!;]V3A"V37D,W0 M?/D>A4&X0*\10;JD"O2?3,1*''6&H\[04T=_J1/=WX+(0/T\I?(LE6OSE:YI M#@FV?:Q!M8#3-Z_FE\'',T(7H]"%9U_\^X&B^Z\V&-T8$/JD[L5_T!V-NJ.S M![QA+2N@*A!M3"D5^P7%*8D]R=*3N ??IL$L"F/23E.323^ZIWU+U8%5&G'8 M6U@P6]K>5OUSZ1TC:]^BF32VX;U9VA\&E NP^WLIS=%Q73_^6>EO4$L#!!0 M ( ,"(5E926%&S+P, "03 - >&POSEE)ZS-5,6F10NF2&MO5 ML["N-*-Y#:12A/U>+PE+RB49#>6BO"I-'4S50IJ,)%TH<+?/>4:BY#T)G-Q8 MY2PC=R=O?RR4N7P3N/O1NZ.CWMWIY7[\I %.2>@5/7^&Z%D/U[48)IT\2_H) M94SX8E=X(_0[XL!#/.YXQQ@M]>;;8D*G(8?M2HZ&A9*;!8V)"UAU6K+@GHJ, MC*G@$\V!5="2BY4+]R$P54+IP-A*LNDBB-0/#HY<#XJLU2FY5+K)[3*X[TG[ M^!ZP[H%!+D1GL$]<8#2LJ#%,RRO;:1YN@H^@H&W?KBKK<*;I*NJ?DPVAN=DD M$Z5SIKLT$5F'1D/!"K"C^6P.=Z.J$$!C5&D;.:[&CO2RVUJT'JR:[IC74-IV,ZX#^MIK3WI;MOT@WJ/B],I\6=CBRZ4-ALVO- M"KYL^LNB,X"I1[@ZK2JQ^BCX3);,#?[9"4=#NN8%OZ[\SQCDFDJMDW;VG_-L_QBQ_'%O[+<_%;9 M-^SUV&ZKK]WD^2&83 [!Y$'4Y. 03*:OTF38;N!;IX2=,T(7#> LEI%O<+(3 MFZ3!9,&%X;+MS7F>,_GHJ&#E#9W8/P%V].WS.2OH0IC;#LS(IOV5Y7Q1IMU3 MUS 1[5.;]A<87I1T!T&;B\N<+5D^;KMZ-FF:@6W8K.T%A'WDJKG\",9QF!\! M#,N#.< XCH7E^9_&,T#'XS#,V\"+#%#. .4XE@\9-Q\LCY^3VLL_TC2-XR3! M9G0\]CH88_.6)/#C5\.\ 0/+ YG^;*[QU<8KY.DZP-;TJ0K!1HI7(C92?*X! M\<\;,-+4O]I8'F!@JX#5#N3WYX&:\G/B&%85\X:]P3B2IA@"M>BOT21!9B>! MCW]]L+I\*-_\7&_T"4$L# M!!0 ( ,"(5E:7BKL

-8?20$3;8T.P6BP^0"X99K>]9!:G M''P\/*;_^UM@O=TWS17RO*].>3]9=MWDUG;;% M6M6R_;W9*$-G5HVM94>']G[:;JR29;M6JJNK:71VEDUKJO]O19VZA\T MG2HZW1@J= 6?M?K6_CKO#L6#;O6=KG2W/9\,_U=J(FIM=*U_J/)\[=;>A;3+VO,<1A_W<7Q%?V M_X2Q6:UTH2Z:HJ^5Z79QM*IR@*9=ZTT[$4;6ZGRROT2\-:6X-!T%25R9W:WH M6O=-Z=%7Y>Y;=X3KQ="^TG3"7I4#.!_D>SIN*EW2TTOQ3E;2%$H,P6T]P @ M1B<#%,\6TH., 61\1,BE@W ?:$6SHAHO&@\R 9#)R2"775-XD"F 3$\(^4_D M068 ,CL9Y'O9KCW('$#FO)#+OJZEW0Z1T_=&T\>D&XR*HNEI,/(@YP!RS@OY MMOC:TS-=N0/]2]I*&_&V;*,>E.F5N%%%0U$<2"4-Z-0&.BO] M7C,[0\/X&2_FK97E *GT@Z1'MR_$1]7Y=% RS):Y,A3$CB8!RJ_5&=+*C-DK M-+W9T.1C^T(L*M4F/@G>A'W2I3!G$#[EB MQBR+:VW4H"^K2ATT?R2'&;,=+NM-U6R5$N^442O=#5TUB!D2PXS9#+O.^8E& M$3IG[H>97JT>C[L1LD+$;(4=DKB5WX.!-T(NB)A=<"FMH7!1)Z7H+=?2*I\, M9AK,2G"SX"_DT$UOBS4-1/&$LDA8I;#C2LD.2R(=BO(:%3C MQ0$ALD3$; DWYZ6Z=M5\K>6P[A/.Z")DBXC9%A^TD:;0LJ(VV'9VN#R 0[*( MF&6Q[.]:];5WH;M\> 06(T7$S(K8YX/4A1>4TQ;:I0YWV]W!5OB8R!HQLS50 MHBB>W?J82"$QLT)@MA@L7\1PN8I9*./9(L5Q.'CN8R*[Q,QV\=+&438DE9A9 M*C!_%,]\3"25F%DJ?@8Y&D/DDY@[Z_!3R5$ZY).8V2BIGN%"=U)6?SZ;( M0NF)4IL!,^A"*;)0>LS4YF<(GXO?Q)+N7?:5CPEWXT^9Y8311!9*F2V$,8.> MCBR4,ELH3,;VM>[3(?FDS/(9I_NO3?J82#XILWP>)8TC46&VY\+TQIC]&YL@X^0G6V#Q8'Q,9)S_^.MM(]\F1;7)F MVP!$5^L^)C).SOZ^\>.W%L9#B:R3,UL'KEF&71Q9)^>V#L0,NCA\XYC9.GAI M-5'NGU+Y86LBH45[H^[ MTRQ*4O<6Y:JOJO=4]LE<-[+<_UYJ_UNO-_\"4$L#!!0 ( ,"(5E8T3CM] M>@( Q : >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'/-VDUNHT 0 MAN&K6!P@N*NJJ\@HSFHVV8YR >2T?Q3;6,!HDMN/Y2SL#\UB-A'?"C6(XEV@ M1PAX^E4.[;CO3L-N?QX6'\?#:5A5NW$\_ZCK8;TKQW9XZ,[E=#FRZ?IC.UZ6 M_;8^M^OW=EMJ62Z][N]G5,]/]S,7KY_G\C\3N\UFORX_N_7O8SF-_QA<_^GZ M]V%7RE@M7MM^6\9557\<;KN'^KI)#Y?)U>+E;57U+V^IJN<.$@B2^8,4@G3^ M((,@FS\H0U">/\@AR.) MP.N$8"<"L1.2G0C,3HAV(E [(=N)P.V$<"<"N1/2G0CL3HAW(M!;4&\AT%M0 M;R'06R8/VP1Z"^HM!'H+ZBT$>@OJ+01Z"^HM!'H+ZBT$>@OJ+01Z"^HM!'HK MZJT$>BOJK01Z*^JM!'KKY&4)@=Z*>BN!WHIZ*X'>BGHK@=Z*>BN!WHIZ*X'> MBGHK@=Z&>AN!WH9Z&X'>AGH;@=Z&>AN!WC9YV4V@MZ'>1J"WH=Y&H+>AWD:@ MMZ'>1J"WH=Y&H'=&O3.!WAGUS@1Z9]0[$^B=4>],H'=&O3.!WGGRL9) [XQZ M9P*],^J="?3.J']G4!O1[V=0&]'O9U ;T>]G4!O1[V=0&]' MO9U ;Y_\;$*@MZ/>3J"WH]Y.H+>CWDZ@=Z#>0:!WH-Y!H'>@WD&@=Z#>0:!W MH-Y!H'>@WD&@=Z#>0:!W3'X6)- [4.\@T#M0[R#0NT&]&P*]&]2[(="[0;T; M KT;U+OY3KV'\?-0AEO/UQJO_YU4CY=SR^WRU^77SLFM2,.\*U\_?TQ4%H=QV%*VVJ?<_C(6&KW-+I4^T!36=GY.+IY[E&=7/]F7;N?LBK+\?R<^K]M*TB#:E:?3IMG+.V ME0MAZ%N7RSI[F+H_4M9/"74YN>Q)^SZDJ[*A8J\FS"M_#W@Z]^V!8NP[6MVZ MF+^ZL>QBQX&E_#A0JL^7>*5'O]OU+76^O1_+D3J%2*Y+>Z(\#O6IZ-7YY%QN MF$Z?_.+\I23SZ74HA2CF_OPKOB26TA>_'\W3[JA[ M8W:YWI\^'I9Y)+8\+K_CWV?\4O^=?0B0/B1('PJD#PW2AP'IPX+TT8#T\0&D M#[Y!:01%5(Y"*DX K @ $0 @ &O 9&]C4')O<',O8V]R92YX;6Q0 M2P$"% ,4 " # B%96F5R<(Q & "<)P $P @ ', 0 M>&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0 ( ,"(5E8*O-.67 < *PP M 8 " @0T( !X;"]W;W)K&PO=V]R:W-H965T&UL4$L! A0#% @ P(A65L2[T8T M P )PL !@ ("!_Q8 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ P(A65A$]=^(W @ SP0 !@ M ("!_28 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0# M% @ P(A65@U:,QFA!P /!( !@ ("!TT8 'AL+W=O M&UL M4$L! A0#% @ P(A65FD?+_.Y @ C@8 !D ("!JE, M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ MP(A65G\]9=G% P ^ @ !D ("!O5P 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ P(A65K \C853 @ ;P4 !D M ("!"G, 'AL+W=O&PO=V]R:W-H M965T&UL4$L! M A0#% @ P(A65O:(S#]( P < < !D ("!"8 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ P(A6 M5G<#S0A< P O@< !D ("!BY 'AL+W=OE >&PO=V]R:W-H965T&UL4$L! A0#% @ P(A65NE8C5G @ ,@8 M !D ("!+ZH 'AL+W=O&PO=V]R:W-H965TQ8 '-$ 9 " @3RP !X;"]W;W)K&UL4$L! A0#% @ P(A65G9XW7 R P C0< !D M ("![L8 'AL+W=O!0 &0 @(%7R@ >&PO=V]R:W-H965T M&UL4$L! A0# M% @ P(A65OV9F#.X @ RP4 !D ("!M\\ 'AL+W=O M&PO=V]R:W-H965T&UL4$L! A0#% @ P(A65JRA MN;4O P LP< !D ("!B-@ 'AL+W=O&PO=V]R:W-H965T !X;"]W;W)K&UL4$L! A0#% @ P(A65GX+I DT! , H !D M ("!'>$ 'AL+W=O&PO M=V]R:W-H965T+H !X;"]W;W)K&UL4$L! A0#% @ P(A65IH\\P+J P 3@@ !D ("! MV>L 'AL+W=O&PO=V]R:W-H965TR@( *$& 9 M " @6SS !X;"]W;W)K&UL4$L! A0#% M @ P(A65J&;_NEW!0 B4 !D ("!;?8 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ P(A65JZ!9^7L @ *0P !D M ("!_! ! 'AL+W=O&PO=V]R M:W-H965T06 0!X;"]W;W)K&UL M4$L! A0#% @ P(A65O2 H@)\ @ J@8 !D ("!]1D! M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ MP(A65BM>45S0 @ +P@ !D ("!&24! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ P(A65GF% G'. @ )PD !D M ("!HS8! 'AL+W=O&PO=V]R:W-H M965T&UL4$L! M A0#% @ P(A65NS^-FHN P M@T !D ("!23\! 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ P(A6 M5B[C37:Z P 6 T !D ("!;$D! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ P(A65G0;I&(.!0 AR$ M !D ("!T%,! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ P(A65B>8,K"O!P +#L !D M ("!$V0! 'AL+W=O&PO=V]R:W-H965T MX ( $L+ 9 M " @39Q 0!X;"]W;W)K&UL4$L! A0# M% @ P(A65BK;V:]3! "!@ !D ("!370! 'AL+W=O M $ >&PO=V]R:W-H965T&UL4$L! A0#% @ P(A65KJO M-3$) @ OP0 !D ("!!X(! 'AL+W=O&PO&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 " # MB%96(' .V20" "I+P $P @ %,D0$ 6T-O;G1E;G1?5'EP =97-=+GAM;%!+!08 6P!; /08 "ADP$ ! end XML 98 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 99 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 100 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 235 312 1 true 80 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://ruger.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets Sheet http://ruger.com/role/ConsolidatedBalanceSheet Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://ruger.com/role/ConsolidatedBalanceSheet_Parentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Income and Comprehensive Income Sheet http://ruger.com/role/ConsolidatedIncomeStatement Consolidated Statements of Income and Comprehensive Income Statements 4 false false R5.htm 004 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://ruger.com/role/ShareholdersEquityType2or3 Consolidated Statements of Stockholders' Equity Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Stockholders' Equity (Parentheticals) Sheet http://ruger.com/role/ShareholdersEquityType2or3_Parentheticals Consolidated Statements of Stockholders' Equity (Parentheticals) Statements 6 false false R7.htm 006 - Statement - Consolidated Statements of Cash Flows Sheet http://ruger.com/role/ConsolidatedCashFlow Consolidated Statements of Cash Flows Statements 7 false false R8.htm 007 - Disclosure - Summary of Significant Accounting Policies Sheet http://ruger.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 008 - Disclosure - Acquisition of Marlin Assets Sheet http://ruger.com/role/AcquisitionofMarlinAssets Acquisition of Marlin Assets Notes 9 false false R10.htm 009 - Disclosure - Revenue Recognition and Contracts with Customers Sheet http://ruger.com/role/RevenueRecognitionandContractswithCustomers Revenue Recognition and Contracts with Customers Notes 10 false false R11.htm 010 - Disclosure - Trade Receivables, Net Sheet http://ruger.com/role/TradeReceivablesNet Trade Receivables, Net Notes 11 false false R12.htm 011 - Disclosure - Inventories Sheet http://ruger.com/role/Inventories Inventories Notes 12 false false R13.htm 012 - Disclosure - Property, Plant and Equipment Sheet http://ruger.com/role/PropertyPlantandEquipment Property, Plant and Equipment Notes 13 false false R14.htm 013 - Disclosure - Other Assets Sheet http://ruger.com/role/OtherAssets Other Assets Notes 14 false false R15.htm 014 - Disclosure - Leased Assets Sheet http://ruger.com/role/LeasedAssets Leased Assets Notes 15 false false R16.htm 015 - Disclosure - Trade Accounts Payable and Accrued Expenses Sheet http://ruger.com/role/TradeAccountsPayableandAccruedExpenses Trade Accounts Payable and Accrued Expenses Notes 16 false false R17.htm 016 - Disclosure - Accrued Dividends Sheet http://ruger.com/role/AccruedDividends Accrued Dividends Notes 17 false false R18.htm 017 - Disclosure - Line of Credit Sheet http://ruger.com/role/LineofCredit Line of Credit Notes 18 false false R19.htm 018 - Disclosure - Employee Benefit Plans Sheet http://ruger.com/role/EmployeeBenefitPlans Employee Benefit Plans Notes 19 false false R20.htm 019 - Disclosure - Other Operating Income, Net Sheet http://ruger.com/role/OtherOperatingIncomeNet Other Operating Income, Net Notes 20 false false R21.htm 020 - Disclosure - Income Taxes Sheet http://ruger.com/role/IncomeTaxes Income Taxes Notes 21 false false R22.htm 021 - Disclosure - Earnings Per Share Sheet http://ruger.com/role/EarningsPerShare Earnings Per Share Notes 22 false false R23.htm 022 - Disclosure - Stock Repurchases Sheet http://ruger.com/role/StockRepurchases Stock Repurchases Notes 23 false false R24.htm 023 - Disclosure - Compensation Plans Sheet http://ruger.com/role/CompensationPlans Compensation Plans Notes 24 false false R25.htm 024 - Disclosure - Operating Segment Information Sheet http://ruger.com/role/OperatingSegmentInformation Operating Segment Information Notes 25 false false R26.htm 025 - Disclosure - Quarterly Results of Operations (Unaudited) Sheet http://ruger.com/role/QuarterlyResultsofOperationsUnaudited Quarterly Results of Operations (Unaudited) Notes 26 false false R27.htm 026 - Disclosure - Related Party Transactions Sheet http://ruger.com/role/RelatedPartyTransactions Related Party Transactions Notes 27 false false R28.htm 027 - Disclosure - Contingent Liabilities Sheet http://ruger.com/role/ContingentLiabilities Contingent Liabilities Notes 28 false false R29.htm 028 - Disclosure - Financial Instruments Sheet http://ruger.com/role/FinancialInstruments Financial Instruments Notes 29 false false R30.htm 029 - Disclosure - Subsequent Events Sheet http://ruger.com/role/SubsequentEvents Subsequent Events Notes 30 false false R31.htm 030 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://ruger.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies http://ruger.com/role/SummaryofSignificantAccountingPolicies 31 false false R32.htm 031 - Disclosure - Acquisition of Marlin Assets (Tables) Sheet http://ruger.com/role/AcquisitionofMarlinAssetsTables Acquisition of Marlin Assets (Tables) Tables http://ruger.com/role/AcquisitionofMarlinAssets 32 false false R33.htm 032 - Disclosure - Revenue Recognition and Contracts with Customers (Tables) Sheet http://ruger.com/role/RevenueRecognitionandContractswithCustomersTables Revenue Recognition and Contracts with Customers (Tables) Tables http://ruger.com/role/RevenueRecognitionandContractswithCustomers 33 false false R34.htm 033 - Disclosure - Trade Receivables, Net (Tables) Sheet http://ruger.com/role/TradeReceivablesNetTables Trade Receivables, Net (Tables) Tables http://ruger.com/role/TradeReceivablesNet 34 false false R35.htm 034 - Disclosure - Inventories (Tables) Sheet http://ruger.com/role/InventoriesTables Inventories (Tables) Tables http://ruger.com/role/Inventories 35 false false R36.htm 035 - Disclosure - Property, Plant and Equipment (Tables) Sheet http://ruger.com/role/PropertyPlantandEquipmentTables Property, Plant and Equipment (Tables) Tables http://ruger.com/role/PropertyPlantandEquipment 36 false false R37.htm 036 - Disclosure - Other Assets (Tables) Sheet http://ruger.com/role/OtherAssetsTables Other Assets (Tables) Tables http://ruger.com/role/OtherAssets 37 false false R38.htm 037 - Disclosure - Leased Assets (Tables) Sheet http://ruger.com/role/LeasedAssetsTables Leased Assets (Tables) Tables http://ruger.com/role/LeasedAssets 38 false false R39.htm 038 - Disclosure - Trade Accounts Payable and Accrued Expenses (Tables) Sheet http://ruger.com/role/TradeAccountsPayableandAccruedExpensesTables Trade Accounts Payable and Accrued Expenses (Tables) Tables http://ruger.com/role/TradeAccountsPayableandAccruedExpenses 39 false false R40.htm 039 - Disclosure - Other Operating Income, Net (Tables) Sheet http://ruger.com/role/OtherOperatingIncomeNetTables Other Operating Income, Net (Tables) Tables http://ruger.com/role/OtherOperatingIncomeNet 40 false false R41.htm 040 - Disclosure - Income Taxes (Tables) Sheet http://ruger.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://ruger.com/role/IncomeTaxes 41 false false R42.htm 041 - Disclosure - Earnings Per Share (Tables) Sheet http://ruger.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://ruger.com/role/EarningsPerShare 42 false false R43.htm 042 - Disclosure - Stock Repurchases (Tables) Sheet http://ruger.com/role/StockRepurchasesTables Stock Repurchases (Tables) Tables http://ruger.com/role/StockRepurchases 43 false false R44.htm 043 - Disclosure - Operating Segment Information (Tables) Sheet http://ruger.com/role/OperatingSegmentInformationTables Operating Segment Information (Tables) Tables http://ruger.com/role/OperatingSegmentInformation 44 false false R45.htm 044 - Disclosure - Quarterly Results of Operations (Unaudited) (Tables) Sheet http://ruger.com/role/QuarterlyResultsofOperationsUnauditedTables Quarterly Results of Operations (Unaudited) (Tables) Tables http://ruger.com/role/QuarterlyResultsofOperationsUnaudited 45 false false R46.htm 045 - Disclosure - Contingent Liabilities (Tables) Sheet http://ruger.com/role/ContingentLiabilitiesTables Contingent Liabilities (Tables) Tables http://ruger.com/role/ContingentLiabilities 46 false false R47.htm 046 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details 47 false false R48.htm 047 - Disclosure - Acquisition of Marlin Assets (Details) Sheet http://ruger.com/role/AcquisitionofMarlinAssetsDetails Acquisition of Marlin Assets (Details) Details http://ruger.com/role/AcquisitionofMarlinAssetsTables 48 false false R49.htm 048 - Disclosure - Acquisition of Marlin Assets (Details) - Schedule of allocation of purchase price consideration Sheet http://ruger.com/role/ScheduleofallocationofpurchasepriceconsiderationTable Acquisition of Marlin Assets (Details) - Schedule of allocation of purchase price consideration Details http://ruger.com/role/AcquisitionofMarlinAssetsTables 49 false false R50.htm 049 - Disclosure - Acquisition of Marlin Assets (Details) - Schedule of estimated remaining useful lives Sheet http://ruger.com/role/ScheduleofestimatedremainingusefullivesTable Acquisition of Marlin Assets (Details) - Schedule of estimated remaining useful lives Details http://ruger.com/role/AcquisitionofMarlinAssetsTables 50 false false R51.htm 050 - Disclosure - Revenue Recognition and Contracts with Customers (Details) Sheet http://ruger.com/role/RevenueRecognitionandContractswithCustomersDetails Revenue Recognition and Contracts with Customers (Details) Details http://ruger.com/role/RevenueRecognitionandContractswithCustomersTables 51 false false R52.htm 051 - Disclosure - Revenue Recognition and Contracts with Customers (Details) - Schedule of revenue recognized Sheet http://ruger.com/role/ScheduleofrevenuerecognizedTable Revenue Recognition and Contracts with Customers (Details) - Schedule of revenue recognized Details http://ruger.com/role/RevenueRecognitionandContractswithCustomersTables 52 false false R53.htm 052 - Disclosure - Trade Receivables, Net (Details) Sheet http://ruger.com/role/TradeReceivablesNetDetails Trade Receivables, Net (Details) Details http://ruger.com/role/TradeReceivablesNetTables 53 false false R54.htm 053 - Disclosure - Trade Receivables, Net (Details) - Schedule of trade receivables Sheet http://ruger.com/role/ScheduleoftradereceivablesTable Trade Receivables, Net (Details) - Schedule of trade receivables Details http://ruger.com/role/TradeReceivablesNetTables 54 false false R55.htm 054 - Disclosure - Inventories (Details) - Schedule of inventories Sheet http://ruger.com/role/ScheduleofinventoriesTable Inventories (Details) - Schedule of inventories Details http://ruger.com/role/InventoriesTables 55 false false R56.htm 055 - Disclosure - Property, Plant and Equipment (Details) Sheet http://ruger.com/role/PropertyPlantandEquipmentDetails Property, Plant and Equipment (Details) Details http://ruger.com/role/PropertyPlantandEquipmentTables 56 false false R57.htm 056 - Disclosure - Property, Plant and Equipment (Details) - Schedule of property, plant and equipment Sheet http://ruger.com/role/ScheduleofpropertyplantandequipmentTable Property, Plant and Equipment (Details) - Schedule of property, plant and equipment Details http://ruger.com/role/PropertyPlantandEquipmentTables 57 false false R58.htm 057 - Disclosure - Other Assets (Details) Sheet http://ruger.com/role/OtherAssetsDetails Other Assets (Details) Details http://ruger.com/role/OtherAssetsTables 58 false false R59.htm 058 - Disclosure - Other Assets (Details) - Schedule of Other Assets Sheet http://ruger.com/role/ScheduleofOtherAssetsTable Other Assets (Details) - Schedule of Other Assets Details http://ruger.com/role/OtherAssetsTables 59 false false R60.htm 059 - Disclosure - Leased Assets (Details) Sheet http://ruger.com/role/LeasedAssetsDetails Leased Assets (Details) Details http://ruger.com/role/LeasedAssetsTables 60 false false R61.htm 060 - Disclosure - Leased Assets (Details) - Schedule of right-of-use assets and related lease liabilities Sheet http://ruger.com/role/ScheduleofrightofuseassetsandrelatedleaseliabilitiesTable Leased Assets (Details) - Schedule of right-of-use assets and related lease liabilities Details http://ruger.com/role/LeasedAssetsTables 61 false false R62.htm 061 - Disclosure - Leased Assets (Details) - Schedule of operating lease liabilities Sheet http://ruger.com/role/ScheduleofoperatingleaseliabilitiesTable Leased Assets (Details) - Schedule of operating lease liabilities Details http://ruger.com/role/LeasedAssetsTables 62 false false R63.htm 062 - Disclosure - Trade Accounts Payable and Accrued Expenses (Details) - Schedule of trade accounts payable and accrued expenses Sheet http://ruger.com/role/ScheduleoftradeaccountspayableandaccruedexpensesTable Trade Accounts Payable and Accrued Expenses (Details) - Schedule of trade accounts payable and accrued expenses Details http://ruger.com/role/TradeAccountsPayableandAccruedExpensesTables 63 false false R64.htm 063 - Disclosure - Accrued Dividends (Details) Sheet http://ruger.com/role/AccruedDividendsDetails Accrued Dividends (Details) Details http://ruger.com/role/AccruedDividends 64 false false R65.htm 064 - Disclosure - Line of Credit (Details) Sheet http://ruger.com/role/LineofCreditDetails Line of Credit (Details) Details http://ruger.com/role/LineofCredit 65 false false R66.htm 065 - Disclosure - Employee Benefit Plans (Details) Sheet http://ruger.com/role/EmployeeBenefitPlansDetails Employee Benefit Plans (Details) Details http://ruger.com/role/EmployeeBenefitPlans 66 false false R67.htm 066 - Disclosure - Other Operating Income, Net (Details) - Schedule of other operating income, net Sheet http://ruger.com/role/ScheduleofotheroperatingincomenetTable Other Operating Income, Net (Details) - Schedule of other operating income, net Details http://ruger.com/role/OtherOperatingIncomeNetTables 67 false false R68.htm 067 - Disclosure - Income Taxes (Details) Sheet http://ruger.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://ruger.com/role/IncomeTaxesTables 68 false false R69.htm 068 - Disclosure - Income Taxes (Details) - Schedule of federal and state income tax provision Sheet http://ruger.com/role/ScheduleoffederalandstateincometaxprovisionTable Income Taxes (Details) - Schedule of federal and state income tax provision Details http://ruger.com/role/IncomeTaxesTables 69 false false R70.htm 069 - Disclosure - Income Taxes (Details) - Schedule of effective income tax rate reconciliation Sheet http://ruger.com/role/ScheduleofeffectiveincometaxratereconciliationTable Income Taxes (Details) - Schedule of effective income tax rate reconciliation Details http://ruger.com/role/IncomeTaxesTables 70 false false R71.htm 070 - Disclosure - Income Taxes (Details) - Schedule of deferred tax assets and liabilities Sheet http://ruger.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable Income Taxes (Details) - Schedule of deferred tax assets and liabilities Details http://ruger.com/role/IncomeTaxesTables 71 false false R72.htm 071 - Disclosure - Earnings Per Share (Details) - Schedule of a reconciliation of the numerator and denominator for the basic and diluted earnings per share Sheet http://ruger.com/role/ScheduleofareconciliationofthenumeratoranddenominatorforthebasicanddilutedearningspershareTable Earnings Per Share (Details) - Schedule of a reconciliation of the numerator and denominator for the basic and diluted earnings per share Details http://ruger.com/role/EarningsPerShareTables 72 false false R73.htm 072 - Disclosure - Stock Repurchases (Details) Sheet http://ruger.com/role/StockRepurchasesDetails Stock Repurchases (Details) Details http://ruger.com/role/StockRepurchasesTables 73 false false R74.htm 073 - Disclosure - Stock Repurchases (Details) - Schedule of repurchased shares of its common stock Sheet http://ruger.com/role/ScheduleofrepurchasedsharesofitscommonstockTable Stock Repurchases (Details) - Schedule of repurchased shares of its common stock Details http://ruger.com/role/StockRepurchasesTables 74 false false R75.htm 074 - Disclosure - Compensation Plans (Details) Sheet http://ruger.com/role/CompensationPlansDetails Compensation Plans (Details) Details http://ruger.com/role/CompensationPlans 75 false false R76.htm 075 - Disclosure - Operating Segment Information (Details) Sheet http://ruger.com/role/OperatingSegmentInformationDetails Operating Segment Information (Details) Details http://ruger.com/role/OperatingSegmentInformationTables 76 false false R77.htm 076 - Disclosure - Operating Segment Information (Details) - Schedule of operating segment financial information Sheet http://ruger.com/role/ScheduleofoperatingsegmentfinancialinformationTable Operating Segment Information (Details) - Schedule of operating segment financial information Details http://ruger.com/role/OperatingSegmentInformationTables 77 false false R78.htm 077 - Disclosure - Quarterly Results of Operations (Unaudited) (Details) - Schedule of quarterly financial information Sheet http://ruger.com/role/ScheduleofquarterlyfinancialinformationTable Quarterly Results of Operations (Unaudited) (Details) - Schedule of quarterly financial information Details http://ruger.com/role/QuarterlyResultsofOperationsUnauditedTables 78 false false R79.htm 078 - Disclosure - Related Party Transactions (Details) Sheet http://ruger.com/role/RelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://ruger.com/role/RelatedPartyTransactions 79 false false R80.htm 079 - Disclosure - Contingent Liabilities (Details) Sheet http://ruger.com/role/ContingentLiabilitiesDetails Contingent Liabilities (Details) Details http://ruger.com/role/ContingentLiabilitiesTables 80 false false R81.htm 080 - Disclosure - Contingent Liabilities (Details) - Schedule of roll-forward for product liability reserve Sheet http://ruger.com/role/ScheduleofrollforwardforproductliabilityreserveTable Contingent Liabilities (Details) - Schedule of roll-forward for product liability reserve Details http://ruger.com/role/ContingentLiabilitiesTables 81 false false R82.htm 081 - Disclosure - Contingent Liabilities (Details) - Schedule of product liability expense Sheet http://ruger.com/role/ScheduleofproductliabilityexpenseTable Contingent Liabilities (Details) - Schedule of product liability expense Details http://ruger.com/role/ContingentLiabilitiesTables 82 false false R83.htm 082 - Disclosure - Subsequent Events (Details) Sheet http://ruger.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://ruger.com/role/SubsequentEvents 83 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 11 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName, us-gaap:CommonStockParOrStatedValuePerShare, us-gaap:CommonStockSharesAuthorized, us-gaap:CommonStockSharesIssued, us-gaap:CommonStockSharesOutstanding, us-gaap:TreasuryStockShares - rgr-20221231.htm 9006, 9018, 9019, 9020, 9021, 9022, 9023, 9024, 9025, 9026, 9027 rgr-20221231.htm ex23-1.htm ex31-1.htm ex31-2.htm ex32-1.htm ex32-2.htm rgr-20221231.xsd rgr-20221231_cal.xml rgr-20221231_def.xml rgr-20221231_lab.xml rgr-20221231_pre.xml image_003.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 103 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "rgr-20221231.htm": { "axisCustom": 1, "axisStandard": 23, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 775, "http://xbrl.sec.gov/dei/2022": 36 }, "contextCount": 235, "dts": { "calculationLink": { "local": [ "rgr-20221231_cal.xml" ] }, "definitionLink": { "local": [ "rgr-20221231_def.xml" ] }, "inline": { "local": [ "rgr-20221231.htm" ] }, "labelLink": { "local": [ "rgr-20221231_lab.xml" ] }, "presentationLink": { "local": [ "rgr-20221231_pre.xml" ] }, "schema": { "local": [ "rgr-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd" ] } }, "elementCount": 608, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 42, "http://ruger.com/20221231": 13, "http://xbrl.sec.gov/dei/2022": 8, "total": 63 }, "keyCustom": 34, "keyStandard": 278, "memberCustom": 45, "memberStandard": 31, "nsprefix": "rgr", "nsuri": "http://ruger.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:TradingSymbol", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "menuCat": "Cover", "order": "1", "role": "http://ruger.com/role/DocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:TradingSymbol", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "009 - Disclosure - Revenue Recognition and Contracts with Customers", "menuCat": "Notes", "order": "10", "role": "http://ruger.com/role/RevenueRecognitionandContractswithCustomers", "shortName": "Revenue Recognition and Contracts with Customers", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010 - Disclosure - Trade Receivables, Net", "menuCat": "Notes", "order": "11", "role": "http://ruger.com/role/TradeReceivablesNet", "shortName": "Trade Receivables, Net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011 - Disclosure - Inventories", "menuCat": "Notes", "order": "12", "role": "http://ruger.com/role/Inventories", "shortName": "Inventories", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012 - Disclosure - Property, Plant and Equipment", "menuCat": "Notes", "order": "13", "role": "http://ruger.com/role/PropertyPlantandEquipment", "shortName": "Property, Plant and Equipment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "013 - Disclosure - Other Assets", "menuCat": "Notes", "order": "14", "role": "http://ruger.com/role/OtherAssets", "shortName": "Other Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "014 - Disclosure - Leased Assets", "menuCat": "Notes", "order": "15", "role": "http://ruger.com/role/LeasedAssets", "shortName": "Leased Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "015 - Disclosure - Trade Accounts Payable and Accrued Expenses", "menuCat": "Notes", "order": "16", "role": "http://ruger.com/role/TradeAccountsPayableandAccruedExpenses", "shortName": "Trade Accounts Payable and Accrued Expenses", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "016 - Disclosure - Accrued Dividends", "menuCat": "Notes", "order": "17", "role": "http://ruger.com/role/AccruedDividends", "shortName": "Accrued Dividends", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "rgr:LineOfCreditFacilitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "017 - Disclosure - Line of Credit", "menuCat": "Notes", "order": "18", "role": "http://ruger.com/role/LineofCredit", "shortName": "Line of Credit", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "rgr:LineOfCreditFacilitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "018 - Disclosure - Employee Benefit Plans", "menuCat": "Notes", "order": "19", "role": "http://ruger.com/role/EmployeeBenefitPlans", "shortName": "Employee Benefit Plans", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "001 - Statement - Consolidated Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://ruger.com/role/ConsolidatedBalanceSheet", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "019 - Disclosure - Other Operating Income, Net", "menuCat": "Notes", "order": "20", "role": "http://ruger.com/role/OtherOperatingIncomeNet", "shortName": "Other Operating Income, Net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "020 - Disclosure - Income Taxes", "menuCat": "Notes", "order": "21", "role": "http://ruger.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "021 - Disclosure - Earnings Per Share", "menuCat": "Notes", "order": "22", "role": "http://ruger.com/role/EarningsPerShare", "shortName": "Earnings Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "rgr:StockRepurchasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "022 - Disclosure - Stock Repurchases", "menuCat": "Notes", "order": "23", "role": "http://ruger.com/role/StockRepurchases", "shortName": "Stock Repurchases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "rgr:StockRepurchasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "023 - Disclosure - Compensation Plans", "menuCat": "Notes", "order": "24", "role": "http://ruger.com/role/CompensationPlans", "shortName": "Compensation Plans", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "024 - Disclosure - Operating Segment Information", "menuCat": "Notes", "order": "25", "role": "http://ruger.com/role/OperatingSegmentInformation", "shortName": "Operating Segment Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:QuarterlyFinancialInformationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "025 - Disclosure - Quarterly Results of Operations (Unaudited)", "menuCat": "Notes", "order": "26", "role": "http://ruger.com/role/QuarterlyResultsofOperationsUnaudited", "shortName": "Quarterly Results of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:QuarterlyFinancialInformationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "026 - Disclosure - Related Party Transactions", "menuCat": "Notes", "order": "27", "role": "http://ruger.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "027 - Disclosure - Contingent Liabilities", "menuCat": "Notes", "order": "28", "role": "http://ruger.com/role/ContingentLiabilities", "shortName": "Contingent Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "028 - Disclosure - Financial Instruments", "menuCat": "Notes", "order": "29", "role": "http://ruger.com/role/FinancialInstruments", "shortName": "Financial Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c4", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:TreasuryStockShares", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "002 - Statement - Consolidated Balance Sheets (Parentheticals)", "menuCat": "Statements", "order": "3", "role": "http://ruger.com/role/ConsolidatedBalanceSheet_Parentheticals", "shortName": "Consolidated Balance Sheets (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c4", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:TreasuryStockShares", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "029 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "30", "role": "http://ruger.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "rgr:OrganizationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030 - Disclosure - Accounting Policies, by Policy (Policies)", "menuCat": "Policies", "order": "31", "role": "http://ruger.com/role/AccountingPoliciesByPolicy", "shortName": "Accounting Policies, by Policy (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "rgr:OrganizationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031 - Disclosure - Acquisition of Marlin Assets (Tables)", "menuCat": "Tables", "order": "32", "role": "http://ruger.com/role/AcquisitionofMarlinAssetsTables", "shortName": "Acquisition of Marlin Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "rgr:RevenueRecognitionMultipledeliverableArrangementsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "032 - Disclosure - Revenue Recognition and Contracts with Customers (Tables)", "menuCat": "Tables", "order": "33", "role": "http://ruger.com/role/RevenueRecognitionandContractswithCustomersTables", "shortName": "Revenue Recognition and Contracts with Customers (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "rgr:RevenueRecognitionMultipledeliverableArrangementsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "033 - Disclosure - Trade Receivables, Net (Tables)", "menuCat": "Tables", "order": "34", "role": "http://ruger.com/role/TradeReceivablesNetTables", "shortName": "Trade Receivables, Net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "034 - Disclosure - Inventories (Tables)", "menuCat": "Tables", "order": "35", "role": "http://ruger.com/role/InventoriesTables", "shortName": "Inventories (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "035 - Disclosure - Property, Plant and Equipment (Tables)", "menuCat": "Tables", "order": "36", "role": "http://ruger.com/role/PropertyPlantandEquipmentTables", "shortName": "Property, Plant and Equipment (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "036 - Disclosure - Other Assets (Tables)", "menuCat": "Tables", "order": "37", "role": "http://ruger.com/role/OtherAssetsTables", "shortName": "Other Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfOtherAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "rgr:ScheduleOfFutureMinimumLeasePaymentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "037 - Disclosure - Leased Assets (Tables)", "menuCat": "Tables", "order": "38", "role": "http://ruger.com/role/LeasedAssetsTables", "shortName": "Leased Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "rgr:ScheduleOfFutureMinimumLeasePaymentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "038 - Disclosure - Trade Accounts Payable and Accrued Expenses (Tables)", "menuCat": "Tables", "order": "39", "role": "http://ruger.com/role/TradeAccountsPayableandAccruedExpensesTables", "shortName": "Trade Accounts Payable and Accrued Expenses (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "003 - Statement - Consolidated Statements of Income and Comprehensive Income", "menuCat": "Statements", "order": "4", "role": "http://ruger.com/role/ConsolidatedIncomeStatement", "shortName": "Consolidated Statements of Income and Comprehensive Income", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": "-3", "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "rgr:OtherIncomeAndExpensesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "039 - Disclosure - Other Operating Income, Net (Tables)", "menuCat": "Tables", "order": "40", "role": "http://ruger.com/role/OtherOperatingIncomeNetTables", "shortName": "Other Operating Income, Net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "rgr:OtherIncomeAndExpensesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FederalIncomeTaxNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040 - Disclosure - Income Taxes (Tables)", "menuCat": "Tables", "order": "41", "role": "http://ruger.com/role/IncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FederalIncomeTaxNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041 - Disclosure - Earnings Per Share (Tables)", "menuCat": "Tables", "order": "42", "role": "http://ruger.com/role/EarningsPerShareTables", "shortName": "Earnings Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042 - Disclosure - Stock Repurchases (Tables)", "menuCat": "Tables", "order": "43", "role": "http://ruger.com/role/StockRepurchasesTables", "shortName": "Stock Repurchases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "043 - Disclosure - Operating Segment Information (Tables)", "menuCat": "Tables", "order": "44", "role": "http://ruger.com/role/OperatingSegmentInformationTables", "shortName": "Operating Segment Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "044 - Disclosure - Quarterly Results of Operations (Unaudited) (Tables)", "menuCat": "Tables", "order": "45", "role": "http://ruger.com/role/QuarterlyResultsofOperationsUnauditedTables", "shortName": "Quarterly Results of Operations (Unaudited) (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "045 - Disclosure - Contingent Liabilities (Tables)", "menuCat": "Tables", "order": "46", "role": "http://ruger.com/role/ContingentLiabilitiesTables", "shortName": "Contingent Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationEffectOnEarningsPerShare", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "046 - Disclosure - Summary of Significant Accounting Policies (Details)", "menuCat": "Details", "order": "47", "role": "http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails", "shortName": "Summary of Significant Accounting Policies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationEffectOnEarningsPerShare", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c52", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DividendsCash", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "047 - Disclosure - Acquisition of Marlin Assets (Details)", "menuCat": "Details", "order": "48", "role": "http://ruger.com/role/AcquisitionofMarlinAssetsDetails", "shortName": "Acquisition of Marlin Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c52", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DividendsCash", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c57", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "048 - Disclosure - Acquisition of Marlin Assets (Details) - Schedule of allocation of purchase price consideration", "menuCat": "Details", "order": "49", "role": "http://ruger.com/role/ScheduleofallocationofpurchasepriceconsiderationTable", "shortName": "Acquisition of Marlin Assets (Details) - Schedule of allocation of purchase price consideration", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c57", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c17", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "004 - Statement - Consolidated Statements of Stockholders' Equity", "menuCat": "Statements", "order": "5", "role": "http://ruger.com/role/ShareholdersEquityType2or3", "shortName": "Consolidated Statements of Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c17", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c78", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "049 - Disclosure - Acquisition of Marlin Assets (Details) - Schedule of estimated remaining useful lives", "menuCat": "Details", "order": "50", "role": "http://ruger.com/role/ScheduleofestimatedremainingusefullivesTable", "shortName": "Acquisition of Marlin Assets (Details) - Schedule of estimated remaining useful lives", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c78", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DeferredRevenueAdditions", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "050 - Disclosure - Revenue Recognition and Contracts with Customers (Details)", "menuCat": "Details", "order": "51", "role": "http://ruger.com/role/RevenueRecognitionandContractswithCustomersDetails", "shortName": "Revenue Recognition and Contracts with Customers (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DeferredRevenueAdditions", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rgr:RevenueRecognitionMultipledeliverableArrangementsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c29", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerLiability", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "051 - Disclosure - Revenue Recognition and Contracts with Customers (Details) - Schedule of revenue recognized", "menuCat": "Details", "order": "52", "role": "http://ruger.com/role/ScheduleofrevenuerecognizedTable", "shortName": "Revenue Recognition and Contracts with Customers (Details) - Schedule of revenue recognized", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rgr:RevenueRecognitionMultipledeliverableArrangementsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c21", "decimals": "-3", "lang": null, "name": "us-gaap:ContractWithCustomerLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c82", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "052 - Disclosure - Trade Receivables, Net (Details)", "menuCat": "Details", "order": "53", "role": "http://ruger.com/role/TradeReceivablesNetDetails", "shortName": "Trade Receivables, Net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c82", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableGrossCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "053 - Disclosure - Trade Receivables, Net (Details) - Schedule of trade receivables", "menuCat": "Details", "order": "54", "role": "http://ruger.com/role/ScheduleoftradereceivablesTable", "shortName": "Trade Receivables, Net (Details) - Schedule of trade receivables", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableGrossCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "054 - Disclosure - Inventories (Details) - Schedule of inventories", "menuCat": "Details", "order": "55", "role": "http://ruger.com/role/ScheduleofinventoriesTable", "shortName": "Inventories (Details) - Schedule of inventories", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "055 - Disclosure - Property, Plant and Equipment (Details)", "menuCat": "Details", "order": "56", "role": "http://ruger.com/role/PropertyPlantandEquipmentDetails", "shortName": "Property, Plant and Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "056 - Disclosure - Property, Plant and Equipment (Details) - Schedule of property, plant and equipment", "menuCat": "Details", "order": "57", "role": "http://ruger.com/role/ScheduleofpropertyplantandequipmentTable", "shortName": "Property, Plant and Equipment (Details) - Schedule of property, plant and equipment", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c3", "decimals": "-3", "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentOtherNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "057 - Disclosure - Other Assets (Details)", "menuCat": "Details", "order": "58", "role": "http://ruger.com/role/OtherAssetsDetails", "shortName": "Other Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfOtherAssetsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedPatentsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "058 - Disclosure - Other Assets (Details) - Schedule of Other Assets", "menuCat": "Details", "order": "59", "role": "http://ruger.com/role/ScheduleofOtherAssetsTable", "shortName": "Other Assets (Details) - Schedule of Other Assets", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfOtherAssetsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedPatentsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockRepurchasedDuringPeriodShares", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "005 - Statement - Consolidated Statements of Stockholders' Equity (Parentheticals)", "menuCat": "Statements", "order": "6", "role": "http://ruger.com/role/ShareholdersEquityType2or3_Parentheticals", "shortName": "Consolidated Statements of Stockholders' Equity (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockRepurchasedDuringPeriodShares", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "059 - Disclosure - Leased Assets (Details)", "menuCat": "Details", "order": "60", "role": "http://ruger.com/role/LeasedAssetsDetails", "shortName": "Leased Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rgr:ScheduleOfFutureMinimumLeasePaymentsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c3", "decimals": "-3", "first": true, "lang": null, "name": "rgr:TotalOperatingLeaseLiabilitie", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060 - Disclosure - Leased Assets (Details) - Schedule of right-of-use assets and related lease liabilities", "menuCat": "Details", "order": "61", "role": "http://ruger.com/role/ScheduleofrightofuseassetsandrelatedleaseliabilitiesTable", "shortName": "Leased Assets (Details) - Schedule of right-of-use assets and related lease liabilities", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rgr:ScheduleOfFutureMinimumLeasePaymentsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c3", "decimals": "-3", "first": true, "lang": null, "name": "rgr:TotalOperatingLeaseLiabilitie", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c105", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "061 - Disclosure - Leased Assets (Details) - Schedule of operating lease liabilities", "menuCat": "Details", "order": "62", "role": "http://ruger.com/role/ScheduleofoperatingleaseliabilitiesTable", "shortName": "Leased Assets (Details) - Schedule of operating lease liabilities", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c105", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccountsPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "062 - Disclosure - Trade Accounts Payable and Accrued Expenses (Details) - Schedule of trade accounts payable and accrued expenses", "menuCat": "Details", "order": "63", "role": "http://ruger.com/role/ScheduleoftradeaccountspayableandaccruedexpensesTable", "shortName": "Trade Accounts Payable and Accrued Expenses (Details) - Schedule of trade accounts payable and accrued expenses", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c3", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccountsPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c106", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:DividendsPayableAmountPerShare", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "063 - Disclosure - Accrued Dividends (Details)", "menuCat": "Details", "order": "64", "role": "http://ruger.com/role/AccruedDividendsDetails", "shortName": "Accrued Dividends (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c106", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:DividendsPayableAmountPerShare", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c109", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "064 - Disclosure - Line of Credit (Details)", "menuCat": "Details", "order": "65", "role": "http://ruger.com/role/LineofCreditDetails", "shortName": "Line of Credit (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c109", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DefinedContributionPlanAdministrativeExpenses", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "065 - Disclosure - Employee Benefit Plans (Details)", "menuCat": "Details", "order": "66", "role": "http://ruger.com/role/EmployeeBenefitPlansDetails", "shortName": "Employee Benefit Plans (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DefinedContributionPlanAdministrativeExpenses", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "rgr:OtherIncomeAndExpensesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:GainLossOnSaleOfOtherAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "066 - Disclosure - Other Operating Income, Net (Details) - Schedule of other operating income, net", "menuCat": "Details", "order": "67", "role": "http://ruger.com/role/ScheduleofotheroperatingincomenetTable", "shortName": "Other Operating Income, Net (Details) - Schedule of other operating income, net", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "rgr:OtherIncomeAndExpensesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:GainLossOnSaleOfOtherAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "rgr:CapitalizedAndAmortizedOverForIncomeTaxPurposes", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "067 - Disclosure - Income Taxes (Details)", "menuCat": "Details", "order": "68", "role": "http://ruger.com/role/IncomeTaxesDetails", "shortName": "Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "rgr:CapitalizedAndAmortizedOverForIncomeTaxPurposes", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FederalIncomeTaxNoteTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "068 - Disclosure - Income Taxes (Details) - Schedule of federal and state income tax provision", "menuCat": "Details", "order": "69", "role": "http://ruger.com/role/ScheduleoffederalandstateincometaxprovisionTable", "shortName": "Income Taxes (Details) - Schedule of federal and state income tax provision", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FederalIncomeTaxNoteTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "006 - Statement - Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "7", "role": "http://ruger.com/role/ConsolidatedCashFlow", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": "-3", "lang": null, "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "069 - Disclosure - Income Taxes (Details) - Schedule of effective income tax rate reconciliation", "menuCat": "Details", "order": "70", "role": "http://ruger.com/role/ScheduleofeffectiveincometaxratereconciliationTable", "shortName": "Income Taxes (Details) - Schedule of effective income tax rate reconciliation", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c3", "decimals": "-3", "first": true, "lang": null, "name": "rgr:DeferredTaxAssetsProductLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "070 - Disclosure - Income Taxes (Details) - Schedule of deferred tax assets and liabilities", "menuCat": "Details", "order": "71", "role": "http://ruger.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable", "shortName": "Income Taxes (Details) - Schedule of deferred tax assets and liabilities", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c3", "decimals": "-3", "first": true, "lang": null, "name": "rgr:DeferredTaxAssetsProductLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:TemporaryEquityNetIncome", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "071 - Disclosure - Earnings Per Share (Details) - Schedule of a reconciliation of the numerator and denominator for the basic and diluted earnings per share", "menuCat": "Details", "order": "72", "role": "http://ruger.com/role/ScheduleofareconciliationofthenumeratoranddenominatorforthebasicanddilutedearningspershareTable", "shortName": "Earnings Per Share (Details) - Schedule of a reconciliation of the numerator and denominator for the basic and diluted earnings per share", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:TemporaryEquityNetIncome", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "072 - Disclosure - Stock Repurchases (Details)", "menuCat": "Details", "order": "73", "role": "http://ruger.com/role/StockRepurchasesDetails", "shortName": "Stock Repurchases (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c3", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c3", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:TreasuryStockCommonShares", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "073 - Disclosure - Stock Repurchases (Details) - Schedule of repurchased shares of its common stock", "menuCat": "Details", "order": "74", "role": "http://ruger.com/role/ScheduleofrepurchasedsharesofitscommonstockTable", "shortName": "Stock Repurchases (Details) - Schedule of repurchased shares of its common stock", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c3", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:TreasuryStockCommonShares", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "074 - Disclosure - Compensation Plans (Details)", "menuCat": "Details", "order": "75", "role": "http://ruger.com/role/CompensationPlansDetails", "shortName": "Compensation Plans (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "075 - Disclosure - Operating Segment Information (Details)", "menuCat": "Details", "order": "76", "role": "http://ruger.com/role/OperatingSegmentInformationDetails", "shortName": "Operating Segment Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c179", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "076 - Disclosure - Operating Segment Information (Details) - Schedule of operating segment financial information", "menuCat": "Details", "order": "77", "role": "http://ruger.com/role/ScheduleofoperatingsegmentfinancialinformationTable", "shortName": "Operating Segment Information (Details) - Schedule of operating segment financial information", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c179", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c200", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "077 - Disclosure - Quarterly Results of Operations (Unaudited) (Details) - Schedule of quarterly financial information", "menuCat": "Details", "order": "78", "role": "http://ruger.com/role/ScheduleofquarterlyfinancialinformationTable", "shortName": "Quarterly Results of Operations (Unaudited) (Details) - Schedule of quarterly financial information", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c200", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c207", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "078 - Disclosure - Related Party Transactions (Details)", "menuCat": "Details", "order": "79", "role": "http://ruger.com/role/RelatedPartyTransactionsDetails", "shortName": "Related Party Transactions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c207", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "007 - Disclosure - Summary of Significant Accounting Policies", "menuCat": "Notes", "order": "8", "role": "http://ruger.com/role/SummaryofSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": "-6", "first": true, "lang": null, "name": "rgr:ThresholdLimitOfLossesPerTransactionForTakingInsuranceCoverageOnAnnualBasis", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "079 - Disclosure - Contingent Liabilities (Details)", "menuCat": "Details", "order": "80", "role": "http://ruger.com/role/ContingentLiabilitiesDetails", "shortName": "Contingent Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": "-6", "first": true, "lang": null, "name": "rgr:ThresholdLimitOfLossesPerTransactionForTakingInsuranceCoverageOnAnnualBasis", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c222", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ValuationAllowancesAndReservesBalance", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "080 - Disclosure - Contingent Liabilities (Details) - Schedule of roll-forward for product liability reserve", "menuCat": "Details", "order": "81", "role": "http://ruger.com/role/ScheduleofrollforwardforproductliabilityreserveTable", "shortName": "Contingent Liabilities (Details) - Schedule of roll-forward for product liability reserve", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c218", "decimals": "-3", "lang": null, "name": "us-gaap:ValuationAllowancesAndReservesBalance", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ProductLiabilityContingenciesTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "081 - Disclosure - Contingent Liabilities (Details) - Schedule of product liability expense", "menuCat": "Details", "order": "82", "role": "http://ruger.com/role/ScheduleofproductliabilityexpenseTable", "shortName": "Contingent Liabilities (Details) - Schedule of product liability expense", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ProductLiabilityContingenciesTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c234", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DividendsPayableAmountPerShare", "reportCount": 1, "unitRef": "usdPershares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "082 - Disclosure - Subsequent Events (Details)", "menuCat": "Details", "order": "83", "role": "http://ruger.com/role/SubsequentEventsDetails", "shortName": "Subsequent Events (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R9": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AssetAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "008 - Disclosure - Acquisition of Marlin Assets", "menuCat": "Notes", "order": "9", "role": "http://ruger.com/role/AcquisitionofMarlinAssets", "shortName": "Acquisition of Marlin Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "rgr-20221231.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AssetAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 80, "tag": { "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "United States [Member]" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://ruger.com/role/OperatingSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r505", "r506", "r507" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID", "terseLabel": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r505", "r506", "r507" ], "lang": { "en-us": { "role": { "label": "Auditor Location", "terseLabel": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r505", "r506", "r507" ], "lang": { "en-us": { "role": { "label": "Auditor Name", "terseLabel": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r505", "r506", "r507" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r508" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r503" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r503" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r503" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r509" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float", "terseLabel": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r503" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r503" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r503" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r503" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "terseLabel": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r510" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer", "terseLabel": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r505", "r506", "r507" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag", "terseLabel": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r502" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r504" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://ruger.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "rgr_AccruedDividendsDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accrued Dividends (Details) [Line Items]" } } }, "localname": "AccruedDividendsDetailsLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/AccruedDividendsDetails" ], "xbrltype": "stringItemType" }, "rgr_AccruedDividendsDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accrued Dividends (Details) [Table]" } } }, "localname": "AccruedDividendsDetailsTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/AccruedDividendsDetails" ], "xbrltype": "stringItemType" }, "rgr_AccruedLegalExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accrued Legal Expense [Member]", "label": "Accrued Legal Expense Member", "terseLabel": "Accrued Legal Expense [Member]" } } }, "localname": "AccruedLegalExpenseMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofproductliabilityexpenseTable" ], "xbrltype": "domainItemType" }, "rgr_AcquisitionofMarlinAssetsDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquisition of Marlin Assets (Details) [Line Items]" } } }, "localname": "AcquisitionofMarlinAssetsDetailsLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/AcquisitionofMarlinAssetsDetails" ], "xbrltype": "stringItemType" }, "rgr_AcquisitionofMarlinAssetsDetailsScheduleofallocationofpurchasepriceconsiderationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquisition of Marlin Assets (Details) - Schedule of allocation of purchase price consideration [Line Items]" } } }, "localname": "AcquisitionofMarlinAssetsDetailsScheduleofallocationofpurchasepriceconsiderationLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofallocationofpurchasepriceconsiderationTable" ], "xbrltype": "stringItemType" }, "rgr_AcquisitionofMarlinAssetsDetailsScheduleofallocationofpurchasepriceconsiderationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquisition of Marlin Assets (Details) - Schedule of allocation of purchase price consideration [Table]" } } }, "localname": "AcquisitionofMarlinAssetsDetailsScheduleofallocationofpurchasepriceconsiderationTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofallocationofpurchasepriceconsiderationTable" ], "xbrltype": "stringItemType" }, "rgr_AcquisitionofMarlinAssetsDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquisition of Marlin Assets (Details) [Table]" } } }, "localname": "AcquisitionofMarlinAssetsDetailsTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/AcquisitionofMarlinAssetsDetails" ], "xbrltype": "stringItemType" }, "rgr_AcquisitionofMarlinAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquisition of Marlin Assets [Abstract]" } } }, "localname": "AcquisitionofMarlinAssetsLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/AcquisitionofMarlinAssets" ], "xbrltype": "stringItemType" }, "rgr_AcquisitionofMarlinAssetsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquisition of Marlin Assets [Table]" } } }, "localname": "AcquisitionofMarlinAssetsTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/AcquisitionofMarlinAssets" ], "xbrltype": "stringItemType" }, "rgr_AcquisitionofMarlinAssetsTablesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquisitionof Marlin Assets Tables Line Items", "terseLabel": "Acquisition of Marlin Assets [Abstract]" } } }, "localname": "AcquisitionofMarlinAssetsTablesLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/AcquisitionofMarlinAssetsTables" ], "xbrltype": "stringItemType" }, "rgr_AcquisitionofMarlinAssetsTablesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquisition of Marlin Assets (Tables) [Table]" } } }, "localname": "AcquisitionofMarlinAssetsTablesTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/AcquisitionofMarlinAssetsTables" ], "xbrltype": "stringItemType" }, "rgr_AllowanceForDiscountsAccountsReceivableCurrent": { "auth_ref": [], "calculation": { "http://ruger.com/role/ScheduleoftradereceivablesTable": { "order": 3.0, "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Allowance For Discounts Accounts Receivable Current", "label": "Allowance For Discounts Accounts Receivable Current", "negatedLabel": "Allowance for discounts" } } }, "localname": "AllowanceForDiscountsAccountsReceivableCurrent", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleoftradereceivablesTable" ], "xbrltype": "monetaryItemType" }, "rgr_AssetsAcquiredAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets Acquired Abstract", "terseLabel": "Assets Acquired" } } }, "localname": "AssetsAcquiredAbstract", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofallocationofpurchasepriceconsiderationTable" ], "xbrltype": "stringItemType" }, "rgr_August28ToOctober1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "August28 To October1 Member", "terseLabel": "August 28 to October 1 [Member]" } } }, "localname": "August28ToOctober1Member", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofrepurchasedsharesofitscommonstockTable" ], "xbrltype": "domainItemType" }, "rgr_CapitalExpendituresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Capital Expenditures Abstract", "terseLabel": "Capital Expenditures" } } }, "localname": "CapitalExpendituresAbstract", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofoperatingsegmentfinancialinformationTable" ], "xbrltype": "stringItemType" }, "rgr_CapitalizedAndAmortizedOverForIncomeTaxPurposes": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Capitalized and amortized over for income tax purposes.", "label": "Capitalized And Amortized Over For Income Tax Purposes", "terseLabel": "Capitalized and amortized over for income tax purposes" } } }, "localname": "CapitalizedAndAmortizedOverForIncomeTaxPurposes", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/IncomeTaxesDetails" ], "xbrltype": "durationItemType" }, "rgr_CastingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Castings Member", "terseLabel": "Castings [Member]" } } }, "localname": "CastingsMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofoperatingsegmentfinancialinformationTable" ], "xbrltype": "domainItemType" }, "rgr_CompensationPlansDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Compensation Plans (Details) [Line Items]" } } }, "localname": "CompensationPlansDetailsLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/CompensationPlansDetails" ], "xbrltype": "stringItemType" }, "rgr_CompensationPlansDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Compensation Plans (Details) [Table]" } } }, "localname": "CompensationPlansDetailsTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/CompensationPlansDetails" ], "xbrltype": "stringItemType" }, "rgr_CompensationPlansLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Compensation Plans [Abstract]" } } }, "localname": "CompensationPlansLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/CompensationPlans" ], "xbrltype": "stringItemType" }, "rgr_CompensationPlansTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Compensation Plans [Table]" } } }, "localname": "CompensationPlansTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/CompensationPlans" ], "xbrltype": "stringItemType" }, "rgr_ContingentLiabilitiesDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contingent Liabilities (Details) [Line Items]" } } }, "localname": "ContingentLiabilitiesDetailsLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ContingentLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "rgr_ContingentLiabilitiesDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contingent Liabilities (Details) [Table]" } } }, "localname": "ContingentLiabilitiesDetailsTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ContingentLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "rgr_ContingentLiabilitiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contingent Liabilities [Abstract]" } } }, "localname": "ContingentLiabilitiesLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ContingentLiabilities" ], "xbrltype": "stringItemType" }, "rgr_ContingentLiabilitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contingent Liabilities [Table]" } } }, "localname": "ContingentLiabilitiesTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ContingentLiabilities" ], "xbrltype": "stringItemType" }, "rgr_ContingentLiabilitiesTablesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contingent Liabilities Tables Line Items", "terseLabel": "Contingent Liabilities [Abstract]" } } }, "localname": "ContingentLiabilitiesTablesLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ContingentLiabilitiesTables" ], "xbrltype": "stringItemType" }, "rgr_ContingentLiabilitiesTablesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Contingent Liabilities (Tables) [Table]" } } }, "localname": "ContingentLiabilitiesTablesTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ContingentLiabilitiesTables" ], "xbrltype": "stringItemType" }, "rgr_ContractWithCustomerLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract With Customer Liabilities", "terseLabel": "Deferred contract revenue liability" } } }, "localname": "ContractWithCustomerLiabilities", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/RevenueRecognitionandContractswithCustomersDetails" ], "xbrltype": "monetaryItemType" }, "rgr_CustomerOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer One [Member]", "label": "Customer One Member", "terseLabel": "Customer One [Member]" } } }, "localname": "CustomerOneMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/TradeReceivablesNetDetails" ], "xbrltype": "domainItemType" }, "rgr_CustomerThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer Three [Member]", "label": "Customer Three Member", "terseLabel": "Customer Three [Member]" } } }, "localname": "CustomerThreeMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/TradeReceivablesNetDetails" ], "xbrltype": "domainItemType" }, "rgr_CustomerTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer Two [Member]", "label": "Customer Two Member", "terseLabel": "Customer Two [Member]" } } }, "localname": "CustomerTwoMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/TradeReceivablesNetDetails" ], "xbrltype": "domainItemType" }, "rgr_DavidsonsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Davidsons [Member]", "label": "Davidsons Member", "terseLabel": "Davidsons [Member]" } } }, "localname": "DavidsonsMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/OperatingSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "rgr_DeferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deferred Stock [Member]", "label": "Deferred Stock Member", "terseLabel": "Deferred Stock [Member]" } } }, "localname": "DeferredStockMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/CompensationPlansDetails" ], "xbrltype": "domainItemType" }, "rgr_DeferredTaxAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets Abstract", "terseLabel": "Deferred tax assets" } } }, "localname": "DeferredTaxAssetsAbstract", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable" ], "xbrltype": "stringItemType" }, "rgr_DeferredTaxAssetsProductLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets Product Liability", "label": "Deferred Tax Assets Product Liability", "terseLabel": "Product Liability" } } }, "localname": "DeferredTaxAssetsProductLiability", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "rgr_DividendsCommonStockUnpaid": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of dividends declared, but unpaid, during period.", "label": "Dividends Common Stock Unpaid", "negatedLabel": "Unpaid dividends accrued" } } }, "localname": "DividendsCommonStockUnpaid", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "rgr_DocumentAndEntityInformationAbstract": { "auth_ref": [], "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://ruger.com/20221231", "xbrltype": "stringItemType" }, "rgr_EarningsPerShareDetailsScheduleofareconciliationofthenumeratoranddenominatorforthebasicanddilutedearningspershareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share (Details) - Schedule of a reconciliation of the numerator and denominator for the basic and diluted earnings per share [Line Items]" } } }, "localname": "EarningsPerShareDetailsScheduleofareconciliationofthenumeratoranddenominatorforthebasicanddilutedearningspershareLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofareconciliationofthenumeratoranddenominatorforthebasicanddilutedearningspershareTable" ], "xbrltype": "stringItemType" }, "rgr_EarningsPerShareDetailsScheduleofareconciliationofthenumeratoranddenominatorforthebasicanddilutedearningspershareTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share (Details) - Schedule of a reconciliation of the numerator and denominator for the basic and diluted earnings per share [Table]" } } }, "localname": "EarningsPerShareDetailsScheduleofareconciliationofthenumeratoranddenominatorforthebasicanddilutedearningspershareTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofareconciliationofthenumeratoranddenominatorforthebasicanddilutedearningspershareTable" ], "xbrltype": "stringItemType" }, "rgr_EliminationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Eliminations Member", "terseLabel": "Eliminations [Member]" } } }, "localname": "EliminationsMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofoperatingsegmentfinancialinformationTable" ], "xbrltype": "domainItemType" }, "rgr_EmployeeBenefitPlansLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Employee Benefit Plans [Abstract]" } } }, "localname": "EmployeeBenefitPlansLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/EmployeeBenefitPlans" ], "xbrltype": "stringItemType" }, "rgr_EmployeeBenefitPlansTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Employee Benefit Plans [Table]" } } }, "localname": "EmployeeBenefitPlansTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/EmployeeBenefitPlans" ], "xbrltype": "stringItemType" }, "rgr_EmployeeCompensation": { "auth_ref": [], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Employee compensation.", "label": "Employee Compensation", "terseLabel": "Employee compensation" } } }, "localname": "EmployeeCompensation", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "rgr_ExcessAndObsolescenceInventoryReserve": { "auth_ref": [], "calculation": { "http://ruger.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of excess and obsolescence inventory reserve.", "label": "Excess And Obsolescence Inventory Reserve", "terseLabel": "Excess and obsolescence inventory reserve" } } }, "localname": "ExcessAndObsolescenceInventoryReserve", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "rgr_Fairvalueassets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Fairvalueassets", "terseLabel": "Excess purchase price of goodwill" } } }, "localname": "Fairvalueassets", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/AcquisitionofMarlinAssetsDetails" ], "xbrltype": "monetaryItemType" }, "rgr_FinalPurchasePriceAllocationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Final Purchase Price Allocation [Member]", "label": "Final Purchase Price Allocation Member", "terseLabel": "Final Purchase Price Allocation [Member]" } } }, "localname": "FinalPurchasePriceAllocationMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofallocationofpurchasepriceconsiderationTable" ], "xbrltype": "domainItemType" }, "rgr_FinancialInstrumentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial Instruments [Abstract]" } } }, "localname": "FinancialInstrumentsLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/FinancialInstruments" ], "xbrltype": "stringItemType" }, "rgr_FinancialInstrumentsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial Instruments [Table]" } } }, "localname": "FinancialInstrumentsTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/FinancialInstruments" ], "xbrltype": "stringItemType" }, "rgr_FirearmsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Firearms [Member]", "label": "Firearms Member", "terseLabel": "Net firearms sales", "verboseLabel": "Firearms [Member]" } } }, "localname": "FirearmsMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ConsolidatedIncomeStatement", "http://ruger.com/role/ScheduleofoperatingsegmentfinancialinformationTable", "http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "rgr_GoodwillAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill Abstract", "terseLabel": "Goodwill" } } }, "localname": "GoodwillAbstract", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofoperatingsegmentfinancialinformationTable" ], "xbrltype": "stringItemType" }, "rgr_GrossPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Gross Percentage", "terseLabel": "Sales and gross margin percentage" } } }, "localname": "GrossPercentage", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/AcquisitionofMarlinAssetsDetails" ], "xbrltype": "percentItemType" }, "rgr_IdentifiableAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Identifiable Assets Abstract", "terseLabel": "Identifiable Assets" } } }, "localname": "IdentifiableAssetsAbstract", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofoperatingsegmentfinancialinformationTable" ], "xbrltype": "stringItemType" }, "rgr_IncomeLossBeforeIncomeTaxesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Loss Before Income Taxes Abstract", "terseLabel": "Income (Loss) Before Income Taxes" } } }, "localname": "IncomeLossBeforeIncomeTaxesAbstract", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofoperatingsegmentfinancialinformationTable" ], "xbrltype": "stringItemType" }, "rgr_IncomeTaxesDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Taxes (Details) [Line Items]" } } }, "localname": "IncomeTaxesDetailsLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/IncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "rgr_IncomeTaxesDetailsScheduleofeffectiveincometaxratereconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of effective income tax rate reconciliation [Abstract]" } } }, "localname": "IncomeTaxesDetailsScheduleofeffectiveincometaxratereconciliationLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofeffectiveincometaxratereconciliationTable" ], "xbrltype": "stringItemType" }, "rgr_IncomeTaxesDetailsScheduleofeffectiveincometaxratereconciliationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Taxes (Details) - Schedule of effective income tax rate reconciliation [Table]" } } }, "localname": "IncomeTaxesDetailsScheduleofeffectiveincometaxratereconciliationTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofeffectiveincometaxratereconciliationTable" ], "xbrltype": "stringItemType" }, "rgr_IncomeTaxesDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Taxes (Details) [Table]" } } }, "localname": "IncomeTaxesDetailsTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/IncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "rgr_IncomeTaxesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Taxes [Abstract]" } } }, "localname": "IncomeTaxesLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/IncomeTaxes" ], "xbrltype": "stringItemType" }, "rgr_IncomeTaxesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Taxes [Table]" } } }, "localname": "IncomeTaxesTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/IncomeTaxes" ], "xbrltype": "stringItemType" }, "rgr_IncomeTaxesTablesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Taxes Tables Line Items", "terseLabel": "Income Taxes [Abstract]" } } }, "localname": "IncomeTaxesTablesLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/IncomeTaxesTables" ], "xbrltype": "stringItemType" }, "rgr_IncomeTaxesTablesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Taxes (Tables) [Table]" } } }, "localname": "IncomeTaxesTablesTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/IncomeTaxesTables" ], "xbrltype": "stringItemType" }, "rgr_IncreaseDecreaseInProductLiability": { "auth_ref": [], "calculation": { "http://ruger.com/role/ConsolidatedCashFlow": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The net change during the reporting period in the Product liability expense which includes the cost of outside legal fees, insurance, and other expenses incurred in the management and defense of product liability matters.", "label": "Increase Decrease In Product Liability", "terseLabel": "Product liability" } } }, "localname": "IncreaseDecreaseInProductLiability", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "rgr_InitialPurchasePriceAcquisitionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Initial Purchase Price Acquisition Member", "terseLabel": "Initial Purchase Price Acquisition [Member]" } } }, "localname": "InitialPurchasePriceAcquisitionMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/AcquisitionofMarlinAssetsDetails" ], "xbrltype": "domainItemType" }, "rgr_InitialPurchasePriceAllocationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Initial Purchase Price Allocation Member", "terseLabel": "Initial Purchase Price Allocation[Member]", "verboseLabel": "Initial Purchase Price Acquisition [Member]" } } }, "localname": "InitialPurchasePriceAllocationMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/AcquisitionofMarlinAssetsDetails", "http://ruger.com/role/ScheduleofallocationofpurchasepriceconsiderationTable" ], "xbrltype": "domainItemType" }, "rgr_IntersegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Intersegment Member", "terseLabel": "Intersegment [Member]" } } }, "localname": "IntersegmentMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofoperatingsegmentfinancialinformationTable" ], "xbrltype": "domainItemType" }, "rgr_InventoryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Member", "terseLabel": "Inventory [Member]" } } }, "localname": "InventoryMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofallocationofpurchasepriceconsiderationTable" ], "xbrltype": "domainItemType" }, "rgr_July31ToAugust27Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "July31 To August27 Member", "terseLabel": "July 31 to August 27 [Member]" } } }, "localname": "July31ToAugust27Member", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofrepurchasedsharesofitscommonstockTable" ], "xbrltype": "domainItemType" }, "rgr_July3ToJuly30Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "July3 To July30 Member", "terseLabel": "July 3 to July 30 [Member]" } } }, "localname": "July3ToJuly30Member", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofrepurchasedsharesofitscommonstockTable" ], "xbrltype": "domainItemType" }, "rgr_LeaseLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lease Liabilities Member", "terseLabel": "Lease liabilities [Member]" } } }, "localname": "LeaseLiabilitiesMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofrightofuseassetsandrelatedleaseliabilitiesTable" ], "xbrltype": "domainItemType" }, "rgr_LeasedAssetsDetailsScheduleofoperatingleaseliabilitiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leased Assets (Details) - Schedule of operating lease liabilities [Line Items]" } } }, "localname": "LeasedAssetsDetailsScheduleofoperatingleaseliabilitiesLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofoperatingleaseliabilitiesTable" ], "xbrltype": "stringItemType" }, "rgr_LeasedAssetsDetailsScheduleofoperatingleaseliabilitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leased Assets (Details) - Schedule of operating lease liabilities [Table]" } } }, "localname": "LeasedAssetsDetailsScheduleofoperatingleaseliabilitiesTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofoperatingleaseliabilitiesTable" ], "xbrltype": "stringItemType" }, "rgr_LeasedAssetsDetailsScheduleofrightofuseassetsandrelatedleaseliabilitiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leased Assets (Details) - Schedule of right-of-use assets and related lease liabilities [Line Items]" } } }, "localname": "LeasedAssetsDetailsScheduleofrightofuseassetsandrelatedleaseliabilitiesLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofrightofuseassetsandrelatedleaseliabilitiesTable" ], "xbrltype": "stringItemType" }, "rgr_LeasedAssetsDetailsScheduleofrightofuseassetsandrelatedleaseliabilitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leased Assets (Details) - Schedule of right-of-use assets and related lease liabilities [Table]" } } }, "localname": "LeasedAssetsDetailsScheduleofrightofuseassetsandrelatedleaseliabilitiesTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofrightofuseassetsandrelatedleaseliabilitiesTable" ], "xbrltype": "stringItemType" }, "rgr_LeasedAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leased Assets [Abstract]" } } }, "localname": "LeasedAssetsLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/LeasedAssets" ], "xbrltype": "stringItemType" }, "rgr_LeasedAssetsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leased Assets [Table]" } } }, "localname": "LeasedAssetsTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/LeasedAssets" ], "xbrltype": "stringItemType" }, "rgr_LeasedAssetsTablesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leased Assets Tables Line Items", "terseLabel": "Leased Assets [Abstract]" } } }, "localname": "LeasedAssetsTablesLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/LeasedAssetsTables" ], "xbrltype": "stringItemType" }, "rgr_LeasedAssetsTablesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leased Assets (Tables) [Table]" } } }, "localname": "LeasedAssetsTablesTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/LeasedAssetsTables" ], "xbrltype": "stringItemType" }, "rgr_LineOfCreditFacilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Line Of Credit Facilities Abstract" } } }, "localname": "LineOfCreditFacilitiesAbstract", "nsuri": "http://ruger.com/20221231", "xbrltype": "stringItemType" }, "rgr_LineOfCreditFacilitiesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Line Of Credit Facilities Text Block", "terseLabel": "Line of Credit" } } }, "localname": "LineOfCreditFacilitiesTextBlock", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/LineofCredit" ], "xbrltype": "textBlockItemType" }, "rgr_LineofCreditDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Line of Credit (Details) [Line Items]" } } }, "localname": "LineofCreditDetailsLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/LineofCreditDetails" ], "xbrltype": "stringItemType" }, "rgr_LineofCreditDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Line of Credit (Details) [Table]" } } }, "localname": "LineofCreditDetailsTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/LineofCreditDetails" ], "xbrltype": "stringItemType" }, "rgr_LineofCreditLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Line of Credit [Abstract]" } } }, "localname": "LineofCreditLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/LineofCredit" ], "xbrltype": "stringItemType" }, "rgr_LineofCreditTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Line of Credit [Table]" } } }, "localname": "LineofCreditTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/LineofCredit" ], "xbrltype": "stringItemType" }, "rgr_LipseysMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lipsey's [Member]", "label": "Lipseys Member", "terseLabel": "Lipseys [Member]" } } }, "localname": "LipseysMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/OperatingSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "rgr_LossContingencyNumberOfLawsuits": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loss contingency, number of lawsuits.", "label": "Loss Contingency Number Of Lawsuits", "terseLabel": "Number of lawsuits" } } }, "localname": "LossContingencyNumberOfLawsuits", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ContingentLiabilitiesDetails" ], "xbrltype": "integerItemType" }, "rgr_MarlinAcquisitionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Marlin Acquisition [Member]", "label": "Marlin Acquisition Member", "terseLabel": "Marlin Acquisition [Member]" } } }, "localname": "MarlinAcquisitionMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/AcquisitionofMarlinAssetsDetails", "http://ruger.com/role/ScheduleofestimatedremainingusefullivesTable" ], "xbrltype": "domainItemType" }, "rgr_MaximumDollarValueOfSharesThatMayYetBePurchasedUnderThePrograminDollars": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum Dollar Value of Shares that May Yet Be Purchased Under the Program.", "label": "Maximum Dollar Value Of Shares That May Yet Be Purchased Under The Programin Dollars", "terseLabel": "Maximum Dollar Value of Shares that May Yet Be Purchased Under the Program (in Dollars)" } } }, "localname": "MaximumDollarValueOfSharesThatMayYetBePurchasedUnderThePrograminDollars", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofrepurchasedsharesofitscommonstockTable" ], "xbrltype": "monetaryItemType" }, "rgr_MeasurementPeriodAdjustmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement Period Adjustments [Member]", "label": "Measurement Period Adjustments Member", "terseLabel": "Measurement Period Adjustments [Member]" } } }, "localname": "MeasurementPeriodAdjustmentsMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofallocationofpurchasepriceconsiderationTable" ], "xbrltype": "domainItemType" }, "rgr_MunicipalLawsuitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Municipal Lawsuits [Member]", "label": "Municipal Lawsuits Member", "terseLabel": "Municipal Lawsuits [Member]" } } }, "localname": "MunicipalLawsuitsMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ContingentLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "rgr_NationalRifleAssociationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "National Rifle Association [Member]", "label": "National Rifle Association Member", "terseLabel": "National Rifle Association [Member]" } } }, "localname": "NationalRifleAssociationMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "rgr_NationalShootingSportsFoundationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "National Shooting Sports Foundation Member", "terseLabel": "National Shooting Sports Foundation [Member]" } } }, "localname": "NationalShootingSportsFoundationMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "rgr_NegligenceLawsuitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Negligence Lawsuits Member", "terseLabel": "Negligence Lawsuits [Member]" } } }, "localname": "NegligenceLawsuitsMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ContingentLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "rgr_NetDecreaseInFirearmsSales": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net decrease in firearms sales.", "label": "Net Decrease In Firearms Sales", "terseLabel": "Net decrease in firearms sales" } } }, "localname": "NetDecreaseInFirearmsSales", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/RevenueRecognitionandContractswithCustomersDetails" ], "xbrltype": "monetaryItemType" }, "rgr_NetDeferredTaxLiabilitiesAssets": { "auth_ref": [], "calculation": { "http://ruger.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total deferred tax assets less total deferred tax liabilities.", "label": "Net Deferred Tax Liabilities Assets", "totalLabel": "Net deferred tax assets" } } }, "localname": "NetDeferredTaxLiabilitiesAssets", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "rgr_NetSalesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Sales Abstract", "terseLabel": "Net Sales" } } }, "localname": "NetSalesAbstract", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofoperatingsegmentfinancialinformationTable" ], "xbrltype": "stringItemType" }, "rgr_November27ToDecember31Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "November27 To December31 Member", "terseLabel": "November 27 to December 31 [Member]" } } }, "localname": "November27ToDecember31Member", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofrepurchasedsharesofitscommonstockTable" ], "xbrltype": "domainItemType" }, "rgr_October2ToOctober29Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "October2 To October29 Member", "terseLabel": "October 2 to October 29 [Member]" } } }, "localname": "October2ToOctober29Member", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofrepurchasedsharesofitscommonstockTable" ], "xbrltype": "domainItemType" }, "rgr_October3ToNovember26Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "October3 To November26 Member", "terseLabel": "October 3 to November 26 [Member]" } } }, "localname": "October3ToNovember26Member", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofrepurchasedsharesofitscommonstockTable" ], "xbrltype": "domainItemType" }, "rgr_OperatingExpensesIncomesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses Incomes Abstract", "terseLabel": "Operating Expenses (Incomes):" } } }, "localname": "OperatingExpensesIncomesAbstract", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "rgr_OperatingLeaseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Lease Member", "terseLabel": "Operating lease [Member]" } } }, "localname": "OperatingLeaseMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofoperatingleaseliabilitiesTable" ], "xbrltype": "domainItemType" }, "rgr_OperatingSegmentInformationDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Segment Information (Details) [Line Items]" } } }, "localname": "OperatingSegmentInformationDetailsLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/OperatingSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "rgr_OperatingSegmentInformationDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Segment Information (Details) [Table]" } } }, "localname": "OperatingSegmentInformationDetailsTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/OperatingSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "rgr_OperatingSegmentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Segment Information [Abstract]" } } }, "localname": "OperatingSegmentInformationLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/OperatingSegmentInformation" ], "xbrltype": "stringItemType" }, "rgr_OperatingSegmentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Segment Information [Table]" } } }, "localname": "OperatingSegmentInformationTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/OperatingSegmentInformation" ], "xbrltype": "stringItemType" }, "rgr_OperatingSegmentInformationTablesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Segment Information Tables Line Items", "terseLabel": "Operating Segment Information [Abstract]" } } }, "localname": "OperatingSegmentInformationTablesLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/OperatingSegmentInformationTables" ], "xbrltype": "stringItemType" }, "rgr_OperatingSegmentInformationTablesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Segment Information (Tables) [Table]" } } }, "localname": "OperatingSegmentInformationTablesTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/OperatingSegmentInformationTables" ], "xbrltype": "stringItemType" }, "rgr_OrganizationPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for organization.", "label": "Organization Policy Text Block", "terseLabel": "Organization" } } }, "localname": "OrganizationPolicyTextBlock", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "rgr_OtherAssetsDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Assets (Details) [Line Items]" } } }, "localname": "OtherAssetsDetailsLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/OtherAssetsDetails" ], "xbrltype": "stringItemType" }, "rgr_OtherAssetsDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Assets (Details) [Table]" } } }, "localname": "OtherAssetsDetailsTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/OtherAssetsDetails" ], "xbrltype": "stringItemType" }, "rgr_OtherIncomeAndExpensesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the schedule of other income and expenses.", "label": "Other Income And Expenses Table Text Block", "terseLabel": "Schedule of other operating income, net" } } }, "localname": "OtherIncomeAndExpensesTableTextBlock", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/OtherOperatingIncomeNetTables" ], "xbrltype": "textBlockItemType" }, "rgr_OtherOperatingIncomeNetDetailsScheduleofotheroperatingincomenetLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of other operating income, net [Abstract]" } } }, "localname": "OtherOperatingIncomeNetDetailsScheduleofotheroperatingincomenetLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofotheroperatingincomenetTable" ], "xbrltype": "stringItemType" }, "rgr_OtherOperatingIncomeNetDetailsScheduleofotheroperatingincomenetTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Operating Income, Net (Details) - Schedule of other operating income, net [Table]" } } }, "localname": "OtherOperatingIncomeNetDetailsScheduleofotheroperatingincomenetTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofotheroperatingincomenetTable" ], "xbrltype": "stringItemType" }, "rgr_OtherOperatingIncomeNetLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Operating Income, Net [Abstract]" } } }, "localname": "OtherOperatingIncomeNetLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/OtherOperatingIncomeNet" ], "xbrltype": "stringItemType" }, "rgr_OtherOperatingIncomeNetTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Operating Income, Net [Table]" } } }, "localname": "OtherOperatingIncomeNetTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/OtherOperatingIncomeNet" ], "xbrltype": "stringItemType" }, "rgr_OtherOperatingIncomeNetTablesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Operating Income Net Tables Line Items", "terseLabel": "Other Operating Income, Net [Abstract]" } } }, "localname": "OtherOperatingIncomeNetTablesLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/OtherOperatingIncomeNetTables" ], "xbrltype": "stringItemType" }, "rgr_OtherOperatingIncomeNetTablesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Operating Income, Net (Tables) [Table]" } } }, "localname": "OtherOperatingIncomeNetTablesTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/OtherOperatingIncomeNetTables" ], "xbrltype": "stringItemType" }, "rgr_PreparationOfFinancialStatementsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the preparation of financial statements.", "label": "Preparation Of Financial Statements Policy Text Block", "terseLabel": "Preparation of Financial Statements" } } }, "localname": "PreparationOfFinancialStatementsPolicyTextBlock", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "rgr_ProductInsurancePremiumExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Product Insurance Premium Expense [Member]", "label": "Product Insurance Premium Expense Member", "terseLabel": "Insurance Premium Expense [Member]" } } }, "localname": "ProductInsurancePremiumExpenseMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofproductliabilityexpenseTable" ], "xbrltype": "domainItemType" }, "rgr_ProductLiabilityAccrualNoncurrent": { "auth_ref": [], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date which includes the cost of outside legal fees, insurance, and other expenses incurred in the management and defense of product liability matters and due after one year (or beyond the operating cycle if longer).", "label": "Product Liability Accrual Noncurrent", "terseLabel": "Product liability accrual" } } }, "localname": "ProductLiabilityAccrualNoncurrent", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "rgr_ProductLiabilityCurrent": { "auth_ref": [], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date which includes the cost of outside legal fees, insurance, and other expenses incurred in the management and defense of product liability matters For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Product Liability Current", "terseLabel": "Product liability" } } }, "localname": "ProductLiabilityCurrent", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "rgr_ProductLiabilityReserveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Product Liability Reserve [Member]", "label": "Product Liability Reserve Member", "terseLabel": "Product Liability Reserve [Member]" } } }, "localname": "ProductLiabilityReserveMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofrollforwardforproductliabilityreserveTable" ], "xbrltype": "domainItemType" }, "rgr_PropertyPlantandEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantandEquipmentLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/PropertyPlantandEquipment" ], "xbrltype": "stringItemType" }, "rgr_PropertyPlantandEquipmentTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table]" } } }, "localname": "PropertyPlantandEquipmentTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/PropertyPlantandEquipment" ], "xbrltype": "stringItemType" }, "rgr_PropertyPlantandEquipmentTablesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property Plantand Equipment Tables Line Items", "terseLabel": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantandEquipmentTablesLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/PropertyPlantandEquipmentTables" ], "xbrltype": "stringItemType" }, "rgr_PropertyPlantandEquipmentTablesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment (Tables) [Table]" } } }, "localname": "PropertyPlantandEquipmentTablesTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/PropertyPlantandEquipmentTables" ], "xbrltype": "stringItemType" }, "rgr_PurchaseOfMarlinAssets": { "auth_ref": [], "calculation": { "http://ruger.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of purchase of marlin assets.", "label": "Purchase Of Marlin Assets", "terseLabel": "Purchase of Marlin assets" } } }, "localname": "PurchaseOfMarlinAssets", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "rgr_PurchasePriceAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Purchase Price Abstract", "terseLabel": "Purchase Price" } } }, "localname": "PurchasePriceAbstract", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofallocationofpurchasepriceconsiderationTable" ], "xbrltype": "stringItemType" }, "rgr_PurchasePriceAllocationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Purchase Price Allocation Abstract", "terseLabel": "Purchase Price Allocation" } } }, "localname": "PurchasePriceAllocationAbstract", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofallocationofpurchasepriceconsiderationTable" ], "xbrltype": "stringItemType" }, "rgr_QuarterlyResultsofOperationsUnauditedLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Quarterly Results of Operations [Abstract]" } } }, "localname": "QuarterlyResultsofOperationsUnauditedLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/QuarterlyResultsofOperationsUnaudited" ], "xbrltype": "stringItemType" }, "rgr_QuarterlyResultsofOperationsUnauditedTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Quarterly Results of Operations (Unaudited) [Table]" } } }, "localname": "QuarterlyResultsofOperationsUnauditedTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/QuarterlyResultsofOperationsUnaudited" ], "xbrltype": "stringItemType" }, "rgr_QuarterlyResultsofOperationsUnauditedTablesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Quarterly Resultsof Operations Unaudited Tables Line Items", "terseLabel": "Quarterly Results of Operations [Abstract]" } } }, "localname": "QuarterlyResultsofOperationsUnauditedTablesLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/QuarterlyResultsofOperationsUnauditedTables" ], "xbrltype": "stringItemType" }, "rgr_QuarterlyResultsofOperationsUnauditedTablesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Quarterly Results of Operations (Unaudited) (Tables) [Table]" } } }, "localname": "QuarterlyResultsofOperationsUnauditedTablesTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/QuarterlyResultsofOperationsUnauditedTables" ], "xbrltype": "stringItemType" }, "rgr_RecognizedCostsOfRestrictedStockUnits": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of recognized costs of restricted stock units.", "label": "Recognized Costs Of Restricted Stock Units", "terseLabel": "Recognized costs of restricted stock units" } } }, "localname": "RecognizedCostsOfRestrictedStockUnits", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/CompensationPlansDetails" ], "xbrltype": "monetaryItemType" }, "rgr_RelatedPartyTransactionsDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions (Details) [Line Items]" } } }, "localname": "RelatedPartyTransactionsDetailsLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "rgr_RelatedPartyTransactionsDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions (Details) [Table]" } } }, "localname": "RelatedPartyTransactionsDetailsTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "rgr_RelatedPartyTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/RelatedPartyTransactions" ], "xbrltype": "stringItemType" }, "rgr_RelatedPartyTransactionsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Table]" } } }, "localname": "RelatedPartyTransactionsTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/RelatedPartyTransactions" ], "xbrltype": "stringItemType" }, "rgr_RemingtonOutdoorCompanyMembeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Remington Outdoor Company Membe Member", "terseLabel": "Remington Outdoor Company, Inc. [Member]" } } }, "localname": "RemingtonOutdoorCompanyMembeMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "rgr_RevenueDeferred": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of revenue deferred during the period.", "label": "Revenue Deferred", "terseLabel": "Revenue deferred" } } }, "localname": "RevenueDeferred", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofrevenuerecognizedTable" ], "xbrltype": "monetaryItemType" }, "rgr_RevenueRecognitionMultipledeliverableArrangementsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the recognition of revenue arrangements under which the entity does or will perform multiple revenue-generating activities, categorized by type of arrangement. This item includes certain revenue arrangements that include software elements. This item does not include multiple-deliverable arrangements for industries that prepare disclosures under specific requirements (for instance, construction-type and production-type contracts) otherwise provided for in the taxonomy.", "label": "Revenue Recognition Multipledeliverable Arrangements Table Text Block", "terseLabel": "Schedule of revenue recognized" } } }, "localname": "RevenueRecognitionMultipledeliverableArrangementsTableTextBlock", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/RevenueRecognitionandContractswithCustomersTables" ], "xbrltype": "textBlockItemType" }, "rgr_ScheduleOfAReconciliationOfTheNumeratorAndDenominatorForTheBasicAndDilutedEarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of AReconciliation Of The Numerator And Denominator For The Basic And Diluted Earnings Per Share Abstract" } } }, "localname": "ScheduleOfAReconciliationOfTheNumeratorAndDenominatorForTheBasicAndDilutedEarningsPerShareAbstract", "nsuri": "http://ruger.com/20221231", "xbrltype": "stringItemType" }, "rgr_ScheduleOfAllocationOfPurchasePriceConsiderationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Allocation Of Purchase Price Consideration Abstract" } } }, "localname": "ScheduleOfAllocationOfPurchasePriceConsiderationAbstract", "nsuri": "http://ruger.com/20221231", "xbrltype": "stringItemType" }, "rgr_ScheduleOfDeferredTaxAssetsAndLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Deferred Tax Assets And Liabilities Abstract" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesAbstract", "nsuri": "http://ruger.com/20221231", "xbrltype": "stringItemType" }, "rgr_ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Effective Income Tax Rate Reconciliation Abstract" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationAbstract", "nsuri": "http://ruger.com/20221231", "xbrltype": "stringItemType" }, "rgr_ScheduleOfEstimatedRemainingUsefulLivesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Estimated Remaining Useful Lives Abstract" } } }, "localname": "ScheduleOfEstimatedRemainingUsefulLivesAbstract", "nsuri": "http://ruger.com/20221231", "xbrltype": "stringItemType" }, "rgr_ScheduleOfFederalAndStateIncomeTaxProvisionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Federal And State Income Tax Provision Abstract" } } }, "localname": "ScheduleOfFederalAndStateIncomeTaxProvisionAbstract", "nsuri": "http://ruger.com/20221231", "xbrltype": "stringItemType" }, "rgr_ScheduleOfFutureMinimumLeasePaymentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Future Minimum Lease Payments Table Text Block", "terseLabel": "Schedule of right-of-use assets and related lease liabilities" } } }, "localname": "ScheduleOfFutureMinimumLeasePaymentsTableTextBlock", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/LeasedAssetsTables" ], "xbrltype": "textBlockItemType" }, "rgr_ScheduleOfInventoriesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Inventories Abstract" } } }, "localname": "ScheduleOfInventoriesAbstract", "nsuri": "http://ruger.com/20221231", "xbrltype": "stringItemType" }, "rgr_ScheduleOfOperatingLeaseLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Operating Lease Liabilities Abstract" } } }, "localname": "ScheduleOfOperatingLeaseLiabilitiesAbstract", "nsuri": "http://ruger.com/20221231", "xbrltype": "stringItemType" }, "rgr_ScheduleOfOperatingSegmentFinancialInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Operating Segment Financial Information Abstract" } } }, "localname": "ScheduleOfOperatingSegmentFinancialInformationAbstract", "nsuri": "http://ruger.com/20221231", "xbrltype": "stringItemType" }, "rgr_ScheduleOfOtherAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Other Assets Abstract" } } }, "localname": "ScheduleOfOtherAssetsAbstract", "nsuri": "http://ruger.com/20221231", "xbrltype": "stringItemType" }, "rgr_ScheduleOfOtherOperatingIncomeNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Other Operating Income Net Abstract" } } }, "localname": "ScheduleOfOtherOperatingIncomeNetAbstract", "nsuri": "http://ruger.com/20221231", "xbrltype": "stringItemType" }, "rgr_ScheduleOfProductLiabilityExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Product Liability Expense Abstract" } } }, "localname": "ScheduleOfProductLiabilityExpenseAbstract", "nsuri": "http://ruger.com/20221231", "xbrltype": "stringItemType" }, "rgr_ScheduleOfPropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Property Plant And Equipment Abstract" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentAbstract", "nsuri": "http://ruger.com/20221231", "xbrltype": "stringItemType" }, "rgr_ScheduleOfQuarterlyFinancialInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Quarterly Financial Information Abstract" } } }, "localname": "ScheduleOfQuarterlyFinancialInformationAbstract", "nsuri": "http://ruger.com/20221231", "xbrltype": "stringItemType" }, "rgr_ScheduleOfRepurchasedSharesOfItsCommonStockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Repurchased Shares Of Its Common Stock Abstract" } } }, "localname": "ScheduleOfRepurchasedSharesOfItsCommonStockAbstract", "nsuri": "http://ruger.com/20221231", "xbrltype": "stringItemType" }, "rgr_ScheduleOfRevenueRecognizedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Revenue Recognized Abstract" } } }, "localname": "ScheduleOfRevenueRecognizedAbstract", "nsuri": "http://ruger.com/20221231", "xbrltype": "stringItemType" }, "rgr_ScheduleOfRightOfUseAssetsAndRelatedLeaseLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Right Of Use Assets And Related Lease Liabilities Abstract" } } }, "localname": "ScheduleOfRightOfUseAssetsAndRelatedLeaseLiabilitiesAbstract", "nsuri": "http://ruger.com/20221231", "xbrltype": "stringItemType" }, "rgr_ScheduleOfRollForwardForProductLiabilityReserveAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Roll Forward For Product Liability Reserve Abstract" } } }, "localname": "ScheduleOfRollForwardForProductLiabilityReserveAbstract", "nsuri": "http://ruger.com/20221231", "xbrltype": "stringItemType" }, "rgr_ScheduleOfTradeAccountsPayableAndAccruedExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of trade accounts payable and accrued expenses [Abstract]" } } }, "localname": "ScheduleOfTradeAccountsPayableAndAccruedExpensesAbstract", "nsuri": "http://ruger.com/20221231", "xbrltype": "stringItemType" }, "rgr_ScheduleOfTradeReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Trade Receivables Abstract" } } }, "localname": "ScheduleOfTradeReceivablesAbstract", "nsuri": "http://ruger.com/20221231", "xbrltype": "stringItemType" }, "rgr_ShippingCostPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the classification of shipping and handling costs, including whether the costs are included in cost of sales or included in other income statement accounts. If shipping and handling fees are significant and are not included in cost of sales, disclosure includes both the amounts of such costs and the line item on the income statement which includes such costs.", "label": "Shipping Cost Policy Policy Text Block", "terseLabel": "Shipping Costs" } } }, "localname": "ShippingCostPolicyPolicyTextBlock", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "rgr_ShippingCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cost incurred during the reporting period in shipping and transporting goods and services to customers.", "label": "Shipping Costs", "terseLabel": "Shipping costs" } } }, "localname": "ShippingCosts", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "rgr_SportsSouthMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sports South [Member]", "label": "Sports South Member", "terseLabel": "Sports South [Member]" } } }, "localname": "SportsSouthMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/OperatingSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "rgr_StockIncentivePlan2017Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Incentive Plan 2017 [Member]", "label": "Stock Incentive Plan2017 Member", "terseLabel": "Stock Incentive Plan 2017 [Member]" } } }, "localname": "StockIncentivePlan2017Member", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/CompensationPlansDetails" ], "xbrltype": "domainItemType" }, "rgr_StockRepurchasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Repurchases Abstract" } } }, "localname": "StockRepurchasesAbstract", "nsuri": "http://ruger.com/20221231", "xbrltype": "stringItemType" }, "rgr_StockRepurchasesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Repurchases [Abstract]" } } }, "localname": "StockRepurchasesLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/StockRepurchases" ], "xbrltype": "stringItemType" }, "rgr_StockRepurchasesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Repurchases [Table]" } } }, "localname": "StockRepurchasesTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/StockRepurchases" ], "xbrltype": "stringItemType" }, "rgr_StockRepurchasesTablesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Repurchases Tables Line Items", "terseLabel": "Stock Repurchases [Abstract]" } } }, "localname": "StockRepurchasesTablesLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/StockRepurchasesTables" ], "xbrltype": "stringItemType" }, "rgr_StockRepurchasesTablesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Repurchases (Tables) [Table]" } } }, "localname": "StockRepurchasesTablesTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/StockRepurchasesTables" ], "xbrltype": "stringItemType" }, "rgr_StockRepurchasesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of stock repurchase.", "label": "Stock Repurchases Text Block", "terseLabel": "Stock Repurchases" } } }, "localname": "StockRepurchasesTextBlock", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/StockRepurchases" ], "xbrltype": "textBlockItemType" }, "rgr_SubsequentEventsDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events (Details) [Line Items]" } } }, "localname": "SubsequentEventsDetailsLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "rgr_SubsequentEventsDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events (Details) [Table]" } } }, "localname": "SubsequentEventsDetailsTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "rgr_SummaryofSignificantAccountingPoliciesDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) [Line Items]" } } }, "localname": "SummaryofSignificantAccountingPoliciesDetailsLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "rgr_SummaryofSignificantAccountingPoliciesDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) [Table]" } } }, "localname": "SummaryofSignificantAccountingPoliciesDetailsTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "rgr_ThirdQuarter2022Abstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Third Quarter2022 Abstract", "terseLabel": "Third Quarter 2022" } } }, "localname": "ThirdQuarter2022Abstract", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofrepurchasedsharesofitscommonstockTable" ], "xbrltype": "stringItemType" }, "rgr_ThresholdLimitOfAggregateLossForInsuranceCoverageOnAnnualBasisExcludingNewClaimsFromGovernmentsOrMunicipalities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents maximum limit of aggregate loss incurred annually for providing insurance coverage on annual basis excluding for certain new claims from governments or municipalities.", "label": "Threshold Limit Of Aggregate Loss For Insurance Coverage On Annual Basis Excluding New Claims From Governments Or Municipalities", "terseLabel": "Maximum limit of aggregate loss incurred annually for providing insurance coverage on annual basis (in Dollars)" } } }, "localname": "ThresholdLimitOfAggregateLossForInsuranceCoverageOnAnnualBasisExcludingNewClaimsFromGovernmentsOrMunicipalities", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ContingentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "rgr_ThresholdLimitOfLossesPerTransactionForTakingInsuranceCoverageOnAnnualBasis": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents minimum limit of per claim for providing insurance coverage on annual basis.", "label": "Threshold Limit Of Losses Per Transaction For Taking Insurance Coverage On Annual Basis", "terseLabel": "Minimum limit of per claim for providing insurance coverage on annual basis (in Dollars)" } } }, "localname": "ThresholdLimitOfLossesPerTransactionForTakingInsuranceCoverageOnAnnualBasis", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ContingentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "rgr_TotalOperatingLeaseLiabilitie": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Total Operating Lease Liabilitie", "terseLabel": "Total operating lease liabilities" } } }, "localname": "TotalOperatingLeaseLiabilitie", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofrightofuseassetsandrelatedleaseliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "rgr_TotalProductLiabilityExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Total Product Liability Expense Member", "terseLabel": "Total Product Liability Expense [Member]" } } }, "localname": "TotalProductLiabilityExpenseMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofproductliabilityexpenseTable" ], "xbrltype": "domainItemType" }, "rgr_TradeAccountsPayableAndAccruedExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trade Accounts Payable And Accrued Expenses Member", "terseLabel": "Trade accounts payable and accrued expenses [Member]" } } }, "localname": "TradeAccountsPayableAndAccruedExpensesMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofrightofuseassetsandrelatedleaseliabilitiesTable" ], "xbrltype": "domainItemType" }, "rgr_TradeNameMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trade name [Member]", "label": "Trade Name Member", "terseLabel": "Trade name [Member]" } } }, "localname": "TradeNameMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/OtherAssetsDetails" ], "xbrltype": "domainItemType" }, "rgr_TradeReceivablesNetDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trade Receivables, Net (Details) [Line Items]" } } }, "localname": "TradeReceivablesNetDetailsLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/TradeReceivablesNetDetails" ], "xbrltype": "stringItemType" }, "rgr_TradeReceivablesNetDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trade Receivables, Net (Details) [Table]" } } }, "localname": "TradeReceivablesNetDetailsTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/TradeReceivablesNetDetails" ], "xbrltype": "stringItemType" }, "rgr_TradeReceivablesNetLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trade Receivables, Net [Abstract]" } } }, "localname": "TradeReceivablesNetLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/TradeReceivablesNet" ], "xbrltype": "stringItemType" }, "rgr_TradeReceivablesNetTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trade Receivables, Net [Table]" } } }, "localname": "TradeReceivablesNetTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/TradeReceivablesNet" ], "xbrltype": "stringItemType" }, "rgr_TradeReceivablesNetTablesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trade Receivables Net Tables Line Items", "terseLabel": "Trade Receivables, Net [Abstract]" } } }, "localname": "TradeReceivablesNetTablesLineItems", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/TradeReceivablesNetTables" ], "xbrltype": "stringItemType" }, "rgr_TradeReceivablesNetTablesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trade Receivables, Net (Tables) [Table]" } } }, "localname": "TradeReceivablesNetTablesTable", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/TradeReceivablesNetTables" ], "xbrltype": "stringItemType" }, "rgr_TraditionalLawsuitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Traditional Lawsuits [Member]", "label": "Traditional Lawsuits Member", "terseLabel": "Traditional Lawsuits [Member]" } } }, "localname": "TraditionalLawsuitsMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ContingentLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "rgr_UnaffiliatedCastingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Unaffiliated Castings Member", "terseLabel": "Net castings sales", "verboseLabel": "Unaffiliated Castings [Member]" } } }, "localname": "UnaffiliatedCastingsMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ConsolidatedIncomeStatement", "http://ruger.com/role/ScheduleofoperatingsegmentfinancialinformationTable", "http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "rgr_UnrecognizedCompensationCost": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized compensation cost.", "label": "Unrecognized Compensation Cost", "terseLabel": "Unrecognized compensation cost" } } }, "localname": "UnrecognizedCompensationCost", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/CompensationPlansDetails" ], "xbrltype": "monetaryItemType" }, "rgr_ValuationAllowancesAndReservesLegalFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Valuation Allowances And Reserves Legal Fees", "label": "Valuation Allowances And Reserves Legal Fees", "terseLabel": "Legal Fees" } } }, "localname": "ValuationAllowancesAndReservesLegalFees", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofrollforwardforproductliabilityreserveTable" ], "xbrltype": "monetaryItemType" }, "rgr_ValuationAllowancesAndReservesSettlements": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Valuation Allowances And Reserves Settlements", "label": "Valuation Allowances And Reserves Settlements", "terseLabel": "Settlements" } } }, "localname": "ValuationAllowancesAndReservesSettlements", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/ScheduleofrollforwardforproductliabilityreserveTable" ], "xbrltype": "monetaryItemType" }, "rgr_VestInJune2027Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Vest In June2027 Member", "terseLabel": "Vest in June 2027 [Member]" } } }, "localname": "VestInJune2027Member", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/CompensationPlansDetails" ], "xbrltype": "domainItemType" }, "rgr_VestInMay2023Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Vest In May2023 Member", "terseLabel": "Vest in May 2023 [Member]" } } }, "localname": "VestInMay2023Member", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/CompensationPlansDetails" ], "xbrltype": "domainItemType" }, "rgr_VestingInMay2025Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Vesting In May2025 Member", "terseLabel": "Vesting in May 2025 [Member]" } } }, "localname": "VestingInMay2025Member", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/CompensationPlansDetails" ], "xbrltype": "domainItemType" }, "rgr_VestingMayTwoThousandTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vesting May 2021 [Member]", "label": "Vesting May Two Thousand Twenty One Member", "terseLabel": "Vesting in May 2021 [Member]" } } }, "localname": "VestingMayTwoThousandTwentyOneMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/CompensationPlansDetails" ], "xbrltype": "domainItemType" }, "rgr_VestingMayTwoThousandTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vesting in May 2023 [Member]", "label": "Vesting May Two Thousand Twenty Three Member", "terseLabel": "Vesting in May 2023 [Member]" } } }, "localname": "VestingMayTwoThousandTwentyThreeMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/CompensationPlansDetails" ], "xbrltype": "domainItemType" }, "rgr_VestingMayTwoThousandTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vesting May 2022 [Member]", "label": "Vesting May Two Thousand Twenty Two Member", "terseLabel": "Vesting in May 2022 [Member]" } } }, "localname": "VestingMayTwoThousandTwentyTwoMember", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/CompensationPlansDetails" ], "xbrltype": "domainItemType" }, "rgr_VestingPeriodAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vesting Period [Axis]", "label": "Vesting Period Axis", "terseLabel": "Vesting Period [Axis]" } } }, "localname": "VestingPeriodAxis", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/CompensationPlansDetails" ], "xbrltype": "stringItemType" }, "rgr_VestingPeriodDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "VestingPeriod [Domain]" } } }, "localname": "VestingPeriodDomain", "nsuri": "http://ruger.com/20221231", "presentation": [ "http://ruger.com/role/CompensationPlansDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r187", "r231", "r243", "r244", "r245", "r246", "r247", "r249", "r253", "r294", "r295", "r296", "r297", "r299", "r300", "r302", "r304", "r305", "r552", "r553" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ruger.com/role/ScheduleofoperatingsegmentfinancialinformationTable" ], "xbrltype": "stringItemType" }, "srt_DirectorMember": { "auth_ref": [ "r534" ], "lang": { "en-us": { "role": { "label": "Director [Member]", "terseLabel": "Director [Member]" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ruger.com/role/CompensationPlansDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r259", "r490", "r555", "r607" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ruger.com/role/OperatingSegmentInformationDetails", "http://ruger.com/role/TradeReceivablesNetDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r290", "r291", "r292", "r293", "r338", "r440", "r452", "r473", "r474", "r487", "r494", "r501", "r554", "r599", "r600", "r601", "r602", "r603", "r604" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ruger.com/role/AcquisitionofMarlinAssetsDetails", "http://ruger.com/role/CompensationPlansDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r290", "r291", "r292", "r293", "r338", "r440", "r452", "r473", "r474", "r487", "r494", "r501", "r554", "r599", "r600", "r601", "r602", "r603", "r604" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ruger.com/role/AcquisitionofMarlinAssetsDetails", "http://ruger.com/role/CompensationPlansDetails", "http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r259", "r490", "r555", "r607" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ruger.com/role/OperatingSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r255", "r443", "r488", "r499", "r549", "r551", "r555", "r606" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ruger.com/role/ConsolidatedIncomeStatement", "http://ruger.com/role/ScheduleofproductliabilityexpenseTable", "http://ruger.com/role/ScheduleofrollforwardforproductliabilityreserveTable" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r255", "r443", "r488", "r499", "r549", "r551", "r555", "r606" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ruger.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r290", "r291", "r292", "r293", "r326", "r338", "r366", "r367", "r368", "r439", "r440", "r452", "r473", "r474", "r487", "r494", "r501", "r544", "r554", "r600", "r601", "r602", "r603", "r604" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ruger.com/role/AcquisitionofMarlinAssetsDetails", "http://ruger.com/role/CompensationPlansDetails", "http://ruger.com/role/ScheduleofareconciliationofthenumeratoranddenominatorforthebasicanddilutedearningspershareTable", "http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r290", "r291", "r292", "r293", "r326", "r338", "r366", "r367", "r368", "r439", "r440", "r452", "r473", "r474", "r487", "r494", "r501", "r544", "r554", "r600", "r601", "r602", "r603", "r604" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ruger.com/role/AcquisitionofMarlinAssetsDetails", "http://ruger.com/role/CompensationPlansDetails", "http://ruger.com/role/ScheduleofareconciliationofthenumeratoranddenominatorforthebasicanddilutedearningspershareTable", "http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r339", "r528" ], "lang": { "en-us": { "role": { "label": "Forecast [Member]", "terseLabel": "Forecast [Member]" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ruger.com/role/IncomeTaxesDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r204", "r339", "r512", "r528" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ruger.com/role/IncomeTaxesDetails", "http://ruger.com/role/ScheduleofeffectiveincometaxratereconciliationTable", "http://ruger.com/role/ScheduleoffederalandstateincometaxprovisionTable", "http://ruger.com/role/ScheduleofotheroperatingincomenetTable", "http://ruger.com/role/ScheduleoftradereceivablesTable" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r256", "r257", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r489", "r500", "r555" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ruger.com/role/OperatingSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r256", "r257", "r459", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r489", "r500", "r555" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ruger.com/role/OperatingSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r204", "r339", "r512", "r513", "r528" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ruger.com/role/IncomeTaxesDetails", "http://ruger.com/role/ScheduleofeffectiveincometaxratereconciliationTable", "http://ruger.com/role/ScheduleoffederalandstateincometaxprovisionTable", "http://ruger.com/role/ScheduleofotheroperatingincomenetTable", "http://ruger.com/role/ScheduleoftradereceivablesTable" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r534", "r595" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ruger.com/role/CompensationPlansDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ruger.com/role/CompensationPlansDetails" ], "xbrltype": "domainItemType" }, "srt_WeightedAverageMember": { "auth_ref": [ "r473", "r474", "r599", "r601", "r604" ], "lang": { "en-us": { "role": { "label": "Weighted Average [Member]", "terseLabel": "Weighted Average [Member]" } } }, "localname": "WeightedAverageMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://ruger.com/role/ScheduleofareconciliationofthenumeratoranddenominatorforthebasicanddilutedearningspershareTable" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsNotesAndLoansReceivableLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of trade receivables [Abstract]" } } }, "localname": "AccountsNotesAndLoansReceivableLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleoftradereceivablesTable" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.", "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]", "terseLabel": "Accrued Dividends" } } }, "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/AccruedDividends" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r18" ], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://ruger.com/role/ScheduleoftradeaccountspayableandaccruedexpensesTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts Payable and Accrued Liabilities, Current", "terseLabel": "Trade accounts payable and accrued expenses", "totalLabel": "Total trade accounts payable and accrued expenses" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet", "http://ruger.com/role/ScheduleoftradeaccountspayableandaccruedexpensesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]", "terseLabel": "Trade Accounts Payable and Accrued Expenses" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/TradeAccountsPayableandAccruedExpenses" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r15", "r498" ], "calculation": { "http://ruger.com/role/ScheduleoftradeaccountspayableandaccruedexpensesTable": { "order": 1.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Trade accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleoftradeaccountspayableandaccruedexpensesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableGrossCurrent": { "auth_ref": [ "r167", "r261", "r262", "r478" ], "calculation": { "http://ruger.com/role/ScheduleoftradereceivablesTable": { "order": 1.0, "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, before Allowance for Credit Loss, Current", "terseLabel": "Trade receivables" } } }, "localname": "AccountsReceivableGrossCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleoftradereceivablesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r460" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]", "terseLabel": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/TradeReceivablesNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r261", "r262" ], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://ruger.com/role/ScheduleoftradereceivablesTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Trade receivables, net", "totalLabel": "Trade receivables, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet", "http://ruger.com/role/ScheduleoftradereceivablesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedEmployeeBenefitsCurrent": { "auth_ref": [ "r19" ], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Employee Benefits, Current", "terseLabel": "Employee compensation and benefits" } } }, "localname": "AccruedEmployeeBenefitsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r1", "r126", "r141" ], "calculation": { "http://ruger.com/role/ScheduleoftradeaccountspayableandaccruedexpensesTable": { "order": 2.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes, Current", "terseLabel": "Federal excise taxes payable" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleoftradeaccountspayableandaccruedexpensesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r72", "r159" ], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less allowances for depreciation", "negatedTerseLabel": "Less allowances for depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet", "http://ruger.com/role/ScheduleofpropertyplantandequipmentTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Acquired Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofestimatedremainingusefullivesTable" ], "xbrltype": "stringItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r64" ], "lang": { "en-us": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life", "terseLabel": "Intangible assets useful life" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofestimatedremainingusefullivesTable" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r7" ], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid in Capital, Common Stock", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r374", "r375", "r376", "r525", "r526", "r527", "r591" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for restricted stock unit under share-based payment arrangement.", "label": "APIC, Share-Based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition", "terseLabel": "Vesting of RSU\u2019s" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r92", "r93", "r341" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Stock-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income to cash provided by operating activities, net of effects of acquisition:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [ "r378" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for advertising cost.", "label": "Advertising Cost [Policy Text Block]", "terseLabel": "Advertising Costs" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_AdvertisingExpense": { "auth_ref": [ "r379" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.", "label": "Advertising Expense", "terseLabel": "Advertising expenses" } } }, "localname": "AdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r370" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-Based Payment Arrangement, Expense", "terseLabel": "Total stock-based compensation" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/CompensationPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r168", "r263", "r266" ], "calculation": { "http://ruger.com/role/ScheduleoftradereceivablesTable": { "order": 2.0, "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "negatedLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleoftradereceivablesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r42", "r62", "r67" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization expenses" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/OtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Asset Acquisition [Abstract]" } } }, "localname": "AssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AssetAcquisitionTextBlock": { "auth_ref": [ "r590" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for asset acquisition.", "label": "Asset Acquisition [Text Block]", "terseLabel": "Acquisition of Marlin Assets" } } }, "localname": "AssetAcquisitionTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/AcquisitionofMarlinAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_Assets": { "auth_ref": [ "r125", "r139", "r163", "r184", "r239", "r245", "r251", "r264", "r294", "r295", "r297", "r298", "r299", "r301", "r303", "r305", "r306", "r408", "r410", "r415", "r498", "r552", "r553", "r597" ], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "terseLabel": "Identifiable Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet", "http://ruger.com/role/ScheduleofoperatingsegmentfinancialinformationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r154", "r171", "r184", "r264", "r294", "r295", "r297", "r298", "r299", "r301", "r303", "r305", "r306", "r408", "r410", "r415", "r498", "r552", "r553", "r597" ], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581" ], "lang": { "en-us": { "role": { "documentation": "Information by date or year award under share-based payment arrangement is granted.", "label": "Award Date [Axis]" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofrepurchasedsharesofitscommonstockTable" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [ "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581" ], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted.", "label": "Award Date [Domain]" } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofrepurchasedsharesofitscommonstockTable" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/CompensationPlansDetails", "http://ruger.com/role/ScheduleofrightofuseassetsandrelatedleaseliabilitiesTable" ], "xbrltype": "stringItemType" }, "us-gaap_BuildingAndBuildingImprovementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.", "label": "Building and Building Improvements [Member]", "terseLabel": "Buildings and improvements [Member]" } } }, "localname": "BuildingAndBuildingImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofpropertyplantandequipmentTable" ], "xbrltype": "domainItemType" }, "us-gaap_BuildingMember": { "auth_ref": [ "r71" ], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building [Member]", "terseLabel": "Building [Member]" } } }, "localname": "BuildingMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r407", "r492", "r493" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r104", "r105", "r407", "r492", "r493" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/AcquisitionofMarlinAssetsDetails", "http://ruger.com/role/ScheduleofallocationofpurchasepriceconsiderationTable", "http://ruger.com/role/ScheduleofestimatedremainingusefullivesTable", "http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r103" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Combination, Acquisition Related Costs", "terseLabel": "Acquisition related costs" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/AcquisitionofMarlinAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r112", "r113", "r114" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "terseLabel": "Purchase price" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r106", "r107" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "terseLabel": "Net Assets Acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofallocationofpurchasepriceconsiderationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsPolicy": { "auth_ref": [ "r102" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.", "label": "Business Combinations Policy [Policy Text Block]", "terseLabel": "Business Combination" } } }, "localname": "BusinessCombinationsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r44", "r157", "r476" ], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r45" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r39", "r44", "r48" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents at end of year", "periodStartLabel": "Cash and cash equivalents at beginning of year" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r39", "r121" ], "calculation": { "http://ruger.com/role/ConsolidatedCashFlow": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "Increase (decrease) in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r164", "r165", "r166", "r184", "r207", "r211", "r213", "r215", "r225", "r226", "r264", "r294", "r297", "r298", "r299", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r415", "r475", "r511", "r522", "r529" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet", "http://ruger.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfTreasuryStockTable": { "auth_ref": [ "r82", "r83", "r84", "r85" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.", "label": "Class of Treasury Stock [Table]" } } }, "localname": "ClassOfTreasuryStockTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofrepurchasedsharesofitscommonstockTable" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r21", "r132", "r145" ], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Contingent liabilities (Note 20)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r81" ], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Common Stock, Dividends, Per Share, Declared", "terseLabel": "Cash Dividends Per Share (in Dollars per share)" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r525", "r526", "r591" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet", "http://ruger.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://ruger.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value per share (in Dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r6", "r80" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r6", "r498" ], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Retirement Benefits [Abstract]" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r54", "r55", "r119", "r120", "r259", "r460" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/OperatingSegmentInformationDetails", "http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r54", "r55", "r119", "r120", "r259", "r458", "r460" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/OperatingSegmentInformationDetails", "http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails", "http://ruger.com/role/TradeReceivablesNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r54", "r55", "r119", "r120", "r259", "r460", "r608" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/OperatingSegmentInformationDetails", "http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails", "http://ruger.com/role/TradeReceivablesNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r54", "r55", "r119", "r120", "r259" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Percentage of sales", "verboseLabel": "Total trade receivables" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/OperatingSegmentInformationDetails", "http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails", "http://ruger.com/role/TradeReceivablesNetDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r54", "r55", "r119", "r120", "r259", "r460" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/OperatingSegmentInformationDetails", "http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r115", "r479" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r313", "r314", "r323" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "periodEndLabel": "Contract liabilities with customers at December 31,", "periodStartLabel": "Contract liabilities with customers at January 1," } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofrevenuerecognizedTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r313", "r314", "r323" ], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "terseLabel": "Contract liabilities with customers (Note 3)" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CorporateMember": { "auth_ref": [ "r532" ], "lang": { "en-us": { "role": { "documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items.", "label": "Corporate Segment [Member]", "terseLabel": "Corporate Segment [Member]" } } }, "localname": "CorporateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofoperatingsegmentfinancialinformationTable" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r28", "r443" ], "calculation": { "http://ruger.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of products sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/LineofCreditDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r524", "r586", "r588" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Current Federal Tax Expense (Benefit)", "terseLabel": "Federal, current" } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleoffederalandstateincometaxprovisionTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r101", "r392", "r400", "r524" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current Income Tax Expense (Benefit)", "terseLabel": "Current" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleoffederalandstateincometaxprovisionTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r524", "r586", "r588" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Current State and Local Tax Expense (Benefit)", "terseLabel": "State, current" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleoffederalandstateincometaxprovisionTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r53", "r259" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/OperatingSegmentInformationDetails", "http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails", "http://ruger.com/role/TradeReceivablesNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer Relationships [Member]" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/OtherAssetsDetails", "http://ruger.com/role/ScheduleofallocationofpurchasepriceconsiderationTable", "http://ruger.com/role/ScheduleofestimatedremainingusefullivesTable" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredCompensationArrangementWithIndividualCompensationExpense": { "auth_ref": [ "r87", "r88" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The compensation expense recognized during the period pertaining to the deferred compensation arrangement.", "label": "Deferred Compensation Arrangement with Individual, Compensation Expense", "terseLabel": "Compensation expense" } } }, "localname": "DeferredCompensationArrangementWithIndividualCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/CompensationPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationArrangementWithIndividualSharesIssued": { "auth_ref": [ "r90" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued pursuant to the terms of a deferred compensation arrangement.", "label": "Deferred Compensation Arrangement with Individual, Shares Issued", "terseLabel": "Deferred stock awards amount (in Shares)" } } }, "localname": "DeferredCompensationArrangementWithIndividualSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/CompensationPlansDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r524", "r587", "r588" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred Federal Income Tax Expense (Benefit)", "terseLabel": "Federal, deferred" } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleoffederalandstateincometaxprovisionTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r382", "r383" ], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets, Net", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r42", "r101", "r393", "r399", "r400", "r524" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "terseLabel": "Deferred" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleoffederalandstateincometaxprovisionTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r3", "r4", "r127", "r137", "r389" ], "calculation": { "http://ruger.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable": { "order": 2.0, "parentTag": "rgr_NetDeferredTaxLiabilitiesAssets", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred Tax Liabilities, Gross", "totalLabel": "Total deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredOtherTaxExpenseBenefit": { "auth_ref": [ "r99", "r100", "r524" ], "calculation": { "http://ruger.com/role/ConsolidatedCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. For example, but not limited to, acquisition-date income tax benefits or expenses recognized from changes in the acquirer's valuation allowance for its previously existing deferred tax assets resulting from a business combination and adjustments to beginning-of-year balance of a valuation allowance because of a change in circumstance causing a change in judgment about the realizability of the related deferred tax asset in future periods.", "label": "Deferred Other Tax Expense (Benefit)", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredOtherTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueAdditions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred revenue recognized for transactions arising during the current reporting period. Deferred revenue is a liability as of the balance sheet date related to a revenue producing activity for which revenue has not yet been recognized. Generally, an Entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.", "label": "Deferred Revenue, Additions", "terseLabel": "Company deferred revenue" } } }, "localname": "DeferredRevenueAdditions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/RevenueRecognitionandContractswithCustomersDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueRevenueRecognized1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously reported as deferred or unearned revenue.", "label": "Deferred Revenue, Revenue Recognized", "negatedLabel": "Revenue recognized", "terseLabel": "Recognized deferred revenue" } } }, "localname": "DeferredRevenueRevenueRecognized1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/RevenueRecognitionandContractswithCustomersDetails", "http://ruger.com/role/ScheduleofrevenuerecognizedTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r524", "r587", "r588" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred State and Local Income Tax Expense (Benefit)", "terseLabel": "State, deferred" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleoffederalandstateincometaxprovisionTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsInventory": { "auth_ref": [ "r98", "r585" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.", "label": "Deferred Tax Assets, Inventory", "terseLabel": "Inventories" } } }, "localname": "DeferredTaxAssetsInventory", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r584" ], "calculation": { "http://ruger.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable": { "order": 1.0, "parentTag": "rgr_NetDeferredTaxLiabilitiesAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Net of Valuation Allowance", "terseLabel": "Total deferred tax assets" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r98", "r585" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Deferred Tax Assets, Other", "terseLabel": "Other" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation": { "auth_ref": [ "r98", "r585" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation", "terseLabel": "Employee compensation and benefits" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "auth_ref": [ "r98", "r585" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost", "terseLabel": "Stock-based compensation" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": { "auth_ref": [ "r98", "r585" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.", "label": "Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss", "terseLabel": "Allowances for doubtful accounts and discounts" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities, Gross [Abstract]", "terseLabel": "Deferred tax liabilities:" } } }, "localname": "DeferredTaxLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts": { "auth_ref": [ "r98", "r585" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from research and development costs.", "label": "Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs", "terseLabel": "Capitalized research and development costs" } } }, "localname": "DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesOther": { "auth_ref": [ "r98", "r585" ], "calculation": { "http://ruger.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.", "label": "Deferred Tax Liabilities, Other", "terseLabel": "Other" } } }, "localname": "DeferredTaxLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": { "auth_ref": [ "r98", "r585" ], "calculation": { "http://ruger.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.", "label": "Deferred Tax Liabilities, Property, Plant and Equipment", "terseLabel": "Depreciation" } } }, "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofdeferredtaxassetsandliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanAdministrativeExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of administrative expense incurred by defined contribution plan.", "label": "Defined Contribution Plan, Administrative Expense", "terseLabel": "Expenses related to matching employee contributions" } } }, "localname": "DefinedContributionPlanAdministrativeExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/EmployeeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.", "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount", "terseLabel": "Supplemental contributions total" } } }, "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/EmployeeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositAssets": { "auth_ref": [ "r514" ], "calculation": { "http://ruger.com/role/ScheduleofOtherAssetsTable": { "order": 2.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement.", "label": "Deposit Assets", "terseLabel": "Deposits on capital items" } } }, "localname": "DepositAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofOtherAssetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r42", "r70" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation", "verboseLabel": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/PropertyPlantandEquipmentDetails", "http://ruger.com/role/ScheduleofoperatingsegmentfinancialinformationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Depreciation [Abstract]", "terseLabel": "Depreciation" } } }, "localname": "DepreciationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofoperatingsegmentfinancialinformationTable" ], "xbrltype": "stringItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r42", "r234" ], "calculation": { "http://ruger.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r343", "r371", "r372", "r373", "r377", "r495" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-Based Payment Arrangement [Text Block]", "terseLabel": "Compensation Plans" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/CompensationPlans" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DisclosureTextBlockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Text Block [Abstract]" } } }, "localname": "DisclosureTextBlockAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DisclosureTextBlockSupplementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Text Block Supplement [Abstract]" } } }, "localname": "DisclosureTextBlockSupplementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DividendsCash": { "auth_ref": [ "r81", "r136" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.", "label": "Dividends, Cash", "terseLabel": "Cash paid" } } }, "localname": "DividendsCash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/AcquisitionofMarlinAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsCommonStock": { "auth_ref": [ "r81", "r136" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Dividends, Common Stock", "negatedLabel": "Dividends paid" } } }, "localname": "DividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPayableAmountPerShare": { "auth_ref": [ "r47" ], "lang": { "en-us": { "role": { "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date.", "label": "Dividends Payable, Amount Per Share", "terseLabel": "Dividend per share", "verboseLabel": "Dividend authorized" } } }, "localname": "DividendsPayableAmountPerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/AccruedDividendsDetails", "http://ruger.com/role/SubsequentEventsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DividendsPayableCurrent": { "auth_ref": [ "r19" ], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Dividends Payable, Current", "terseLabel": "Dividends Payable" } } }, "localname": "DividendsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPayableCurrentAndNoncurrent": { "auth_ref": [ "r1", "r2", "r128", "r140" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.", "label": "Dividends Payable", "terseLabel": "Dividend payable" } } }, "localname": "DividendsPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/AccruedDividendsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r180", "r196", "r197", "r198", "r199", "r200", "r205", "r207", "r213", "r214", "r215", "r219", "r413", "r414", "r447", "r450", "r483" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic Earnings Per Share (in Dollars per share)", "verboseLabel": "Basic earnings per share (in Dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedIncomeStatement", "http://ruger.com/role/ScheduleofquarterlyfinancialinformationTable" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r180", "r196", "r197", "r198", "r199", "r200", "r207", "r213", "r214", "r215", "r219", "r413", "r414", "r447", "r450", "r483" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted Earnings Per Share (in Dollars per share)", "verboseLabel": "Diluted earnings per share (in Dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedIncomeStatement", "http://ruger.com/role/ScheduleofquarterlyfinancialinformationTable" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r50", "r51" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Earnings per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r216", "r217", "r218", "r220" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/EarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r185", "r385", "r401" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "Statutory federal income tax rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofeffectiveincometaxratereconciliationTable" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": { "auth_ref": [ "r401", "r583" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.", "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent", "terseLabel": "Effective income tax rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofeffectiveincometaxratereconciliationTable" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary": { "auth_ref": [ "r583", "r589" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to equity in earnings (loss) of unconsolidated subsidiaries exempt from income taxes.", "label": "Effective Income Tax Rate Reconciliation, Equity in Earnings (Losses) of Unconsolidated Subsidiary, Percent", "terseLabel": "Effective tax rate, percentage" } } }, "localname": "EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/IncomeTaxesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": { "auth_ref": [ "r583", "r589" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent", "terseLabel": "Other" } } }, "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofeffectiveincometaxratereconciliationTable" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r583", "r589" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent", "terseLabel": "State income taxes, net of federal tax benefit" } } }, "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofeffectiveincometaxratereconciliationTable" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": { "auth_ref": [ "r583", "r589" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent", "negatedLabel": "Research and development tax credits" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofeffectiveincometaxratereconciliationTable" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r582" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized compensation cost" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/CompensationPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityClassOfTreasuryStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Equity, Class of Treasury Stock [Line Items]" } } }, "localname": "EquityClassOfTreasuryStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofrepurchasedsharesofitscommonstockTable" ], "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r80", "r151", "r175", "r176", "r177", "r191", "r192", "r193", "r195", "r201", "r203", "r224", "r265", "r312", "r374", "r375", "r376", "r395", "r396", "r412", "r416", "r417", "r418", "r419", "r420", "r421", "r429", "r453", "r454", "r455" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "Fair Value Measurements of Short-term Investments" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_FederalIncomeTaxNoteTable": { "auth_ref": [ "r609" ], "lang": { "en-us": { "role": { "documentation": "Table of federal income tax note for schedule of investments. The federal income tax note may be qualified for security investments, non-security investments and/or for the combination of security and non-security investments.", "label": "Federal Income Tax Note [Table]" } } }, "localname": "FederalIncomeTaxNoteTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleoffederalandstateincometaxprovisionTable" ], "xbrltype": "stringItemType" }, "us-gaap_FederalIncomeTaxNoteTextBlock": { "auth_ref": [ "r609" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the federal tax basis of investment holdings. This item captures the aggregate cost of securities, aggregate gross unrealized appreciation for all securities in which there is an excess of value over tax cost, aggregate gross unrealized depreciation for all securities in which there is an excess of tax cost over value, net unrealized appreciation (depreciation), and an explanation of the differences between tax and book.", "label": "Federal Income Tax Note [Table Text Block]", "terseLabel": "Schedule of federal and state income tax provision" } } }, "localname": "FederalIncomeTaxNoteTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "auth_ref": [ "r425" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.", "label": "Finance Lease, Liability, Noncurrent", "terseLabel": "Noncurrent portion" } } }, "localname": "FinanceLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofrightofuseassetsandrelatedleaseliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancialInstrumentsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.", "label": "Financial Instruments Disclosure [Text Block]", "terseLabel": "Financial Instruments" } } }, "localname": "FinancialInstrumentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/FinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r161", "r284" ], "calculation": { "http://ruger.com/role/ScheduleofOtherAssetsTable": { "order": 5.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofOtherAssetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable": { "auth_ref": [ "r63" ], "lang": { "en-us": { "role": { "documentation": "A table containing detailed characteristics of finite-lived intangible assets acquired during a business combination. Finite-lived intangible assets are assets that have no physical form, but have expected future economic benefit, and are expected to be used over a defined period. Acquired finite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the Entity) and in total. Additionally, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period are also disclosed.", "label": "Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]" } } }, "localname": "FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofestimatedremainingusefullivesTable" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r68" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "Estimated annual patent amortization expense 2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/OtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r68" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "terseLabel": "Estimated annual patent amortization expense 2027" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/OtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r68" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "Estimated annual patent amortization expense 2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/OtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r68" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "Estimated annual patent amortization expense 2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/OtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r68" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "Estimated annual patent amortization expense 2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/OtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r282", "r283", "r284", "r285", "r444", "r445" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/OtherAssetsDetails", "http://ruger.com/role/ScheduleofallocationofpurchasepriceconsiderationTable", "http://ruger.com/role/ScheduleofestimatedremainingusefullivesTable" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r63", "r65" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/OtherAssetsDetails", "http://ruger.com/role/ScheduleofallocationofpurchasepriceconsiderationTable" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedPatentsGross": { "auth_ref": [ "r66" ], "calculation": { "http://ruger.com/role/ScheduleofOtherAssetsTable": { "order": 1.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date of the costs pertaining to the exclusive legal rights granted to the owner of the patent to exploit an invention or a process for a period of time specified by law. Such costs may have been expended to directly apply and receive patent rights, or to acquire such rights.", "label": "Finite-Lived Patents, Gross", "terseLabel": "Patents, at cost" } } }, "localname": "FiniteLivedPatentsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofOtherAssetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedTradeNamesGross": { "auth_ref": [ "r66" ], "calculation": { "http://ruger.com/role/ScheduleofOtherAssetsTable": { "order": 3.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date of the rights acquired through registration of a trade name to gain or protect exclusive use thereof for a reasonably expected period of economic benefit.", "label": "Finite-Lived Trade Names, Gross", "terseLabel": "Marlin trade name" } } }, "localname": "FiniteLivedTradeNamesGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofOtherAssetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfOtherAssets": { "auth_ref": [ "r521" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of other assets.", "label": "Gain (Loss) on Disposition of Other Assets", "terseLabel": "Gain on sale of operating assets" } } }, "localname": "GainLossOnSaleOfOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofotheroperatingincomenetTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "auth_ref": [ "r42" ], "calculation": { "http://ruger.com/role/ConsolidatedCashFlow": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.", "label": "Gain (Loss) on Disposition of Property Plant Equipment", "negatedLabel": "Gain on sale of assets" } } }, "localname": "GainLossOnSaleOfPropertyPlantEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r29" ], "calculation": { "http://ruger.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r160", "r270", "r446", "r485", "r498", "r541", "r542" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofoperatingsegmentfinancialinformationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "auth_ref": [ "r280", "r281", "r485" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.", "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]", "terseLabel": "Goodwill" } } }, "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill [Member]", "terseLabel": "Goodwill [Member]" } } }, "localname": "GoodwillMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofallocationofpurchasepriceconsiderationTable" ], "xbrltype": "domainItemType" }, "us-gaap_GoodwillPeriodIncreaseDecrease": { "auth_ref": [ "r543" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Period Increase (Decrease)", "terseLabel": "Increase to goodwill" } } }, "localname": "GoodwillPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/AcquisitionofMarlinAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r27", "r184", "r239", "r244", "r250", "r253", "r264", "r294", "r295", "r297", "r298", "r299", "r301", "r303", "r305", "r306", "r415", "r484", "r552" ], "calculation": { "http://ruger.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "terseLabel": "Gross profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedIncomeStatement", "http://ruger.com/role/ScheduleofquarterlyfinancialinformationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r69", "r74" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]", "terseLabel": "Long-lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r25", "r124", "r133", "r147", "r239", "r244", "r250", "r253", "r448", "r484" ], "calculation": { "http://ruger.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "terseLabel": "Income before income taxes", "verboseLabel": "Income (Loss) Before Income Taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedIncomeStatement", "http://ruger.com/role/ScheduleofoperatingsegmentfinancialinformationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r185", "r386", "r387", "r391", "r397", "r402", "r404", "r405", "r406" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r186", "r202", "r203", "r237", "r384", "r398", "r403", "r451" ], "calculation": { "http://ruger.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r174", "r380", "r381", "r387", "r388", "r390", "r394" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r46" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Income tax payments" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r41" ], "calculation": { "http://ruger.com/role/ConsolidatedCashFlow": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Trade accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r41" ], "calculation": { "http://ruger.com/role/ConsolidatedCashFlow": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Trade receivables" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r441", "r520" ], "calculation": { "http://ruger.com/role/ConsolidatedCashFlow": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "terseLabel": "Contract liability with customers" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": { "auth_ref": [ "r41" ], "calculation": { "http://ruger.com/role/ConsolidatedCashFlow": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Increase (Decrease) in Employee Related Liabilities", "terseLabel": "Employee compensation and benefits" } } }, "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable": { "auth_ref": [ "r520" ], "calculation": { "http://ruger.com/role/ConsolidatedCashFlow": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes.", "label": "Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable", "terseLabel": "Income taxes receivable/payable" } } }, "localname": "IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r41" ], "calculation": { "http://ruger.com/role/ConsolidatedCashFlow": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": { "auth_ref": [ "r41" ], "calculation": { "http://ruger.com/role/ConsolidatedCashFlow": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net", "negatedLabel": "Prepaid expenses, other assets and other liabilities" } } }, "localname": "IncreaseDecreaseInOtherOperatingCapitalNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r208", "r209", "r210", "r215", "r342" ], "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "terseLabel": "Dilutive effect of options and restricted stock units outstanding under the Company\u2019s employee compensation plans" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofareconciliationofthenumeratoranddenominatorforthebasicanddilutedearningspershareTable" ], "xbrltype": "sharesItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r122", "r135", "r178", "r233", "r423" ], "calculation": { "http://ruger.com/role/ConsolidatedIncomeStatement": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r269" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r515" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Inventory, Finished Goods, Gross", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofinventoriesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryGross": { "auth_ref": [ "r517" ], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Inventory, Gross", "terseLabel": "Gross inventories" } } }, "localname": "InventoryGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet", "http://ruger.com/role/ScheduleofinventoriesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryLIFOReserve": { "auth_ref": [ "r516" ], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount by which inventory stated at last-in first-out (LIFO) is less than (in excess of) inventory stated at other inventory cost methods.", "label": "Inventory, LIFO Reserve", "negatedLabel": "Less LIFO reserve", "negatedTerseLabel": "Less: LIFO reserve" } } }, "localname": "InventoryLIFOReserve", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet", "http://ruger.com/role/ScheduleofinventoriesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r170", "r477", "r498" ], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Net Inventories", "totalLabel": "Net inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet", "http://ruger.com/role/ScheduleofinventoriesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory, Net [Abstract]", "terseLabel": "Inventory at FIFO" } } }, "localname": "InventoryNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofinventoriesTable" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r156", "r169", "r221", "r267", "r268", "r269", "r442", "r480" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryValuationReserves": { "auth_ref": [ "r60", "r517" ], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation reserve for inventory.", "label": "Inventory Valuation Reserves", "negatedLabel": "Less excess and obsolescence reserve", "negatedTerseLabel": "Less: excess and obsolescence reserve" } } }, "localname": "InventoryValuationReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet", "http://ruger.com/role/ScheduleofinventoriesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessAndRawMaterials": { "auth_ref": [ "r517" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate carrying amount as of the balance sheet date of items held by the entity which are partially completed at the time of measurement and unprocessed items that will go through the production process and become part of the final product. Includes supplies used directly or indirectly in the manufacturing or production process. This element may be used when the reporting entity combines work in process and raw materials into an aggregate amount.", "label": "Inventory, Work in Process and Raw Materials", "terseLabel": "Materials and products in process" } } }, "localname": "InventoryWorkInProcessAndRawMaterials", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofinventoriesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r30", "r232" ], "calculation": { "http://ruger.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "terseLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsOwnedFederalIncomeTaxNoteLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of federal and state income tax provision [Abstract]" } } }, "localname": "InvestmentsOwnedFederalIncomeTaxNoteLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleoffederalandstateincometaxprovisionTable" ], "xbrltype": "stringItemType" }, "us-gaap_LandAndLandImprovementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Real estate held and assets that are an addition or improvement to real estate held.", "label": "Land and Land Improvements [Member]", "terseLabel": "Land and improvements [Member]" } } }, "localname": "LandAndLandImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofpropertyplantandequipmentTable" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseContractualTermAxis": { "auth_ref": [ "r593" ], "lang": { "en-us": { "role": { "documentation": "Information by contractual term of lease arrangement.", "label": "Lease Contractual Term [Axis]" } } }, "localname": "LeaseContractualTermAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofoperatingleaseliabilitiesTable" ], "xbrltype": "stringItemType" }, "us-gaap_LegalMattersAndContingenciesTextBlock": { "auth_ref": [ "r76" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.", "label": "Legal Matters and Contingencies [Text Block]", "terseLabel": "Contingent Liabilities" } } }, "localname": "LegalMattersAndContingenciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ContingentLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r594" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Schedule of operating lease liabilities" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/LeasedAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r427" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "terseLabel": "Total undiscounted future minimum lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofoperatingleaseliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r427" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofoperatingleaseliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r427" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofoperatingleaseliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r427" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "terseLabel": "2027" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofoperatingleaseliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r427" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofoperatingleaseliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r427" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofoperatingleaseliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r427" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofoperatingleaseliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r427" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less: Difference between undiscounted lease payments & the present value of future lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofoperatingleaseliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r428" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "Leased Assets" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/LeasedAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r11", "r129", "r143", "r498", "r523", "r540", "r592" ], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Stockholders\u2019 Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r20", "r155", "r184", "r264", "r294", "r295", "r297", "r298", "r299", "r301", "r303", "r305", "r306", "r409", "r410", "r411", "r415", "r498", "r552", "r597", "r598" ], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilityReserveEstimatePolicy": { "auth_ref": [ "r148" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for estimating its liability as of the balance sheet date for the ultimate cost of settling reported and unreported claims incurred and claims adjustment expenses (including effects of inflation and other societal and economic factors).", "label": "Liability Reserve Estimate, Policy [Policy Text Block]", "terseLabel": "Product Liability" } } }, "localname": "LiabilityReserveEstimatePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_LineOfCreditFacilityExpirationDate1": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Date the credit facility terminates, in YYYY-MM-DD format.", "label": "Line of Credit Facility, Expiration Date", "terseLabel": "Revolving credit facility, expiration date" } } }, "localname": "LineOfCreditFacilityExpirationDate1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/LineofCreditDetails" ], "xbrltype": "dateItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r17" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Credit facility with a bank" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/LineofCreditDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.", "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage", "terseLabel": "Line of credit unused portion per year" } } }, "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/LineofCreditDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]", "terseLabel": "Line of Credit [Member]" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/LineofCreditDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": { "auth_ref": [ "r536" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.", "label": "Loans, Notes, Trade and Other Receivables Disclosure [Text Block]", "terseLabel": "Trade Receivables, Net" } } }, "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/TradeReceivablesNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "auth_ref": [ "r77", "r78", "r289", "r290", "r291", "r546", "r548" ], "lang": { "en-us": { "role": { "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.", "label": "Loss Contingency Nature [Axis]" } } }, "localname": "LossContingenciesByNatureOfContingencyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ContingentLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyClaimsSettledNumber": { "auth_ref": [ "r546", "r548" ], "lang": { "en-us": { "role": { "documentation": "Number of claims settled.", "label": "Loss Contingency, Claims Settled, Number", "terseLabel": "Number of settled lawsuits" } } }, "localname": "LossContingencyClaimsSettledNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ContingentLiabilitiesDetails" ], "xbrltype": "integerItemType" }, "us-gaap_LossContingencyDamagesSoughtValue": { "auth_ref": [ "r545", "r546", "r548" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.", "label": "Loss Contingency, Damages Sought, Value", "terseLabel": "Total amount of damages claimed (in Dollars)" } } }, "localname": "LossContingencyDamagesSoughtValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ContingentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyNatureDomain": { "auth_ref": [ "r77", "r78", "r289", "r290", "r291", "r546", "r548" ], "lang": { "en-us": { "role": { "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.", "label": "Loss Contingency, Nature [Domain]" } } }, "localname": "LossContingencyNatureDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ContingentLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingencyNewClaimsFiledNumber": { "auth_ref": [ "r546", "r548" ], "lang": { "en-us": { "role": { "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.", "label": "Loss Contingency, New Claims Filed, Number", "terseLabel": "Number of new lawsuits" } } }, "localname": "LossContingencyNewClaimsFiledNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ContingentLiabilitiesDetails" ], "xbrltype": "integerItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]", "terseLabel": "Machinery and Equipment [Member]", "verboseLabel": "Machinery and equipment [Member]" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofallocationofpurchasepriceconsiderationTable", "http://ruger.com/role/ScheduleofpropertyplantandequipmentTable", "http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r182" ], "calculation": { "http://ruger.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Cash used for financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r182" ], "calculation": { "http://ruger.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Cash provided by (used for) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r39", "r40", "r43" ], "calculation": { "http://ruger.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r26", "r43", "r134", "r146", "r153", "r172", "r173", "r177", "r184", "r194", "r196", "r197", "r198", "r199", "r202", "r203", "r212", "r239", "r244", "r250", "r253", "r264", "r294", "r295", "r297", "r298", "r299", "r301", "r303", "r305", "r306", "r414", "r415", "r484", "r552" ], "calculation": { "http://ruger.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://ruger.com/role/ConsolidatedIncomeStatement": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net income", "totalLabel": "Net income and comprehensive income" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedCashFlow", "http://ruger.com/role/ConsolidatedIncomeStatement", "http://ruger.com/role/ScheduleofquarterlyfinancialinformationTable", "http://ruger.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Attributable to Parent [Abstract]", "terseLabel": "Numerator:" } } }, "localname": "NetIncomeLossAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofareconciliationofthenumeratoranddenominatorforthebasicanddilutedearningspershareTable" ], "xbrltype": "stringItemType" }, "us-gaap_NonUsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Countries excluding the United States of America (US).", "label": "Non-US [Member]", "terseLabel": "Non-US [Member]" } } }, "localname": "NonUsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r31" ], "calculation": { "http://ruger.com/role/ConsolidatedIncomeStatement": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income, net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonvotingCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock securities that do not empower a holder to vote on corporate resolutions or the election of directors.", "label": "Nonvoting Common Stock [Member]", "terseLabel": "Nonvoting Common Stock" } } }, "localname": "NonvotingCommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet", "http://ruger.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "domainItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r533" ], "lang": { "en-us": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of Operating Segments", "terseLabel": "Number of Operating Segments" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/OperatingSegmentInformationDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://ruger.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r239", "r244", "r250", "r253", "r484" ], "calculation": { "http://ruger.com/role/ConsolidatedIncomeStatement": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating income" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r425" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Total operating lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofoperatingleaseliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r425" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Current portion" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofrightofuseassetsandrelatedleaseliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r425" ], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Lease liability (Note 8)" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r424" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofrightofuseassetsandrelatedleaseliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r426", "r497" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Lease term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/LeasedAssetsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r243", "r244", "r245", "r246", "r247", "r253" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating Segments [Member]" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofoperatingsegmentfinancialinformationTable" ], "xbrltype": "domainItemType" }, "us-gaap_OtherAccountsPayableAndAccruedLiabilities": { "auth_ref": [], "calculation": { "http://ruger.com/role/ScheduleoftradeaccountspayableandaccruedexpensesTable": { "order": 3.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer.", "label": "Other Accounts Payable and Accrued Liabilities", "terseLabel": "Accrued other" } } }, "localname": "OtherAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleoftradeaccountspayableandaccruedexpensesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.", "label": "Other Assets Disclosure [Text Block]", "terseLabel": "Other Assets" } } }, "localname": "OtherAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/OtherAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsMember": { "auth_ref": [ "r116", "r118" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other assets.", "label": "Other Assets [Member]", "terseLabel": "Other Assets [Member]" } } }, "localname": "OtherAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofrightofuseassetsandrelatedleaseliabilitiesTable" ], "xbrltype": "domainItemType" }, "us-gaap_OtherAssetsMiscellaneous": { "auth_ref": [], "calculation": { "http://ruger.com/role/ScheduleofOtherAssetsTable": { "order": 4.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other miscellaneous assets.", "label": "Other Assets, Miscellaneous", "terseLabel": "Other" } } }, "localname": "OtherAssetsMiscellaneous", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofOtherAssetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r162" ], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://ruger.com/role/ScheduleofOtherAssetsTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other assets", "totalLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet", "http://ruger.com/role/ScheduleofOtherAssetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Component of Operating Income [Abstract]", "terseLabel": "Other income:" } } }, "localname": "OtherIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_OtherIncomeAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Income and Expenses [Abstract]" } } }, "localname": "OtherIncomeAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": { "auth_ref": [ "r86", "r94" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.", "label": "Other Income and Other Expense Disclosure [Text Block]", "terseLabel": "Other Operating Income, Net" } } }, "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/OtherOperatingIncomeNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r32" ], "calculation": { "http://ruger.com/role/ConsolidatedIncomeStatement": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other income, net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherOperatingIncomeExpenseNet": { "auth_ref": [], "calculation": { "http://ruger.com/role/ConsolidatedIncomeStatement": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.", "label": "Other Operating Income (Expense), Net", "negatedLabel": "Other operating expense (income), net" } } }, "localname": "OtherOperatingIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_PatentsMember": { "auth_ref": [ "r111" ], "lang": { "en-us": { "role": { "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.", "label": "Patents [Member]", "terseLabel": "Patents [Member]" } } }, "localname": "PatentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/OtherAssetsDetails", "http://ruger.com/role/ScheduleofallocationofpurchasepriceconsiderationTable", "http://ruger.com/role/ScheduleofestimatedremainingusefullivesTable" ], "xbrltype": "domainItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trade Accounts Payable and Accrued Expenses [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r38" ], "calculation": { "http://ruger.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Repurchase of common stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsCommonStock": { "auth_ref": [ "r38" ], "calculation": { "http://ruger.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.", "label": "Payments of Ordinary Dividends, Common Stock", "negatedLabel": "Dividends paid" } } }, "localname": "PaymentsOfDividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r181" ], "calculation": { "http://ruger.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payment, Tax Withholding, Share-Based Payment Arrangement", "negatedLabel": "Payment of employee withholding tax related to share-based compensation" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r35" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "terseLabel": "Cash paid to sellers" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofallocationofpurchasepriceconsiderationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireInvestments": { "auth_ref": [ "r37" ], "calculation": { "http://ruger.com/role/ConsolidatedCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.", "label": "Payments to Acquire Investments", "negatedLabel": "Purchases of short-term investments" } } }, "localname": "PaymentsToAcquireInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r36" ], "calculation": { "http://ruger.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Property, plant, and equipment additions", "terseLabel": "Capital Expenditures" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedCashFlow", "http://ruger.com/role/ScheduleofoperatingsegmentfinancialinformationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "auth_ref": [ "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r340", "r491" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for retirement benefits.", "label": "Retirement Benefits [Text Block]", "terseLabel": "Employee Benefit Plans" } } }, "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/EmployeeBenefitPlans" ], "xbrltype": "textBlockItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/CompensationPlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/CompensationPlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r519" ], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments": { "auth_ref": [ "r34" ], "calculation": { "http://ruger.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.", "label": "Proceeds from Sale, Maturity and Collection of Investments", "terseLabel": "Proceeds from maturity of short-term investments" } } }, "localname": "ProceedsFromSaleMaturityAndCollectionsOfInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "auth_ref": [ "r33" ], "calculation": { "http://ruger.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.", "label": "Proceeds from Sale of Property, Plant, and Equipment", "terseLabel": "Net proceeds from sale of assets" } } }, "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductLiabilityAccrualComponentAmount": { "auth_ref": [ "r486" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Recorded amount of the accrual for a material component of a product liability contingency.", "label": "Product Liability Accrual, Component Amount", "terseLabel": "Total Product Liability Expense" } } }, "localname": "ProductLiabilityAccrualComponentAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofproductliabilityexpenseTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductLiabilityAccrualPeriodExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of loss reported during the period pertaining to product liability.", "label": "Product Liability Accrual, Period Expense", "terseLabel": "Insurance Premium Expense", "verboseLabel": "Total Product Liability Expense (in Dollars)" } } }, "localname": "ProductLiabilityAccrualPeriodExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ContingentLiabilitiesDetails", "http://ruger.com/role/ScheduleofproductliabilityexpenseTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductLiabilityContingenciesTextBlock": { "auth_ref": [ "r545", "r547", "r549", "r550", "r551" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of exposure to material amount of loss arising from allegations of damages pertaining to and arising from one or more of the entity's products.", "label": "Product Liability Contingencies [Table Text Block]", "terseLabel": "Schedule of product liability expense" } } }, "localname": "ProductLiabilityContingenciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ContingentLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProductLiabilityContingencyLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Liability Contingency [Line Items]" } } }, "localname": "ProductLiabilityContingencyLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofproductliabilityexpenseTable" ], "xbrltype": "stringItemType" }, "us-gaap_ProductLiabilityContingencyTable": { "auth_ref": [ "r292", "r545", "r547", "r549" ], "lang": { "en-us": { "role": { "documentation": "Information and financial data about the reasonably possible loss or the recognized and additional reasonably possible loss from product liability related to an individual product.", "label": "Product Liability Contingency [Table]" } } }, "localname": "ProductLiabilityContingencyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofproductliabilityexpenseTable" ], "xbrltype": "stringItemType" }, "us-gaap_ProductWarrantyLiabilityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Warranty Liability [Line Items]" } } }, "localname": "ProductWarrantyLiabilityLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofrollforwardforproductliabilityreserveTable" ], "xbrltype": "stringItemType" }, "us-gaap_ProductWarrantyLiabilityTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about product warranty liability, including, but not limited to, reductions in the liability for payments made under the warranty, changes in the liability for accruals related to product warranties issued, and changes in the liability for accruals related to preexisting warranties.", "label": "Product Warranty Liability [Table]" } } }, "localname": "ProductWarrantyLiabilityTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofrollforwardforproductliabilityreserveTable" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract] [Standard Label]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r73" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofpropertyplantandequipmentTable", "http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r75", "r461", "r462", "r463" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/PropertyPlantandEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r71", "r158" ], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Property, Plant, and Equipment", "verboseLabel": "Property, plant and equipment" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet", "http://ruger.com/role/ScheduleofpropertyplantandequipmentTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofpropertyplantandequipmentTable" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r73", "r144", "r449", "r498" ], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "totalLabel": "Net property, plant and equipment" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentOtherNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after depreciation of long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.", "label": "Property, Plant and Equipment, Other, Net", "terseLabel": "Net property, plant and equipment" } } }, "localname": "PropertyPlantAndEquipmentOtherNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofpropertyplantandequipmentTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r73", "r461", "r462" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property, Plant, and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r73" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Schedule of property, plant and equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/PropertyPlantandEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r71" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofpropertyplantandequipmentTable", "http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Useful life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Quarterly Financial Information Disclosure [Abstract]" } } }, "localname": "QuarterlyFinancialInformationDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_QuarterlyFinancialInformationTextBlock": { "auth_ref": [ "r52", "r223" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.", "label": "Quarterly Financial Information [Text Block]", "terseLabel": "Quarterly Results of Operations (Unaudited)" } } }, "localname": "QuarterlyFinancialInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/QuarterlyResultsofOperationsUnaudited" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Receivables [Abstract]" } } }, "localname": "ReceivablesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ReceivablesPolicyTextBlock": { "auth_ref": [ "r535", "r537", "r538", "r539" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.", "label": "Receivable [Policy Text Block]", "terseLabel": "Accounts Receivable" } } }, "localname": "ReceivablesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "auth_ref": [ "r123", "r432" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transactions with related party during the financial reporting period.", "label": "Related Party Transaction, Amounts of Transaction", "terseLabel": "Amount paid" } } }, "localname": "RelatedPartyTransactionAmountsOfTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r150", "r432", "r433", "r596" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract] [Standard Label]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r430", "r431", "r433", "r434", "r435" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r95", "r149", "r605" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r95" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development Expense, Policy [Policy Text Block]", "terseLabel": "Research and Development" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedStockExpense": { "auth_ref": [ "r42" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement.", "label": "Restricted Stock or Unit Expense", "terseLabel": "Cost of issuances restricted stock units" } } }, "localname": "RestrictedStockExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/CompensationPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted Stock Units (RSUs) [Member]" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/CompensationPlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r8", "r81", "r142", "r456", "r457", "r498" ], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r151", "r191", "r192", "r193", "r195", "r201", "r203", "r265", "r374", "r375", "r376", "r395", "r396", "r412", "r453", "r455" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contracts with Customers [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r324", "r325" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenue Recognition and Contracts with Customers" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/RevenueRecognitionandContractswithCustomers" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r481", "r482" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r179", "r184", "r230", "r231", "r243", "r248", "r249", "r255", "r256", "r259", "r264", "r294", "r295", "r297", "r298", "r299", "r301", "r303", "r305", "r306", "r415", "r448", "r552" ], "calculation": { "http://ruger.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Total net sales", "verboseLabel": "Net Sales" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedIncomeStatement", "http://ruger.com/role/ScheduleofoperatingsegmentfinancialinformationTable", "http://ruger.com/role/ScheduleofquarterlyfinancialinformationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_RoyaltyIncomeNonoperating": { "auth_ref": [ "r31" ], "calculation": { "http://ruger.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Ancillary revenue earned during the period from the consideration paid to the entity for the use of its rights and property by another party. Examples include licensing the use of copyrighted materials and leasing the extraction of natural resources.", "label": "Royalty Income, Nonoperating", "terseLabel": "Royalty income" } } }, "localname": "RoyaltyIncomeNonoperating", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesMember": { "auth_ref": [ "r117" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business.", "label": "Sales [Member]", "terseLabel": "Sales [Member]" } } }, "localname": "SalesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r259", "r531" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]", "terseLabel": "Revenue Benchmark [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/OperatingSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleoftradereceivablesTable" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]", "terseLabel": "Schedule of trade receivables" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/TradeReceivablesNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.", "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]", "terseLabel": "Schedule of trade accounts payable and accrued expenses" } } }, "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/TradeAccountsPayableandAccruedExpensesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r97" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "terseLabel": "Schedule of deferred tax assets and liabilities" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r530" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of a reconciliation of the numerator and denominator for the basic and diluted earnings per share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r96" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Schedule of effective income tax rate reconciliation" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock": { "auth_ref": [ "r63" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.", "label": "Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]", "terseLabel": "Schedule of estimated remaining useful lives" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/AcquisitionofMarlinAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r0", "r12", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Schedule of inventories" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.", "label": "Schedule of Other Assets [Table Text Block]", "terseLabel": "Schedule of Other Assets" } } }, "localname": "ScheduleOfOtherAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/OtherAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "auth_ref": [ "r79" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.", "label": "Schedule of Product Warranty Liability [Table Text Block]", "terseLabel": "Schedule of roll-forward for product liability reserve" } } }, "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ContingentLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r73" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table] [Standard Label]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofpropertyplantandequipmentTable" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": { "auth_ref": [ "r222" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.", "label": "Quarterly Financial Information [Table Text Block]", "terseLabel": "Schedule of quarterly financial information" } } }, "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/QuarterlyResultsofOperationsUnauditedTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r108" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Schedule of allocation of purchase price consideration" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/AcquisitionofMarlinAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r56", "r57", "r58", "r61" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofoperatingsegmentfinancialinformationTable" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r56", "r57", "r58", "r61" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of Operating Segment Financial Information" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/OperatingSegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": { "auth_ref": [ "r82", "r83", "r84", "r85" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.", "label": "Class of Treasury Stock [Table Text Block]", "terseLabel": "Schedule of repurchased shares of its common stock" } } }, "localname": "ScheduleOfTreasuryStockByClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/StockRepurchasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r227", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r253", "r259", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r287", "r288", "r485", "r606" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofoperatingsegmentfinancialinformationTable", "http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r227", "r228", "r229", "r239", "r242", "r247", "r251", "r252", "r253", "r254", "r255", "r258", "r259", "r260" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Operating Segment Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/OperatingSegmentInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofoperatingsegmentfinancialinformationTable" ], "xbrltype": "stringItemType" }, "us-gaap_SellingExpense": { "auth_ref": [ "r29" ], "calculation": { "http://ruger.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenses recognized in the period that are directly related to the selling and distribution of products or services.", "label": "Selling Expense", "terseLabel": "Selling" } } }, "localname": "SellingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r41" ], "calculation": { "http://ruger.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r495" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "terseLabel": "Vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/CompensationPlansDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r496" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized", "terseLabel": "Shares reserved for future issuance (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/CompensationPlansDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r91" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant", "terseLabel": "Shares available for future grants (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/CompensationPlansDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/CompensationPlansDetails", "http://ruger.com/role/ScheduleofrightofuseassetsandrelatedleaseliabilitiesTable" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationEffectOnEarningsPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of treatment of share-based payment arrangement in earnings per share computation.", "label": "Share-Based Payment Arrangement, Earnings Per Share Computation, Description", "terseLabel": "Customer payment description" } } }, "localname": "SharebasedCompensationEffectOnEarningsPerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermInvestments": { "auth_ref": [ "r130", "r131", "r138", "r518" ], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.", "label": "Short-Term Investments", "terseLabel": "Short-term investments" } } }, "localname": "ShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r49", "r183" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/SummaryofSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r152", "r227", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r253", "r259", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r286", "r287", "r288", "r485", "r606" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofoperatingsegmentfinancialinformationTable", "http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r164", "r165", "r166", "r184", "r207", "r211", "r213", "r215", "r225", "r226", "r264", "r294", "r297", "r298", "r299", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r415", "r475", "r511", "r522", "r529" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet", "http://ruger.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r23", "r80", "r151", "r175", "r176", "r177", "r191", "r192", "r193", "r195", "r201", "r203", "r224", "r265", "r312", "r374", "r375", "r376", "r395", "r396", "r412", "r416", "r417", "r418", "r419", "r420", "r421", "r429", "r453", "r454", "r455" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet", "http://ruger.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://ruger.com/role/ConsolidatedIncomeStatement", "http://ruger.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r191", "r192", "r193", "r224", "r443" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet", "http://ruger.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://ruger.com/role/ConsolidatedIncomeStatement", "http://ruger.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "auth_ref": [ "r80", "r81" ], "lang": { "en-us": { "role": { "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross", "terseLabel": "Restricted stock units issued (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/CompensationPlansDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r5", "r6", "r81", "r89" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Common stock issued \u2013 compensation plans" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.", "label": "Stock Repurchase Program, Number of Shares Authorized to be Repurchased", "terseLabel": "Total Number of Shares Purchased as Part of Publicly Announced Program" } } }, "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofrepurchasedsharesofitscommonstockTable" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount remaining of a stock repurchase plan authorized.", "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount", "terseLabel": "Share repurchase authorization" } } }, "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/StockRepurchasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r5", "r6", "r80", "r81" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Shares", "terseLabel": "Repurchase of common stock" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ShareholdersEquityType2or3_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r5", "r6", "r80", "r81" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Value", "negatedLabel": "Repurchase of 4,440 shares of common stock" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r6", "r9", "r10", "r59", "r498", "r523", "r540", "r592" ], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total Stockholders\u2019 Equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet", "http://ruger.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholders\u2019 Equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r422", "r437" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/AccruedDividendsDetails", "http://ruger.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r422", "r437" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/AccruedDividendsDetails", "http://ruger.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r422", "r437" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/AccruedDividendsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r436", "r438" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_TaxesPayableCurrent": { "auth_ref": [ "r18" ], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Taxes Payable, Current", "terseLabel": "Income taxes payable" } } }, "localname": "TaxesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityNetIncome": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of net income or loss attributable to temporary equity interest.", "label": "Temporary Equity, Net Income", "terseLabel": "Net income (in Dollars)" } } }, "localname": "TemporaryEquityNetIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofareconciliationofthenumeratoranddenominatorforthebasicanddilutedearningspershareTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_ToolsDiesAndMoldsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used to cut, shape, and form metal and other materials into goods for sale.", "label": "Tools, Dies and Molds [Member]", "terseLabel": "Dies and tools [Member]", "verboseLabel": "Tools, Dies and Molds [Member]" } } }, "localname": "ToolsDiesAndMoldsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofpropertyplantandequipmentTable", "http://ruger.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TrademarksAndTradeNamesMember": { "auth_ref": [ "r109" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trademarks and Trade Names [Member]", "terseLabel": "Tradename and trademarks [Member]", "verboseLabel": "Trademarks and Trade Names [Member]" } } }, "localname": "TrademarksAndTradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofallocationofpurchasepriceconsiderationTable", "http://ruger.com/role/ScheduleofestimatedremainingusefullivesTable" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockAcquiredAverageCostPerShare": { "auth_ref": [ "r82" ], "lang": { "en-us": { "role": { "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.", "label": "Treasury Stock Acquired, Average Cost Per Share", "terseLabel": "Average Price Paid per Share (in Dollars per share)" } } }, "localname": "TreasuryStockAcquiredAverageCostPerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofrepurchasedsharesofitscommonstockTable" ], "xbrltype": "perShareItemType" }, "us-gaap_TreasuryStockCommonShares": { "auth_ref": [ "r82" ], "lang": { "en-us": { "role": { "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common, Shares", "terseLabel": "Total Number of Shares Purchased" } } }, "localname": "TreasuryStockCommonShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofrepurchasedsharesofitscommonstockTable" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r22", "r82" ], "lang": { "en-us": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]", "terseLabel": "Treasury Stock" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockShares": { "auth_ref": [ "r22", "r82" ], "lang": { "en-us": { "role": { "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.", "label": "Treasury Stock, Shares", "terseLabel": "Treasury stock, shares" } } }, "localname": "TreasuryStockShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r22", "r82", "r85" ], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedLabel": "Less: Treasury stock \u2013 at cost 2021 \u2013 6,709,898 shares 2020 \u2013 6,709,898 shares" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesBalance": { "auth_ref": [ "r188", "r190" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount", "periodEndLabel": "Balance End of Year", "periodStartLabel": "Balance Beginning of Year" } } }, "localname": "ValuationAllowancesAndReservesBalance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofrollforwardforproductliabilityreserveTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": { "auth_ref": [ "r189" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense", "terseLabel": "Accrued Legal Expense (Income)", "verboseLabel": "Accrued Legal Expense" } } }, "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofproductliabilityexpenseTable", "http://ruger.com/role/ScheduleofrollforwardforproductliabilityreserveTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r206", "r215" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted average number of common shares outstanding \u2013 Diluted (in Shares)", "verboseLabel": "Weighted average number of common shares outstanding \u2013 Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedIncomeStatement", "http://ruger.com/role/ScheduleofareconciliationofthenumeratoranddenominatorforthebasicanddilutedearningspershareTable" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Denominator:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ScheduleofareconciliationofthenumeratoranddenominatorforthebasicanddilutedearningspershareTable" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r205", "r215" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted average number of common shares outstanding \u2013 Basic (in Shares)", "verboseLabel": "Weighted average number of common shares outstanding \u2013 Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedIncomeStatement", "http://ruger.com/role/ScheduleofareconciliationofthenumeratoranddenominatorforthebasicanddilutedearningspershareTable" ], "xbrltype": "sharesItemType" }, "us-gaap_WorkersCompensationLiabilityCurrent": { "auth_ref": [ "r19" ], "calculation": { "http://ruger.com/role/ConsolidatedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Workers' Compensation Liability, Current", "terseLabel": "Workers\u2019 compensation" } } }, "localname": "WorkersCompensationLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://ruger.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)-(d)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(4))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(g))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(5))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r148": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/subtopic&trid=2560295", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column B))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column E))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900988&loc=d3e1280-108306", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900988&loc=SL124452896-108306", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org/topic&trid=2134510", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(l)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(o)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(p)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(q)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(r)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "60", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "https://asc.fasb.org/topic&trid=2235017", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(b)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/subtopic&trid=77888251", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r49": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r502": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r503": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r504": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r505": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r506": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r507": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r508": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r509": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r52": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "270", "URI": "https://asc.fasb.org/topic&trid=2126967", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r536": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/subtopic&trid=2196772", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q1)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "15", "SubTopic": "50", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.BB)", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(h)(2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=126898976&loc=d3e600178-122990", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "610", "URI": "https://asc.fasb.org/topic&trid=49130413", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "720", "URI": "https://asc.fasb.org/topic&trid=2122503", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 104 0001174947-23-000239-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001174947-23-000239-xbrl.zip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ǖ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

8BX_]%]4N);_0KF.[E+TZ M0JAV*:I=2JC:I=1N7ZI=BO+B*!#K[ O;V"Z%&J4$[ #CS0-::['E:55 ,_OMRH+6*P(T)0[JR\@4 MB+45!Y]$3&*_5.-<7$)O-:I;:M+M-JH[X[#7KRYP+:/94.S_>3,N!6)MV?\* M:^!@4J'5JS!GZU86M&:%C8$BA+R:6J+"\&IJ20W"GRH,7Z]]J3"\"L,_-\5: M@5@'\Z2.87A=[S<6.&J=P[P=O9$O E*3_>CMWFGE%1B=;M&)!-(Y2[I<'-*-;V10!LU5=T,PB0%/BH+Z,3(%86W%PN(B+T6]4-[#1 MU:L+7+MGY#0FC@!<1R\&.,7^Z\NX%(BU9?_'CL.;[> M;X6V!S\#*<5]QW9!0?OLS?SPGOUC9OE C/#"J-N\Y8[8[[X7T,SAKNGCB :&WH!-0.)FJH@9QAIA)4[PLJ4L')^-K)" MB\'-H)8L(5 K9Q, Z#[ 'B]\Q%Z-,)?'#UBJ#4<4,L M;R$]H:"TI7=L.2K6QY6*AVS5@2Q+M#H4MK:!Z2,?\LF ^P)5>?_/U+5?!OZ; M]]L]M:;?RVZ[7[71W*EOBGX5_6Y%OZMRIA3]*OK=":8/]Y9[QQ55*:HJ$J:7 MVS&V$HA0:,*H8*+>N4D;+I1DCY5U)UQ!:!J-;9];_B00-M*"3^DHO4AZ.8-$ M-4GJTCO=G#64-=G0*[W7R#>[;>UK7Y>QE_586KDAO8@\PM>BZ.D%=#*P@Q9K947.U4MY+KV?RL9IMUY)$L*;'?6TG='42%IGJCB7J' M&UNO]!Q1I;<:O9<'0)12"!2(IP_BX16"6R^T'&KQGU$'RL*4WLI;#W:LL]0[ MO9Q]/(\%87[;<8W!6!YP^LX'K(P_!>+S ?'PO/[#LN2-4]%#FTM:P"F%?1FB M6@I1>1#57E0#%)H6T:3L/R7-%(BUU0E^3V5MYKK&!HZ/8R-O-G#X#DPI_7BN M0-J6J\3-P',*N>Q*Q3/P>J"K8RYV'E;H6HFN5X:Y:($7AZ^%J.XQ4+7CH2W' ME[FD>72!^%)^ P7BLP'Q6#J"**HH&TU&I]%>L",TFZJ.D^HXS::JX]RPR_+K.&$3@_QEE3]X,'-" M&M7^;O08T_PX_.SY;]NOOWEC5T"0N#4(IR4@>_<%''ENC/+83>S"3S]Q/YP[9!] MM$*KI'+:TC?^.4H&G^%.XBI88LCP@ R] !8T%MS;TPG>92J?Y:*1A>T^P$>> M_Z2=G^'',EDO8 $/9]. O;+8A%O!S"=N,$;=#M"6+/N: 54A@8T]Q_$>@\)+ M:M?=I7I4SZJV]/M/ :CTSK:,V]1G9XMS(543=^47J ^(!ZK5ZLS7EL14A^I% M(#K(EM,??06J-E0W:3VSK;6;E1Y8OM/.3*W9TK7N">Y,U\R.KNE%[TPU%ZPO M=ZL!B$?IW">8[G>973U;FZ-[XB,S>AHAF)LSYQKU #$ MLAC;LH;*.R(E7[?=RLY2,8WJ#BQI%MJC6.5%*1"KQ856[U'H5E2)K[_;L[_[ M%GH!PIG7$W<\[:6MZ]77!'O=@F!4_$N!6'/^]0'3/=PG=AV%]TNW%IN5]X'U MM%[%(>QTE?/KV;..&H!X1.=7Q. ^VD'HVX,9\+:$R;%7>ND-)_1.JR!'3GDP MFOW*@VATFXK7/7M&4@,0C\+K/D19F#>4A5FZWM'36IVC.*7R@]C1FJVCC!W+ M#Z*AM5N[-DI:2G+SU2;E)9'+#VUWQ''!9J-MNPE01\O6GIN]38G+\Q/XZIBW MO2)=[%5J.!'C/X<OXAW52_15R=GUVYE*SE9::YU!/'IR]IQRL;"E(XQIZ#0[IS5W MHM\W&OD,BYILR.SW%EO7J!SLY\K$:@#B(1-ZJ-!ZSF9[9>SJD\V5L6)6.,^G MB&2:4D S^OEFYRC&=:I7&ATJP-3XS_3U6NSJ=2$,[E\OA/M_S;6#%? ^+;'Y>]0D:[E# MP-3%OE,I)FN9?CI!9;[7#O;+F?K>@XT=F 9/++SG#!$\Y81E-DJ>I=Y5^+W, MZ*/\E^Z[(!ZJT$BHH@R*B.@A2PUK@X>7@*KNLR81(P^)O&-R[Y>^\)BW&B8^ M?;48\$NU=&)^.A8J"6L@F;X=S$4&F0@,GI_=6C_Q8[WYDM:ZAX?O9J[H!*7K MXD/'@Z7PTY))ZF)IN'!=!T)==2 4'0AUU8%PPR[7=B \;/*"Z$ 0LH\<%AP5 MFZBPE)_($Y/L)&& J$,0Z+<@1SC\>&*%P$ "8+>7X3THGG?W@.CSLW5BAHU] M;[)>4(4>,*?0LAUD4[9+O0?AOT,@M@!>9S;:+\4J&)5ML,_ -@Z2V; \$^:6-BZ P;T1X"G\G9]M$--) M \:Q]0#4,G">$&'X2+1)7#?:/Z/M)X8!&][SX5\)6I%O3ZPG-N#,"L41X'V! M,Q1KBFY\(!L.E0YR@K*^V>C2V:^0]LV&(;ZF>_V??^MWNOUW\2W/H2'>A#Y* MW*'G!K,)]X$.D$^0*%Y'2=IFZ:Q0O@+EUS$W2CI81G=*8\2E%6YWQ*U@D6&" M5YS\YDUGCN6#5OIX*(-EUW2U_92"3\NE*HF[U4(2KWM( U'GY-X"XU=M557F MWJ*I<9*I>ZFMG5KN7K(UE;RG0@=U!O%8R7L"DD3:RHY80*Y"UGZAM;4N[FKD>O5IK3?ZN5NPU"OG9GM$IKFJBAT?9E@#4 \?!^*6[)G MKC)^K-\2<^:#\&/M'I[.C4.]I[7UMM:L>B&TKC5[KP3 M=46N=]W0MWDCT^DH0$#N1FX-[Z4+GCUR'U!D.<.90QH6AJ>MOS#*B$[) 8>M MN7/![%"XL5.JE\:FSBPX/TM&SL3A@Z@S#2AG& M#3TT&.PI2.\*A])XK@._1+_3SZ?S,]RG-0QQ^ \U<>8B;V1Q3JV)K;S]';]UG$0&-""YXH! M2>G4BU71+(R& 94A';E>R!YP&3O)UI!4K&6 /TFW<66/]*-')X/A$SA,GTT] M#!/;<+^!"1"["((9+/!HA_>V*Z*;\0FC?WIX;[DN=S0,[#DSXC!WGC<*+A&A MO@7+AA038.J0*W/(8V>&/%S,\;/=C$@X/Q.>]4;N\RJ*H3];C2-7HM/%^Q7! M;&2N(.M!,D^ LS[>$;"R'W&F,PV7F(IX$\GP6<% 3 M;!#@>%W'W/"F04&> ?TUL$ 33 MJ0.((\+3H@]]#H# ,X)-> 2:-0+F@VP&?OO D2:M )YIL'D%N#2BU&TW5YI> MJ4T^UD(B=-!LKH.4S*#&N?B9-? >.'NT0!##05+"FQ2]7V]N/N/?@]D D#S$ M/CEB!7F.&;D]@N,?AB#[?2[469D?@]>+Z&3F+! !L&%IRF:"(ON- S9*#SA YEB/(F[J\SNT M4$@0D!H/-H4X;<"K^,C&:,L4A8*4%Z@0T+IW0%R^BY8)QE[ON#NT5^!]75JB MH=(215JBH=(2CYR6N.&V':HGT):ID?!Q2?V;#LKJULBXR-OA\P>;/TIOQNI< M$6&EY,JPU-)R)5&#'?[ G2#RR:Q7I$:=GT7+4;JABX0; MO0H9IG2[1)OS:=HV'U$BHYO-ER2O,,THGF8RA(Q^H_\R3FM,3ZFF+-%:T\46 M%^(ZP6II'-[.%TRLU-$&R<)D_*NZQ@:)6*)W8(B00^(%XAL M8J$V *^SQZ!IN:C=#;CC8889O_SP[9_7'R_U/H@/P.[$'LH;46]*RL-OMS*K M$UZ NE5,>YN*C5+IW'A0!H57=C@I? >="UAR?$3W_?PLF$VGG@_/65,;%.^9 M,[8=!W4TA"KB>])K*R\)J>=D(DH(&2$ ;]&NJ&G@@9VL3$I:)4,;:]* MDGC!*8>%)E-)V$BS74@EVY1JMGW.XB[O69]C4=@&UH4B"WO)YEZ'N[UCIRBM M.ILMNS6JLSGZV:Q,63W8V1R]8V#.&2M'SU7;8AA+G5+P\@]PJ=.NMACZHK(* MJYL@]9Q +)L1[Z3]YIH/8RX$+ N0Y$4)ZVWD\8HQ-(?0B.J&JN73@H)2&.\!E@'G+L-4V"D?+9;08) 55WSB8=(64$*=*8^I:.;Z M(8EC4==:D;: V<2DJ(T\V%GZP#+E1W$>#B7!Q$<2/W1O/7!F#8=4PN2):*OG MQH]EHNY'ZHB3YA&Y\AU-E>\H\AU-E>^X3[YC0:V**Y"V]8^9Y0.M.4_L9C:! M!9ZH(07["+?]1-*X/(9I.0ZG/!S*G)<;M5QW%J7T$7?#'$&0.L-9$%#J(&7P M:TF+1YEP(IK;.580,LJ/8/\6. Q4,LJI][_26]5K@%6A5DI)0^@(NMS M\VCX9#FS?'=*[C*[9NZ>275*6C/TTTS&:[7-XK/Q*K"O;K^IF2K+4/%K!6*= MI-X:22=*J!-15Q:NVKJAZ15O3M@VVLM2_*H%8[>=6[(<#<:6GKMWKQ(-%3L\ M!6*E0#RB:+@1"0.E\WJPV@6U4E928;Z\C0%8FTE MPPXC,\I&:*O=J[S6WFKGK\X\GOPPJR^']?Q3093\J-CA*1 K!>)1Y$>NL1ZE M^:]K';-? RB[G6Y!#D4E*>K+XQ2( M=9,4^'8)3SR<2&\U]#864T4U4?BCMTQ^G+L59UEXWJ+#YM'X8;,@CWNI(%8] MN**WM:X2*<^<&2H0ZR925HR\VTZJK.@AVBY_=/GRYIZ5(@L=1&#U\X(K;[6T MVP7%[H_092IZO>J@L%D,1\]7LH/"EDWV=F;K]4.X41R^Y87_QT)H8AMD5WA? M"Q[Z$]F7<:+[.I6V*;73@Q6(SP1$51._O!;9-'-;-W6JL>Z;^:L0Z[2O;JMS MDN.$.D8GMV]/U<0_ WZM0*R#U%LCZ0Y5$]_JUR"_UZQ^<,7LMJH/8Z>HZAHE M&NK+U!2(-1<-!ZJ);_6K7Y^"DJ&8F':)7+??KGQTR>RKFD;%TQ2(M94,%:R) M;^MFY?E>+6KBFWKE$_1:W4Y!Z0E*?M27\RD0:RL_*E$3W];0CUUUFP.T^4Y1 M':3*A++5-BH/94OKM8KR/RK)45^>IT"LK>0X1DU\:R&1J3+5W6:WLJ 9E2W7 M-WKM8Y._$@ *Q-J#^)QJXMMZ40V^RX32Z.J5#U 45VM>HJ&@BA<5?U,@UDY* MX-MK5@^??QK4T<1*]8/>()RK'OLQU8 0Q0L5B'63*/4NAS?[E5>UV_W*MV#O M53]*I/>-@EJV5:H:_C\N+]EGFSNCM^R[=A-W[(.7F;Y0?1 !V_R+AM.[U(4BV=?UESRLB:]++7A M:*OOV.W3%#9\Y5L#>_B.?;4F7*#CJXLNF'PRQLKQR[3^$'$I2BG3+H^8'^'#'4MTM:%*,/Z]4)T>5@C.&$%E(AI M'B(*N RC8=)AS;.8[-[!'?,0&3RR\YPPE M[Y23^&6C=(X9$ -^+^TVDKC==_3\:#8,@T;"UXKR["@0Z^P?V]@]A?JF!.P''W+[H9S^*0MY/AM:5NAZOY$OC>M(C3BVW5!' M;RQPTCKO1V_W&OE&E=1D0T:GV^@7NR$5^JDO4U8@UD&T+;T,4L[6EV]NL"U>T9.8^((P'7T8H!3[+^^C$N!6%OVO\(:.)A4,-N5 M9;MFN[K3@]M%U/R59*=TBKP+5ZLN5%8AU MD&T5#<2WJ]L*K%E=WUNS" =7.: 916!-B8/Z,C(%8FW%P<%"+FV]TZ@L"VOI MS9P6U1& @^.L+N;TEE%("H-B__5E7 K$VK+_HP?B*]P7V*@N:&9E$[/,5J%I M64<-Q.=JH=)6+51$"Y6V:J&R89=K6Z@4U;A";Y;7%V-5CQ:,KV9XPH@//=\* M;0]^!E**^X[M@H+VELGP$7LUPL0@/V"IIB:OWQX1.75/E2HT MB+]4J*YZ\S)!$#7=BWBH/EVIS$H\$/M=R)4H*(=J%?#K8US%0Y8?A8?#UC8P M?>1#/AEPGYFZQGX9^&\ :6NZQ.P&Y2J I8>6_"%X.&VM@&2]R?!*)QX8)3YPA)2%VC=UIY M;^U.N^CV)L?=D-XQJMTA:/W**],3&]V7Q>ZJT'!7W2(="L1G N+AQ]8L]6J@ M-!M:08@AK:7";*>ZDES/YN=!VZP3\:7%M("]]WWJAY5#?_8P*4!:F MNF;S.*U]3/DPM!^X\Z1A M%136433.SQ":V'?H\RG\#A,X1^R%WFXWVE&Q%/-\9A@OT=.83:6,EM+8$ =N M^_!DZ,'#NMXP\C[ M#0MBY=?4"D(6/GI4 A8TV'4$9&8%^881/?)C=@>J2;M[?C:U@]!S-/KT^P=, MKO7A*_'OOU_]O\L^2__BRX?O[/H:7]PP#/;EQ\*7\$CFLS]]R[USN _8?O"< M!UP9SXE6M["VD.F]?OO\S.'PW:4UQ,)#N$%CAS=.KW+PXOTMS7*/Z#93S+>D MCB^JU#@_PY(@/%-FPU4(Q?AWJIP#\L.' GB-/0;QZ(;Q^GA*R>41;[$&MF.' M3R>/6]S[74JB[X[=L?7@^?0/(E'K#E/1Z&[_Y-BA. @#3=XM_&:$3&5H4P&M M!B^"GW, '[[!0_ !!]^/0+& %??LE1QL=PYC9WX?\#<;& )1%KB$;6>Q,/'[ >:PKRMN""B4?E7=$-%/VP3$;$ MXL75FXWVPC=Z@\G#G><6$G3V:.&UL0&/@)4%;K#D6IZ?P8>@1>#^42N 58CH M$F1$ B\"/9;;W,<'L9U #":^?FL&O_1"K^M\T5&=+T3GBX[J?+%AEVL[7Y3( MIPIFAUL(B&\DI+_![;0H[_S:A6O-49L^W9X6T:Z]>-=VLFMB2B^:#7V>EY^? M(6O#;\%R04$PL1,KI]9(VH9'(L%O<_0@2 %;BNL9>[<+ M9GX\4$2S(?.P:GQ7Z)+;GR8]^B[/KLV]K-OK)V^I-:/MJLS^\ M)\L)G\JEO2I@)-IHA@Y31"1)CI0MX%6]Z(N(&&O.D/:EDVO4I'@0GCZAQ#M- M4$(S9-Z4>*$O2#BP.D8STL%3^C>8!=&3Z(*3;P.< ]3<\EWX%!8([CT_ MO(0O)_";!_A%Y+04G/$4,;\],7X2)M)SH,:T?0G\R5C*N!2?$FIHI')_?08J M]X*BK3D%:5<*X)]+2KHSYR6!!6Q6^NG=,)@-?')R[^=/7RW]T!: M?#P6@;-(?(;63Y)M1)M&"WUJ&8[5;I@O8W)+.]<^8(3,??JO0/PX63A><63# M9W[ 8J=W$%KA+/3\)Y#(?$1.QN3'((>G/@!E3RT'1##*Y!"_2.!,N=I<#UW\ MZ"P7 0^T%H;<#RWR]/'A;,%=A[;*'-#--#IR0,UV _HD+^D5G(4,;"#N$4_H M'+OST+@;6T/ %_:[]%SR)P)*1N=GR '3ZCW&9/OSK%#:E''P=M&V[+3G62/9 MENEWL=2K\)%^L]&*'JGW<9";X*OG7OY^=?6=?;9="X@/2/+O@)Z9S\MP'1Q< MH\(3AXL)^C5>J*GO/=@C+K5L("OV:(?W#'."1>0++4#X\41XY8$&+9]"=3;E M ""%!B)6+2\_?$@7'-9^L'S;FP7L#]=&JKD)2 M"WG?T9G_ZC__UC.,YCL\"_JK_NXUL+;X4";B4"3;>O20;8F#6_R-QC[]=GW[ M\8I^*_\J4*5A&N'P'O[E6G<&@D#9YD MY),6<#$$B4D*T1%I $H*_3'PE/,@N?DJM*"=-7-& CHW@+WZ(C$B6AP@%:$C MW -\#FO/X,YK;,6"C?.SVY7 K#H"9OD\0C%@AG008/1N3&>)8TM27"RI/%?P M1/@!'8TKVOC#0WB)M@OK=%581X1UNBJL4\VPCM#.GY#@![, M/0 \Q:"Z#;% M["K-L3TWS9V1C^K==W"!I&8']VW"49S#I1I:4\2+,+;A_L.%IHOVZ/E_X3OE M]^=G/I"$[1.SE(D3Z*1V D]H$R-[: %7E*6FJ;P9MIHWA%(M ;$DQ(#"L_R?HRQ!O0#3$/8L2,REGGMO* M,3K[MMM:KW]2S8K[3F5G9Z&?1*6.4N\7,1"[E/NY?9>GN72N7$T6JM]RZE5K01]3 M#9NS&-(UW2BK2?KKP["J3:B/7'#'/+!\76,V=+,W#:W7R=X\"A&WE?;,Q7 M']N81VZ)C'+;O<,X(H:AXX1S322/::(&:[3.RLF&$($)#&<.);)0R'+PQ$1L M@Z*L\-S,I90M>TZKUM(9@5$V\_R[!33+3"P9);VW'CALA;M,Y.?!)BE%*Y60 MA2P)W^ZE/A0QVF V"'VL8U\-K/@Y)I18(ITV;GMAN^F7S+\4WF;Y/B;ZQ6D> M&;3%86=Y2!$6"=\8-^8_Z3V8V/'$/)=?AC;"@='9H17<:Q2G3:*[$BNG%'L] M1&9;DM#VP7-E@L\!R^&.G,@;Q19)A',]S'WCXX??V7 QK /PG(^EOTYR '' M>\0TE7N@*-C3 ^4]4D.A5#N$T8Q3I@IU,[ QO\4=P??64Y2$]*(7%][!+AS* MM96_?]%N-)N8=P+HQ'0Y[-"$%SE:A\4L&XC8H=Y*L,A7[T&>;U./[5 9^;//)!$N,/'G@S?XA#64ZVH&)URI=( M.0.F,H;+(U0**>$]%S6SZ([1;Z9>(+)=Q7V-23*ZUP#&7SS$[&7'P5Q64!-$ MZ>$ [LI,-OH),^EN%OP(2POPEM$[TFEM])IM,TA[*H-49)#V5 9I-3-(\6:@ M#3##-$YO -_*ZR:SX*6^'[#QS(VMF@7AMY@GBFF@0[@]XI+"OV*Y!.(ME2MD:''QYTA6HZ<;6PIE)]U4:IB!22Z2:549=;F+53HP MV.>Z3:VJ=(\=$=&ZE#7M)H7P#W!)/-^.>VT9A[H9O]CQT1\L=72^?=@RU.MI MU)^?416:O:Z[6!;U"6[G4'^:W0-N[VT?F:U/%R>83:=86932O:BL*ZK( A7\ M_&P"FH\/-D1 [1U%@KOLN"KM/;R/ $(P \D 5W%L#7Q,[GP4@9/^B-7YJ M6&@*/QVR"#Q8A*.TL1S'>X(?17L(GES8'ZAP29/6I$ED#!FA1)0!H/L/ZRH= M>T+U:!))HKX2"\,3A,@6RX] ]XW\,U&1'15E9?K8 MP:X=S[VC^S*6OK14G:Y\/Y[LF%DC4,&PC '^!*V7: 1^"V3 DDW#JK)2S1O@ M$GR4+2V+Y3^0YPR!GOFR5 .5<5AQ&-62D3_1GXG:/EFI-;](4DP1[Q6!C0J\ M +K$&$!\R*4C&*V%+B0;-0[16MK,.MGP]0.E,S!-AI'@0F>H8;2U9K/) A 7/K8>\$A* M4:U=;"F&Y!Z.G)W.DXA+.:!S47]@@.WOUI,WPNU]]7S Y0?+1Y*TSL^0#%^D M?+M$ES.A"J(>DJ4UT271YUCC1.VCXQ-HI"SLNBMP&=Z\F%?P*/(*OB4^75") MQ3DVL_R$['"?])L!7K=02LN8S*/6\?&, ND=RC[2=B"[5-04)@D3ZC%#>_A M%ONB]#*^^UK4P!?>C%BY6$J:5=>=S44^/;08BM4A>,_H=XUAT'P,#=L 8"(TWVV[@M^2) M#][,3SK%$U$"-\6^LAH>/I3BT&@2 MHKA(2)LZ(EOV2/95>+!L1Y3%HS6IWIAM#B!CF;B%*.>$E1#C2=O8R6V:*"_K,\/*!48;A'QL6">3$CW1]*_ M%%TJI&>#;3NB MPQS/2%@O1*A^L=\W#N@:KX?ZE+&W2;U-$EJ(G:$1\:)E9-PHZ*EET+>9#!=;F?)IHK:O9'6 K:M"X%[ZD8HYQH>@M MZ,S&QL='7H21S; 'KZ/TH\L.5Q).@'B+2Y-9#H_ MFU)*Z)!\XVBH64_8VSF";]ZZ8:TF]8Y/8C08O/@S'_CT9KV[Y-6Q@O&;9_ET3!]I*!8V M\$OQM>Q)M@S$GO$N 972T>9 8PED8'R"&J0WT^EA,IY/0[P$QTSNWXA/Z;\> M2D!TQ$6=*I,)7Q0:P(%:Z%^>D :&V)!+I?HJT7;=R[1_35L93'!YS,3A_8>1 M=,OTBJ-E5L7]LBBH16X7(L N"3U<01"HMP/Y((BI((GO^ AXI.IXSUQ'DC4 M4C_-[L"4#X)9U*4PU>0>2!>#>>(?(SX(3Q*[!4:H/B2) M3.Q;DL=T4@&JC68F^:?FE=U6M@%Z[(855S[V7MYYWHC"PYA&+4+5:#.C_.+8 M/G#(25FBT#V_(P8QL$5.6+:E8!Q!$48S+4 A+9$S@_F7/*0.I^3'# (J+\F8 MTW&S69PWF]U?,+^_5M)K&!=,\H8- F,#'B=:RZN(*25F*YOS',7B M,#Z$EGDF-H3FGRT'4226&":O!O/9JQM"0Q6XSM2?JQPAF/L.QP&(+_S.#J)R M( PI? %Z$*=XX!#Z$89$W7#.KD,^8?H5NV0_[. O]MF2FAQVW?="S@P]J@.( MTR8P:P:N1-I?95&!6Q(;Q-]?N>Z,,LVQLR;>W,_ :0'NR_]+^I)%.L(L"*1K M.\X 88KD[&B%/B$*9?#41'V:$H#1+M9#$3PL$4M("F% 13 M+\#<,\OV02FVZ8($,N:(-CI>&QKV'8AB2]P.=Q]LWR-PA5C9*4K3:JHH#45I M6DT5I3FE*,VJ*B"\_LE0 ,QI@1\Z-EI)(O:"*B!@B5#TVPQ.40K)8";R>#/V M3%;2H4'3:LO9/YG'I!T6U=R )8(*F\B(];9H%W!F# M5B8G?F0RH5.-#$+R:(OD1J#B092R!EH!$&WDU$I/+L+T*P7NH MNSNHYJ(2=H@-#M#!EGIQ-"3)B9HID.M3)JAC8I1?+MZD7$;M*IN9\E_0E9JM$GO43-CHH$N%S' $1QJ9K)%]3AC$ZP(88SDAK M$TNG#2T92R0E:39?1!8)DVT3#0RB[.>_**UQ-IDFND02XQ"^-:$/A!@+%*,N MXC =B7R9%2G,;<&[Z$QC?6!@.<1.@GNL8<997&*&!?R#ACF+ET8=8S".<^>* M.) H-IO1'1P):RP%AIR@8WND_KBB#?W#-E1A @H,O@X8(T5LT-23 MOJ^Y;.^8LZ90E H+(3/P2+UYL/ECE.E [EU?EHB@FF1%A=EHG6.HB=QK'C8B M0-,-04]412UQ:$J-,_)'8N 8I#/\IL'^C_>(P=A[^Y _R$ MV UHZJ$I@O@7NA[ED&<'H217#31(;VEP1&).H)[2:"(&M@P80743#O0P\ASO MCBX GJD,\(TXADC(W!>:5;*-N8X98E=K7R;VC'HQV/)42A4G(@OB)O_T*?+/ MW-+FNU2FOD3*%(H='V[*B0N7950<$U\L6B8E5P0[C-)#P X(9K:P"8:.94^BR4MD,H-A"\>$?!,5SX0]"N^6/_5H MI*9DEHR\NO'T-&#NMKQY%$@.HIJ,!55:O#C MZ8J&K/!?N&,QO(=4>G!+:J2 M#'B4W29_&?FJ";7ATU0TCL'U->9:L?4*)\2C-F7_FJ$.KK%[&\?N$59%<$F@ M"^\P?(N_"D"GIU-Z1(,-QP8Z.#.'FH>,'F3BOL0&6&QN^LR /X!PL$'*"IY# M&UC ?B)P? ^X!6!7DSB1!K_< ^7IP )H8 .1R&5@65KE)+G+E=1I4/8*+^E( MSIJ^#Y5&\4H#<$;0?2.N!; ML#! E)%J%9T9&N!4J(3E%>($$S'G> 'E7.+A>(%0RM!TH5Y]/EV.01P5Q;K? MM#+Q%,L5K.>@DND4&B+6@45D:2*9O_V).D6]L^CM%'25\R+E!6RP;[&7'-T2 MD2\:7T4[&T<$%HA_VY&^)E <9)+,0%4CK](#C^OR:/N1RBCN,:%6-/,N*(TS,/F*8W7>*E9(7<:&4XJJ2.ZVZFRT.AZ M'\QB6EDW<2(%#1?O_[RWT2-&D1.T7J8@MVSIV<=KBJT[Y@(9J)Y&$7PF*R!! M6LE:S\AT(@K1DE(&L+.$HILHI7#DXY Z; B37"A9R+DW:IW2>PZ"38PWGV!J M@P.4[-CWGB>+=A(PTVFCTYEK$RF/K E>5'$/-!&#V37^0A6 F4RFP2P4@9 4 MLO!>S;\ACGUL:&V1'E>2'Z/1YZN[,I1;G0XP):6W&5=DB;P%_$UU>5*\"F1HQ %6&!T,2^%&GU'A& M[UJ3]#K5B8KT=XI[C)AT-8D^IV0[81=MZ4!%)?3\+*WCBE)L!QC1)RD^7'B&.5;G4I#8R#D23(&P+'G="RH!\?L9_RHIZ M2W9#A56K%\4HFH9C2@B(:%=0)CE;B30'I"9@ E 4_Z23B^W Y-2B9$X2/Q/2 M1ZB>!WBN,-BED=E@OU.G)JJ;)^\>KKS0HP0L)X ?1"3R8!^C5%S8CI(JTCU" MT\U21 U,W$@ET.;AE]&K62!+=9(=),E. "!0?4 21T-Q/O+0^D2)'G ^@25G M(QE>P%OXE%K$POB8(U0Z0,>3AV'^R!V<*@KX5Q2- Y1AD43&_0^?_ R9V<&2 MU/#^@"[MPR=9PCMSRZ$?'&VS3'C-]USXNXB_)W+H-!NG?P4^IDA!9BA[_J/E MCRZ_>!YU)[])(HO((;[+.Y\N/#A-HD@S=U"(-1DHL<7L!_RO)D*@8XDQ1V L MDZ5,O<<3E"$;'G*J8(S8I3 Z17Z3=**EG\=07B3,H^SZ]"/"O8O94$DVJ>R' M1]67#NP%W^;;P5_BQWBIZ?N0_,I1IT,I)T;8H :4%!%<'K+[HB40R9%3U-4T%&KQMI*O(1B]W/W*W4]&F H6928*-1VJO,#LD1U IWO ME!0-O&U&%H/(\!-*<;!P;3-Q73I(N,A3;OT%3V"&1*S\4@X"JM_9; %BH>B) M0O]$JB9'M(*BV H%MP+AAEKQ:I%%-';P)O,'H5P#L61R"Z0W(H9E Y(2!SGZ M0)+ER=TQ%#Q%%N?-!@&Y3$/83?J:"T@.ZLW:V@=N*!^X\($;R@=^2C[PC?HB M_6$Q>_3KA?4_3=W "V05T2(0_J>+ QF\O[[]]'?6O2)7@?'N'W];/WY\NF%7OWW[X_;\[.]7/_[OIUOVX_KF M_QY06TQS9YO"C%X@G/NQ<1Q/ 4.?;1 G^Z1F]L0MCT6CP%0O[IQ=T=!-G*IZ M?B5'^J2J05^+KDLR\PU].50^*7M^I ",=#34Y5"SP03(./E=[O2_,M OMG"6 M@WLT)DNWTS_.]FXCH",W[8+3B SWI!0@G2),B*8\UI68IG)S>K,<1'+R[B$, MPB.V8C7!9:)SI=!]J3[A ?7"U2'OU9E.D^K"I9[M1TAO>&8FE"'7G9Y(P'Z1J18XB(F>L4L<)J*$@QZTF][//UUZNO M'ZZOOK ;4,8^_?W3U]L;TL]N_OC^_0O]^^K'?Y^??;RZO3HA@2LN'^#BZ\=/ M_X_=?F,?OGV]^?;E&K;YZ2-;AI2C;UZT91MRQYF*6;J_7C0OZ-\XRSCZ]]8 M/=JC\/XMZS=?OF.2+PX]Q[&F 5ROZ&_Q_<;9R&^Q=Y87?^2+WC3XV<7[=>/ M@5G0#^))S<4VVTN8Q3CXGV93QQ %EFV0%^8ZE77Q WUU(;4K^HY>EF$ZB/'9 M]B=X!]FK[Q^NOOW&KC^R7^R?;UW/_8H#2>#'Z 0$P'_@JX: <1?8[J\7(VZ_ MO9J-[-#S<8GKT<7[5O^7-YE'W[^._=_A*(.)59/3Y>$T&VW;73H!>V=LM=II M6&C"]?YGEYJ9G6=W2_8S/W6[.O1D4#+JH)OO\GKM801]]$?7.%Y-MJ4QL M68LJFMX5=>\\-HFTFXI$MB*1UEH2N<'NQ[);9%1/_>G?,\SFKR5UZ(HZMJ*. M]EKJH+F.G^,DQ]I1@Z&H82MJZ&"^"!4X>RQ#%I_C'-B$0(Y^NN:2TWU#UD>5 MO3XMY?417I^6\OH4XO5)^68B@[*@*!FYN:->@UO:IJP,QWA9/AL[Y&4VWPN=O9H/ 'MF6_U0?7,"A?XMJ183; M_3IJ\_U!)A9]PU!"(A1^Q'TGRCGU/[F,"Z#C@K24E;AG2U#_7P%[%:9&'+Q. M^I9'F5(4&TE7>D0;$LDQ2S2=)'7-MRE6D2DTMEWVB_U^'F_2EXD?WV'@ X=Q M^L 7L:$1#J6@?M))OOT':E$; MT$T.[+$8>0RQ5Q+RZG-QXVM"=2'BKFC9ICEQCSC,HG)'%N:N21Q(/AZ/,$LQ M=+SN :IKDA>^RF0'O)8^R->"KH9IQ3'3XV:^$]XJ^HC]47(D8;HL)K-ZD+%6 M[,3=,&39.V\=93)>68"I,$GZ-?1H7+B0XZWV @TX-XD>G]T;AIL#$?85\P%O!AE):$/3R2"J&D-ZD_F; M"@;DU_(D1=W<(\<49H$C.29&X)]>A6VC:6A]JKD7M<42_1>M 98>/MYS2L#. MK9BD^Z,]4EE I/BP56J/N#[1_F4O=@&:X @BZ8DV&0_:S7EC=/Y6::L4L % M_T:0TCB08TTE(N3!44XV#2^G\Z#^NB/1V!/GV(G\PA'==L*.N#^!J(L!6-+M/E.WAR[ *_UU MU!,_DG'$M[@;S1T2 [[$STG;3^%VQ.%![(6+Q1!BY II,9:-<^O2Y1(A'$$@ M4S:%T!-=\^V,U),]+>6_Y.;?L5?&Z_4G*VJE4Z^0LATAIVE,*HH<3I07 MYZJQ6<"I:C]UV*LR*^79BQXSF*]Y?K8A67/)<=6(-?\F6VK%K1JPVXF++4UB M!JWEO_58%?K9R,- QJ[1-&\$:-AH:BV1I0--B?(8_[B6%K"%)LH[Z$<:5]U&Y(*!TX MEDKTD8C[S<<:8LS?O+1R(!!"K05LZBM3(])X$[SY_'+WX36 M!,352$.A[^(A#V=A\:]9<$4<\@#6A]"2@"&^ MPLSV:"J,ME*M?KT\Q+=T??3Z(F<11N#:F-_R1GL[17'F.UV@2IV=L(EC=X.B MSD*&8(3.2DZJ\(EM-2^"\(+OR%;"XJ@J2I*W:J2O_BEC@NGK?OC X&*IWKYQ MY)3;E\492PLS!BOXJ.A; MSN>#:UGF^%_IJ&3C_&R[:-R&?J0I8!:C;\&Z\!OU"EH3?XM;+Q47?B-6NCP$ M)_KHKXS!,16"DT>Z90P.!\U@YZ5=8G#!=D&XE=J&18VII'%5\'T:R\C&/H"2"C\%2T-/:8^Y)T-7L;=] MX:P?.IX8IV>O<;^FD9D)YIV?S042E^M)LT#.G\ITQ8B;JY)+?/"4XGF:" *" M?FD%\[%*E$2H>4J-U,IT<5X._LKX8!"[RT\M/IA,B*,X:#2"6DR20JF'J3!) M#V#ZT81^1#/N9RY\3@8<35"BT)S\V@*JI%R,:$Q2U(5/JM5BK37G(?F(!82< M>17UGL\(CLS74EB(Y8>Q?A4%8]Y2T$M83W2E!24&,DX1TWD\$"RYW_-CU>?M M*@Q4Q4.TD")(?(FV%R ]P-2BEBY:JJ;K)KP]^^@5:5],Z7W?*)VU,FY14E5,"=' C[5M1K MB9J[-EO#_XBGH288"G8'?\Q/3,@TT4EWC:>..ZN:QLL['J2[Q[,=FL?3H"8< M?BE&S1(-T(L3_U%B5&7<:"XU%$I CER5 .*+3KO1!'73<<@<6)6/'JMA%C6C M1[TL.H&HJ3DNUNXWVM%BV1:941(&*B+SX"QO=)\TN(]GBBWTMT_#$36X%X]- MJ!^;T&/CR:$R%2;J:Y\\*SK<+VU>+X\/3SD>> 5:GA )4NQAJ-:E<9J,_@^$ MP5 :8S52I4!UE,U7;>GLIN-8/&DK.^Q8E#Z77)\4G7BC2XHB.)(?CVJFT#U\XTTC M@\A*C$Q^-F'"+3NO)< N.;ZBB;P//VVR M9D.?;Y82%Y=^2Z<]1I;EW$34.:9]?K8"K3%O(\G@.<"^2<4%\Q$S5M'*#=X> ML)%/1D5:5) N1#.97R_T9O,E",@-M=$ ;5)V'+>A,=JV>R$+@U=_3=7#__FW M?J?;?Y>I)=Y0;@V<1'A&(A?M7 JP#/[ 5793B39SQ[>*^69I1S?TRNKD)P]O 6[3Y)>.W+&4<20X>S\DE&DFU M]ZIB;T6WJ^E6D%:*%X:2:D2&Z%!60DGJ'<:'(:8H4%08U U+^(&HG6/$0/\K M*(A:EE-*3":*+,HE"SC >PY_1!.EB"I6Y82FCVY>E\D>5#P=2)W47BO2/%&&1:.AJ, 5\]QQM4T[=X$;[9M?HC^M8OWZ2S>; O$6MFUHD\Y M7M-1U/P\<95$QA+8]$ R1K/9KI'1ONVQ?O&$,WYE$G79IWR I.KM>PYUE1-= M.-&[RHE>GT[343O3@KH9K7"UK&F66@8[>__J(_8JCE(8O5D A@W&^']BVB$Z M"EEPC]Y8%,BO,1_MD,RZ)!5N3;]FJ6,)Y0TI,:7 B1?T-J^_O-W<1439B7HF M :%+*GBWVZR6LGW2D1RZ& .!E7S5EA\J<:X.V&H"H M;EZU02S[YBV^_8-T9:F[5JFSG+]KY4 M_>4*16;^9\M>]F+5HLV7R[M+"W_/9U_T'V(YP:\7E_ OS-&P MPE\O[)_A6WV8RKM/M%V[F%W5PGFUE]IGJ[K^FFL=NA'HOI MEW9!ML1=OZ_UNWH9N"M%&BV^\M:WJ$W2D ,S&%!C)Y>'M25]65\;_(@W])6' M4F5:*U%:R22O9WX#=D-ANZLUS4[E+L(:<5 W];0&(!Z(9_WN>T$FT;ZV["HN M5J MK9$S1E\S^CLJ7B?'H7)CK=G4*(I<'Z:T"NT2'IO*Q]^R2\-LM#!0*D-- M/\%$V,HA4PF()5]TJ_*OR"X'5G0LT8(];56KS Y_OJX:"ODAN1# MFZ[UC,)D]^L29<&FZ,;BM$-ULM#&&_D5TA1Z*KA'8EAH6X,%05HIG+DV^ M=Z]W#FP+]X906:YU#GOMG4W+3-;2_P21]A(7QBJR,T M6]T#'V'9XK8HOO(U6[YX(O17/@M-HA58^@7[[]COWQ;-K /9%\L,94CJAZP,B'74V8-^S!U MBZ$;M:L[_9G:Y8_0%9_5[GV=%Z.4)+51< :\(G7HC- M,0^:DU%>\"3?F9H='4ZUIYR16R'-Z&E=LU:^R+KI%#4 \4!T(0[0:G4UO3@'9\T9ULY8-'3-Z)62 M)U(U:V"MV]C"+C TZHJY+W8Z25/KF$=Q1"EKKC8@'LB: M^\C'W/>I9QB-F@RMGS5.>8MVN[N^&O7*S-W=W%$ MKFD5I\E%2"DW_E?/'6YT8/:U?D?I-I72;;8_PE;K*$=8"6,IBM9<58 ]+!0$ M5HDS" 2M\03V6EKW>?&"TL]K_Q#4.O^WH9E'OOCS/1$KWSOO_0V?&^D:SR+= M.(>TL=![*E>KN9YJ-2=:S?54J[D-N\S7:DZU)%,MR51+,M623+4DR]FL9=D5 MS^,O6G)H>=&Y>OD#OZTJ3<2^V!9-]XUFT]XL&4#_B0;0U\917 ,02[E/>8^\ M9KBJ 8C'ZTN6NKZUP58-0%0%+=4&L>P+M[Z/G.CB$P^3G5I/8N(X#J$;#OT9 M3^I:%O9:M?9F1;3_^2X0@+E%8OLIKK0Y5;NM==H[IK<_]_YRQ1Q 1VLU-Y<- M'K'+W!;!>YL&T(\")E%2W\!]M!.YD8W'V.OE\CI73!Z @6'402 LTH7*3?\*^/LAM1;SE:2-)ZEHS M1U97I2@R[="^#/CPTOYY>6^/X":^9>*_EV/8QV4[1;SD_*V8SKD:%=]];S1+ MD6WI=GWAQ.G?^6_E+O+3HF&V:T:)12L-.Z&MVR\%;8=GUY\F4\=[XF*8**CF M8A(DJNP#[O*Q7>="4J'S13O\3>YGL^+7U #T9WXK]D:BJ>GM4EH%'D@>_.GY M?Z5\O>GK4=L;(??T(;67_"P/S*&.2G\M!)'=EE1XA %+:3=C&6Z=W3*W9V=P1 M\'G(IVTPU^V65=>BBLAJ ^*!>-07;@4\<;%(1V"OOH[ ;U/N@_KGWM'.8ATP M5QV$UC25/KTW&G6MU:UE75E.7TSMK@;ZTZ*=I VD=4?8:]6L+TY%(C1[N+=% M2-YR:DE?\_[:*[&7//QBUYEM)\-S]\1?OQ0=6ZF*M0'Q0 P+0ZR@$* MFXXD M"XW1T,M7&7-&/#O%1SR/OZENQ<*XZH:?X U7*?65/\P=,X F$U!4 CQ>#:!T M+Q\\9.4:FUH^>\#9KNR%_K8V&*P!B >YL:O:O.45*KKYCJW]WKAX?S4+[SW? M_E\.4-Q;/@A\X@SZ.[96#VZG]>#KKY^W3.9">B5N=$/O3("(U>!F2@T6@&W0 MS#O'@*C=U)I+4U;G/@!L8NE6KD/#,O3:HMNKM[5 M.AVDA2;S9F$06B[^I#9XJ@&(1[NK>N:N-CM:J]=1=[5B![S-7Y5&Q6C!^>YKIGX+#2 $PK']0Z&MN:)I#Q< 9-"Z"V'X7BW2QLP:DVQ M'=91#W*OLI-X2]]A1]?N![&?U/FNZ9'8UIK=YUZ050@B.UHOQWSHJ@CKQ5?^ MX*%EN]@QP?)=$ KUS>*-=O));B0SBF5L#^VUO8)-K5E.QD$-+\0^F&P!5V[V M2Q&VAY<:. 'K+;OUN17,_"?A&8QM%2L$C >ESY=3!DJA!DKD",RXB#I:5P=E MQ^Q)IV!M$%8#$"M1+&:[8+/M$$HT]#D'17Z>NZVU%W&9E+VWUL@#FFWVM=X2 M5AL3\;* 2TVKJ,H;TI?!^P:+2 >]N:T*;9Z@ [IM;IG-0\O'TYQ_9MBH]# MB)6>-)-"XI4[VH8BU0R::G&3/4Y23:>IQ72:OII.(Z;3]-5TF@V[S#>=AOZP MF#V"=P?_TVR: !DL7\@-^9"^!#-69&<^X&]@.77Y1R6U]= MNRR\]V8!O!5^PW\..2PQY;[P3#" TWJ]<"U+YD%J.E#9TX'^FUL^X^X(:% - M"E*#@M2@H",,"E)GE?.LFD?'5[&NP;J%A12(=0BN216FLWS P%<>@LD%BKT_ M"5@ ]F[UQVWT]TJ+>.#N+!666YP\WS68,Z!.;=M3VR\)<].IF5JS>913.WPBI@A"NL"Q,XSZ*)FUY:HX MN!DE>]#&WET5 @'J>- M5!!BI&PJ>E4&*!A'M94PN)MOX]\];T29"=Q_L(<\N($MK[H-;5F3_FPBO=A[:-)Y3HZH]O7VCFT M3W5TA]3@\MVZOJZUZ7AMEH31=:H38;;=N]>'_#'>< #11+4PLE_/(BK2OFTW2]E '1 M=?1MY<::"5Q-N;.VQYIIEA*[.[2L6NB?;#2H&N=W[H((Q!I-;-<.0A1I M#[RVC$1NZQK M3;V4F7.5R-=;T;%>C47:&*O;%*K7VN8-'(BQO[Z-BK[L$#"8FR< M"(M$$MQ7OJYMWN:T"]4*9XLSW(L![WJ(>HZ8FSK%;4YQ'_Z_ZRFV#]V5ZEA) M@ N\OK[9@/$Q1]Z@-5EN':UCG)22M!>KVPIQ+>.DE/2]N,L6B#,THW\J^N2) MA7U4CH'"5&TQ5;ULC"0L8\NF*"=QHN7K+4(]_>(%:^2(WC2U5OM@AN))WIN)LHWVM[T>BBNEW1E_K MI$(.^_"4[7&G:[I1O>F9>^HG,2>1P;>R#[2\G(=H)QL3:XP> MS",GOO1.8:+TV/C:CV'DQ5>_L/#D@4+SA>9N"97DE/*TRDW32NNSF?20=9*H M<[BY5\_(>[MWMM9.9]G.,5U5G>5!/?$[GF5OLZ"LNC]^8[;6*AY?.]MSA_-M M:3VCE R:.AJ?.^ / \>E]"FKHP&ZDZSHF=7+X-I;P3PQN:12E!2F:HNI2M0& MH5N*IER)\6)2W6"A]?-Y]/3>SPT6)8]\]KT)#CZSW1F(&)E=XKG!;X14\;M; M1.FGGZ%OP19LU_*?KD,^"4 V(4"^1V6R.5RC36#].;KEJ:M]V/# $4C!:'; MHCV*(73BI+"?\_(87,%H:OU>_;H)K5%HZY;ZHD"L30)1K/1DU)S:N55B#B*M MV=^XRS?T'-/Z+94JM"OZVDVMDV/61XW0M[^J:D?(4*$S5 M%E,'4A]P_IF=3 "5=7F%*8JK2F4#\L_<@^&!0VCU)"=L97^$>$*4$68(@S&>D@SJX? MCP+\47#QOMUH/JLDT-+/,*MV'^80>XW>LYJ44?XA=HYQ$_6C'*)2%Q2(-5<7 M/MK.+.0CI3#LP:8D#G,PJE:C_ZRZ_M1*9U3JNG M]=K/REEQC/3@(YYPN]?6.DV5]5NR9G+$$V[U.EJS7?\"U[I)6@7BL]=7I$7Q M'-A=\1J+1-X"T]O$[[I]4S./TV#WM(^X!)UEYS-N=[6>J;26.F@M.Y]QIP^V MQU&\GDIO42#67&_Y8 7WH'\\V"/NCE1P)@?[^D#JW$WH#?^*\1:[AOG0@?_D M\0T;C=;!!L!502Y5.E)3T)F:C>1 M_0 ?G)_]\@;_]LLT>O?8HQ:-37C;K3T!"_,K?V0_O(GE:N(#C=UPWQZ_8Q/+ MO[/A94W$>OPR&]XU+7[Y&\Z9-<0:%LN^@^[X#M[][QEW$:WM)KN\C!XATA:/ MP!]KC\E(CDGLX#+TIF]99QK&'T0/T$#U75"3/NHAQ[KZ[,N:2U[6I)>E-AQM M]1V[?9K"AJ]\:V /W[&O0/8"'5\]1$&[F7[J3?08?A6=.: V1LYJ;/G<^NM2 M=&AYRZ:$[M(P%!,/+6"Q>Q^OXM_@]EZD%[NDO[]E=@C8'%Z\O\6[@4X6['B MM//+&RO'+M/X0<2E*"=%;/2'Q>P1O#OXGV:S!9#!\H7< J0;D(>J^8Y_^/;/#IU(NZJN/G@/,,&"VR\)[;Q: V16\+H,_KWU^^6M'^(VIP$03_0WX,OV*+S'59HO+^;5 M1#3E%A4]>8T=3["PYDJ8^^7.^IB7^6RRD3 M*[DO=W# =/>HNT\;,L* 6=-5L*7!?G^LHANG<@1)L]K;-K/Z23 M0'3_4(CN]#2CN6/CKII@>OTT'F.?KC#K41T %+#D0L^35EMKYYBNQK1^*5??:N[?YSTW81Q[$>"EF'KUCTA5UB;\!B:Z+24A)*Z;:1)J?-8CK M;XY1Y^9"ZEQ5TZB=F\IMQ_62/)&I98\4^=4!Q TJVCZL+R:'5*A]33\ZW=1Z M.:J3JS)ILO9GNQ?[J\+95EL%))1<#JR BU:XAE'RA-_P B#3;2=AX_H&;T"YLXH33-6H!8HC+\ M/ B\VNKV!UE%BVAD=A#,0.V.ZF?3ZC>;.I9[W.DZ1FM?3_PU[>_CS <\"/(@ M@;ZVC\O[^T1,+"W M3/SW<@R$<&D8N"@P)^.=S&VNJ&J];;V\7=L@[F6J;4Z-0N, MK,?S9:A=?2:37;=H)^4E\5<1L;G$>SP]>@[5&ZRT6EIG7)F U8P;4DE M:]8+Q+5WQ#S J-$JCJ,S-^H&X7M7:BP]NE]W7[FMZCM;? M55&Q:G^T>W'""AQM!55 E:RYH[:U3U'9\?+;0(KV"K,)E4"J#XCE\=43).;# MNJ!5WF896N!!^//!TMI:6J^YN=NF4C1/"<02=>'G0> 55+=KE*QI[E,!662R MIIYCV'N-+NY>DJF4;,T"$:Q$2RU S)VN:58L77/OP0XJ[-2O-;F7^G$-H[W+K?+G7IHGE7MI[EW_ MES?WLJ/U6H65@58!1F_SR'W\E!WUNR86J=3F ^P M/BE(*@NS7B"N9S;[),GG3-;K]333W*S<50II=3_7 R37EG>L%0R$J+S+^H&X M0=:44@,02^.P)TC+JEMF5:EX@PYX$)Y\L*0T4S.+HV^E9M8"Q/(TX>=! MW]56MNN4?[EWSX."\B^[-7,UEBBB2DF_+ Z_2L34 L3MBF5?EN,*WI12 M^8PII08@EN 4WC7GJ=\LLFV48J9E*,.5.MM*I*+GY)(_^'3F#^]!OT"G1/YS MN?[Z>7L5)WE91L\A%2>)8#93AQ2(K]ZWM%9K,?&%B:\1\F%* Y\_O9JF?:H$ M684IA:EJ)EVW]AZUO8(7;G"-&X:J,RCT()_-.1YAG,':1L?&<]>HYTV+;VO-[F;S0YW=%F=WJ#(:LV]JS1Q# MP=3A;:-7E5<6L*:HHO=LJC=+OWX'NWUZ1^N:1Q%[L2;U)K0&#B>_.WQP?B:] MZ=/HW6,/'3!Z$]YV:T]XP+[R1_;#FUBN)C[0V THB^-W;&+Y=S:\K)F\:5KP MNK_8[V\X1R>X-YE:[A.FH;A>"$^''AXAX<,*^8B-;1>4-MMRX'WP 466&X#H M]QF@8K#^X_*2?;:Y,WK+OEMW_!V\^]\S[B(^VSJ[O(P>(=H5CZ0"%4O/QTC. M1^S@,O2F;UD'W5CR@^B!#CJQ=D%-^HR'L$7N9U_67/*R)KTLM>%HJ^_8[=,4 M-GSE6P-[^(Y]!;H6Z/CJ(0K:>OJI-]%C^%7JO&/DK,:6SZV_+@<<+A6L/R5T MEX:AF'AH 8O=^WC[_@:7]"*]V"7]_2W#/ -[>/'^%B\%NN0^(%\ VOGEC95C MEVG\(.)2E%/0':!M++E7](?%[!&L&OQ/L]G&GUGO"[EU'](7ZR:^3H0>*[AG MGQWO,2CELK^Z=EEX[\T"RQT%KQ>N;\F\BC@CW"O'D6YG^MV2 M6X!5ZEC3 (@N^ALP$%O\_K++>+5AB]=N@69LDGF"'#$ M?H;]<[P.*?Y;+W1-KR2^W=^U4 MO%9]+2)6$%;54%SYF4PG@>1]&O?D1'*_J9F[MCO*C>.C)-VNY6:I6A1T*_H< M$#^T'<[-X74KN#O#L>_ M7+FCJ]3F_G_VOO3';23)][L _0]\WNU]-L"21>JV>PV4KX8';KN>[9[&?!I0 M8JK$:8K4D%25-7_]B\B#AT3QID2IB-GM[JJ2R,S(R#A_$9& 0!C)D^F%36^L M<2!8.5J.965T8951]6G;DK2CRSNXX?):7=0G M;?(2[P(GM=4G7O(2#V2S6DL/TX88-Q]^+HCK4K/&GKNV2=P%35,;U@.8]+:S M XO>)F:-?PDE2>']O/#3S0RR5MBD:7A90 GC\"! MK4Q?GK??>\F82E9"[ED;L\IFK3?!9BL72BE&PH$\'==BLIW3N'FWTJQ[XDIH MX@2I!VKA4._'-+2Y8=(T1)MG>%I+/'>CL?C\FH)<^\/1=())-6(\(+[V@C7C M)VOA$,TE[PG[]R?K=K$ 2F(#.K&]I"#64&G58GXJ'K$RIC&M-1I]V6NTS,LQ MY@AN?M5^8OU-:_N]"=6*(HIS KC<*25+:%L)N2)%'@\K,Q;/[9M6*U0R$5 9 MR1/U?>:T32H#-'8C!;V0FI]6&],>T=( MM#$]6E]S%@N^*JM+[/8;,;$&/Z3BXEOA=M7(K&UGW0A=] M>:;4$L$[IW%UY]CZ-FQ;79Y40KC4X1'SC>711J/K4?-%86>5T%$=7 X=JY! M(*\7@.E"\(&7//*^O_$+[?-]THPB$O0'TI.'0X'?OBY#O\Z2+%9D)4,=TQ6U MCZWNJ+-B\L$K3^!*A\8;F(6IO%E*:H,E'E075A\B:0M&1KF/(D M'0[D:;_Y->N7ANIMEW@)V.BL#?X04.6V#?Z>\A+/DYI016J"5NO)=)RW)]- M(!%5>Y+&9[!?<"@0;'$Q4!X[;CDD4J!X:^D9:A35B3P9M-G3JJ@YE2?5];(Y M-S7+F%F54!/4D'IU^ XNG4+S7'_7'-.P3E2[GSDJ,ZF^4T(#=C6]I%W5<#\Q MO2AX[^N2<=XM9;PLF=FI/% NIW(F^RVD;2O=E>UX-QYQUK25#N^0>47FP:=@ M5TD=-$;RL+KF4^?6895:!)D(.)XJ\NQZX/^5&@$9.7 F#Z\/U^E[)0M"=%=: M.O9: D)N'42DGTW\U"=]^$8_PCZQ?3G7NMI[)YSTH_G>_:S/HYQ7:A8U7[)TN=/Z%CK5)C%+NMYQD.?V:K M>##JS38Q[9\4G )Z )9XOL5NVG R+[B%?-VX"3]_EBDE/9#5_H49R#6Z[L5( M>K37PT0>#=J6F%73%5$4TT:'$R\MW]HN\>Q9ZPH!%!_9B/<60/%TEWC.Y,A[ M V6\I6/S'T.__#S(UZ6_HW?V>FU;=$9+0M!1E2=*9<5TY];Z521"\E)P-).5 M_N64FIT@$Y*7@@K8]=-9HVRDZG(AW\@FA()84'K (X @ER]L/MI.L+VORTR' MK:H7U-0J*^!B=DF BZR[&O2KWU43 _K)ZW^9QVB:/K1UAO1=*T%DKS3OKP2A30_X+1#-7K(@(=B9N@@KZ[[K9=- \+AV/9"6# M^7-%$JGV4VYMC*=PRJUY$:MR7GK8_90B2. 7W0['A6S"H-]7DM*'M_TPUL25 MOI!'Z9N]UBR9_4*6OH.7MWPMK34'')174C]XTZ;BY_YJO/E.V'3']4:S=N@, M6;8'W_9L/&U*#XK;X"DSS83WP2]HXK('A'X3692_K/]S26.L&^*_$%\88]E0 M$=*$SW@!6R1.]&7]F)?UZ.-C<6KZ4O< ,8.;[82(*1 M&O[62_$U_%/HO'WB'*>60[2_;N8$KA\\?T/)71N%?.:A#]"DE8.7[[\\>_$L M FNG__U*PN[NQN+9FQ]T:"@8.3CJBT4ZM0R[#-,'"1?BG(KN -U&S+VB_] D M0X>GNO_L]\?X,>U-!6^$_RGLM?,WOX*,L2)Q*)"7MD/3_*] ML$M, V+/'OS M15S*=^%+^=&_E-_]2_GK2WPF+'0>NZ_2\N+Y>]LT-!1&P(6-Z(67AS(A@H6<*0^ E8E6"G^G4P=?-FNX7F+@Z W_FQ86Z+?@N[Z MYW=XMK$$5\'R^!!-$(IW0/*%0=P?\+VWIKWXZV;1_R=^[Y_@=Q'01AL\/V=+ M]O55O(K'R#)_H_2D,-PN^9_?MVMXY*[;@6L:6K<4+%P2*_>YJYYEB]/D M+WD9.;_8JQH];'ZBFF^T%#Y>]1D5 ?FY(A_3?77N-HN,Z=A(Z^$ MK]?$6EGE5GAEOF2J@V_B83]A#;/'1"_W^.2D;#4HQE;JL[1U9&$DP=/9F*X6 M_OGN;9VU+'W;WH.^^!]M#>;U.V:!RM(G:]&3GGLK(B&R6NV_YG^A/RFO7W0[ MABMM' ,4WT8SS9U$K'LP#72FD CX))CHD&$-UA9!VEN'L)ZOHO?(T@"#R5E3 M=:K;:RQ87013@'O2[6;CV#_!:_$(/#W9TXUDYSY]^9C/";(M-#+9M?EFN'_= M$0=_ ;M1?!_G1@TY.1O8S+,WL\,$YR^TB4-8LQ6QT5ZW\^'GQG8\ M_@F';!SBHGFK2UJ.S8[/L=G#FI=?(H=(M]23?L#)AQA%F;QV.2?0LP^8@>9[ M6)-W,*4D,%4DX'AJ3C$&ZG;^@!7 C]2F8G/#-'-MNQ[\R\1&!'32X8(9LA(P MHV"B^%7X*\57@>VFPTL<>WN_DC3))=A(2 +2S>$BP+90?FT(%6+=SN/*AKTA MU^H&NL+SK6<[4=X'%D:>QYH9("=US_"@<9-P!_\B7J\N-;TG6J.B]*S"=5A, MN YBA&MF.:G6(R=#_!269VZH,QQ&E'%C+GQ !^9E;98\0DQD5WO'&'A-P!&# M;_V+]:V2UKPTXSF7L;]_^EW(5_ @'<^E.%D#/6 +OKAU"=X.PPNS,SQVZQFF M\1^\) ^:85(?#RP4;6%X8$8";X;6S$0P,,?80W\W?#-K:4ME_!PO)@R M\+CAZ#?XQUU84K\37ZT07<]NE+4%+LG%AAN:/=H"PPW$;W;T8+H!#>,4&P*O?;;[>V=4&S, M/-M$^#4VKDTAFK:%6@%[LF(IHX0/ L.9=J]%56N!P*"' 7^Y 8HROIS&@.OD1I39%H/>Q( MLH47 %&V)CP$SL+$%<-F'6Z+P/? >O"I\P25U:28 !@?,TB+W_O:[JT;BA>& M;R3?'+IB"W!@L'\;@8LMHY%S3^@T9GJ]D+EXX@DO"[O^,G690 VA'7H/%Y^: MA\)LRI*>JBE"F:H]!2\&^JYA+#DMQI*3G/93D*W(']@,6=Q'GW$!UI&ODM X MBNRE8JNHN0;0K!BS38_)OXQ<59NP2Y4\(+ 0D4U8.(G+0W?/WZ-*%CUJ#/. M26,_6O X=SMW#=W0G!WH5G"6PX*5NN,+\6WQ5*K0'K:V0^& M2V4@B-I0VAI,8TO7'-V%I^J4NI1./^P-7-IQ?RQ+@B&IQX(8%8S2N?O]'7Y-.)8R L86*Y"Y"[BGX E25\\ *?PW#<[$V4DT4*=,>])W$.^P M&,]@7FPHG\#"?7Z.X./7M]+SI4/ Y[.DN0V+?R&Y*V.S868UJ(*>E")]]I ( MB,J8[_>28%5"7ZT/FH.5,%A@1#_X[ W;-2Y^P]O[X$@2MD+UEVYGT =G<^?N M7R-9LH@G#=D?>])OPF.7V6:)0V.M>&[V'$X]E(7!!;E+ W3@XPITEZ"+X;)] MHZ?*75<1 98\<+Q=JC@=_ Q^ -0M>M[4D0!_U7#_0EX ]QD6\PED$WP/^ ?/ M8($,R:@NU/4:?%@TUHZMDT40:"J(=REC*MT-/9-W.J)A7/YXV,K:IAP'_P5^ M#%"1RD+.-CILP/48-<6A M<+*H_23M5V+$C;<^.R40]P-R$*# MAAYW3*IN08R%I&K$RS%9>IT+9*YGN3CR):.?[PH+,S]HJ$LF?,_$;V$$R,#L M-WZKV^&8CSTYJYE"TOHZPT-/Z%Z\%[6%D&&HE_R *<]MJ"1-_ /LXWI FZ0K"/ .AV M6"$RCZ13:RH2KL:TIB;=P]HM'DIF-!(Q:9>%_7CW!/BPZ)\@":T: 5L$WC ^ MF-98T0]U.Q@\YWXR_!^\ 05M'V[(8:T7& J4E[:.@ZF*^2YR,T1J5P'JN-C*=X[Q%K05F;3.ZM(??T))X9[#*1=KD$*+N/[@I%(0+J3$X85R MLX4P&S)Q4"W7]ZL%G]QX#%&BCBFBI!]5X=2@I0(.9*,&6I<."I;\T=6W]^"G M4G5*89O/_)^?O0BR.]\(*F /B/1UZ^DVR+XHXI.F'%%E"14M J$&\2.G_C.Z MG?B'/%_PT7Q@+<#ON+ON?\V'.,$^_);3[H%+SM_&4[)A*"J?T,T&)0> 5-I8 M< _NQ#_Z49@4<8_!8:@NM>VB.6K-)VAXH M@H6>'U$A(OKS@4U5PF=$T^UO@R^\L[>.YVNL+Z"E5\2QI/<&*]&C\193FVMK M#2T'GZ$P3, XBFWL<.-T&<#?J)9)&!JY__(;=PN&PH/A,@,*K!)TW[?S?]&L MNGWX^6!OALZL-/HU'?%S,M^YYA]V)(+.J;'_2-FW)IE!QM%E@9LM89X>U31N MR B%#,1-PK^C)<"MJQARP/]]@56SVSC@M'N"JKL@P$L95B&5!]FED;-T<1%HT(DGQSD#2BBJEWAA\0\.,2PY)(LQUB@SYE\2 MM%(%> 66$]C[@GW#/,N%HX:Y_25U'+BOY"\;!",S\WT)YOLF_YV,T)Q&*HM' MN0":,6>&^4)#YY#O'\%> \#F^'#"?>^P)X"T!@^!^P[H8T1E&B-(*//'40S4 MUE>S B)TF"Y4A",I\2A M\;+*B$%],@)N%'/JM\[&=OVX2KR>/0[)YI^?P]V@GF,8X\V"!!YA=9W8G!J8 M%S3GED3XGWY7HFMT0U8?K?#A?V/*L]OAWQ 1?O3YX:H8-GP-UO*(8U%B@]4Z MNLFN'V6&S<(]QDO$%A)2X=2J6&XM/3!MA RC2\/;2[7P2BP,Y!/+F?-( N\4 M?9AJDC#Y,^V/I!O.Y4:LXX2)D3<]_\,".1@K O"R M,+P^Q$+ ;M%9^(FFF1]1T_QOB)"?4 ;1+8'-XS +M]M!!O!8 MZ /#%WS)>*081'-T%A+!4 DR3 \<"B? %U)09_!66AG 0EI4;89QF7-B&N2! MT7".T33-M2T,.,O2#F-8]+N&A=+1\L WV%K)*6H:RA+Y M0-W0$=1&24)#:AS&[YOL2#4:@@PH"=\EH6WJ>-LIIH27!>!;_UOMJ;XNXN2)AFV>B.6)AFV>J((\41U(FO@>!16:.04AQ\HX+\"3M>K9;U-: M$.F9Y6'EV(I^EO]__3 GO^O;.VIOA#9U"K33997$*P4AR%MFL%#]#*8&F""LPA?KF3T_ M0(IH(; NO96+&3-:#LG+0L VV#V R,G8L*# S/[#Q@%#-"MP$&\PUB5]\DN'GWA-H5H0LZS, M4N.C^;E4)+&*\'KZ472=SD![&!%A'CEX MGR!)<>PQ];.XVPTNDO">=C1" .XK.A38CR$4@Y@3[Q$C"JP10X!Y% ][FLSACFX4K@:8P8:[PLW2J 7U46U8[\H M1QL<[QW;.+S71LV!J%I[[A+G01.Q@JT5^H5A;;9X"_T$%UM!V,&F24&F>^:. MK7&HCBM\8$0D[!5_O7IZ*D8M".]6T^'=^2_=H/!U+9OL8/_KT4FBL2?XF<*\ ME%?2'Q:+*P#/_'MK>S3G1Y%(-""'86MQ.41YK4/;6(+-P\)<\3>&X8Y8- 1- MI" &PN&M 5\'-^9>!,GA=_W/M 8RO/6VV+-IN+;W?6G[F&A5FR^%IV'* TO? !J \2B9%9EIVF-'0#O&; ?4D_LCP0QCH$\4IV (1:&C.LCX<'<,Z ME+>9X$:L=JA@E^=FXI?0H_XNQ[%[9+&RC']CSH9>,HL(1-E/8PUF.GW.EB5X M8^XFYO<-Z^"3,;;\$XSOJ 6Q1&HZEBC_)9@4OC[C4P5QEMK:,'>ODA_\[,TM MB\X<=".+8$?]:^@&09R@_YO+0J(N37G_T?L.1KA#R;&C<4]GRS[TG)O8+V0> M\@2OEE]#0J_ 1T&"GV\84U[= R1$M\X0I O[OT2R[#S[L408I? MCD(B_?5%JAP%:$JCK(P6IV2=+6JCX M@0,6<&5[]1[:&LM&L(0$2PO\'#M\,"C/<()D"L*9 M<](C.O3V[[1'*Q5DM.IB0Q%4"UJML"&ZP9&M/K @$)#HAM'VKH=?,)@)[-L@ MDL&:;P:5*RRBO0$;F H\/%56FD,/F8)+:&R'E;#X30BI3VCQ/DB\=Q%=(;82 MC+1*@IT5)V6W\QW+I$+G:]Y6X\& E#.U!8N5T>6S MW118_/[)L*>+K&4,&"WE2/QP2+;-B)(_U,4TO;D$JYWOQO5UO6T^T' BKCH< MK$8=$[&:62"1Z3JN40 M6S4\4J [ND2ZO9U[RZT9:F 7<4878(<8WB-6%C&5C28DNO1!#QO$U8-W;SN^ M*P?."#R_AR.^S:A;LW5YDFV. 3;#8B4_5/V+<#*O7_B+T/<07_?+X."Q>H80 M%IG'WN+W%/0+6&L[=!HM@JE#K*0PEJP>AO4D"@7S6$<#-!FZ';@;EKV&V\_0 M]3J\U=F%BZZH2[GC,'\LM\#!#0+_%6"C]Z,DP9YZTEM-!^=V[HF:_Z!$P5BC MA^88&IP-;\X;KIP%C]+C&7D,C>R5(*YAA??4P:.'10^1]4FB&2.TSIB=QO]D M6."FL)X4%H,H\',.T0;L++\I?_5BH$G^8$&HF)H7*O9)^&(%M<:Q[S<>""86 M3H>,/66$UZ @PDN-0WC1!V7@J7J&/1TKL-^7?D9P]J!T0/RRB*H -ED4N#0?^R]ZB\_;IX]<7OEN+J4MPZB#.BFCUM6)MKM@<%(0_ M#?JYYW6P&- =1H!N+?V#B/\4%*-9G]=XL7KG!\?H5GBZQ-_.$Q>U!6%+@W38 M4FZ&#&9SY.;D6L[L+AI5E??#JH?PM(=#;G[!CF6#;X@"Y/9HG/-I":H".+!XW6;M;;&SMGXU"0Y,9Q% M6@C95RG?.S8-B0-OTJGFO" 6'R]Z)X /N%UOV7_K M88YE;UO3YC%^K6ZDW[HFW6.[%P27^F^L F<5#1P8Z#O,[W&@\0C^*K\YY?Z:_+S[9U M_QF+1%BGEZ*.>8%GGWF&,R[N!K6USIO>3E&JS\^S,*1 M/# ;U:6LK;K/&5Q1,P@.PEB8AQ&@=; 3+JNZ" *ITL)P0 >+SNF81U_P1B/[ M;\,X+:9F6;$66GP,8/S)$GUSF1U)%>^#01[ER%.ZG4@VFJ^6FZ9:J(\*2&%L MI(7M0JP@D2SY>62Q1=$5)VPAT(?"DD0#P[5X7?A1W0[&<^D;>-0Z]&Q84##% M-)[FP9OD2&\/AX3CRVR1!N4O4"!2P&G48A$!%@Y']6OC. 9JON,)\;0E\-8F M+C>ZHCBN@(_FM!W](2B /806.?#*!E$KQXM]EJ'!LK8CXR^0"?Q?RO'?PUG8 MQAH^XOB'\B>-Z<=^FF?]@2+!8[UHEN0 $A7R6T*=5P[.,^ 2'I;B9 MQ%I9[ M2+2_$AWB3*/M.,//;Z&$L7G:HL5>T&FX07,E?A%V47+V0$I+J)RV\4 M[8(3RGHP4+/.QV0PF*<1,%"H]]B! *@B_/_KW%-BXA8\N55^S 6ZM<(RB?PT4(H(>Y-]]5#J::%9SMCZ%JTY9O/[PBYH MB\%6Y@.$EH;2TW\Z/@IL="]PO6A_0[%B/@N#?C1X M/_]D=.D]Z3?_H<'+4)CB)_R9W6$LS[^V^KT? \-\_9-_5 [759;C80/ULM, M:9%U9NP$*WYNO&"7ANJ4+;6^Z5CM\'+AV<^-\ >#?<)B&&+HR#1PYM6ED(-] M#5X1?D=,4\B];['3.C[$/&CBHF\WKL/9@3C04K@5.#O5N$&-M1.>9 M(A@@&(IN;[V%O?8U\MY)!G/+PS/3Z7A '#Q.<>7[+F[ECI!TU _RFV)>-?II M4!#]-,B/?D)6^*']+(Q^BO]^X]/T;.'2#QSFT[8(/&B 4! 2-4B 1*4R6BTL MP\\Y&-H4[3H=!)=8 2F=:QFTG&)9\)[T!QTB26.> M2D$]X6VMA_0VC^6- C M^B>-&7++ELHW/J'$(VO0#HB'%?60\'<^I(0.LM(V&Y/J>F)I-)B)TZ^WM'K, M8?H#/@ G1 LQ;1$:8]E>5%MQS_?](:JQ#N=J[UM$+HLQBZTP_^L(MBQ>HS[! M/.RP(!9KF!>+]5GPZS>"U53D S(%^QUO5^]MXVDBK84&DU?#H MF,S,7%9[LHP/:6%@%C&B(!#:"U,SUCYXE$K.T'3+>Y!S;%P@S]SPH8%4H+,^ M[-2L9D]AMKH_[CKQC33)%: 0>., .@R)C>I%.,U3E(,%\2C#O,,!;W7PU#T# M5?H[/.&"-FW*8\Z,$0BM3J++:\W6@&,*XE:&<>V;Z(.RLU3M4H]CX5UL7.IS M@!A\>C"V5'CQ=/R'Z_$L-/\KS4(+P0?.^\$#48*15:R@>VUH3)4;WAT<%1K9B18Y3E@DTC5EH>.3+722L- @]FA6 MT"'N\E1804#2<)A3A7WG$Y!1V!1J6.[<.Z]2'])X8U[L8$_#M8I.\%5!7,3P M:+>\BXSP#H=\*<0K-$9>V--,I86'@N\IP9Y$^T ):]_3<.AX];IK M_\JYQX7L,%'(UJ"R>M MI;_'SCTVO:[N)F?N:O1.4JDRG'!.4MT06KTDPJN5U%BM&2W"JI[U^1O]) M1C2;$Q8A>O >UFZ>@1"H#<0'BUC QWX@4>1B0J5,%/.&@!2#SU^GGQ2C(YD) MM&\NL=^&+"I6\"WF@L<2L+'0\=0!^THZ51?%#O,K2?Z MC8;(N'O2[00(+/H=WM!CO<9R70\6CY@C1-+2]$H(MXM9ZI[TWC!IS7K,RQVR M- 5N"0%!=!:U9#.D%!6K'APERXK#>[H=COMB4I5GZ ^7$*3]/=%FFGV()_R+ MRJ$3=>A+ A5/6E Q Q5/6E#Q1?6DN3N)- M2/5,>X/CH33=-DW-824PM+Z28]@B?,AJ<;\1K 7V;*MV-&Z]##C(S( UE23\ M"-$WQ%&/.-,A@E>D0_EPWB16)?'2U=OO[Z0?]@;DYK0_DJ6WHK'WNU!=5D^Z M%6,JT0$-B@!$B1PMVYD(0%*GXTQI7AUOU Z//-9>,WN=HYE[;2#*JLF"QN\>^0.EH$VKV%C M+;QGL+D9?H-2YK@C2K.B'B5GO6O#S'>M['# #)@*A.HZ& T)CZ_D)Q%J<8M8 MLM"]8Z48'V^_O_5!K_=;@_W)(?<:FP8;UV#?'T=[6+"(8<;@8F%Q2=!Q'WEK MOQ8SS#J.O2# 9$@$"FKS\)EAUPD+1M@]C%8U4J:F8:.@^6-XC );?:45*+) JNLK(3I70T3.0OTR$BXU@,_G*(U!R6T MIE]]1K?UB2_@/6'_+HH_@5,"3L0!1/J6]5/6<(EL.2SQ-W MJU<2C#)+@K+S&),&L]C8MIHR*9N4LEWCL?V'=V+A@N+_NJ'[1JWR0V%>?MCR M64]CG/DTTGLK)#E?WQN.!MB_]Z#?)? M]U;XE/XOSZA+_:OGB!=0Q!5(#,%M+"8 C],6?]T[8,KI^$C;>86=V3UX&'/H M@0ROI"G&$B+(F;EMZL^$U^[I:2^)B[!PHOC!"05C"X+1//U-Z+&QD2$EB QE M?VWD#0?+K^D]-;VA\""R3Z NL*SF3LB)7^?.2Z#&'57@M[Y \2/@U>SA$?GJ M!GF?(/3JT=$V59(NCL?BE](R 3!!:/J8?_[4T. _2+>!%=4RPA4SPD=TX"Y" M%KSTG.):S;F?/U?[0UD=3&5U-'H1TEYO_,W378L])C)'>*TF61Y57>'/.:@[ MCWTPE2)Q;VF76'Z)I;B*VDHQAA"WQ,;*+X>O/S1]U-YH$_HU?NB5-$-[" .F M+#P+CAK"2(GC9KJ#])%TVHT9,@Q_*2#QCCPICJS_76)I_;TG\F-.=J\G$?=Z MD,N]OM-V5+G]L+E9+P*4Q/U"O*]+)+TP^'UG>W 8LY8'RB&.J0@AXE@WD=PY ME,K5L$,H XJ]R&^,GSY MA5Z_I]+B.'_*64$Z'6C)O&IOW"^A]H26"V7)#P/2FM^B,#$D[5/BN'Y4%'G8 M/T2(GX,_L]#]>3+AE283'AO?P:H.+!1YJ!PF[ H>P(NS\;S:9-+OE43(LVFZ M27@I>E:(O=_C)SS5K2R2N6)P.5PQDOL-$829:9\B#8=-)OXQ:3@ZMRBLB/-' M32;^7H6U/)M41O93VG]IHE$9H0?_[,T/1P.B:1P-Y^%/. #$/2^'C"^'0R;R M]-)DXP7X6V*82\>+=UX27$D;[1:GC;PE9 YQ4?DTN*.UV>MW7IXF/2Z.C8B=BC5HLB M!&4])C:"86<9$I ^D*H<4*U4HOK("PD5O+ F59H-%!R+U.?G)_E!X'JX$%SF?3)B(0A<[Z0CSI2"(_,WZF-+"I M&C13;O:]H#!NS5"GRN!N#6:%K.A"M29TX5.@<>)UNZ"@YUFOFZ\Q7M(JP^9T M**NK#'22N0QT7%/?S1 #[4\*9N7E?M$^*UC'!A1QA=31-A6\LQ>H\OM=J-D+ M[4PG1G%]Q._^G19AAZJVQ#"NH#&,=".%NKY)0=NW;DNUI9M:8U-DE M)8R^^"#0%P&+\-)ZUDVEVXFT4Z'-"4Q@*EIK3"=GDHWM8K,%I(>VP89:$@B) M-6W4\)4.V^06&6>C_6EG[VR+VJ.4^=YJ)FT"\7U%<):5P2ZRT'C:/Q&-E5$F&E<1ZJFT[WRYA1QIMUQ.Y>=HV5OC:$SR::@K;;*^I'FW;>Q!0TMQ0/,D-6@YR$Y2-/\_0@'!8[#4;;H?HSU,*=',4\-7_F1PW[20@0AUCD&UM)RK2ON!DP?G/%;H=UFSPR M_TV6[@FX>)K)FK+J:Y 6:'SC^)5@0*J1P5?X[L&_:! 02?;)6MAV9[0WQ!'-9;9N=[MO JJ3^OS/S!3JPQL65[K#GQ!@?T8-ME M&<4"#0P@M^'?T=ESL*\;GTVXST&+$ =U.WQ54F11[,**+0'C:GZ?9,<&B<9( M0Z6394O@=A)LU6I)R7KC'YHS4/X,A M)"5*3&+X1AX(_/#1L=<8G,2-_@D'+FS'&%&1-ODOV_-*RALZDF&08R0#7Y?$ MTYQ"ZG0[8I4N:PDM%EKCF(;<54^^!4;).@5F#-BIK=!)B]8)K^ M_/*8:+Y"FJXZ"+&EA> RKS,B=&[ZO8%A':+8!F%1%!M'++-*#&:F+S532++^ M9>2&&)UZ21PEA$+JC"NJ IQ5*^?7SD[-XJ3"3*2<9S$M_UP)__0OAG].E$PZ MTM$VNQX6)EMD(A+U4A;"2\'D]]\TL!J=G:3(Y=)1&1MA5M5V=) "#*ZJI^A9 MB) 4NU#+U";'F?$"DYO4QZE@VZRKH'>98LZ"])[)8_5P0%^U)#]1"ZVB?L,3 MKBU^2DL\?5[[VT$PI_9:\:PZ;5A$IYV+!9);HBEERKG>\[G=?E H'!N" U.J MUU2'A*B]JUD* 0L/H_!8^ MA>KS(@UQ0G%_(; 2^Y0,#C.J;=> #.>6U?P8%:FU?>K$K5R'Y[H5HW/=BE:C MMTM\.AH]8R@UG,P_KWS+UD*@A&@KTV^H8%#LR5D E1QB5N4_?CK*O_;+T= 0 M?9UF0-.Z8YP$[#8LBI,:U(.7?A\%I1W'I(5 R]V.<%-3"@+Z)>H!]N)1M[I. M(5Z)Z/_#&)1 _R.NCT/R*(S:(0(G;2^7+O%\%+X30FLNX7 0T_U@V%O7W/G. MN0_N8R!OOX9"-W2*]7:!4]SE#K'*.T3MTEUC]; ]!^ISA#FMK:"D9X!P+)6B M1>6PTJ5#*(I=WR)*= \WB.LW7 Y<9R4,FF3!%H"0#L&*%OC-TH#_=-8NPTEW M.V)[26><7N!1Y#S1-_E"O/=\<9^LCWQIWW%E!4^3EF@$Y[$0MI8X&&%S[6)+ MM=,W.BBXT21!;!3=+658A TS+BO?$&36-@1A#4%F;4.0VAN"Y%9THZ(:5 M/-MQT;,=G=/Z4:CU@R8#_*/; :,!=//:9GK\WGC 1SB&2PO%CC.#P8JU^+-0 M5OB/99:(QDTN)H:]66[[+QN M?V.4S=^0A8LQWQUX&*D7M\HMY;FXRK!WV#TS9G.Q[A%WBXYX/BBVLKH^M*T6 M+:"JYQR*NCZS)-J7TVHX(_M+F+K7K8>\AQ2WTC;UUO-6>PKF( M2ON2JF%:5#74U*@S4G!)/Z%CCPVZUU>LYRKV0'OVYHXR"?9*^/!S0W2#=EJ@ MC?E^DO6&'BXOE;R 0RQV!#5U1@P;62NX681WS(-[I+%^M52>HKS>T/9T6,Z\ M@G^:]"RW"6FQ/B5%3DR M6M>Z-9<@#7C'UN@[-"?L6W4[VPTV1@CI$WP8]F>Y^++YSS:0"%L)N[0UV*VE MTR:&H,V)\8#.O?O>FC1V(#QDFI8:^T,.K**@?YBBHITN30FN2X2U>?57S MM57(ESM*42Y?EB'JD2#TC)Q@#;2QB>'Z=Y$5J8.X>'4!PKG*8QM4PEKB>TSS-09ZE;+P@W"RN5C=NIP<=>%.4 M6Q(L+^9L8Z7-\6?5^>A:4*!<44R&QWOIAHV2QA>0EH'*"=4>*'':@.P=MG>T MO(0ABQ-9F=9=0=I@FI>9A5>4YJ.I/.ZG3[4[8]5NH7K)6[3Q:=P7PP4X2^QLNJU'U9"XU+*,M6,:Y( MZF4M-*Z@-/\?SE_)=%DG35ELSLN:8=1V0B'.N-\6XM!"G'&_+<0I4XA3"7K) MGX90%JGTR7J ?=G.K@0@*>D9-<$/YV]&.$KWOX10OG:00 I+(1#BULIUFPG2N%Y^1)X$4@ M.A:Z)V:*TJ(E.!\_??QZ,6VT+F"))QJE$ LEVN]"KBJ]*5K,.%G8!<7+*@T: MCW0IDS#Q>5OL^3?<\O$HNSJ01Y,657026D_D :K+YH*)JL)&'+N'O_,AJZP< MS*\BQ9F?CHU3GZ\DT5[_[?[3=O[Z9-TQJMU:^C?MT2=N0HJ]/Y(GZI-JN'>: M,ZU$BA0[TYDJ3_J7UR^V$&Z1@C9!7(1"._5:1?5?9+JEA!NKSF1U5MD A-/8 MDO5?E32J]?MRO^BTG3/HUZSZ\S,(AE?A*.=G<%XP[4&1MP%S6CM MW:4+MUE.<&7_KIDLA,X9,$$J#^6IDN[^M)C=4XN/7$-*G0\OS2N&>E<@&(%D"1G#<;T!V[>Y,S?+ Q?_P[RUKA5,"BI'GF56TA!GG0&&(M7#!DIQ%H"0E*0+VLYNH!G-C[/$+&>AH%,JL3\%#J# M09D#5&.8*OEI\4S0(E5:I$J+5&F1*D\9J=(VDFE (YG/M/DN_+^QWCCV UF3 MF'K\QD$0IM,2?MM159V2(E&+1X.O ?8Q+3/.JSC-Q].Z:7[ZI.S;K6&BT><> MO7EGR3/.BHPO+GO"$U6>3 ]K#"\W6SM3SD#%,5(Q'=+0U.PMXIP6*\,B"# - M.Z_G/4GU#":I,X+XH3XTF\G!ZEE#^E1_FZ!R'B2CN\TZ+K5>C)@:%+Q8%6/2XA\.) MK%0'YFF 6CV'!!RJBJQ.:S%.FJ=5/U.XDVC5QN8NZ63C $EIX/]*1'.-K447 MB^UZ2\>BO _1#?[;)/@?P'BW:QO.^#_T]T>9,L'*F_1E-4,M3HN0.A%"Z@1' M#H)\/#H9>K]YB*I-%KU^I7"=6BP'VNDI$<,S&EVWX4!%[4,W\UI&FA MAFAIR7KEX8K9O-T\OF9EXR4\I>3V#9EOS-Y,<@$>Z*(FM MRI=;>Z3:!XTEP\(R$DL@^3+3MA;^8-O7Z.L;!M4K \W+2-1!OC.HJI-4Z'5M M$ZD6FM="\UIH7@O-:Z%YS8+FW6FTF:J,+;<6MGL0VVD<0JQ,= ;[ 7GD,QCK M.M]W:L."XOF<:X#CE0F@%"%V7RW84J.Q.+S]RG=ER"K?0S%L20L%J^O.]M67 MB F=]R?+TZQ[ TQ<9OZ&-AL.S"<@S>1!S$B @@G "VXE425-1_)@?!$3WV*@ M1V1CNP:XKDA;;8.> ;@'9'VY?8;XCMA1)HC$B:ST6SQ!/II-08W40K/38[A_ MUQS3L/A,!:3&Q3)\2)+1X2*?F=(5/,8YI5@(VJ[ M9J&8X^^&B_%$S2+V-DE<*K+ZM&;R-;_U9/Y3G,JS\V 'VDF=#4>DA'CIBVTM MTJ8[#F;R;-RB4!HH"3*>WG!X7CEP#;,Y,R8*A_GRBC5!4WZLB'"*C?\0G49Q M,;>[84$WR7!%@ G^N'4-Z[[;P;RO"UX%!A$6A-O9>N2#<(;L\*& Q\E MRZTIF6!RNCWI \.\N))#6-#*L_D;(N$KZ5%S:\3#A",=.*HG&A(Y#N[H)P!D M!+8C"PRE#%:FZ-KK \84IV:*?EH63)N/824"M M$!9/M,5*@!8LH("T!-:4=D1S*),G']VL#*&2PG"AU?([\@5>^N.1F _D=UC! MJNC1GG#%_P :_GBT+V2A*X>0RUCJ1WOK7,A*C8<$FO9[<=4XY7\A'8-A155Y MTBA0I1T%RD:!*NTHT)1=)HX"30(B9S8':['ON![MP6Y=.I2%>@'4 %MK!EQO M ]6D 9^V[H71U^UH#EB%*QSG3#\I]"@&DU=,:?I/8NKX(-0L/<*+I3G9MQZE M9.,1TS2^Z;@DO6XG5MF'WA-1^-1Z+:_M)Q>G[4^WXI+:_L0++:/M3[O4,MK^ MQ"M-T?9Q((P*M+TOR5 B&/Y2&2XY[%@R6=3M+$ &VN#AL[_!5]V5L0%WUL&O M+\RM#A\'F<71S7.0/]3'J$9P19T4D*A,<,6N*4:05>>Y3"].EIUNQ25EV8D7 M6D:6G7:I9639B5>:(LOBZO JE&477O*#[0<(^;HACH;VXV>BN<3-7?*3_)0J MFIM/<]3ZT-?K^\4^E;69K[*W=$;RBR*BS*=56Z#YG;W>:-9.,NFKP:UUJ/\! MN@W5)_B.)JI,4)BHB+L=OV2<:5/Q[97F2N2!CC=!C\ TZ;?Y,U&#ZP2\Y35H M:# '5II'/X):WQ9;%Q_>6CH+6,-7EB@[4"$+57N_-73LJM'MP"]NO_\AJ7UE M?--7(XOYG_^:JLKD-7^]I-V#C*9=$J5[8L';3',GZ;9DV6BAP'9@%6L^_4]Z MT.!?:,&P[VZTW9J!J1WB&OJ6?L+F_2@>Z]+'Q2V"K9)9X>QAXCT&3?PL['N+FM,VC2* ?6XC6[DTZ631?.LIEZ^:?NA&77&$/I[&U=-\.[<:"58Q'SY1]71W]$G^4X5X6C2^@ MG)699Q U'BGEOR[_<%D\+ $$*(^+=FF_AII5L#1/3W-%'A>=!G^:TM6B51?G M1>@>J>V_\+J!8@^Z($CUY5'JW&7A% 'S-1K=#$=?M"6UYFK*W(ZJA295Y ME2WQ)#7/L?Q1D% M*S22%3)(C?V'@5MRN*2##A/3WFB$[/*.58M(&\R;9NPL MD?I&P4RT"%72%@O8DN=BU)E&%NF@M\7"V1)=(""*%ND?&(7Y#<$R0Y*BAN!G M$7!_EU:",QXV8ZQ.!>0K,YFH*/FRU*(V16@?N7>MF&[8$L]MW/F<$93PY1+* M<9&B2.IKU!MLZ"R)LE9CE=T.E'[)?A$8B8]*CTPED')_4(L(.1L92[:-*$9& M11Y.FM=$I>B0@TR2^M2^<@D?MW786THU1?O%UU?UX())NKT%IR!N@3^P=?X^ MG"M.=65^2X&#/K[(_&=4VU+R-"E(W5#E7280B$+/,M[>-TC9-$6&?58O/:[@ M,(L8#24.4Y$GZNA,AUEIZXD3=IG(B! ;Y0.4U52%^(-";-D@#8IXQ;80".R+ M!1(B&M%8&[1N9KZC@$,FX1'6RX)$3K@^!VBC^:4Y$BW-F6NNX?K]*&A)CH!" MTD?U(M#W@M7#:EL]S*J'U;9ZN$SU<"6%'F&/)+:JH[PL&>>3):/:<==1]'T, MYIYBL76"Y7>2L=[ "1I>@+B&Y1/65P1!(93MJ(00J&[05@O:(Q?!S5@SZ%!L M/YB><*\=.O6$/@.1UW[-03P&F[:?%03K=@X,5H:W]H>I<.0U@J:MA6$2AKH& MR]IP:<@"+7 M"/C^^^WQDMS#%I#]],9OS>Z=?^QA>?AF>.9@[2EX8K_H.885*FN>7WOHMHI# M'SV50X\4D!_V>^Y?Y-#T*CA@_$0X(%*7'\, Z3&8:[KWDZ=RZN$>!X>0";5Y MD(E267,1&5 VQT[_>*7$#_0#M:5WV"H^YNF-30XU@.]ND8;IS*?(BEIPQD#L M<5^B)&+)K.R^_1.06L<99B@/QI-+E%?YV>20L05@YT:E68]]CAH->NJ((7E< M]Y7TWE@N09IAR&9.O$="K"B3[46,_D=;(Y'B@E>Q'0(N64 FC]RJD?Y6/[>DY@YTO^QC[_0U&PY[CS"E[64 M QXYU&M)Q^:)$4_J286\"QHH>5EZ$N%:-&R-"&J!/-([Q%H>:5[L U!8.<3S MNRZ*Q(ANPZI93R.>/(A-Y-I.3".8I?BM2QLKV1;O)TM_[=(O+6F7([9"H*QA MZ]BJB?X5TS>T4Y1K6\ ?.[^'%&WT%$[>T#:.Y"=Q%H;+DC+138L]&Z @Z2_H MZ5L'B9I\^__D2[UE*_TF%DK_ M^ .6J3Q[,^W-]B\.ZSQYKM9UJ6U[2K2SN^7U*'>L'.76TF]9,4J 84ELX9S2 MYZ[@XTN*#OB?PG+<\S>S'C:TR]X+#[["*G7$TKN=NU"I#E^^/]W#[Y87TY,] M+'F3LW1E3T&TNRM_FO6DK[.7/M'\J^%ZOF3R\\.5M;_:7]VO<_\N\;.L1$V6 M/],R.=:@UU66=30\V4+CK23U]K1@Z)LNJ8H?:1_JKQ)O0]?=4:63KFM1( M!G<9SMK-J,8.1P!)/U-QI M,HP%>\1;-B=%XA3I^%.FSG#/GDBM3U8&LOJ4NRN5*4;,36M55OL%AL[7VG_9 Z.!P$) 2R^< MI(K-8U1V(+4PX5=+^F(_\,AZGR63Y=A$_UM;<\!27G8[[PV'+#S;<5&>F!J. MBM72YMKW(].FU5S"QS\705**A[HCSO<5O-R7-_VHO(&_N_AW]]F;42]&["!L M0**?D-P-%IV;DLY?Y&?<0H-V1I0V ZR:=#TXF)5M@I1B!>IT[LY^N:/"OL%G M08E'RRB^%BM6=0F$2R-;F;&=^W3CO 7\%].?Z6"PW73:.RSW$E/I8!L:1A<, M/89&%S^RSK#(U^4[X&O#^Z@M1,XOJXS$)A<6IGG9GH^,IQ_F@ MH8=DV?VN_42,]UM14/Y.PYQR")%W<'>'A^*NV^%7]]>7N+DW\ V7@!# <6'D MP38?*,J(,\:"OE]Z-+P54&.N67^A%#-<:1(EK M(!IS"!J MY.<&-&PRH$M1^M'=8P'^S1HK>'';-[JVNT$0U@VQLA#B [Z27NOW\!RX<]&C M&^T+@UZWXQ,MF)$(#(*GZ#/)G V!YZT4<&<&':VAO*!W#BZZC4QS#VK8=KP; MQ)-)QR11]I8K@[;E"FNY,FA;KI1IN9*(Z (]^;O#/+'DJ:@F"P>4OP 7MK2<*&(9? M@UBWI068Y/=4K9 ;6(O#WZ_A&O'.2"F5&4JD)_>G+Q]+:XD_K*U+=*$;8+UK MPT,9_I&0.[8F8!U?9=RH(9VQ 76 ,Z)C6I?]\H)2G0&;+=Z\!5\D.O?VI%OO ML'N*'$4P@Q5N( 6P<0UMO4+U"NWK M*43=ST)\#ZDSZ9,A)R^M+M]3MBX2Q5 MX5??V:Z'B'36B>L M)F'85Y[_!=($CI49D'CAX9ON=NYZ<.\-VNX*)USS+E.$LP1(X#_\\=9,7G ) M$7ID5." '%VLL!#!KZK@THH"D,6#I? "1:]0]Q0$+%)<:Y&35C_<>^*-6%+V1+4LZ'[ZVXW M&U-T](N5$@DB#03BH0@.R=X/VF(5R" '+#TX?KW;T8Z_-A"E_"UH4(OVIL"( MR._"4$9_!I; M,<.Y1V:B7!D[ 3!)0>GR7!7&+X'TQ]7R"SR!9PC#?3#FUR2 M3(-,4>P:1 NW:ISWX>,*?VBO:/K@GDYZAQBGK+*R!E%?\W[.(SM+;VK4.ZQL M]\-M.63I.7R;PS*I$BX.E:\,Q2>D+5=%)?R:7 ^MSYD9Y'!FZ"*[G6".(5N^ M#"OPZO1HXFO>JG)LBIVN\&:*\D8]^60:X WJE@U^/A;Q1*FB[V347ZI8M<%3 M]*"*5"9B&C'Z/F%\MM6')Z\^Q#95$K'00&P+$=M"Q+80\0R%B.U993RK_MGI M50\RFRN=\5ZM6L7%;,E//E+1EJ,\\TPU>NVVZMU6\XJ;?J-MGRS)U5AJ/##* M6>^E*X>[]TO W9%TGVW7_6I]U[ G""N2H51+@K>WY0I5-J$MT\.NT $JZEFJ MF*[W!,>G/L'168H+&UE=4FGXT:\?+A%M3'I&?<'%88[@(EMAMT/KI*5*PHEU M1PXS'8P(%&8\Q=JA#4LZK8I%!K%/@>00;^M8KLCE_]'[WA,8LF[G7UO'<'6# MR1<,\C]HCF%O75@C LO"?W9[TI\(?UK"*LE/WK/1C0(8$*-J2Z9MW6/YQW;^ M+[+P,*L6?BE]#7M\L,INA_S4*.:9IKYPZ" L7=MZ*]L)VE;2QH<2 TM*:E^9 ME$_FUCCM*A-'#/*P3]F,+N.4I'-@T ^7;P8#RIC_K#RB?&ZJ#_-0?5"J]QWO M'.*_Z8OMM>'E-KR<$/P:-S*\S!#U;7SY-,=6\8FU >8+.JQF1IAKTPSEB1M7 M^!-+\&-+*]9(IM3Z,BPE2UZD_.*.3O[,RK&\\+EIU&O04B[D(-^3)8&CU)M& MO@8MY4).LKV25W*0[96\EI-LK^25'&1CKV2=J)#!\!>_!^XI>QQ/"[0X+I.: MYK>4[_2']I.C0GFY3<(05T6>#*^CK_01FB<7AIJ@5'EE\&S]=']/P\O]<_;'Q8"/ED"%\& M^5!45K>6_ME> MY+K# WDR21](<44HM,I.M'[K+W*FQ6W Z>D.^, LO-"SK=VT+'I=)[+:7M>& M'6G1Z[H_1B;=DFK/]0QV<=&K.I9'2GM5FW6D%5W5<3M]Y*H*!RJPOW,SD3J2 M1^I9AE-<\C'6;W07M[/A0"?I(:CKL+2;78U5]$X.9_(D0T"KO9,GMJQS'^0L M0]*C/<73VM'Y->18GK0:LCGG6/@V#N0LN9E3%$K64?075V*7N7['_T72@(%A M.V" #1@8M@,&R@P8J*3\UY\%E-A+O6PUVBA/-=JPDAI LERR)HZ12E&L!<0" M4*)+2\=>TZH_K!#<>K:S\^L[)ZW]%8*'- XSP&-2I4+?E^L MB+[%FOP/XHC\MWX#8G\C\#2<+$ WTS:K:ZL)VV9U5UA,V. &:&TMX>6<53-+ M">L.Y/M*:3R)@?WPWQ@@PG$[-\J@-QFA$GOI*U34I',66'T*J(Z:=64\WB,T M5BF.T7M/JCOC.8!VS3CH0.@A^X=+^D9]P'5,O:+&C!H9AVA0=O65F.&X[=5OKNN0>,@' M8GW4N@S5J^Z:?89"U[A_\FO<"'\AKZ[Y< P]T[U\VZE6??P@0\6O)SH M&8*TRC3&[JPF2'OE$NJL*BC_0:O#&$W4'G33HU<%#GK4.X10G^*@3X&AWH,R M%D)25P=MG.2!-H[K'U]"X'? ?/ X;Z5YDN&Y(:RJ4+/=#AM//I >#=.4M,W& ML7_2KTG)G*ZH];+ZAW]O#6\'K*XY%M@-+LY8(N[7Y1\63M- MH2OZ-^W<]?0 M#&A1D0.O8Y/*,"$2$+F%0I\<"MWBGUO\\]/#U#8 _UQ+T(069CT2W"?CH#AC M60AA*=!V@AR)OD]6WR:&Y$?Z(Q;QXAJ_Q+I3+EQ#38:QN.AHM OL3QKLNG-L M?;OP)*%K=P?[K+%5Y;$ATXEF_J! W:]S[[PZL##XUOV=)_0_2F]^= F=00N1 M>WAZ:Q>Q6:_<.VU#3;/_@*!UCB%9%K9;O_"M_)[MU]?#X8>,>/%; M7FP?HH/ 'X#1_SX@PCND04*+$WDZF!9CE'.IDLR @&D*(*"!VBTXDT8[=/= M?4JUQ-L[2%>)+2KJG$(D]0BSB(&FE7A45ZWWP_8TTX=2Q.26KIG1*I457TB2 MME'EP>@LO4FO^P0K%16))SB11].S%&/4;4_D3SZ'\%6O+B:_>P%+K,^1\\LK MAKV8X@IULJ%'O''@HER-]Q;*;=TY]@8(N;LS-*/X\!2"LAQ1QR"'TF5H V5DOGK9A$O6NF&%^2W5D%%X/#!\2&V2]1*PU9R-%)RY#O(B=P?GF428B/,C\CJP)5M M7E"G]K$S1=&G0*UX7<7B DFB0^D_J=F;M1]A441KX2,"__3*795^GM*U M63T5AG>.83N29V,)JRJ'RPHEPE*,QV&_W0[%_4J&1;\'SJ]AZ_@3'#]\&GZW MDQZ)0SM3;*G@1=06,,U*6AJ69BT,S<=N@5]('Q]J8K'9.AO;)6Y/^D0K;-7( MZC3=WG@HRU>DV]DX]H/APCGXM9% 3>G=ED/"_F;/7>EV0?N\JGUEPNIY'6)B ME2[L_=.W[_!S-$FN7=[!^=_\*T,.))7^X)EKPN8MTXQS":13##%@<'3KZV%/WWW.=\WH4 M)<\M!YE0>UG[6M,CS6(VVFXMRHI#Y>OFKMOY[QQ37T>Y#-I0Y] [S=##F8;Q M 9AU&M,16%H;I@G_(4O)B]R;@UG?*H>SF(X@P2I1 J2L='RBE0[ZO4,5'ZP4 M) W>2Z80L,B0+1Y'>%#AMV&M!\Q=5#*@,%AX5"XXA(HDVC$AMBC=6X'%?[^B M[*<3++2ALEN[UPP+A.=RZ\'MP+_2NFG&J[\:;WJ2WQ"@V7(BQX57ZK_PN@U/ MLFQ42J9!L%.4)ZTT%-4+6@MPU. 8V'F!9#;HV= _*Z]1 MO..IQHT?(7!HE@1B'A_'U;"[UW"=?\K%)1BNM& 32LT=J 83F"[*4;A&%%;= MCF9)Y$$S.77YLS\L,UR2#9_E:CA+== LP"(0,PEC469)+IL_WL:K&YA;.@RT.!PMV@T M!"OD#>B-)5),EA[MK4F-K:WIX8HT"<6P@QM+4H\84:!<.'GT\O&]O6 M>VOV7I8T67/43M9DDS5'[63-E%TF3M:LCZ^/S-=,L-BCQJ%HNW-''(K&C!'] MR=U&CCZ@Y*'Y;T>F44KD) MG86F]?3A(1X:8^"X@@JU'U%U:2"IP^V6A%:R<-.:9SNHM= _M.PUR&L/W1^; MNI/27'.!?5BMDKE%)Y8(TH+;)+FX-? >S<76U)A^$M]D7A7J*U!=V+ZIMB&G MP!SB:LZK:<&4\035JD:6[KWI+1(=*W89R=L6/2=OT=-.*VV[];3=>L[;K:<] MJRV([F[%B+7]@U"S4G8 BG\F"0/N_J:MN" M[26!ZB:W,AK)T]D3;L.VE\JJF]ZSOCR8%:Q=/OOLVS?O@Q!1JTV?UA)/4. 4 MHRU9Y<6?M,(-LW_P2HRKP[7$D(R]Q+X5:[C2-!#I2O;60$;N_99O_0O?^=4E#A>[78,=TH[[DZ8GHFJJC%&78&.J.IB-YW*^E4\S9J#MJ#'6'T['<'S6O#\\)IL4?%8TT M1X! .3;N T6BO>$0%8NFZ#W'P/DQL!(;WHETCF9CV) M:I9^&<8'.] AB%73S'=413&6O_7@..9;FL'Y80>];^X8L.W6<1 ]$9T\%WL; MAD-YF,&.O"+X^FD.O9RXJ_O4)RH(F73EW9YZ*2>P8:>N3@?RM'^R$>#-J*ST M-1^JN1J\ IY;?Q+,78O[P0EX8,FE&7&3V4 >#%O-5<,QU^$'%3[FT42>#MK2 MW!J.N0Z'K/ QCV?R=-2,*KS<=7(GP:*5P&72_JS?R&;K+%9@.+B9<9E8;G7T MRU5B,LJO M]Z3WQ-,,4Q0+8GV?6'_E\Q&K+S8Y'=BY%(<,,G-(59#/'P[1W*VSHV]\NWMG M:F[DAC8+XGG,YF?0>>,_A *&^,_A=G35@CN?O;FCH.(*\4YIL*]!-;"OPT(- MT2[FU[GS$E[\1;@N_&<&6G?%G^^$K+B.K7/C0^SU#NX1D; 64.QW$\#VKV&_ M\4\@^Z0D>P)4I+E/,1Y=1S[; 2W'!TZ?]M0=V!/ [7C9P6'M,LL$Z[ MFJ*KJ25]L9>*4'H#.J3C;ULPR 98]\[^JU\W03*/O)SA0^G(RW X)G[\Y=DP M*!DW,^Q?TV:4:]J,RC[+_A'=2?B?)[N_^8?$1:^R@G?Y=GN/+;+426/(/+@F MGAE>TV9&U[29<<-N_'( (:!V.N.!3O.U?%YZ-L9ECU:]I;TFK M:LC\F.I\A5*E$6HI"%PDQAT&QB2C762EBJZ>]5&RSC/.W:*UW/$JX>-5BQ_N M[>+?6\/QD\HXO$_TLH@]ZZVKP]_%B0]GO5GZ9-\K/?&+N]5[.3(>*8T"NV^W MWLIVL+OG#_LM"3ZLMS?_M'R05=M/BFC[RO9[^D#31WN+'9+:2%.[FLN+- DK M50V;K.JL,:[#])K\H&L*GHVN*7@V4AKFH1:/-XD[/.CCC?YB/["&8^JX=EHG MVXFE\,1%O;]!AO+)BGGSP.O*3ZI14SRI2;HG=;:;72.WU>F5G($CJY>638O. M%XWGQ<7P HDY00$:ZMB8SV5I;'8_\RGG20X\<<1$9IKFR5&T-,U&TSRIDI:F MV6A:*&/3;(10VI%17.VUG'/FX7BGL<2'\G!8OM*\F9>S]DEX_::X ]/RB95F M'N$%W+OZ?)+V;E9UIOW,0RIY&0(K/Z!E!^(,?ZPT[W=M]P_BO25^:0$M*?BQ M$J=N6.R+\3*7-;X:NI!4Q<>!3MQ,9'FGIDF4#R\X]Z9%-PJ)3"GO2%UM4CM*' MA2M*#5IQVA?#T)3:!A86J@I-FK8T;J(C2<*!*-[OMESE3:&"*8T?EV^"_7F^T;'!.OH)K@'_::R MMX\0)UGR-?4P-[:=F.1H.Q%>>+=SQYH7SD\UF3-L^.2;057/B8M>&-5Q4%T= M,[!L%P=@R[&M*>G-7MDF6 (NDVP/=&XK?)1.S6;-1CY9J*>Q.R:>N_0<_\R' MA[)/?;KCPT)?\#:8;+2F:'R)$R_AUQM"FY'1(T'A8SNNS.TRZ\9ODJF#HT[_ MUNVL8>US(H'#J&! T81/%IWR>4\?&-#'"K/T9ZPY_]B,W+=GO1W6!CV M2.-?9I.648+J!(R=-96P\YU_'GY'4(PI&9Y'B!@L]]:&#> /[P5-<"(NLKKQ M9G]J*HXH=QZP%CLY/3@MY8K[K!Q>>*@#W]O=87\^/(5CWGJB>SX9Q;MQPERG MT\M==TL/(&B_*EA2#DXUJK,O@4(/FF&B.??1=GY#]D]N(*4F$XKI=4D3#\4- M=3M\Y#*]72XVP$%&V[=W+F]$>U4B>5"QB%?K$?$1"8(#N2T7336Z-LSB1F5B M6&KRUDAR4H-CPZ4S+^\M:@O.J5,,[\%K1OGF1L=1QTO-<*0'T4(B3L^(1I+L MA5L7Q2,!AYU=V6X'&':+ YRIH;FA?4SH5&D)1>F:[H4]GWT57_$[WEKIG>:8 MMA0,BE[;.C'9<&:/=@NAK[QA*X_T7U[ P07SL V++>0[CI!F$ANVPJ90T'A! MLJ'?+V'HWYK )YKH&G<@.SZP,SUNU(]ZA\'I8+1[R@#ZT1D7/NT-$A:.7)FR M^/$9%S_N*4<7S^-&*A6ABBS"1WUZ^S;,3C!WY47K!4C18<52M*;HXJ_8?B<" MUP&VL1VZQ%?,MC#!;GOVYKT0I]0R_O4E?N]43E#S3G=4\>G6%,AY'^<72&"K M>U&5MM%<%P-@]A(,?GB#9,N^:MALYC@ MA_>2&_CN#?P;=7582SY=PVM<,5.-:NU&*:>Y$[,R[H3@W"/.Q)]@0GVRX&P, M'C??56:>P1U!_[%H9(O"@#M(( M-"A51E'K86KL> HVH>:"E44G)GVZMET:*/)QDI!%+N/D4TN)I%$.B MOVTM].?5R=.5AI.*I>&X3FFHI%YVM7F7?20K2AW2$)D8O>S@JJOTJJ=0J!16 MIAX*C>6Q$I,WJD4<#I_N59]6?-4G=5[U?NI5+U6(4AS:O7"5YWUDD7;\.G>]5G%=WUZGNARQ*LUP#->VXZ' ML>)NQ]$0%K>3[ >>E^&N,/K+AJWWI%S/3@_!*H,RX>O# 21Q+F'L^C] MFVDOX=-!7J_;.4R,'.X%>>?_O^ATC;O>AV0%6YQ#)L)X F M]J3O"/'P2TM"7Y 8ZAD%!!*=>R)HS:ZT!_B*!=X-I@DYNH3[-SWI*\6UA!]$ M/Z^)3W0['#RIVUN40[#P^WOB]#B&DH)7A+,4NR[0O@&:DN1VI&$[&4P$_8TJX:A:;4!$-[OW60([)D M1(?E^V:R0!9[)YMEQ@)<@0AG9;]X8W]S;#>Y1'NJQJ,GC\B44-1K+XB!EK-[ M&,(X]IQ:465[I,B 9SJD0+?CH[%\*&V*SS14"JP9ZT(#!X?R\M?EW@:H,CZ^ M?"4!!$-"%H039F:&DGQ,&VO8_=Q#![7 M62#_)B]V<+;%C@\62]]:@7=YL8JB:J"=4A/2+E 4JB*8ZO/EY3*'N:HMNI0%5()37%^)(TQ:35%,W1 M%%6#=I6Z4+N^IDC%&@S+U6Q5KREFH\9JBC)9TOR:(JDT);.F*)*'J413))1X MQ&J*?@,UQ:A_09IBI+2:HH"FJ%:>UP28+Y>-+1(+01GP1RC1N9]:32I-2[CZ M^=*G1R1U@31JLHT5?\TQZ5KOQ1D$57S^S0FE>B^^2> M[\)>#]D%Y;XI3,4"2,M'V]%=8NTSJ&A"X)\_WWR\L;L!&CQ[XSW:<78N4HME MV<6S))<_[%6WLP3[1G/6+)NVT*A$<9GQY/^)?QRH8VVQZ\866QG07A[$-,%* M,I8FTG!C@%@U75'&_F";#]C,9 .&_,+8:"8FZ6C-"=T;RM$ET6%)\(<;TUB@ M :O+".H*4FJ/*QL>#?N5= .%]WQ+@:SP2#@I Q[(2X=YU3A-%-.L,?R2[T+L M*6T7KD>("<]!RPX_!\I$?!,_M"98PVY8-(5'R]M-FGG;:(YW$99)\?LW*'#_ M:NNQ()*IXC0-UAB J7F793L]XC!\,_Y)%BUC&,X$H='!10BG.VV:+-[[.^9K M#<] 9CI\-_LV4M8%[J3)7NQZ>.1A(KEZW;#DH2^:,]APVX;[P'4+MIY SVF*!/=^H3+!!G '/ MB-Q]2 8+R4OS7(POX:$:6J&VBWV)W 5(N5 ;#'>[AGW2OD@N;,]8&@L-62_F M;<]=0J0O-C"H\J('9@)< \&IR/T"1;% $!WLVSO2'P0X>6-NX=.@ '["!S>. MO31 ' +A$/JFW=>% N"_-*CHAP_U1H95BJN3P(;3%FS(P(;3%FS8X+:QX,5FY +N,3\>AYB[^[&ZT MA?@Y-\7YC5Y@X^J-"XPA_BLT=[3_R[/]"1#L!=/TY\>/BC@^!H)>C(->UVF] ML-ER&$]G6=4C#B:Z0<+!CBW[T=$VS][\ RQ["8UL/1(*.M*7N\Q"YV HIR_S M2--U." $?=*1 Z=>4BSE8KNSAZ>MGI=RU2Z@6:=6[8$=FZ1U.GJU9Y7UK/IG MIU<]H^&HC?)(<)]( M"(9MRH@R_$D[ZC 7^>.<&I!W7^4<;7N<33#F]5J%O! M[: QCH;_R.-_!UO)-CT^<5KZP5"4M,'OR9GT8?&>/-_( P&#.F&.R6@VD-7I M815?IB/./#.^T?0=U4G?B3J5E>%AFN\)T7=<*_^.1_)T?-A8IUKZGF!@O$+] M_7<\+'\QT M9G+-#KMP73*Y9G62:R#W^[60JPGSNJF<".=:GL(42672K_5^*?*@?U@;D'=7 MA2[@=1];B=ZE&8YM*$^4=#.^/;;FPJF$2'O?A.<&QUF72-T*F3 F-9 M/)&SJS@ <.SL3FK#/96SJS@:<>SL M3FK(O3A-6"X'1YR-CPZ2 =5[ +4&:$:SD3P=JD_)OY$,:GW^F$/FW#"+/?_D#D?(7DVQJ MEWAY*3OFU>V#5G(2Z4#(G!2+PNX*7I^/CKU^Q[#>L$->!0B.*KM4['/T2GWX MZ3D:2 SP9)W=)X^LW2^VA2MR;-.D4&M6#75<+BG]J3Q6#EMDG(-'*R!_B;#( M6'38G>-"R5\BQ' >[E?1D$JW?9NB=<^)B$EQ<\M@%$YT]D<\YX$\ M&*0;9GF#&N@UKE33S[,91PV<][#$ILQZQRQW#>,%%\ L OZ+Z2 M*&2*8RE07MSW-)65A>3B6B7>/9\3IZ YMF3.-,2601V-9+PU@-Y MT"]8[MJX@/^T1, _C5+*%,33[%HR4],2X?%42DV&\JBZH-VYD[BG2FBD'%B) M0'KJ@2GRK"$YUZJH5<*12Z760)X6;<#03&K-2C@\67CKRK'[3RMT/ROA%Z5: M(\.9/!H]*>SGJ4ZM1,(E_=3ZLC)^4N&'4YU:B>Q(JF >*_)D=GD1[!:FGY5Y M2F14TIAG.!W*DPQ=?*[HRI_@P&KT\X=#51X,VP.K]L!J##<,ABC>+A^@_^8W MV]8?#=.\F,!BN\2SAV+EC3VS-BC3]*!, M%KM'?5IQV&8'9=H#N["@3/J!3=5TOZ)IPOD@)/.>;!P@ )_:>R$!A7:);5BF MH M=I@M"^*XD-@F>S6JIVSX'N4JHO(SD4C.U>+H0G7&"^MHW7AL(T&-*:6,[-Q-LU00-.>6IY3*X$QSGAJ$UF=7MZSM+]]I&YS*+7WX MN2&6;GA;I^UX^<26V,9Z!/!JTK>Z:%8&JXER'\FQREAD-;7RJZ?&I M2FRUB3R9M 5&C8E>57*F4SC3=JY+8V);E9PIR%+UO C3EQZV[7KSZT:\; D4 M8C:\],-8$U?Z0AZE;_9:LV3V"UGZ3AQC^5I::\Z] 4_O1U_VKRT8_LM=\+[- M&['#+]LU?'7!?EZP5FP:V[)N/,""NIU?7^)_[?^X]W&)_T#T6SBL?WYG [:_ MD8WMH,_QWG 7INUN'?(#UO76M!=_W2SZ_\0O_1,[W1K-W__-=452:O7"07&,S%!^TD!X.N+GR Z-(C<8BDN<#7IFD_NJ^DS\;&)<%;;J3D"S** MM"KX].5CKBORSK9PH:S-WC?#_>N.K5R[)XI_*6[4T*W8 /UQANW!E?CEM?1> M>S!TU[:R+W[0G,7#X4G?D=59?&'R9-?>O0&UR\?SB,/)@7D MP;A.>: T6AZ,FL*5KW->I_$Y%JX0S9JS]$+R8-P_BSPXS*9=A#S(?:6G]5SI'S$W6:/= M1R0-;B(L0<-KB?V4'6+N),-B5_H/. ;X_7'+OC-#E]JS0.' M3P/9D,)!RCDX*&5-9_$W4M9T%C3&9;(.*A2 M>MDNU?^YN9$^&L347TEWL%XPN?_0GQAC%G$(IP[Z-&HU_K^MY@#OF+N/AJ59"T,S/UGLXL-= M.=08<)L)7.<-PA&<+=F7 ]F>5H_6^74.AGR/'526?_IK[7:^$7=K@G:"0P\& M)DC/_["TK8XJZ<6O+^=OZC$ ^"\-"\<+P(=Z(\-*#"J6<1%R'K;*O83+!J) ,,!,G3YEN3;115 GQ@*XY,^G=PO$YPO'9PO+ #^A7OT99VX#^X M8)#H\,7W9$'6<^)( X5J%/55522X^&[JWP*?U?GNVGJ-D+ING/C\]E%T T97YC3.ZE*(J!O7-NFWKZBX_D MVH"&*]-Q/9=:FO#W+U*HQ785L.7ZDN,[* A MA(_)G;^M^ :>BI MH^1DE$G+*"VC9&$4I?]2:3FEY90,G**^'#2=5>K&G'+/ M83C]A6WFYI'\__;>M#EQ)&L4_NX(_P?=>N\\3]4S&".Q5_=4!,:XBFX;>\#5 M/?W>N#$A4&+4)21:BVWFU]]S,E,+(#:!0 )U=7>Q""GS[%N>@X#%Y8%[HRTN M+]RRZA!;Z&'4=.$4!O=,_K::.KW+-JIE\]R=OX73Q.J^6C/)X*OB5A'I+GDE MX'SZ_ M*T8=$'@* )8*A9@IN)Z3I/6'MG<#\$'.9X=K@Z^F85G"Q#2&JAWW*>,8A3W= MQA/=Q7)DEFLYL9",<[+[@MDN\GLCF)6*N7(Y(OTG%&:[B.2-8 8F7*V2C"/$ M^X'9;E)V,YC5XZ*S0P\*7VYUJW3T>HJE+&S"'S._ I<%@%B-;ZD @LJEC M]P4L!A:LD6PF2KQ*6^&NQ??R1,P>[H3N<-FA.KB(;M<"9.:K)RQL#P7#D)+? M-,.P?@P8%D[)49@3Q >#82PFP''[(82;Q+>JYM J\*4R_%3/8^]32W H;J8G MUD<*LW/U1])4V^!1/*M>.0? XQZUY39X+&2]2_:)Q[UJ[*WP>-P>1_OH;;'7 M-A9[K)0NS55*;W( ;NOZYV4'Z7:L6,[*BX]77GSXRN(D%A6?8SWQ<>@FEIKH MO55M';A@JW1=O,9F%CO4:26CFB^CACU00S6CAHP:/ B)!:P.S\@A(P=&#JRP M-XGTD+AZWC35[DH%,=["O%HI5ZQ&C)6?1N6C%"N I4(A5XB:6#P- !?CI> J M2(92Q!&;IP'@4LSE_;5[FV#?J!:P*N7*E5AFSQX-9KO( MZLU@5CNQZK'=Q.]&,*N4*I[;ST'6ZB:G)W4VB;EJ3 M6\N)"9D6GP29NB'42N!D;#"R,4U0VT6J;DIKY9R4R=4H'!K2 ?K8DG7>1$UF MX>V<#-VV>V74A0+$0\")Q0*.XT&6('CC[! M MPS+K;=LV;8O"P,*"D;8[5?3.Y5.VV#R7)6.+U?3.Y50VY3JKG!G.P,DT?3 MTEM)U_5^^2&*;A=K8]=6R^ZM3G>'KM]=HN$(AB?9M*?/IJQ;#(36JF$1:WKP M;G'+'?M#TY9@4F&+5M]\;0)=G!!<'4(OKM;>L;7QCH(]MY=W-,S' IT[TQ@+ M-OQ$L WZ]\P,(+IG9&U+>%/M$7YU>=&AX) UH:L.-2(T+,L8J Q$'W'4B%3X MJ=-MT%?B3Y]HBV_+&--N_JI-$VAC@]\!IT3("K7"+6PHCG!X56V56'DA,,!$ MF,BJ0M<%-Q;^]QIQ.#,X[*J\94HS%#.-,?@"MO4X#'SF20$4&H3@@1( MM&E>>-2)V\]^?HS.K6K"=08.PM(L0["(^8JCY)1FSBP)B-!G"AZHJCWL@P<-B2.UGL#OWW.;G4Z]VY@BG'YAWQ MN65 %@H\T)P*(.\4G%3F2;5EH@CNM985:L=GA<4#;IO+HOKQE[]H8FXCB\3" M\7>P0IK.#$WR11&=EK&++ J5/D"O&TYCBE<^[6 RWY,767N0;1N\D(:N-.F7 M+T0?@,6PM;&\T#H<&OA@FH.(S590JU[U@U"O.P!8T3K)3 >GVA5(%B+,QR,2!.H$+_8_Y M,NDN=?("",!I9I%7FA=:,@ $X*6 B>)8%KB: "O;,76A3S3C+>_5MR?> MN% MC8J1V"@FTVT&F_0*4+4&&_[T&12E0DQ-U0G8> %:>N*T=._1TKU'-,*^D)@8 M?)4BX:L8#[[0T.!B1, !IK YG/+9-UX),-.KH5%'ATD=ZM@K\EA^0?5D\N@. M2 K .$@-\D(4D#PHXZ@=XXD(Q:&Q!A1P"K'@^2@!KN%>L%YG"!82^!8S @VV M2<:6,,1(A2R@7:0.P5)0 30*'SX\ : A[5Q>J/J?#ACQ7'3V910#: VME%4@ M3ZE,8S(59#,X FKPBEQ 0N7<]>(<1;@<'@\"&DQ!>YH/LV\6B6O%L,MJ(1MV M28==5@O9L,LUNTS6L,N]"<1R)(%8BC_V #\'**-81(-"):]TS+EL4\N.2CR9 MA[-5ZGY9:"Y9A,U;=O0AAB.(DO-_XTHP]XJ #,6ON72-6^=B66$C M=]U[PX76R' TY?*B3P3=$,!+!"&.DO$%3$C+#IJC:0A*[4)1E4@453ZR2?3@ MV"[WX!HVN.0L6%X4F%OFDXZ/+UI\* M^OC(ZT%6U5'2 /;1#*-?NYSKL7Y +)BP&/![P&SI.Q@-NKQ :6 2\!^I?;275%,!96JR3 VG MRFC9H*[C2,6D 0ZS7ZS\)'U7VC)9ERXIA"=]U%?]Z(._J M0-;A5?CS;L!^5F C;7W@/C8_]]R&\P+[8)%2IF"%[_E>_O+B5N7F.EN*.U+8 M^QAV^B!;%MCJ0,JV;=%%LE52],,A[)F1%X@+,0-^F# QUTC(NL/P_PA M,'#UG(D)-D1@K2WP//"MCFZ&=S6R+UQI ?<#9TZ(KM"!R_Z^A27;AO4"C>D! ML,#>W-O^1._[47U=V'W7&(SH+Z,C*&S[EQ=K]_]@Z*81 P2"!. OX]1MG7HD M>5.+UWK60'%1&;&1\+F\F)<^>1HP]0@-)0TEC\@*&]6AY6I 4$=C ]4>U;V@ MI?07^ RHB24(!X;%QI:/B8*UPJ"^35!A$_"VP1_%90 ]FPC:*4V_P*?P\XG3 MA^^%$9$UV)[_.5[/X[?\,U2&;T33\.\)YHXP6,*7E@=^$[!M'8^CZHYJR>@& MRWU@)NJ*\& $QCUT%F@QT3D98OC#8A8&*/W!2 ;L!]R*7-!ZP#?F#T*3I[A MSY) :IS0K!4NE-L$KV G& [H="]^S0/0-%C#S(DYH+(P=3"*XC*RZ^0,W;", M#SMWL_[/[-F5X5*]A2-T_+O3TFJ&'3"OR80")E!IPA:,AIB@&+ UW7!7/AMB MHL$DC&D%/P2F515'UEC*GPVVGS68P-XQ!6XXH>LXF[S[;\O;[)D$I3$-&T$L MU>,12XTAZCE9T)! 1,#HCA@J M@GX+M/&6I&DH;*'8LWH(27&FJ84P5+@5X M_.+H1!#+F-XIU /TA+]!>P1?7(%E1^2(WZMP0()!D/2*:PAX(/Y&J.2Q?$ID659I,/JO#(5(Z2EGX:0^\!%AM V2, O?RI'B.A7T] MS@<9B1%?ZXV83+C-?NW=$1AW8EA,N+'R+RXT_(YFECR0*2/?<#P VDN389I/0;.GPLB$XITW,5FH9"!(1G]:=BZ4J4 MKHI7HM G QDL07DR 6E/0Z \\(4F LA(Y"9&(P%Z8D: +/QI("DP2J(T]Z>C MO%"%R&L?)AK0!U/EN$ 3875YH8XQ%0D6" VT+"R)UB-:S%/V^(GZS*^@-MR@ M&7X($KTQF8!VM_Z;%IA8N(Z1H2GN;Y],PR:L) 6NO9??AHZ&1 RVPH#0$&$# MO>G& VCY3!@^=U3)_&(N?^8DO^/.EPYL;DS4T<)+U9"):S.Y.KE!4CNJ4ZWZL:3R;S13B]G<-#4 M(8U7H^T' &#,RB^G(9^YZVF)TCSP/*4$^LH!/B \[M4'_3G$SUT%S'F6P8"R M. M H8$,$+'X2E2PL0:>/1;8[N5%8+\>5N!?7[S\]T82)1'L&,J4JS*+8I99 M9)E%,J0$%;-1F,I,TNO+2[=51#>8MS 7B#>P#0=54NN M1=@Q,$KA&V:XASO2-^EC1/:8/ #2,R4'V&SI2J87<]W!8.7NC%:I),94JG3CF@<\D.1:/?/F.76A!^@\$AM]>$[92#H>7AD-4,S> M+E V)1/W$B-H&HH%EZJ>0_P"EP6QT,GD3K@N/,C KD7FPX-E*0^'JCFF+*5: M8_@%/F.XN,) !,RKF<*R(]9(8("QF1B2-S0 M.GI*W.$-]UK3'PDD=#>('1:AH2),DQ]>,DIVBU,6),Q3&WCNEZT7^Q>3\"B_XQW[3(#LKD M?,&F8KY$IH(=R[YYB1-W7)<1I@F^'^(8?T>SB/QW*AZ<>3$P/7 Z%39BM!(; M,:X:FXU+ YA'(JQ+0 =2@SS 0C/))HU7T'L;[(B!C.NVL&5QP)#,@?5K87X9 M$\I7K%QX27V-NQY6S..2J5M"YYT19#%J67E%M87Y(4R7$18^P1)!S:\V]N\4 MK"Y>R'XY.D(/&,%4!R,TB+VEF&!QJS;5GH',(AC83UY0'>,B\(J6(?'4G&\; M!.*JH5E!3SU[&4+Z% NSE2Z4?+# 7M_DJ7?WJ?!#-]YX>LQRS315XT PT?09 MT%!KL+J(GC5A:,L);[2BB-Z+5DA:#,F<8@3%=%XP&VL3S5L&RO&!J8))A09= MX#BY#Q*6_%U,F-)THJ$3&QT&-P%[ZO(_6GV2.%.@%+)!=RS$EC+S,:C%)6HE MH[@/,2I8_+^+84%1^MC_]+'RR75D@8"X(6KUY1G6>1#OR7.K@_W"3*R?)R 8O[IW!6WTKHXQ13B0@B_+"63F/+>'X% X@6[!,@=J88*:&1N& MG:-XP!))L%/_!/$]('3YCP/;\(U/]\"?G]U<&J9PX<4,WA$\QD_@NC'PRPLW M"'Y*EDFT6B6Q%IOL"52PS9S:G*T0#-2HN4AU3RH-Y D[,P4 VT=UX6Y%A)30 M@71P9 7/29#+:%6!X>O6&)57L5RP3O#[L+A*ZNM!K!:6,9@ MHH0+A^=2NS%I"PIQ))"4I84.EI2:*]=!*)5FHF[ MEII]^!(L>H)KP"("&0V&I,*% *[$#3UM4[Y,$^G[*U].C/J7HM4U284#J'\Q M3/U[)?*1#( H!?8"V@";F@!+ZNBY+Y$9 ?-&P//LJZAF6I MKM@'QASGA*[S@JP<=/.L@ Z9.X8I"Y:F3IB30-OQR />^*(_Q5XXZFJ:^R[JH5=I#J&R@N M:Z3B:?1@:0I+STB!/AA" .Z0D)H ]&>&^&:RC !Z 9L=B"V09^(RR? M(ZB:DO$XA>PV8 %W_)45/+ '!&%@Y:K #%89ESQDLV#QR M0ODR#T8#&!!]9%J!1P)0[[DJECTT3^V[7PP\0C''V-RL:QKYW%Q^:LW91<", MCK;/P*$A4C>@6 IP%=;6&A.BX6OOL9<7L\_E%EAHBFS-$A"3OV MQS2X JGJ MAFD#SZCW(%+AMQBFYKV( M5/>PX4+V\)1D7+1B&"FF8IB-#;">,Q[++$/=1%< T'8;*&IJO0,9Z+*;3N+] MT"XO_(9HC<' =(#YSN/TH!2M2$6*J4CE:>Z0[KS+"4+&DO$@H732EY)U _K8)V(&>@##=I]E+&AHN[!H\HT\Z@VZ;IR 92UO%;RB4?#$/42=PRXQ M" @/D6/Y71T[8PH):AT=!@(-=P$("MCZZDVWWGF4"+B.BCP+!P_X>7;KT?2: MZ-""C>50$A<' 04Z0N,3,:^#!#%A1HW+:W@^D4=>V!FB,6VYVB?!5CQ^ZQW: MCV<\LZAPC>6U>B_S["H\TJ MGLZ@G2A)PLV&=L7]62I6<<+A<"= MF*!'P0Y$6$0#VS(@3TRC3U'%8UR.KJD_T+*C-0V!CMR!K,U#X9GV'K1"#P]AH;E_!W= MT[IZ\'+_P)5[9Z^,E(I9%BT8.)IL"C1DN8? 7<)5;+1:*2FFQDY/X58]X&4Z M]AJ:4@/_;41T]!-,8V*J- 6H#M%A8L$)^BW]*B&9/@S]'GWA,1WXCIYW8U3CD1H55'U.;G@;^.6+BF7^ M%"DG+AB*T:HHBC%UAWE"=YWV5:"9&(6P!D-+@@"L^/CR@O(UC74,93;,9JX5 M,A[;X+DM^MX]QQCH]CXQ;):^#SR%O$_HJ*H35W !W!?MMKQP M0VBTE=G??J*S1P([BG+QU]*+^"LJ:V$[/GF2"RIQ-L) #%<*EJC0CKNL0&@O@GDT^8 MZ*/EV(LQ]8O!0!V G2$I%T21:LU@B:*4-A9DB$8*9\=AW"0F/R"_J%_]N)M) MN,W#:0A[$Y$WQBM@SFMHF %QZE<#QS11:[K/HNZNYW)JP>%"M(OA.P8NV;$D M_"6]H=>V#)0>G@7HXS$B #+&1&P_GS1TW*D-J!R)'AHZ=%ULD[CK]&_@\1N8 MD,OV[AJ)%G:-8A% F>8*\3MV\Y\P[:/F"6]-.HL)3QPMV8K[,5F.:0*QB0TS@B U^!3 HLI4"_&VV:'2 MW#=ED+@"A^-5/8P!F!#7N44I"XJAH0OC1^O=H^TJ[_S%Q@60D"N\KWD[),.F M32Q6QW[%74:C8IS71_.4)ZQZ-'+ZFZSA?+6E(=N\N")F:R],RX+_8_=20N.W M-IW((NNT\>; RXIYN/+BW\%Q+GX T(WQNB4>M# $)9PP-Z7A(X:S347#0D(W M+8/>LSHR##S!Y!,*X3J;/*>[>%_Z&0BPX_0 M,AU\G^W:F^Q5QD0 MJRGLPJTLY](CM@TKZM#RW] )[Q-0X\"O"]SZB7=0H%ZVDA<:E$>VG')'RRD\ MBYD-+J$=7&Q?[<]4%*^'D(3=,?<$(S\UI48%TD:TP=NDXHB$-7N3CK6WQ:&K MGX3 ##^.PMG*/%H+M#C8$/TIG!RX;J_%8^UU<3[NIV"?:H]>60J=)OO]DF\Z M&HV/].%5]5BA:*GXTSXAX+X1H +NR;X9 AXN]6[ISE0/E"^IV/_<[UWHE3#- MEW_1SUBIX^D;G='*?(HQE?GX"@&DWGH1-6MTM3MW2991EQ>ND%JIO_@\VR5J M0%P[['0#Z1<-;%BI, \R"J3'X3WGNBW%7KB^\KO58VVA=P(&&7R-G"L=2\Y) M:VAA)I2UR4[*2=I)B'8Z=:D8K2JN&&_K)CJ_?!.I6#D]J;BA5;_7K>_9L%\I MUPMKY?HFIEZT[>\FV$-L/ ^G2R6[L)U@/R)!;R7:-W&JJLEBS@7A?AS9OG6M M5"FKE6*U4J6L5NIHM5(':C47J'[E0=YM M2KJWB^KS3*-WM(2?+'FB&<866\FJP/ZB9O4"^ZK.8X*1 19C-F/7?2^JJI[R+5I%:C*DB=9%] MWPAFU3X+.M*J1K.IAJ9= >F^T6Y_0U9$LXA''%QCOKIS^;"C2#B^78)S>T

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�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